Development of flexible methacrylate-based packaging materials towards an implantable optical glucose sensor by Van de Walle, Elke
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Faculty of Science  
Department of Organic and Macromolecular Chemistry 
 
 
Development of flexible methacrylate-based packaging 
materials towards an implantable optical glucose sensor 
Elke Van De Walle 
 
 
 
Thesis submitted as fulfillment of the requirements for 
 the degree of Doctor of Science: Chemistry 
 
2016 
 
 
Promotors: 
Prof. Dr. P. Dubruel 
Prof. Dr. S. Van Vlierberghe 
Prof. Dr. M. Cornelissen 
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ISBN: 
 
Picture on front cover: confocal image of HUVECs (Human umbilical vascular endothelial 
cells) grown on top of a polydopamine (PDA) modified and VEGF/VE-cad AB biofunctionalized 
PLMA material. On the back cover, a PDA cluster is shown which was deposited on a PLMA 
surface. 
 3 
 
 
Promotors: 
Prof. Dr. P. Dubruel 
Prof. Dr. S. Van Vlierberghe 
Prof. Dr. M. Cornelissen 
 
Examencommissie: 
 Prof. Dr. Du Prez, UGent (chairman) 
Prof. Dr. Hoogenboom, UGent  
Prof. Dr. Vlaminck, UGent 
Prof. Dr. De Vos, UAntwerpen 
Prof. Dr. De Vos, UGent 
Prof. Dr. Demoustier, UCL, Louvain-la-Neuve 
Dr. Ronny Bockstaele, UGent 
Prof. Dr. Cornelissen, UGent (promotor) 
Prof. Dr. Van Vlierberghe, UGent (promotor) 
Prof. Dr. Dubruel, UGent (promotor) 
 
 
Universiteit Gent 
Faculteit Wetenschappen 
 
Vakgroep Organische en Macromoleculaire Chemie 
Krijgslaan 281- S4, B-9000 Gent, België 
 
 
 
 
 
Dit werk kwam tot stand in het kader van het IWT-
SBO GlucoSens project van het IWT-Vlaanderen 
 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
 
                                                  Dankwoord 
 
De laatste zes jaar ben ik op ontdekkingsreis gegaan in een wetenschappelijke wereld die me 
heel wat kennis maar vooral heel wat unieke ontmoetingen geboden heeft. Ontmoetingen 
die elk hun eigen steentje hebben bijgedragen aan dit proefwerk. Graag wil ik aan elk van 
hen een welgemeende dankjewel uiten. 
Deze tocht begon in de zomer van 2009 dankzij Prof. Peter Dubruel  die me het project 
GlucoSens toevertrouwde en me dus de unieke kans gaf om m’n wetenschappelijke knobbel 
verder te ontwikkelen. Naast Prof. Dr. Dubruel wil ik ook Prof. Dr. Sandra Van Vlierberghe 
bedanken voor de dagdagelijkse begeleiding. Zij zette steeds weer de puntjes op de i en 
zorgde ervoor dat er op moeilijkere momenten knopen werden doorgehakt. Ook een 
dankjewel aan alle juryleden van m’n examencommissie voor de waardevolle feedback op 
dit doctoraat. 
Tijdens de eerste vier jaar kreeg ik ook een metgezel mee. Samen trotseerden we de 
uitdagingen binnen het project. Daar waar ik PMMA onder de loep nam, was PDMS haar 
stokpaardje. Ik wil Valérie dan ook bedanken voor de leuke samenwerking en de soms late 
maar gezellige uurtjes die we samen naast de ‘donuts’ doorbrachten. Ook Ronny Bockstaele 
en zijn voorganger, Geert Morren wil ik uitgebreid bedanken, want door hun rol als 
projectleider bleef het overzicht behouden, wat soms niet gemakkelijk was in dit multi-
disciplinair onderzoek, GlucoSens.  
 
Prof. Ria Cornelissen mag ook zeker niet ontbreken in dit plaatje. Dankzij haar konden we 
ons uitleven in de in vitro en in vivo wereld. Verder stond ze ook steeds klaar voor een 
wetenschappelijke discussie of een extra woordje uitleg. Uiteraard heb ik deze testen niet 
allemaal zelf gedaan. Een oprechte dank wil ik dan ook geven aan Karolien Gellynck, Heidi 
Declercq, Johanna Aernoudt en Greet De Smet. Ook na het aflopen van het project stonden 
zij paraat om  live/dead en MTT assays uit te voeren, alsook om mezelf te introduceren in de 
wondere wereld van cellen, laminaire flows en fluorescentie microscopie. Ook Lise De Moor 
wil ik bedanken voor de in vivo evaluatie van de materialen in ratten. 
Later in dit doctoraatswerk kwam Prof. Winnok De Vos op ons pad en dit zorgde ervoor dat 
dit werk uitgebreid kon worden met immuno-assays. Graag wil ik Prof De Vos bedanken om 
me toe te laten zelf met de confocale fluorescentiemicroscoop te werken, alsook voor zijn 
grote toewijding om de optimale R-code te vinden om beeldanalyse mogelijk te maken. Een 
speciaal woordje van dank wil ik hier ook schenken aan Ine Van Nieuwenhove. Ondanks het 
feit dat ze het zelf druk had met haar eigen doctoraat, was het haar nooit te veel me bij te 
staan tijdens de immuno-assay experimenten. Bedankt hiervoor! 
Naast ratten hebben we ook geiten getrotseerd. In deze context wil ik dan ook Prof. Lieven 
Vlaminck bedanken om deze in vivo studies mogelijk te maken, alsook om me als publiek toe 
te laten tijdens de operaties. Dit was een zeer leerrijke ervaring. 
 6 
 
Voor de karakterisatie van de materialen wil ik graag Eva Ryckeboer (NIR metingen), Maaike 
Op de Beeck (hermiticiteitstesten), David Schaubroeck (SEM metingen), Ken Kersemans 
(radiolabeling experimenten), Heidi Ottevaere (profilometrie) en Prof. Joris Delanghe 
bedanken. Zij ontvingen mij en m’n staaltjes steeds met een glimlach en lieten me steeds 
gaan met een verzadiging aan wetenschappelijke informatie. Ook een speciale dank aan de 
‘PBM-girls’ Els Vanderleyden, Valérie Kodeck, Diana Giol en Lara Misseeuw voor de XPS 
metingen, die vaak ook tijdens het weekend uitgevoerd werden. Bedankt ook Veerle! Jij was 
er altijd voor elk toestel gerelateerd probleem, maar ook voor een gezellige babbel en zoveel 
meer. 
 
Marc en Mario mogen ook zeker niet in dit lijstje ontbreken. Graag wil ik hen bedanken voor 
de vele uren die ze besteed hebben in de ontwikkeling en het maken van de mallen. Zonder 
hun technische kennis en handigheid waren er geen donuts en dus ook geen in vivo 
experimenten mogelijk. 
Ook m’n thesisstudenten Arn Mignon, Stéfanie Allyn en Jens Mincke wil ik bedanken voor de 
bijdragen die ze leverden in dit werk.  
Uiteraard wil ik ook m’n PBM collega’s bedanken. Werken bij PBM heeft me heel wat 
collega’s bezorgd, maar belangrijker, ook heel wat vrienden. Els, Thomas, Miriam and 
Vincent, thank you for the beautiful moments and pleasant evenings! Diana M., Diana Giol, 
Olga and Mamoni, thank you for the nice girls nights and your friendship. Jasper, Lara, Geert-
Jan, Mieke, Tim VG, Kenny, Arne, Tim and Stijn, thank you for all the laughs and beautiful 
moments in the lab. Birgit and Ine wil ik verder ook bedanken voor alle leuke lunch babbels 
en de vriendschap. To all PBM-members, thanks for being you! 
Leen, Pieter, Paul, Tom, Piet, Isabel, Tom, Michael, ook een dikke dankuwel voor de fijne 
practicareeksen die we samen beleefd hebben! Ook m’n huidige collega’s van VKC-Centexbel 
wil ik bedanken voor de steun en interesse en verder wil ook Elien, Eske, Jente en Bram 
bedanken voor de leuke studietijd samen en het gedeelde doctoraatsleed en plezier! 
  
Op ontdekkingstocht zijn is fantastisch en leerrijk, maar kunnen thuiskomen en weten dat er 
mensen achter je staan die je steunen door dik en dun, is een nog veel groter geschenk. Ik 
wil dan ook mijn ouders, Marc en Marianne bedanken dat zij deze ontdekkingsreis voor mij 
mogelijk gemaakt hebben, alsook voor hun steun en raad! Op hen, alsook op m’n zus Karlijn, 
kan ik echt altijd rekenen. Liefste Kenny, bedankt om me te steunen, me lief te hebben en 
me steeds opnieuw op te monteren tijdens de moeilijkere momenten, alsook om m’n 
persoonlijke IT-expert te zijn. Deze wetenschappelijke ontdekkingsreis is nu misschien 
afgelopen, maar ik hoop dat onze reis samen voor altijd mag blijven duren… 
 
                                                                                                                  Elke Van De Walle 
         17 July 2016, Gent  
 
 
 7 
 
                                     Table of contents 
 
Dankwoord                                                  5 
Table of contents            7 
List of abbreviations          13 
1. Introduction : Diabetes and its management      17 
1.1. Introduction into diabetes       18 
1.2. Problem statement: the need for continuous glucose monitoring  
(CGM)                                                                                                                      20 
1.3. Glucose sensors        22 
1.3.1. Electrochemical sensors         23 
1.3.2. Optical sensors        26 
1.3.2.1. IR absorption spectroscopy     26 
1.3.2.2. Fluorescence spectroscopy     28 
1.3.2.3. Alternative optically based sensors    28 
1.4. The role of polymers in glucose sensing applications    29 
1.4.1. Mass transport limiting membranes     29 
1.4.2. Polymers used as immobilization matrix    30 
1.4.3. Glucose sensitive polymers      31 
1.4.3.1. Polymers used for glucose recognition, as an alternative to 
enzymes        31 
1.4.3.2. Glucose responsive hydrogels     32 
1.4.4. Polymers used for the enhancement of electron transfer  37 
1.4.4.1. Conducting polymers      38 
1.4.4.2. Redox polymers       40 
1.4.4.3. Composite materials      43 
1.4.5. Improvement of biocompatibility for in vivo applications  45 
1.4.6. Conclusion        49 
1.5. Research goals and thesis outline      50 
1.6. References         52 
 
2. Development of a flexible PMMA-based packaging for an optical glucose sensor 67 
2.1. Introduction         68 
2.2. PMMA as biomedical material       69 
2.2.1. PMMA: a short history       69 
2.2.2. PMMA: production processes      70 
2.2.3. PMMA-based composites and copolymers    71 
 8 
 
2.3. UV-induced polymerization for the production of methacrylate-based 
 polymers         72 
2.4. Development of poly(ethylene glycol)-based materials   74 
2.4.1. Characterization of the starting compounds and the  
homopolymers                                                                                               75 
2.4.2. Development and evaluation of copolymers of MMA and 
 poly(ethylene glycol) monomethyl ether monomethacrylate              79 
2.4.3. Development and evaluation of copolymers of MMA and  
poly(ethylene glycol) dimethacrylate      82 
2.4.4. Development and evaluation of copolymers based on MMA,             
PEGMA and PEGDMA       85 
2.4.5. Influence of PBS buffer on the polymer mechanical properties 87 
2.4.6. Intermediate conclusion on the evaluation of the PEG-based  
materials as potential  packaging for an implantable glucose  
sensor                                                                                                         89 
2.5. Development and characterization of butyl- , ethylhexyl- and 
laurylmethacrylate- based polymers      90 
2.5.1. Characterization of the starting compounds BuMA, EHMA  
and LMA and evaluation of the developed homopolymers  91 
2.5.2. Development and characterization of P(MMA-co-EHMA)  92 
2.5.3. Development and characterization of P(MMA-co-LMA)  93 
2.6. Evaluation of the developed materials as packaging of glucose sensor 
electronics         97 
2.6.1. Evaluation of the polymer optical properties    98 
2.6.2. Evaluation of the polymers as hermetic barrier   99 
2.6.3. Preliminary cell tests: Cytotoxicity and cell interactivity of the     
developed materials       101 
2.7. Conclusion         103 
2.8. References                    104 
 
3. Surface activation and functionalization of methacrylate-based polymers             113 
3.1. Introduction                    114 
3.2. Plasma activation of the polymer surfaces     117 
3.3. Post-plasma grafting of 2-aminoethyl methacrylate    121 
3.4. Surface functionalization with polydopamine     124 
3.4.1. Background on polydopamine      124 
3.4.2. PDA immobilization protocols and characterization   130 
3.4.2.1. PMMA and PMMAPEG as substrate materials for PDA     
deposition       130 
3.4.2.2. PLMA as substrate material for PDA deposition  135 
3.5. Conclusion         138 
 9 
 
3.6. References         139 
 
4. Surface biofunctionalization to enhance the cell interactivity of methacrylate-             
based materials          145 
4.1. Introduction         146 
4.2. The enhancement of tissue integration via Gel B biofunctionalization 149 
4.2.1. Surface immobilization of bio-active biopolymers onto PDA-coated 
surfaces         149 
4.2.2. Immobilization of Gel B as biofunctional compound   150 
4.2.2.1. Surface characterization of the immobilized Gel B layer 150 
4.2.2.2. In vitro evaluation of the  Gel B modified samples  153 
4.2.2.3. Effect of substrate mechanical properties on cell response,       
using Gel B as a model      156 
4.3. The enhancement of vascularization via the immobilization of VEGF                
and VE-cad AB         160 
4.3.1. Immobilization of VEGF and VE-cad AB onto PDA-modified 
 surfaces                                                                                                          160 
4.3.1.1. Preliminary experiments to determine the required          
angiogenic factor concentration      160 
4.3.1.2. Characterization of the AB and VEGF functionalized  
surfaces                                                                                   162 
4.3.1.3. Stability study of the AB and VEGF functionalized surfaces    164 
4.3.1.4. In vitro evaluation of the biofunctionalized PDA-based         
surfaces        165 
4.3.2. Immobilization of VEGF and VE-cad AB onto AEMA-modified           
surfaces         171 
4.3.2.1. Immobilization strategy       172 
4.3.2.2. Characterization  of the AB and VEGF functionalized  
surfaces                                                                                             173 
4.3.2.3. Stability study of the AB and VEGF functionalized surfaces 175 
4.3.2.4. In vitro analysis of the angiogenic factor functionalized           
AEMA-based surfaces      177 
4.3.3. Study into the orientation of the immobilized antibodies  182 
4.4. Conclusion         184 
4.5. References         185 
 
5. In vivo evaluation of a biofunctionalized methacrylate-based packaging for an  
optical glucose sensor         191 
5.1. Introduction         192 
5.2. Development of a UV-transparent mold for the production of dummy and   
fiber-embedded donut-shaped implants     193 
 10 
 
5.3. Determination of the optimal implantation site: an exploratory in vivo  
study          195 
5.4. In vivo evaluation of the surface modified PMMAPEG-based packaging   
material          198 
5.4.1. In vivo biological experiments in goats     198 
5.4.2. In vivo biological experiments in rats     201 
5.4.2.1. Evaluation of inflammation and connective tissue capsule 
formation       202 
5.4.2.2. Evaluation of  capillary formation    204 
5.4.2.3. Evaluation of capillary formation in VE-cad AB  
functionalized 3D scaffolds: a proof of principle  205 
5.5. Evaluation of the applied sensor design     207 
5.5.1. In vivo glucose measurements via an optical fiber-based design 208 
5.5.1.1. Experimental set-up and in vivo optical measurements 208 
5.5.1.2. Visual evaluation of the explanted sensors   210 
5.5.2. In vivo glucose measurements via an embedded commercial  
microdialysis probe       211 
5.5.3. Further evaluation of the membrane-based sensor design  213 
5.5.3.1. Dummy membrane-containing sensors to evaluate the         
filtering effect of the applied membrane   213 
5.5.3.2. Evaluation of the explanted membranes: a diffusion       
experiment       215 
5.6. Conclusions and future perspectives      219 
5.7. References         220 
 
6. Experimental section         223 
6.1. Overview of applied techniques      224 
6.1.1. Nuclear Magnetic Resonance spectroscopy    224 
6.1.2. Tensile testing        225 
6.1.3. Swelling tests        226 
6.1.4. Static Contact Angle measurements     227 
6.1.5. X-ray Photo-electron Spectroscopy     227 
6.1.6. Scanning Electron Microscopy       228 
6.1.7. Profilometry measurements      229 
6.1.8. Atomic Force Microscopy       229 
6.1.9. Infrared spectroscopy       230 
6.1.10. Radiolabeling experiments      231 
6.1.11. Fluorescence microscopy      232 
6.2. Experimental methods        234 
6.2.1. Chapter 2: Development of a flexible PMMA-based packaging for an 
optical glucose sensor       234 
 11 
 
6.2.1.1. Production of PMMA and PEG-based copolymers  234 
6.2.1.2. Production of BuMA, EHMA and LMA-based copolymers 235 
6.2.1.3. Soxhlet extraction      235 
6.2.1.4. Gel Permeation Chromatography    236 
6.2.1.5. Tensile tests       236 
6.2.1.6. Swelling tests       236 
6.2.1.7. NIR optical measurements     237 
6.2.1.8. Hermeticity testing      237 
6.2.1.9. Cytotoxicity testing      237 
6.2.2. Chapter 3: Surface activation and functionalization of methacrylate- 
based polymers        238 
6.2.2.1. Plasma treatment      238 
6.2.2.2. Post-plasma grafting of AEMA     238 
6.2.2.3. Surface functionalization with polydopamine   239 
6.2.2.4. SCA measurements      239 
6.2.2.5. IR mapping       239 
6.2.2.6. XPS measurements      240 
6.2.2.7. AFM measurements      240 
6.2.2.8. SEM measurements      240 
6.2.2.9. Statistical analysis      240 
6.2.3. Chapter 4: Surface biofunctionalization to enhance the cell       
interactivity of methacrylate-based materials    240 
6.2.3.1. Immobilization of a Gel B Layer     240 
6.2.3.2. Immobilization of angiogenic factors onto PDA-modified     
surfaces        241 
6.2.3.3. Immobilization of angiogenic factors onto AEMA-modified 
surfaces        241 
6.2.3.4. SCA and XPS measurements     242 
6.2.3.5. Profilometry measurements     242 
6.2.3.6. Radiolabeling experiments     243 
6.2.3.7. Cell culture and cell seeding     243 
6.2.3.8. Live dead assay       244 
6.2.3.9. Immunolabeling assay      245 
6.2.3.10. Confocal image processing     245 
6.2.3.11. Statistical analysis      246 
6.2.4. Chapter 5: In vivo evaluation of a biofunctionalized methacrylate-      
based packaging for an optical glucose sensor    246 
6.2.4.1. Production of donut-shaped implants    246 
6.2.4.2. Goat implantation procedure     246 
6.2.4.3. Rat implantation procedure     248 
6.2.4.4. Histological analysis of the explanted samples   249 
 12 
 
6.2.4.5. SPE Gel electrophoresis      250 
6.2.4.6. Diffusion experiments      250 
6.2.4.7. Statistical analysis      250 
6.3. References         251 
 
7. Discussion and future perspectives                             253 
7.1. Discussion and future perspectives      254 
7.2. Future opportunities        260 
7.3. References         261 
 
8. Nederlandstalige samenvatting        263 
8.1. Inleiding         264 
8.2. Ontwikkeling van een methacrylaat-gebaseerd verpakkingsmateriaal 265 
8.3. Activatie van de polymeeroppervlakken     266 
8.4. Biofunctionalisatie van de verpakkingsmaterialen en hun in vitro            
evaluatie         268 
8.5. In vivo evaluatie van de methacrylaat-gebaseerde glucose sensor    
verpakkingen         270 
8.6. Conclusie         271 
8.7. Referenties         272 
 
 
 
 
 
 
 
 
 
 
 
 13 
 
                                  List of abbreviations 
 
AAPBA 3-acrylamidophenylboronic acid 
AB antibody 
AEMA 2-aminoethyl methacrylate 
AFM Atomic force microscopy 
AIBN Azobisisobutyronitril 
BA Boronic acid 
bFGF Basic fibroblast growth factor 
BPO Benzoylperoxide 
BSA Bovine serum albumin 
BuMA n-butyl methacrylate  
CAM Chick chorioallantoic membrane 
CCA Crystalline colloidal array 
CGM Continuous glucose monitoring 
CNT Carbon nanotube 
ConA Concanavalin A 
CP Conducting polymer 
DA Dopamine 
Da Dalton, unit 
DBD Dielectric barrier discharge 
DEA N,N-dimethylaminoethyl  
DHI 5,6-dihydroxyindole 
DOPA L-3,4-dihydroxyphenylalanine 
ECH Electron conducting hydrogels 
ECM Extracellular matrix 
EDC 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
EGDMA Ethylene glycol dimethacrylate 
EHMA 2-ethylhexylmethacrylate 
E-modulus, E-mod Elasticity modulus 
EPC Endothelial progenitor cell 
ePTFE Expanded poly(tetrafluoroethylene) 
FA Focal adhesion 
Fab Antigen binding fragment 
FAD Flavin adenine dinucleotide 
FBC Foreign body capsule  
FBGC Foreign body giant cells 
FBS Fetal bovine serum 
Fc Fragment crystallizable region 
 14 
 
FDA Food and Drug Administration  
FRET Fluorescence energy transfer 
Gel B Gelatin B 
GO Graphene oxide 
GOx Glucose oxidase 
GPC Gel permeation chromatography 
H&E staining Hematoxylin and eosin staining 
HA Hydroxyapatite 
HEMA Hydroxyethyl methacrylate   
HFF Human foreskin fibroblast 
HPMA 2-hydroxypropyl methacrylate 
HUVECs Human umbilical vascular endothelial cells 
I  Intensity 
ICAM Intercellular adhesion molecule 
IEP Iso-electric point 
IOL Intra-ocular lens 
IR Infrared 
ISF Interstitial fluid 
K Kelvin, unit of temperature 
LMA Lauryl methacrylate 
LRP Living radical polymerization 
MAP Mussel adhesive protein 
MAS-NMR Magic angle spinning nuclear magnetic resonance 
MES 2-(N-morpholino)ethanesulfonic acid 
MIP molecularly imprinted polymer 
MMA Methyl methacrylate  
MSN Mesoporous silica nanoparticles 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Mw Molecular weight 
N Newton, measure of force 
NIPAM N-isopropylacrylamide 
NIR Near infrared 
nm Nanometer, unit 
NMR Nuclear magnetic resonance 
NP Nanoparticle 
Pa Pascal, unit 
PAAm, PAM Polyacrylamide 
PANI Polyaniline 
PBA Phenylboronic acid 
PBS Phosphate buffered saline 
PC Polycarbonate 
 15 
 
PCA Pyrrolecarboxylic acid 
PCCA Polymerized crystalline colloidal array 
PCL Poly-ε-caprolactone 
PD Polydispersity 
PDA Polydopamine 
PDMS  Polydimethylsiloxane 
PDOT Poly(3,4-ethylenedioxythiophene) 
PEG Poly(ethylene glycol) 
PEGDMA Poly(ethylene glycol) dimethacrylate 
PEGMA Poly(ethylene glycol) n monomethyl ether monomethacrylate  
PEO Poly(ethylene oxide) 
PES Polyethersulfone 
PET Poly(ethylene terephtalate) 
PGEMA Poly(2-glucosyloxyethyl methacrylate) 
PHEMA Poly(2-hydroxyethyl methacrylate) 
PLGA Poly(lactic-co-glycolic acid) 
PLMA Poly(lauryl methacrylate) 
PMMA Poly(methyl methacrylate) 
PPD Poly(o-phenylenediamine) 
PPy Polypyrrole 
PT Polythiophene 
PU Poly(urethane)   
PVA Poly(vinyl alcohol) 
PVPAA  Poly(vinylpyrrolidone-co-acrylic acid) 
QCM Quartz-crystal microbalance 
RGD Arginylglycylaspartic acid 
RGO Reduced graphene oxide 
RMS Root mean square 
SCA Static contact angle 
SEM Scanning electron microscopy 
S-Hynic Succinimidyl-6-hydrazino-nicotinamide 
SPE  Serum protein electrophoresis 
SS Stainless steel 
sulfo-NHS N-hydroxysulfosuccinimide 
Tg Glass transition temperature 
TGF Transforming growth factor 
UV Ultraviolet 
VE-cad AB Vascular endothelial cadherin antibody 
VEGF Vascular endothelial growth factor 
VWF Von Willebrand factor  
W Watt, unit 
 16 
 
XPS X-ray photoelectron spectroscopy 
 
 
 
 
  
 
 
 
 
Chapter 1 
 
Introduction: Diabetes and its management 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 | Introduction  
 
18 
 
1.1. Introduction into diabetes 
According to the international diabetes federation, in 2013, 382 million people suffered from 
diabetes worldwide. Estimates even say that by 2035, this number might be increased up to 
592 million people, which corresponds to a 55% increase over two decades 1-2. As a 
consequence, diabetes has been the focus of many research groups as illustrated by the 
number of research papers published so far (see figure 1.1). 
 
 
Figure 1.1: Distribution of people suffering from diabetes worldwide, the number of papers 
published covering this topic and the distribution of the top 35 funders worldwide 3. 
 
To understand the main causes of diabetes, insight should be provided in the glucose 
household of a healthy patient. Generally, human plasma glucose levels are maintained 
within a very narrow range (3.5-6.5 mmol/l) via homeostasis 4. This process involves two 
hormones (i.e. insulin and glucagon) which are both secreted by the endocrine pancreas. If 
glucose levels drop below the above-mentioned lower threshold (cfr. hypoglycemia), 
glucagon is secreted by the alpha cells of the pancreatic islets of Langerhans to initiate 
glycogenolysis. In this way, stored glucose is released from the liver and used as an energy 
source. Insulin on the other hand is secreted by the beta cells of the pancreas and promotes 
the absorption of blood glucose to skeletal muscles and fat tissue. Within the body, it is 
provided in a constant proportion in order to remove glucose excess (cfr. hyperglycemia) 
from the blood which otherwise would become toxic 4-5. Conversely, if the patients are 
unable to absorb glucose properly, their blood glucose levels will remain high for a 
prolonged period (i.e. chronic hyperglycemia) and they will be diagnosed diabetic.  
Diabetes is not a single disease entity but represents a group of diseases associated with 
various metabolic disorders, all related by the occurrence of chronic hyperglycemia. Its 
pathogenesis involves both genetic as well as environmental factors and dependent on the 
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origin of the disease, 3 types of diabetes can be distinguished: type I, type II and gestational 
diabetes, which are schematically explained in figure 1.2 6.  
Type I diabetes or insulin dependent diabetes is an auto-immune disease in which the beta-
cells in the pancreas are destroyed by the body’s defense system itself. As a result, the body 
is not able to produce its own insulin and thereby no appropriate control of blood glucose 
levels can be achieved. Daily injections of insulin are a prerequisite to assure the patient’s 
life. 
In case of type II diabetes (non-insulin dependent diabetes), the body is able to produce its 
own insulin but it is unable to respond to it, again resulting in glucose build-up in the blood. 
Type 2 diabetes comprises 90% of people with diabetes around the world and for this type, 
no daily insulin injections are needed to treat the disease. Adjusted diet, increased physical 
activity or oral medication (sometimes combined with insulin doses) are mostly sufficient in 
this case. However, recent studies state that genetic predisposition to obesity also leads to 
an increased risk of type 2 diabetes 7-8. 
The third type, gestational diabetes is similar to diabetes type II and affects a number of 
women during their pregnancy. In this case, the insulin activity is again blocked, probably by 
hormones produced in the placenta. This type of diabetes is temporarily and normally 
disappears after birth. However, these women and their babies have a higher risk to develop 
type II diabetes in the further course of their lives 5, 9-10. 
 
 
Figure 1.2: Schematic illustration of the causes of diabetes type 1, 2 and gestational diabetes 5. 
 
Apart from short-term complications such as blurred vision, frequent urination and lack of 
energy, the long-term complications could be life threatening and are of great concern. 
Examples include heart and kidney diseases, blindness and nerve damage 11. Because of its 
chronic nature and the gravity of its complications, diabetes imposes unacceptably high 
costs on countries at all income levels.  
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To date, diabetes is still not curable, however, intensive insulin therapies in diabetic patients 
can dramatically delay the onset of serious complications. Furthermore, it has been 
demonstrated that tight or continuous blood glucose control can introduce substantial 
reductions in overall medical care costs. In this respect, glucose sensors play a key role, as 
they allow the patient to maintain normal glucose values in case glucose abnormalities (i.e. 
too high or too low concentrations) are emerging 12. Despite the array of tools at our 
disposal to tackle the disease – effective drug therapies, advanced technologies, ever-
improving education and preventive strategies – the battle to protect people from diabetes 
and its life-threatening complications is still ongoing.  
 
 
1.2. Problem statement: the need for continuous glucose monitoring (CGM) 
Till today, the finger prick method includes the most common way for patients to analyze 
and control their glucose values at home on a daily basis. To this end, the patient places a 
blood droplet on top of a disposable test strip, which contains the printed electrodes 
including the reference and working electrode. The latter is covered with the enzyme 
glucose oxidase (GOx) or glucose dehydrogenase (GDH) and as a consequence, 
electrochemical analysis of the blood droplet is enabled after insertion of the test strip into a 
read-out system. Overall, this method is experienced as painful and includes a higher risk of 
infection. Moreover, it is characterized by a non-continuous nature. As blood is only 
measured periodically (4-5 times a day), periods of hypo- or hyperglycemia might occur 
without the patient’s knowledge and without appropriate action. Especially patients 
suffering from diabetes type 1 fear episodes of hypoglycemia during the night. Because of 
this fact, researchers realized the importance to develop a system that allows for continuous 
glucose monitoring (CGM) via an appropriate sensor which is equipped with an alarm system 
to inform patients about deviations from normoglycemia 13. Furthermore, it was proven by 
the ‘Diabetes Control  and Complications Trial of the US National Institutes of Health’ that 
the likelihood of the occurrence of complications of diabetes such as eye disease 
(retinopathy), kidney disease (nephropathy), nerve disease (neuropathy) and vascular 
disease, decreases if diabetic patients maintain normal or near-normal glycemia 14-15.  
 
To date, CGM devices for the in vivo measurement of glucose are electrochemically based 
and considered minimally invasive, as they are not fully but percutaneously implanted. In 
this respect, subcutaneously implantable needle-type electrodes have been developed and 
commercialized such as the CGMS units of Medtronic (i.e. Minimed) and Abbott (i.e. 
Freestyle Navigator). Herein, subcutaneous glucose values are measured every 1-5 minutes, 
during 3-7 days 12, 16. Afterwards, the system can be replaced by the patient. 
Alternatively, microdialysis sampling may be used, during which a hollow dialysis fiber is 
implanted subcutaneously which is perfused with isotonic fluid. In this way, glucose is able 
to diffuse from the tissue into the fiber and is finally pumped towards the external enzyme 
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electrode for detection. Commercial microdialysis probes are provided by Menarini 
Diagnostics (GlucoDay), which apply the electrochemical glucose sensing principle (described 
in §1.2.1). These systems operate for 48 hours and provide glucose values every                      
3 minutes 17-19. 
 
Non-invasive CGM techniques have also been developed such as the GlucoWatch, which 
consists of a watch-like glucose monitor, worn around the wrist. Herein, glucose is extracted 
through the skin via reverse iontophoresis. To this end, a small current is passed between 
two skin surface electrodes, which draws ions and glucose-containing interstitial fluid (ISF) 
towards the surface for analysis 20. However, due to a lack of accuracy, slow operation and 
the occurrence of skin irritation, the device was removed from the market in 2007. 
Alternatively, due to its easy and non-invasive assessment, tear fluid has also been 
considered as medium for glucose measurements 21-22. To allow for continuous monitoring, 
glucose monitoring lenses have been developed, wherein the signal is read with the aid of an 
illumination and recording unit held in front of the eye 23. Although several issues still need 
to be tackled, such as improved lens biocompatibility, interference control and the need for 
extensive calibration, Google, in a cooperation with Novartis are currently working on the 
development of a commercial product 24. 
 
Apart from percutaneous sensor implants, fully implantable glucose sensors offer a 
minimally invasive alternative, since implantation should only be conducted once (i.e. one 
time invasive). In this case, the ultimate implantable CGM device should offer real-time 
glucose information on demand, should operate for 1 year minimally and should require 
minimal recalibration 25. Unfortunately, stable, functional in vivo glucose sensors are not 
commercially available yet, which can be explained by the lack of a stable tissue-sensor 
interface, needed to survive complex in vivo events, as will be described in  § 1.4.5. 
As a consequence, the current work targets the development of a biocompatible packaging 
for an implantable single‐chip optical glucose sensor, intended for long-term CGM, based on 
near infrared (NIR)-spectroscopy. The overall and initial concept of the CGM system, as 
proposed in the GlucoSens project, is presented in Figure 1.3 and discussed below. 
 
  
Figure 1.3: NIR-based glucose sensor, which is encapsulated in a biocompatible donut-shaped 
polymer packaging. 
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This concept describes a donut-shaped (1-1,5 cm in diameter) biocompatible packaging, 
which houses a single chip optical spectrometric sensor, together with inductive power and 
wireless data‐transmission electronics. Subcutaneous implantation of the sensor e.g. in the 
upper arm of the patient is envisioned and glucose concentrations are measured by sending 
NIR-light through the cavity of the donut, where it interacts with the ISF. After reflection by a 
mirror, placed at the opposite side of the sensor chip, the absorption of the light can be 
measured by a spectrometer, which is integrated, together with the NIR source, onto the 
chip component. Herein, accurate measurements in a glucose concentration range of 1-33 
mM is targeted. Translation and read-out of the glucose quantities are further enabled by an 
external wearable or portable read‐out device. Since the analysis method is reagent‐free, it 
circumvents the need for direct contact between the sensor electronics and the body 
environment (i.e. the ISF) and as a consequence the sensor can be fully encapsulated in a 
biocompatible packaging. Development of the latter comprises the subject of the current 
PhD.  
For further information about the glucose detection system, the build-up of the integrated 
sensor chip and the development of a calibration model enabling the analysis of the 
measured NIR spectra, the following PhD manuscripts can be consulted, which cover the 
research results obtained  in parallel with the current work: 
1) Spectroscopic detection of glucose with a silicon photonic integrated circuit, by Eva  
     Ryckeboer, Photonics Research Group (UGent). 
2)  GaSb/Silicon-on-insulator heterogeneous photonic integrated circuits for the short-wave  
     infrared, by Nannicha Hattasan, Photonics Research Group (UGent). 
3) Exploiting expert information in multivariate calibration of an implantable glucose  
      sensor, by Sandeep Sharma, Biostatistics and Sensors Group (MeBioS, KULeuven). 
 
Prior to defining the exact requirements the biocompatible packaging should fulfill, cfr. the 
research goals (§ 1.5 ), glucose sensors will first be described in a broader context. First, a 
brief overview is given of the glucose sensor principles typically studied and finally, an 
overview is provided of the role of polymer materials within the world of glucose sensors.   
 
 
1.3. Glucose sensors 
The basis for tight glycemic control includes frequent glucose monitoring. To this end, blood 
glucose concentrations are measured by means of a glucose sensor (mostly through the 
well-known finger-prick method) to aid in administering proper levels of insulin and to 
maintain homeostasis. Generally, a glucose sensor consists of three important parts 12:  
- A (biological) recognition element such as enzymes, proteins, antibodies or nucleic 
acids (i.e. biological elements) or functional units like phenyl boronic acid (PBA)-
containing compounds. These elements differentiate glucose molecules from other 
molecules.  
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- A transducer which converts the produced chemical signal, originating from the 
interaction between glucose and the recognition element, into a measurable signal. 
Different types of transducers exist including electrochemical (amperometric and 
potentiometric), optical, thermometric, piezoelectric and magnetic ones. The 
majority of the current glucose sensors are electrochemically driven but due to some 
shortcomings, the current work is situated in the world of optically-based sensors as 
discussed below.  
- A signal processing unit which ultimately transforms the measured signal into an 
interpretable read-out.  
 
During the last 50-60 years, glucose sensor technologies have significantly improved, but as 
pointed out in the upcoming sections, several challenges remain to achieve accurate and 
reliable glucose monitoring. Generally, based on the transducer system, two main classes 
can be distinguished including the electrochemical and optical sensors. 
 
1.3.1. Electrochemical sensors 
Because of their good sensitivity, reproducibility and low cost, the majority of the currently 
applied glucose sensors are electrochemically-based and dependent on the detection 
principle, potentiometric, amperometric, or conductometric sensors can be distinguished 26. 
Herein, the enzymatic amperometric glucose biosensor includes the most common 
commercially available device. In 1962, Clark and Lyons came up with the initial concept of 
these glucose enzyme electrodes 27. Their first device relied on a thin layer of glucose 
oxidase (GOx), entrapped on an oxygen electrode, which monitored the oxygen consumed 
by the enzyme catalyzed reaction: 
                                                           
                                                         
222
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GOx
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More precisely, upon interaction with glucose, the redox centre of the enzyme molecule, 
flavin adenine dinucleotide (FAD), is reduced and the redox product, gluconic acid, is formed. 
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Later on, in 1973, an enzyme electrode was developed to amperometrically monitor the 
produced hydrogen peroxide as a measure for blood glucose 28: 
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Since these inventions, a lot of research focused on the optimization and adjustment of this 
system and today four generations of electrochemical glucose sensors can be distinguished. 
 
The first generation of glucose biosensors rely on the principle discussed above which is the 
detection of hydrogen peroxide produced in equation 1.3. A first disadvantage of these 
sensors includes the high potential, needed to oxidize H2O2. As a consequence, a minor 
selectivity is manifested, because at these potential values (0.7V/SCE), coexisting electro-
active species such as ascorbic acid, uric acid and drugs (e.g. acetaminophen, a constituent 
of paracetamol®) act as interferences 29. By the application of permselective (i.e. membranes 
that selectively allow the permeation of a molecule) coatings, researchers have tried to 
minimize the access of these interferences towards the electrode surface (see § 1.4.1) 30-32. A 
second drawback of this method includes the oxygen dependency of the reactions. 
Fluctuations of free oxygen and its stoichiometric availability are critical factors which 
determine the accuracy of the glucose measurements 33.   
In order to compensate for the previously mentioned shortcomings, second generation 
glucose sensors were developed. In this approach, oxygen is replaced by non-physiological 
electron acceptors which are able to carry electrons from the enzyme towards the surface of 
the working electrode. Herein, minimization of the electron-transfer distance is crucial for an 
optimal performance of the sensor. Examples of artificial redox mediators include ferrocene 
34-35, conducting organic salts 36 and quinone-compounds 37. In this mechanism, the mediator 
(Mox) is reduced (Mred) (equation 1.5) due to the acceptance of electrons which are formed 
during the oxidation of FADH2 to FAD (equation 1.3). 
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Next, the electrons generated during re-oxidation of the mediator (equation 1.6) are 
detected amperometrically and are a measure for the present blood glucose. In this set-up, a 
solution is offered to the oxygen dependency problem as well as to the selectivity problem, 
as lower potentials can be used that do not provoke interfering reactions from coexisting 
electroactive species.  
Effective mediators should be stable, non-toxic, possess reversible electron transfer kinetics 
and should react fast with the reduced enzyme in order to minimize competition with 
oxygen. In vivo, this type of sensor is excluded due to possible leaching of the mediator 
molecules 12, 16, 33, 38. On the other hand, for in vitro measuring set-ups, this principle is 
frequently used such as in the glucose test strips and the Freestyle® blood glucose 
monitoring system 39. 
In the third generation of glucose biosensors, no mediators or reagents are used, but a direct 
transfer is created between the active site of the enzyme and the working electrode. As a 
consequence, this generation of sensors is characterized by a high selectivity and they allow 
for the development of implantable needle-type devices for continuous in vivo blood glucose 
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monitoring. To ensure direct electron transfer, organic conducting materials based on charge 
transfer complexes are used such as tetrathiafulvalene-tetracyanoquinodimethane (TTF-
TCNQ) 40-41. It should be noted that on normal electrode surfaces, only a few enzymes such 
as peroxidases exhibit direct electron transfer potential 42.  
Even though improvements are made throughout the previously discussed generations, 
factors as temperature, humidity and interference still control the enzyme’s activity strongly. 
Furthermore, thick enzyme layers, surrounding its redox centre, might inhibit the electron 
transfer process 39.    
Because of the shortcomings of the previous generations of sensors, a fourth generation was 
developed which focuses on enzyme-free detection methods in which glucose is directly 
oxidized on the sensor surface. Research in this field focuses on the development of metal- 
based, composite-based and carbon micro- and nano-based electrodes for glucose sensing 
39, 43-44.  
Parallel to the use of GOx enzymes as glucose recognition elements and other proteins such 
as glucose dehydrogenase, glucokinase and lectins, a lot of attention has been paid to 
phenylboronic acid (PBA) as sensing unit to detect glucose. PBAs are able to bind cis-diol 
containing compounds such as carbohydrates through reversible boronate ester formation. 
Due to this property, they are often termed ‘boronolectins’, as they are recognized as a 
synthetic mimetic for lectins, which are natural carbohydrate binding proteins. In case of 
glucose, multivalent boronate ester formation is facilitated in aqueous media via the 
complexation scheme shown in figure 1.4. Herein, only the charged phenylboronate can 
form a stable complex with glucose, since the neutral complex between PBA and glucose is 
highly susceptible towards hydrolysis. Contribution of the latter to the represented 
equilibrium can thus be neglected 45.  
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Figure 1.4:  Reversible boronate ester formation with β-D-glucose in aqueous solution. 
 
The main challenge concerning this method includes improvement of the binding affinity 
and selectivity 46. Previously, it has been shown that simple monoboronic acids are 
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insufficient to meet these requirements, although selective glucose binding can be pursued 
by the initiation of multivalent glucose interactions, by using multiple boronic acid 
functionalities, which are properly positioned for example onto a polymer backbone 47. In 
this respect, it should be mentioned that PBA-containing hydrogels only show glucose 
sensitivity at a pH close to the pKa of the PBA unit. In the end, only the dissociated, charged 
forms of PBA are able to form a stable complex with glucose, meaning that the typically used 
PBA-based hydrogels (e.g. 3-(acrylamido)-phenylboronic acid (3-AAPBA); pKa≈8.2) fail to 
respond to glucose at physiological pH. To solve this problem, researchers started to use PBA 
groups, which are characterized by a lower pKa or they incorporated amino groups which 
stabilize the complex between PBA and the diol 47. Since the applicability of this method in 
human physiological conditions, its use in diagnostic and therapeutic applications has been 
evaluated 48-50, including its application in both electrochemical and optical glucose     
sensors 51-52. In the former case, the PBA-moiety is typically linked to the electrode via 
conducting polymers (see § 1.4.4.1) in a covalent way, whereas in the latter case, the PBA 
moiety is in close contact with a fluorophore. 
 
1.3.2. Optical sensors 
To date, optically based glucose sensors for in vivo monitoring are commercially still 
unavailable. Nevertheless, the interest in the development of such an optical glucose sensor 
has emerged, due to the availability of new technologies, such as cheap and reliable optical 
sources and detectors and because of their reagent-less nature 10. 
Generally, optical transducers are used, which facilitate glucose detection via the use of 
different properties of light to interact with glucose molecules in a concentration-dependent 
manner. In this respect, (near)-IR- and fluorescence spectroscopy include frequently studied 
techniques. 
 
1.3.2.1. IR absorption spectroscopy  
In case of IR spectroscopy, glucose quantification is based on the selective absorption of light 
by glucose which is described by the Beer-Lambert law (equation 1.7). Herein, the 
transmitted intensity (I) is correlated with the glucose molar concentration (C), via the 
knowledge of the intensity of the incident optical radiation (I0), the molar extinction 
coefficient (ε, expressed in (mol/L)-1cm-1) and the path length (L, in cm). Due to its additive 
character, measurements are mostly reported in absorbance, A=log(I0/I) 
10.  
                                                                                CLeII 
0
                                                           (1.7) 
Both the MIR (4000-200 cm-1) and NIR (14000-4000 cm-1) region include attractive spectrum 
ranges for glucose detection. In the first case, light absorption arises from molecule specific 
fundamental stretching and bending modes. Despite the specific nature of the 
measurements, high background absorptions, especially by water, limit the applicability of 
this wavelength region for glucose quantification. In the second case, absorption arises due 
to overtone vibrations or combinations of C-H, O-H and N-H stretching vibrations. Problems 
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associated with this technique include substantial overlap with interferents, its temperature 
dependency and its sensitivity towards scattering. Due to its less specific nature (i.e. low 
absorption bands), several wavelengths are generally used together with multivariate 
analysis and calibration to calculate glucose concentrations 10, 53. Furthermore, it has been 
proven that combination spectra are preferred over first-overtone spectra for the direct 
measurement of glucose in an aqueous environment, due to an enhanced selectivity 54. 
Figure 1.5 shows the absorption peaks of glucose in the first-overtone band (FOB; 1550-1810 
nm) and combination band (CB; 2070-2375 nm), together with the absorption peaks of the 
most important interferents. 
 
Figure 1.5: Absorptivity of glucose, water and the most important interferents in the near-infrared 
region. (Based on data from Amerov et al.55, figure retrieved from Rijckeboer et al. 56) 
    
Despite its shortcomings, NIR spectroscopy is a very attractive technology for non-invasive 
glucose measurements. In this respect, transcutaneous measurements occurring through the 
fingertip, lip, tongue, the forearm and earlobe have already been explored because of the 
potential of NIR light to pass through different skin layers over a distance of a few mm 57. 
Nevertheless, more than 20 years of research did not yet result in the same accuracy as 
achieved with current invasive methods. The main reasons include the extensive light 
scattering induced by skin and the impact on the results of contact pressure when 
positioning a sensor on the skin 57. 
 
Based on these findings, the GlucoSens project focussed on the measurement of glucose 
concentrations inside the body to rule out the problems associated with transcutaneous 
measurements. As a consequence, an implantable, NIR-light glucose sensor as presented in 
figure 1.3 was proposed. Further motivation for this choice was provided by previous 
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research that showed succesfull in vitro NIR glucose measurements in serum (RMSEP(root 
mean square error of prediction ) = 1.08 mM 58) and whole blood (RMSEP= 0.95 mM 59, 1.4 
mM60, <1mM (CB) and 1.20 mM (FOB) 61). Furthermore, during the course of the current 
project similar NIR-based glucose determinations were achieved by the project partners in 
ISF mimicking fluid (RMSEP= 0.79 mM) and serum (RMSEP= 1.16 mM) 62-63,64. 
 
1.3.2.2. Fluorescence spectroscopy 
In fluorescent detection of glucose, light is sent through a fluorophore containing sample. 
Herein, the fluorophore is able to absorb light and thereby it is brought in an excited 
electronic state of higher energy. Upon light emission, the fluorophore loses its vibrational 
energy and returns to the ground electronic state. Measurement of the light emission allows 
determination of the glucose concentration 65.  
Several fluorescence-based techniques for glucose sensing have been developed. 
In a first group, enzyme catalyzed reactions are used to change the fluorescent status. 
Herein, the intrinsic fluorescence of the enzymes can be used to determine glucose 
quantities, due to quenching upon glucose binding. Alternatively, fluorophores, such as 
fluorescein, may be bound to the enzyme or an oxygen dependent fluorophore may be used. 
In the latter case, upon glucose oxidation, oxygen is consumed and a change in fluorescence 
is manifested. Apart from enzyme-based systems, PBA can also be used as glucose sensing 
unit. In this case, PBA is linked to a fluorophore, which couples the molecular recognition of 
glucose to a change in fluorescence 53, 66. 
 
In a second group, affinity binding sensors are used, which use a fluorescently labeled 
analogue of glucose that binds competitively with a receptor site specific for both glucose 
and the fluorescent analogue. In this respect, Concanavalin A (Con A), a glucose-binding 
protein, is frequently used as the receptor molecule whereas fluorescein-labeled dextran is 
commonly used as a competitive binder 67. Increased glucose concentrations displace the 
(quenched) dextran from the ConA sites, thereby increasing the concentration and 
fluorescence intensity of free dextran molecules 66, 68. 
 
It should be mentioned that fluorescence and other optical principles were not targeted in 
the current PhD. 
 
1.3.2.3. Alternative optically based sensors 
Apart from IR- and fluorescence-based spectroscopic techniques, optical techniques such as 
Raman spectroscopy, polarimetry, scattering 69, optical coherence tomography, fluorescence 
energy transfer (FRET), occlusion spectroscopy and photoacoustic spectroscopy have also 
been studied for glucose sensing purposes. They are all based on a different optical principle 
but a detailed discussion is beyond the scope of this work. Nevertheless, these principles are 
reviewed by Oliver et al. and McNichols et al.10, 53 
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1.4. The role of polymers in glucose sensing applications 
In literature, most reviews focus on the description of the different glucose sensor principles, 
as briefly described above. In this work, the role of polymer materials in glucose sensors will 
be emphasized. Over the years, they have gained tremendous recognition in the field due to 
several advantages. First, their chemical and physical properties may be tailored over a wide 
range of characteristics. Secondly, polymers may be fabricated in diverse shapes such as 
films, fibers, membranes, capsules and porous structures. Finally, they can be easily 
modified with biological compounds, which makes them ideally suitable to mimic natural 
sensing organs 70-71. 
Based on their fulfilled function within the glucose sensor, a division is made between the 
different polymers described in literature.  
 
1.4.1. Mass transport limiting membranes 
As mentioned before, electrochemical detection of glucose is complicated due to the 
existence of other interfering electro-active species. As a consequence, a basic 
electrochemical sensing unit is built-up of an inner metal-based or carbon electrode, a 
central enzyme layer (see also §1.3.2) and an outer mass-transport limiting membrane, 
previously called a permselective coating. The latter coating should block interferences and 
enable selective glucose diffusion towards the electrode. In this respect, acetylcellulose and 
Nafion® are frequently used as they are known to eliminate ascorbic acid, one of the most 
abundant interferents 72. Additionally, poly(urethane) (PU) includes another popular outer 
membrane in glucose sensor applications, due to an obtained durability, biocompatibility 
and long-term stability of the sensor function in vitro. In this respect, it was shown that the 
presence of hydrophilic segments inside the PU structure are responsible for an enhanced 
glucose transport 73. On the other hand, to prevent the passage of interferents,  
polyethersulfone (PES) was in this case used as inner membrane. Since in the biomedical 
field, PES is widely used as blood purification membrane, it can already be mentioned that it 
was also selected as a barrier membrane in the current research work (see chapter 5). 
More recently, Wang et al. developed electrospun PU fibers which offered an increased 
linearity to the glucose sensor compared to conventional epoxy-PU membranes 72. 
Nevertheless, in the latter case, Yu et al. could demonstrate a successful operation of the 
sensor for 10-52 days in rats 74. 
Other examples include the use of polycarbonate (PC) 75, polyvinylchloride 76, poly(o-
phenylenediamine) 77 and hydrogels 78. 
 
Since the sensors that apply a single polymer membrane are frequently characterized by a 
slow response, narrow measuring range and low current, different systems, i.e. multilayered 
membranes, have been proposed and evaluated. An example in this respect includes the 
work of Matsumoto et al., wherein the electrode is coated with respectively g-
aminopropyltriethoxysilane (g-APTES), acetylcellulose, Nafion® (the inner membranes), 
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glucose oxidase and polydimethylsiloxane (PDMS) (the outer membrane). The sensor proved 
immunity towards ascorbic acid, uric acid, and p-acetaminophen and it showed fast 
responses in a broad glucose concentration range 79. 
 
In case implantation of the sensor is targeted, it should be noted that most of the 
aforementioned membranes do not offer a suitable interface for an in vivo environment. As 
a consequence, an additional biocompatible coating should be applied, as discussed in § 
1.4.5. 
 
1.4.2. Polymers used as immobilization matrix 
As pointed out in §1.3, dependent on the glucose sensing principle (electrochemical or 
optical), different compounds such as enzymes, lectines or other synthetic compounds play a 
crucial role within the signal generation and transduction of a glucose sensor. To allow for 
close contact between the electrode and the transducer, most of these compounds have 
been immobilized onto polymer materials.  
Polymer membranes used as immobilization matrix have been studied extensively and 
typical examples include cuprophane 80, PU 81, redox polymers (see § 1.4.4.2) 82, copolymer 
hydrogels 83, poly(vinyl alcohol) (PVA) 84, polypyrrole 85-86, silica 86, etc. Apart from 
membranes, the use of polymer beads as immobilization matrix has also been explored, such 
as by Shibata et al. They developed injectable polyacrylamide hydrogel microbeads that 
contained fluorescent diboronic acid based monomers, which were bearing long hydrophilic 
spacers to maximize their mobility and opportunities for glucose binding. As this system 
showed sufficient fluorescent intensity during in vivo transdermal monitoring, it showed 
unique opportunities for continuous glucose monitoring (CGM) 87.  
 
Different immobilization strategies have been developed, which are characterized by their 
own specific advantages and disadvantages. Generally, two classes of immobilization 
techniques can be distinguished, including the non-covalent immobilization protocols 
(physical adsorption, physical entrapment and affinity binding) and the covalent techniques. 
It should be clear that the performance of a biosensor is highly affected by the selected 
immobilization process. Further elaboration on this topic has already been performed by 
Guimard et al. 88, Lange et al. 89 and Rahman et al. 90, but is beyond the scope of the current 
work. 
It should however be noted that in the design of biosensors, immobilization of biological 
compounds such as enzymes on the transducer surface includes a critical step. Herein, 
immobilization should preserve the compound’s structure and function in order to maintain 
their biological activity after immobilization. Furthermore, to assure stability during long-
term applications, immobilization should result in the formation of stable bonds and 
desorption of the enzyme during sensor function should be avoided.  
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As a last example,  the more recent development of glucose sensor contact lenses could also 
be mentioned. Herein, polymers such as poly(ethylene terephtalate) (PET) 21, 23 and PVA 91-92 
have been used to house glucose sensor electronics or other glucose sensing compounds, 
such as fluorophores. 
 
A complete presentation of all polymers ever used for immobilization purposes within the 
world of glucose sensors would be an impossible job. Nevertheless, during the further 
course of this work, more examples will be given since most of these polymers exert 
additional functions within the glucose sensor design, as will be explained in the upcoming 
paragraphs.  
 
1.4.3. Glucose sensitive polymers 
1.4.3.1. Polymers used for glucose recognition, as an alternative to enzymes 
As pointed out in §1.3, the recognition element constitutes one of the compounds building a 
glucose sensor. These elements mostly consist of biological compounds, such as enzymes, 
which specifically interact with glucose and induce an electrochemical reaction to quantify 
the glucose content. Herein, the biological compounds need to be immobilized directly onto 
the electrode or via an immobilization matrix such as a polymer network or hydrogel, as 
described above. Due to their high costs and their lack of storage and operational stability, 
research has focused on the development of synthetic alternatives. In this respect, 
molecularly imprinted polymers (MIPs) have gained a lot of interest 93. Their synthesis is 
based on the polymerization of a functional monomer and a crosslinking agent, in the 
presence of a molecule (e.g. glucose), which acts as a template 94. After polymerization, the 
template is removed, which results in the creation of recognition sites in the polymer matrix 
that are complementary to the analyte in its shape and positioning of functional groups. To 
organize the functional monomers around the template, covalent, non-covalent, 
electrostatic, but also metal ion coordination can be exploited 95. Malitesta et al. were the 
first to synthesize poly(o-phenylenediamine) (PPD) imprinted by glucose via 
electrosynthesis, to be used in combination with a quartz-crystal microbalance (QCM)-based 
transducer 94. The same glucose imprinted PPD polymer has also been evaluated with a 
capacitive transducer, which allowed for sensitive glucose detection 96. Ersöz et al. added 
metal coordination in their MIP’s design as a promising binding mode to prepare highly 
specific template polymers for the recognition of glucose and they could prove higher 
glucose binding affinity compared to the well-known glucose binding protein,     
concanavalin A 95.  
Apart from PPD 97, hydrogels including poly(2-hydroxyethyl methacrylate) (PHEMA), 
crosslinked with poly(ethylene glycol) dimethacrylate (PEGDMA) 98, poly(allylamine) 99-100 
and styrene-based polymers and micelles 101-102 have been evaluated as glucose imprinted 
polymers. The latter micelles were proven successful for the development of a voltammetric 
glucose sensor 102. 
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Recently, glucose selective MIPs, using boronic acids have also been explored. To this end, 
copolymers of phenol and 3-hydroxyphenylboronic acid have been synthesized by 
electropolymerization, in which D-glucose is used as a template (Figure 1.6) 103. Alternatively, 
4-vinylphenylboronic acid has been used together with methylene bisacrylamide as 
crosslinker 104. Upon the application of boronic acid moieties, Manju et al. were able to 
synthesize a fluorescent MIP (fluorescein and PHEMA-based) which shows changes in 
fluorescence emission on the event of glucose binding 105. 
The main disadvantage of MIPs includes the low density of imprinted sites, which often 
results in slow diffusion of the analyte and in longer time intervals for sensing (7-20 min). 
Nevertheless, response times between 3-5 minutes have been reported for PBA-based MIP-
grafted electrodes. Although higher than GOx-based response times (< 1 min), these values 
can still be considered acceptable 104. Figure 1.6 demonstrates the synthesis of a PBA-based 
MIP and offers a nice representation of the MIP’s concept. 
 
 
Figure 1.6: Synthesis of D-glucose imprinted poly(phenol-co-3-hydroxyphenylboronic acid)52. 
 
Apart from MIPs, boronic acid (BA)-based polymers have gained a lot of attention because of 
their glucose interactive nature (see also § 1.3.1) and their synthetic character. Most of 
these polymers are hydrogels, which are a group of water-swellable crosslinked materials. 
PBA-based hydrogels thus combine the merits of both BA (glucose sensitivity) and hydrogels 
(biocompatible, water-swellable), a concept which has been exploited for many purposes. 
Due to the existence of excellent reviews regarding their synthesis, properties and their 
applications within the world of electrochemical and optical glucose sensors 47, 52, 106, this 
topic is not further addressed in the current PhD.  
 
1.4.3.2. Glucose responsive hydrogels 
Hydrogels are defined as hydrophilic polymer networks which are able to absorb high 
amounts of water (up to thousands times their dry weight) without dissolution or loss of 
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their three dimensional structure. Preservation of their structure is enabled due to the 
existence of covalent crosslinks or physical crosslinks such as entanglements, hydrogen 
bonds, Vander Waals interactions, ionic or hydrophobic interactions 71. A special class 
includes the stimuli-responsive hydrogel materials, which are able to undergo abrupt volume 
changes from a collapsed to a swollen state in response to environmental changes, such as 
temperature, pH or electrical stimuli. These intelligent materials possess both sensor and 
effector functions, as they can sense the stimulus as a signal and respond to it by inducing 
structural changes. Due to this combined property, glucose responsive hydrogels have 
gained a lot of attention for their use in glucose sensor applications but also to control 
insulin delivery inside the body 107-108. 
The ultimate goal in diabetes control includes the development of a closed loop insulin 
delivery system. Herein, insulin release systems based on polymeric materials are frequently 
studied, also referred to as the polymeric artificial pancreas, as they try to mimic the 
pancreatic activity of healthy people. Initial systems consisted of polymer pellets, such as 
ethylene vinyl acetate copolymers 109, which were impregnated with insulin and upon 
implantation, a sustained release of the hormone was provided. Additionally, signal sensitive 
polymeric insulin release systems have been developed, wherein insulin release is activated 
upon application of an external impulse such as ultrasound, a magnetic field, electricity, etc. 
These systems have been reviewed by Uchiyama et al 110. Nevertheless, as also stated in the 
latter review, these systems do not contain a regulation system that controls the insulin 
release according to changes in the glucose level.  
To obtain the latter goal, glucose-responsive hydrogels have been studied extensively, also 
referred to as stimuli-responsive or intelligent materials. Based on the glucose recognition 
mechanism, most reviews subdivide this class of glucose responsive polymers into GOx-
loaded hydrogels, lectin-loaded hydrogels and PBA-based hydrogels 107-108, 110-111. These 
materials combine glucose recognition with a response signal which causes insulin release. In 
the next part, the general insulin-releasing principle is explained for each class, but for a 
detailed explanation, the above-cited references should be consulted.  
 
In case of GOx-based glucose detection, pH sensitive hydrogels are mostly studied. As 
described in § 1.3, upon action of GOx, glucose is converted into gluconic acid, which lowers 
the pH inside the hydrogel. This change in pH alters the swelling behavior of the hydrogel, 
due to a modification of the polymer’s charge density, upon capturing protons. Glucose thus 
triggers a volume change of the insulin-loaded gel (swelling or collapse of the gel), which 
enables its controlled release.   
The initial system, developed by Ishihara et al. enabled insulin release upon swelling of the 
hydrogel. To this end, a GOx immobilized membrane was combined with a poly(amine) 
(copolymer of  N,N-dimethylaminoethyl methacrylate (DEA) and 2-hydroxypropyl 
methacrylate (HPMA)) membrane and upon conversion of glucose into gluconic acid, the 
increased acidic conditions resulted in positively charged tertiary amino groups in the second 
membrane, which caused swelling of the material (due to increased hydrophilicity of the gel 
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and electrostatic repulsion) and subsequent insulin release 112. To increase the insulin 
permeability and release rate, capsules as well as macroporous membranes have been 
developed 83. In alternative systems, insulin release is enabled through contraction of the gel 
113. Recently, Chu et al. developed a closed-loop insulin system, wherein a GOx-based 
membrane is integrated within a silicone based insulin reservoir (Figure 1.7). Due to the 
GOx-catalyzed production of gluconic acid, shrinkage of the pH-responsive poly(n-
isopropylacrylamide-co-methacrylic acid) nanoparticles, which are embedded in the bio-
inorganic albumin-based membrane is caused. Because of this collapse, nanopores are 
created across the membrane and thereby instant insulin release is facilitated 114.  
 
Figure 1.7: Scheme for glucose-responsive insulin microdevices: (top) polydimethylsiloxane 
(silicone) tubing microdevice with a bioinorganic plug and the cross-section of the device with 
embedded hydrogel nanoparticles (NPs) and (bottom) cross-sectional diagram of the membrane 
response to glucose at high glucose concentrations. CAT, catalase; GOx, glucose oxidase 114. 
 
Apart from GOx, lectines are also frequently studied as glucose sensing molecules. Lectines 
are proteins which specifically bind to carbohydrates and in case of glucose, Con A is most 
frequently studied (see also § 1.2.2.2). In case insulin delivery is targeted, glycosylated 
insulin derivatives have been developed 115, which are bound onto hydrogel immobilized Con 
A. Based on the competitive and complementary binding behavior of Con A with glucose and 
the glycosylated insulin, insulin will be released in a proportional response to the blood 
glucose levels. Hydrogels used for immobilization include poly(vinylpyrrolidone-co-acrylic 
acid) (PVPAA) 115 and poly(2-glucosyloxyethyl methacrylate) (PGEMA) 116. If in vivo use of 
these systems is targeted, covalent linkage of Con A with the hydrogel matrix includes a 
prerequisite to minimize toxic effects such as an undesirable immune effect due to    
leaching 108. 
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In case PBA-based hydrogels are used, similar mechanisms as for the lectine-based systems 
have been described. The addition of glucose will enhance swelling of the network, due to 
an increased hydrophilicity of the hydrogel, which is caused by the formation of negatively 
charged glucose-borate anion complexes. As a result, the release of insulin is facilitated in a 
diffusion controlled way. In case of chemically controlled release, systems make use of 
competitive binding between gluconic acid modified insulin and glucose onto the PBA-based 
hydrogel 117. It should be mentioned that Zhang et al. could prove that the volumetric 
change of the PBA modified hydrogels is highly dependent on the chemical structure of the 
immobilized PBAs 118. 
 
In case of the last two classes, the Con A and PBA-based hydrogels, sol-gel phase reversible 
hydrogel systems have also been described. In this case Con A and PBA act as crosslinking 
agents for respectively glucose- and polyol containing polymer chains. In both cases, the 
crosslinks are reversible, meaning that in case free glucose is penetrating the hydrogel, 
competition will exist. 
 
 
 
 
 
Figure 1.8: Panel A: Sol–gel phase-transition of a glucose-sensitive hydrogel. Large circles represent 
Con A, a glucose-binding protein. Small open and closed hexagons represent polymer-bound 
glucose and free glucose, respectively. Panel B: Sol–gel phase-transition of a phenylborate 
polymer. At alkaline pH, phenylborate polymer interacts with the polyol polymer such as poly(vinyl 
alcohol) to form a gel. Glucose replaces PVA to induce a transition from the gel to the sol phase 119. 
 
In case of the Con A containing gel, competition will exist between the external glucose and 
the internally hydrogel-bound glucose molecules to interact with Con A (Figure 1.8, A). In 
A 
B 
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case of PBA-based hydrogels, this competition exists between the free glucose and the 
polyol polymer (figure 1.8, B). Since glucose only has one binding site for the borate group, it 
is not able to act as a crosslinker. In both cases, an increase in glucose concentration will 
thus result in a decreased crosslinking degree of the gel and an increased swelling, which 
results in a higher insulin release 119.  
 
Apart from their use as artificial pancreas, glucose responsive hydrogels can also be applied 
in glucose sensor devices. In this case, the glucose-induced swelling can be read out by 
electrochemical methods such as conductometry 120 or optical transduction, upon the 
incorporation of a fluorophore inside the lectin and PBA-based hydrogel systems 47, 121. In 
this respect, the development of a polymerized, crystalline colloidal array (PCCA) sensor 
should be mentioned, which was developed by Holtz et al 122. Herein, highly charged 
monodisperse polystyrene spheres are embedded as crystalline colloidal arrays (CCA) into a 
glucose responsive hydrogel. Due to their dielectric periodicity, PCCA hydrogel films 
selectively diffract light of certain frequencies. If the glucose concentration is increased, the 
hydrogel (reversibly) swells and as a consequence, the lattice spacing is changed which 
causes a shift of the diffraction peak of the PCCA film towards longer wavelengths. Typical 
hydrogel examples include poly(acrylamide)/poly(ethylene glycol) with pendant PBA groups 
123, acrylamide bisacrylamide hydrogels and its copolymers with n-hexylacrylate 124.  
 
The main drawbacks of glucose responsive hydrogels include their slow response time 
towards environmental changes such as changing glucose concentrations and their lack of 
reproducibility. To overcome the first issue, adjustment of the hydrogel dimensions could be 
considered 119. In this respect, hydrogel films with a micrometer to submicrometer thickness 
have been developed 125. Furthermore, the development of injectable systems such as 
nanoparticles (NP) or micelles to control insulin release in the body, has gained a lot of 
attention. Zhao et al. developed mesoporous silica nanoparticles (MSN) as insulin reservoir, 
which are coated with GOx and catalase enzyme multilayers. In the presence of glucose, GOx 
converts glucose into gluconic acid and due to a pH decrease, the enzyme multilayer shell 
starts to swell and enables the subsequent insulin release 126. As a non-enzymetic 
alternative, similar worm-like MSN have been developed by Sun et al. They applied both a 
crosslinked and non-crosslinked polymer shell onto the nanoparticles, bearing 
thermoresponsive N-isopropylacrylamide (NIPAM) to allow insulin loading and 3-
acrylamidophenylboronic acid (AAPBA) as a glucose recognition moiety to allow insulin 
release 127-128. 
Other recent literature examples of glucose responsive hydrogel materials, used for insulin 
delivery and glucose sensor applications are listed in table 1.1.  
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Table 1.1: Examples of responsive hydrogels used for insulin release or for glucose sensor 
applications, recently described in literature. 
Material 
Glucose 
recognition 
Application Ref. 
Cationic chitosan hydrogel GOx pH-induced insulin release 129 
Polymeric micelles (copolymer of 
MePEGA, AAPBA and NBA)*. 
PBA 
UV- and glucose induced 
 insulin release 
130 
Amphiphilic Glycopolymer NP 
(p(AAPBA-r-MAGA)*) 
PBA Glucose induced insulin release 131 
Biodegradable cellulose/poly(acrylic 
acid) 
/ 
Oral insulin delivery 
 (pH-induced release) 
132 
Poly(diethylaminoethyl methacrylate) GOx 
pH and glucose induced  
insulin release 
133
 
DEAEMA/PEGDMA hydrogel particles 
containing GEMA/Con A complexes 
Con A 
Glucose induced swelling intended 
for insulin release and sensor 
applications 
134 
N-alkylacrylamide-based hydrogels PBA Glucose induced gel shrinkage 
135
 
P(NIPAm-APBA-NBDAE-RhBEA)* 
microgels 
PBA Glucose sensor applications 136 
polyacrylamide hydrogel microbeads PBA CMOS-based glucose sensor 137 
PEG diglycidyl ether (PEGDGE) 
crosslinked polyetheramine 
 
GOx 
Impedimetric glucose sensor 
 for tears and sweat 
138 
Poly (styrene-co-acrylamide-co-
AAPBA*) microgels embedded in 
poly(acrylamide-co-2-
(dimethylamino) ethylacrylate). 
PBA NIR-PCCA based glucose sensor 139 
pNIPAm-co-AAc* microgels140   
AAm-AAPBA* 125 
PBA Fabry-Perot optical glucose sensor 125, 140 
Ag NP with a P(VPBA-co-DMAEA) 
shell 
PBA Insulin release 141 
*
MePEGA:poly (methoxypolyethylene glycol acrylamide); AAPBA: 3-acrylamide phenylboronic acid; NBA: 2-
nitrobenzyl acrylate; p(AAPBA-r-MAGA): random copolymer of 3-acryl aminophenylboronic acid and 
maleimide-glucosamine; NIPAm: N-isopropylacrylamide; NBDAE: 4-(2-acryloyloxyethylamino)-7-nitro-2,1,3-
benzoxadiazole (NBDAE), RhBEA: rhodamine B-based FRET acceptors; AAc: acrylic acid; AAm: acrylamide; 
P(VPBA-co-DMAEA): poly(4-vinylphenylboronic acid-co-2-(dimethylamino)ethyl acrylate) 
 
1.4.4. Polymers used for the enhancement of electron transfer 
Glucose biosensors make use of a glucose sensing unit such as an enzyme or PBA. As 
mentioned in §1.3.1, the greatest challenge lies in the successful immobilization of these 
compounds and the preservation of the sensing unit’s stability and performance after 
immobilization, whilst being in close contact with the transducer. In the end, electrochemical 
detection of glucose is associated with the exchange of electrons between the sensing unit 
and the transducer. To improve the electrical contact, the immobilization polymers 
preferably function as an electron conducting interface between both components. To 
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realize these goals, different polymer types come into play and based on their 
physicochemical characteristics, composition and electron transfer mechanism, three main 
classes can be distinguished, including (intrinsically) conducting polymers, redox polymers 
and composite materials.  
 
1.4.4.1. Conducting polymers 
Conducting polymers (CP) were first recognized with the invention of iodine-doped 
polyacetylene in 1977 142. Generally, conducting polymers are described as ‘synthetic 
metals’, due to their electric, electronic, magnetic and optical properties, which are inherent 
to metals and semi-conductors 143.  The conducting properties of the polymers originate 
from the alternating double- and single-bonded sp2 hybridized atoms which are present in 
their organic chains (cfr. conjugated system). A planar conformation of this system 
maximizes sideways overlap between the π molecular orbitals which is critical for their 
conductivity. In their neutral, uncharged state, conducting polymers show almost no 
conductivity, yet upon oxidation (p-doping) or reduction (n-doping) of the conjugated 
backbone and upon providing a counter anion or cation (i.e. dopant) respectively, charge 
carriers are formed 88, 144. Apart from polyacetylene, typical examples of CP include 
polyaniline, polypyrrole, polythiophene, poly(paraphenylene), polycarbazole, polyphenol 
and polyfuran 89. They can be synthesized chemically, via condensation or addition 
polymerization, which permits up-scaling of the materials, or electrochemically, which 
benefits from the deposition of polymer layers with a controlled layer thickness, going as low 
as 20 nm 145. 
Compared to metals, semiconductors and other conductive materials, CP are favored 
because of their inexpensive nature, their convenient synthesis and processing and their 
stability in air. Furthermore, due to the availability of a broad range of molecules which can 
be used as a dopant, their eventual properties can be easily modeled 88. 
Since 1980s, the application of conducting polymers for biomedical applications also became 
popular, due to the recognition in that time of their compatibility with many biomolecules, 
such as those used in biosensors. Herein, the mild conditions used for polymerization are 
ideal for the simultaneous synthesis of CP and incorporation of the biological compound 146. 
Due to their biocompatibility, their ability to entrap and release biological molecules in a 
controlled way, their ability to transfer charge and their potential to easily change their 
electrical and chemical properties, next to biosensors, conducting polymers are extensively 
studied for their use in tissue engineering applications, neural probes, drug delivery devices 
and bio-actuators 88. 
In sensor applications, conducting polymers act as both immobilization matrices and 
physicochemical transducers to convert a chemical signal into an electrical one. In this field, 
CP enjoy the advantage that electrochemical synthesis enables direct deposition of a 
polymer film with controlled thickness onto the electrode surface, followed by biomolecule 
immobilization. It is thus possible to deposit CP in a very precise way over defined areas of 
the electrode to intimately interface them with biomolecules such as enzymes. In this way, 
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an effective electron transfer mechanism between the enzyme and the final electrode is 
enabled, which enhances the sensor selectivity and sensitivity. The exact electron transfer 
mechanism is not yet clearly understood but the electronic phenomena in these systems can 
be explained by the concept of solitons, polarons and bipolarons 147. 
 
Further improvement of electron transfer is enabled by the use of redox mediators such as 
ferrocene, which can be immobilized via entrapment, incorporated as dopant or immobilized 
via covalent linkage on the monomer 148-149. Furthermore, to enhance the response time of 
the sensor, nano-fibers and nanotubes have been examined due to their porous      
structures 150. Synthesis routes of these nanostructures have been reviewed by Xia et al. 151 
and some recent literature examples of their use can be found in table 1.2. 
In case of electrochemically based glucose sensors, cyclic polyenes have been frequently 
studied, including polypyrrole (PPy) 152, polythiophene (PT), poly(3,4-
ethylenedioxythiophene) (PEDOT) and polyaniline (PANI) 153 (Figure 1.9) which are 
characterized by a good stability, conductivity and a straightforward synthesis 88, 144. Recent 
literature examples of the application of these CP in glucose biosensors are listed in         
table 1.2. Herein, the glucose detection method is specified as well as the appearance of the 
CP. As sensing unit, GOx is mostly applied as specific interaction enzyme. Additionally, Welch 
et al. applied PEDOT/PSS (polystyrene sulfonic acid) polymers as a platform to grow 
combined brushes of poly(glycidyl methacrylate) and poly(2-hydroxyethyl methacrylate), to 
enable the subsequent covalent immobilization of GOx. In this way, leakage of the enzyme 
could be prevented 154. 
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Figure 1.9: Chemical structures of conductive polymers, frequently used in electrochemical glucose 
sensors. 
 
Apart from the introduction of conducting properties, upon charge injection (doping), the 
change in electronic band structure is also accompanied by a variation in the optical 
properties in the UV-VIS and NIR-region. As a consequence, CP are also studied for optical 
glucose sensor applications, although, to a limited extent. Nemzer et al. developed a GOx 
immobilized PANI-based glucose electrode, which enabled glucose detection via a GOx- 
catalyzed reversible redox reaction that alters the UV–VIS absorption properties of the 
polymer 155. Similarly, Pringsheim et al. developed PBA-carrying PANI-based polymers, which 
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result in an altered NIR absorption spectrum upon interaction with saccharides. It should be 
noted that in this case a lower response is created for glucose compared to fructose 156. 
Alternatively, Jin et al. produced an interpenetrating hydrogel network of polyacrylamide 
(PAAm) and PEDOT. Herein, the hydrogel microenvironment changed (i.e. hydrogel 
shrinkage) due to the GOx catalyzed glucose reaction and as a result, a blue shift in the 
reflection peak of the film was manifested 157. 
 
Table 1.2: Recent literature examples of conducting polymers used in glucose sensor applications. 
Conducting 
polymer 
Sensing unit Appearance Glucose detection Ref. 
PPy 
GOx 
GOx 
GOx 
GOx 
film 
film 
film 
nanotube 
array 
SPR* 
amperometry 
Impedimetry 
amperometry 
158 
159-161 
162 
163 
PT GOx film amperometry 164 
PEDOT 
 
 
PMB*/PEDOT 
PSS/PEDOT 
GOx 
GOx 
GOx 
GOx 
GOx 
Film 
Film 
film 
Film 
film 
n.s.(CV) 
voltammetry 
electrochemical/optical 
amperometry 
amperometry 
165 
166 
167 
168 
169
 
PANI 
GOx 
p-toluenesulfonic acid 
GOx 
GOx 
GOx 
nanofiber 
nanofiber 
film 
nanowire 
nanoparticle 
hydrogel 
amperometry 
amperometry/impedimetry 
optical/amperometry 
amperometry 
electrochemical 
Amperometry 
170 
171 
172-173 
174 
175 
176 
*
SPR: surface plasmon resonance; PMB: poly(methylene blue); PSS: polystyrene sulfonic acid 
 
1.4.4.2. Redox polymers 
Apart from intrinsically conducting polymers, redox polymers are also widely applied as 
electron transfer media. In this case, electron motion is enabled via an electron exchange 
reaction (electron hopping) between neighboring redox sites, which are contained within the 
redox polymer. These redox sites can be oxidized or reduced and are either covalently 
attached (into the polymer chain or as pendant group) or electrostatically bound 177. To 
enable for appropriate electron hopping, segmental motion should be enabled. 
 
Originally, within the world of electrochemical glucose sensors, soluble redox mediators, 
which are non-physiological electron acceptors, such as ferrocene, have been applied (cfr. 
2nd generation of glucose sensors, §1.3.1). However, these appeared inadequate for the 
long-term stability of devices or for in vivo implantation, due to possible leaching. As a 
consequence, in an attempt to develop reagent-less glucose biosensors, their immobilization 
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onto polymers has been investigated. As mentioned in the previous paragraph, their 
successful immobilization onto CP such as PT 178 and PPy 179 has been demonstrated as well 
as their use in glucose sensor applications, a topic which has been reviewed by             
Saleem et al. 180 Apart from CP, their immobilization on redox polymers also resulted in 
promising results. Polyquinones and polysiloxanes were initially studied as redox-based 
immobilization polymers, but due to their insolubility in aqueous media, water-swellable 
redox hydrogels were introduced as a superior alternative 181 (typical examples are given in 
figure 1.10). They were initially introduced by Heller et al. 38, 182-183 and similar to the electron 
conducting hydrogels (ECH), discussed under the CP, the cause for their unique properties is 
twofold. First, these hydrogels are able to dissolve and diffuse water soluble chemical and 
biochemical species at a rate almost equal as in water itself. Secondly, these hydrogels 
differentiate from common examples in the sense that they also possess electron-
conducting properties.  
Generally, they consist of a crosslinked water-swellable polymer network which possesses 
redox center containing tethers. Similar to the conducting polymers, the hydrogels serve to 
electrically connect the redox centers of enzymes to the electrode and therefore, they are 
referred to as ‘electrically wired enzymes’. Electron-conduction in these type of materials is 
established by the self-exchange of electrons between their rapidly reducing and oxidizing 
redox functions and the exchange is enabled by collision of the involved redox centra, a 
process which is described by the Marcus-type collisional electron transfer theory 184. 
Electron transfer in redox hydrogel films has been studied in depth by Forster et al. 185-187  
To facilitate the above-mentioned collisions, segmental mobility includes the most important 
prerequisite. In the end, this property will determine the electron diffusion coefficient (De) of 
the hydrogel material, which is a measure for the transport of electrons through the redox 
polymer. In this respect, hydration is playing a key role, meaning that it positively influences 
chain mobility as well as the material’s De. Apart from chain mobility, mechanical stability of 
the hydrogels includes a second prerequisite. Binyamin et al. demonstrated that an 
adequately cross-linked redox-hydrogel should withstand shear stresses of 10-2 N/m2 188. The 
mechanical strength of the hydrogels is mainly determined by the crosslinking density of the 
material and the molecular weight of the starting polymer. The latter property clearly 
enhances the segmental mobility and the hydration of the polymer accordingly, whereas 
crosslinking counteracts these phenomena. As a consequence, a highly crosslinked polymer 
backbone should preferably be combined with redox functions at the end of the tethers. 
Using this approach, free movement of the redox functions is facilitated and the collision 
probability and the GOx electron collection efficiency are enhanced. Optimally, these tethers 
consist of long and flexible spacers consisting of 8-15 atoms 189-190.  
Typical hydrogel materials studied in this field include poly(vinylpyridine)                         
(figure 1.10, A) 191-192, poly(N-vinylimidazole) 193-194 (figure 1.10, B) and a copolymer of 4-
vinylpyridine and 4-aminostyrene. Typical redox centers tethered to the hydrogels comprise 
ferrocene and Os2+/3+, which is complexed by substituted or unsubstituted pyridines.  
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Crosslinking of the nitrogen containing hydrogel complexes is typically done on the electrode 
surface itself, with the help of a diepoxide such as polyethylene glycol diglycidyl ether and in 
the presence of a GOx containing solution 183.  
Alternatively, the UV-induced crosslinking of a ferrocene-based poly(dimethylacrylamide), 
containing photoreactive benzophenone groups has been reported 195-197 (figure 1.10, C).  
 
To date, osmium-containing redox hydrogels are used in different amperometric biosensors, 
including the commercialized freestyle navigator system of Abbott Diabetes Care, which is a 
miniature subcutaneously implantable glucose sensor 198. Rajagopalan et al. also studied 
Os(bpy)2Cl]
+/2+ complexes of poly(vinylpyridine) and they could prove that quaternization of 
the polymer backbone with methyl iodide is able to enhance the rate of electron transport. 
Furthermore, due to the presence of positive charges, a superior electrostatic interaction 
with the negatively charged GOx enzyme is obtained, which stimulates their electrical 
communication 199.  
Similarly, Calvo et al. synthesized poly(allylamine)-based polycationic redox hydrogels    
(figure 1.10, D). In this study, ferrocene was covalently attached to the polymer and 
crosslinked on the electrodes. Alternatively, after modification of the polymer with pyridine 
and crosslinking onto the electrode surface, ruthenium ([Ru(NH3)5py]
2+/3+) as well as iron 
pentacyano complexes ([Fe(CN)5py]
2-/3-) have been immobilized 181. Furthermore, polymer-
enzyme multilayers, which are constituted via electrostatical self-assembly have been 
evaluated. In the latter case, the obtained films were characterized by a less random 
conformation compared to the crosslinked hydrogel films, which enabled a superior 
structural characterization of electron transfer and its kinetics. Nonetheless, they observed 
that only a small fraction of the enzyme was electrically wired by the attached mediators 200. 
 
An important issue that needs to be addressed when wiring enzymes includes the enzyme’s 
activity. Indeed, enzyme denaturation causes a loss in sensor selectivity and sensitivity. In 
literature, examples have been reported where precipitation occurs when mixing the redox 
polymers with the enzyme solution. To prevent precipitation, which is caused by 
electrostatic interactions, sodium dodecyl sulfate was successfully added as a surfactant 201.    
 
More recently, Wang et al. developed branched poly(ethylenimine) nanobeads, immobilized 
onto ferrocene for the application in glucose biosensors. The application of hydrogel 
nanobeads minimizes the insulating property of a hydrogel’s polymer backbone and in this 
respect they offer an elegant alternative for the use of composite materials (discussed in 
§1.3.1.3) 202. 
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Figure 1.10: Examples of redox hydrogels: a poly(4-vinylpyridine) backbone bound to an Osmium 
containing redox center, via a 13 atom containing tether 182 (a), a poly(N-vinylimidazole)-based 
redox polymer, covalently bound to an Os-containing redox center 194 (b), a ferrocene containing 
poly(dimethylacrylamide) polymer containing benzophenone groups 195 (c) and poly(allylamine)-
based redox hydrogel 200 (d). 
 
1.4.4.3. Composite materials 
Apart from the advantages of CP, summed above, these polymers are characterized by an 
inferior mechanical strength and to achieve sufficient conductivity, they have to be doped 
and oxidized by a counter ion. In order to enhance the mechanical properties, attempts were 
taken to copolymerize the CP with other polymers such as polyvinylchloride 203, but a 
sacrifice in conductivity is unavoidable. The same applies for the addition of dopants, which 
are also characterized by an insulating nature. As a consequence, the overall conductivity of 
CP is limited 204. 
 
To improve the electrical conductivity, charge density, electrocatalytic activity and their 
strength, research has focused on the development of composite materials, wherein 
conductive polymers have been combined with metal nano-particles (NP), metal oxides, 
graphene or carbon nanotubes (CNT). 
In case of glucose sensors, it was shown that metal oxides, metal nanoparticles and alloys 
are able to enhance the sensitivity and selectivity of glucose detection and that they act as 
electrochemical catalysts with high electrocatalytic activity for glucose electro-oxidation. In 
this context, the use of nobel metals such as Pt, Pd, Au and Ni is limited, because of their 
increased price and easy surface poisoning 205. Nevertheless, in literature, Pd nanoparticles 
have been dispersed into nano-fibered PEDOT via a chemical or electrochemical method 206, 
Ni has been used in the development of cubic nickel hexacyanoferrate/polyaniline       
A B C 
D 
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hybrids 205 and thiolated Au NP have been evaluated as immobilization carrier of GOx 207. 
Herein, the biocompatible nature of gold nanoparticles offered a compatible environment 
for the immobilized enzymes 208. 
Carbon nanotubes, which were reported for the first time in 1991 by Iijima et al. 209, are 
characterized by high mechanical strength, electrical conductivity and chemical stability. 
Together with their minimal surface fouling and their ability of low-potential detection of 
hydrogen peroxide, they became very attractive for amperometric glucose sensing 210. 
Next to CNT, the use of graphene has also been explored in CP composite materials. 
Graphene is a 2-dimensional allotrope of carbon in which the carbon atoms are held 
together in a honeycomb like lattice 211. Pristine graphene, graphene oxide (GO) and reduced 
GO (RGO) are recognized as ideal candidates for electrochemical biosensors because of their 
high electrochemical activity. Their combination with CP is only a recent finding and it seems 
that the combination results in improved material properties due to synergetic effects. This 
topic and the use of these composites in sensor applications has recently been reviewed by 
Lei et al. 212 
 
As presented in table 1.3, the discussed composites are applied to enhance the electron 
transfer and the sensor response speed of GOx-based glucose sensors, but recently the 
design and the development of non-enzymatic glucose sensors have gained increasing 
interest (cfr. fourth generation of electrochemical glucose sensors) to meet the enzyme 
electrode drawbacks. Enzymatic detection usually shows good selectivity and high 
sensitivity, but the most common and serious problem of enzymatic glucose sensors lies in 
their lack of long-term stability owing to the nature of the enzymes. 
As a consequence, CP composites have been studied as an alternative, wherein the enzyme’s 
function within the glucose oxidation process is replaced by the composites electro-catalytic 
effect. In this way, direct oxidation of glucose at the modified electrode is enabled.  
Recent literature examples of enzyme-less CP composite-based glucose sensors can also be 
found in table 1.3 (sensing unit is indicated by ‘/’).  
 
A special class of composite conducting polymers include the electroconductive hydrogels 
(ECH), which are polymeric blends or co-networks of inherently conductive electro-active 
polymers and highly hydrated hydrogels. Herein, the electrical, the electrochemical and the 
optical properties of the CP are combined with the in vitro and in vivo biocompatibility, the 
high degree of hydration and the concomitant high diffusion ability of small molecules 
(including glucose) inside the hydrogel material 146. The use of these polymers have been 
studied for implantable biosensor applications including glucose sensors. In this respect, the 
combination of PHEMA and PPy have been applied in a GOx-based sensor design.213 
 
Also in case of redox hydrogels, the use of composites has been studied in an attempt to 
increase the sensor output. In this respect, researchers have investigated the incorporation 
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of enzyme modified graphite particles 214 and single-walled CNT, inside redox polymer 
hydrogels 215.  
 
Table 1.3: Recent literature examples of CP composites used in glucose sensor applications. 
CP Composite material Sensing unit Detection principle Ref. 
PPy CuFe2O4  
Fe3O4 
Graphene  
Reduced graphene oxide + Au NP* 
Au NP 
Carbon nanotubes 
/ 
GOx 
GOx 
GOx 
/ 
GOx 
Amperometry/CV*/EIS* 
Potentiometry 
Amperometry 
Amperometry 
Amperometry 
Amperometry/CV* 
216 
217 
211, 218-219 
220 
221 
222 
PT Cu NP / Electrochemical 223 
PEDOT Graphene/PEDOT-PSS 
Au 
Carbon nanotube 
Pd NP/PEDOT nanofiber 
GOx 
/ 
/ 
/ 
CV 
CV 
Amperometry/voltammetry 
Amperometry 
224  
225 
226 
206 
PANI Poly(styrene-sulfonic acid) MnO2 
Graphene 
Carbon nanotubes 
Au NP 
Cu NP 
Pt NP 
TiO2 
n.s. 
GOx 
GOx 
GOx 
/ 
GOx 
GOx 
n.s. 
CV 
CV 
Amperometry 
Amperometry/CV 
Amperometry 
Amperometry 
227 
228 
229 
230-232 
233 
234-235 
236 
*
CV: cyclic voltammetry (CV); EIS:  electrochemical impedance spectroscopy; PSS: polystyrene sulfonic acid;   
  n.s.: not specified 
 
1.4.5. Improvement of biocompatibility for in vivo applications 
If the developed glucose sensor is intended for in vivo applications, attention should be paid 
to the tissue-sensor interface. In other words, all sensor compounds should be characterized 
by a suitable biocompatibility and to realize this goal, encapsulation of the sensor 
compounds into a suitable packaging biomaterial includes a prerequisite 71. 
Upon implantation, tissue damage will result due to incision and a host reaction will be 
evoked. Initially, due to blood-material interactions, proteins adsorb to the biomaterial 
surface, also called biofouling, and a provisional matrix forms, which constitutes the initial 
blood clot at the material/tissue interface 237. Next, inflammation occurs, which is defined as 
the reaction of vascularized living tissue to local injury. Herein, exudation will occur wherein 
fluid, proteins and blood cells escape from the vascular system towards the injured tissue. In 
the initial stage (i.e. acute inflammation), the migrating cells mainly consist of neutrophils, 
whereas in the next stage of chronic inflammation, mainly monocytes, macrophages, and 
lymphocytes predominate. Continuation of the inflammation stage three weeks post-
implantation usually indicates an infection 237. Action of the monocytes and macrophages 
typically results in the initiation of the healing response. In the end, macrophages represent 
complex cells that secrete a large number of cytokines, which are small protein molecules 
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mediating immunity, inflammation and other actions. During this healing process, the 
formation of granulation tissue is initiated by the recruitment of fibroblasts and vascular 
endothelial cells towards the implantation site. As a result, new small blood vessels are 
created by sprouting of preexisting ones, also called angiogenesis or neo-vascularization. 
Furthermore, because of the action of the fibroblasts, proteoglycans are produced and in a 
later stage collagen, which eventually constructs a fibrous capsule around the implant. Apart 
from the formation of granulation tissue, the foreign body reaction is also characterized by 
the presence of foreign body giant cells (FBGC), which consist of fused monocytes and 
macrophages and which attempt to phagocytose the implanted material. Figure 1.11 
summarizes the different events of inflammation and the wound-healing response. It should 
be noted that the tissue response is dependent on the severeness of the injury created 
during the implantation procedure and of the amount of provisional matrix formation. For 
an in depth discussion of these topics, an excellent review and book chapter of Anderson et 
al. can be consulted 71, 237. Furthermore, possible mechanisms underlying the failure of 
subcutaneously implanted glucose sensors has been reviewed by Gerritsen et al. 238 
 
 
Figure 1.11: Sequence of events involved in inflammatory and wound-healing responses leading to 
foreign body giant cell formation and fibrous capsule formation. The important factors which 
direct monocyte/macrophage fusion are displayed 71, 237. 
 
In order to prevent sensor failure, researchers have tried to control inflammation, the 
biofouling process and the fibrous capsule formation. The upcoming section will indicate 
that polymers again play a crucial role in the realization of these goals.  
 
To control in vivo tissue inflammation, different polymer membranes have been evaluated, 
whether or not releasing anti-inflammatory drugs or other tissue response-modifying agents. 
In this respect, drug loaded poly(vinylalcohol) (PVA) and stacked layer-by-layer assembled 
PVA hydrogels have been evaluated 239. Apart from a decreased inflammation, these 
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materials were also able to supplement the sensor’s oxygen levels. Vallejo-Heligon et al. 
developed tubular, porous dexamethasone-releasing PU coatings which were capable of 
mediating the acute inflammatory response post-implantation 240.  
Dexamethasone and other corticosteroids are able to impair collagen formation in post-
operative wounds and as a consequence, they constitute ideal candidates for inhibiting the 
formation of a fibrous capsule. Conversely, caution is needed, since these hormones tend to 
inhibit angiogenesis by down-regulation of vascular endothelial growth factor  (VEGF) 241. In 
an attempt to control and localize drug delivery, a PVA hydrogel coating has been developed 
which contains dexamethasone-loaded poly(lactic-co-glycolic acid) (PLGA)           
microspheres 242-244. Similarly, Yu et al. developed a coating for implantable glucose sensors 
consisting of dexamethasone loaded PLGA microspheres which were incorporated into a 
nordihydroguaiaretic acid (NDGA) crosslinked collagen scaffold 245. Implantation in rats 
showed a significant decrease in inflammation, nevertheless, a thick fibrous capsule was still 
present around the implant 246.  
In addition to dexamethasone, Grifford et al. suggested the use of nitric oxide to be used as 
inflammatory agent in biosensor devices, as it is known to play a role in wound healing by 
the down-regulation of mediators, active during inflammation 247. In this respect, PU-based 
membranes, which are frequently used as the outer membrane in electrochemically-based 
glucose sensor systems are typically used as polymer carrier 248-249. 
 
As part of the inflammation process, many researchers have focused on the reduction of 
biofouling, which describes the initial adhesion of proteins and cells onto implanted 
materials. This process has been indicated as the primary reason for sensitivity losses of 
sensors during the first 24 hours after subcutaneous implantation. Gifford et al. identified 
serum albumin as the primary biomolecule responsible for this fact. Additional compounds 
include biomolecule fragments with a molecular weight below 15 kDa, IgG (169 kDa) and 
fibrinogen (340 kDa).  As these compounds adhere to the sensor surface, diffusion of glucose 
towards the sensing elements is decreased due to the formation of a diffusion barrier but 
also due to the consumption of glucose by attached cells 15. Furthermore, if proteins reach 
the electrode itself, passivation occurs, which hampers H2O2 oxidation in case of enzyme-
based sensors 250.  
To prevent the aspecific protein binding, several polymer membranes have been evaluated 
as electrode coatings for their anti-biofouling potential. The most promising results have 
been obtained with the hydrogel-based materials, wherein poly(ethylene glycol) (PEG) is 
most frequently used because of its favorable biocompatibility. Due to its polar, water-
swellable nature, a hydrophilic interface is created between the solid surface and aqueous 
bulk, which masks the underlying surfaces 251. This hydrophilic shell is responsible for the 
PEG’s protein-repellant nature and forms the basis of this stealth behavior. Recently, Chu et 
al. developed a closed loop insulin delivery system (cfr. figure 1.5) and they observed that 
PEGylation of the sensor surfaces with chains of 20 kDa resulted in minimal inflammation 
after 30 days of subcutaneous implantation in rats. Furthermore, a decreased thickness of 
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the fibrous capsule (<50 µm) was observed compared to the non-PEGylated surfaces and in 
case a lower molecular weight was applied (2 kDa) (<500 µm) 114, 252. The biocompatible 
properties of PEG were further demonstrated by the subcutaneous implantation of a 
crosslinked 8-armed amine-terminated PEG hydrogel, since few adherent cells such as 
macrophages, neutrophils, foreign body giant cells, fibroblasts and collagen were     
observed 253. Heo et al. developed a fluorescence based sensor, encapsulated in a PEG-
bonded polyacrylamide hydrogel and implantation in the ears of mice revealed reduced 
inflammation compared to the non-PEGylated sensor 254. 
Another hydrogel example, which is characterized by a promising in vivo biocompatibility 
includes PHEMA. In this respect, copolymers of HEMA and 2,3-dihydroxypropyl methacrylate 
(DHPMA) have been synthesized, in which the porosity and mechanical properties were 
improved by using N-vinyl-2-pyrrolidinone and EGDMA. The in vitro glucose diffusion 
coefficients were determined 255 and implantation of the hydrogel coated GOx/epoxy-PU 
based Pt sensors resulted in a maintained function for at least 21 days in rats. Furthermore, 
a reduced foreign body capsule (FBC) thickness was observed compared to the bare epoxy-
PU based Pt sensors 256. It was also shown that copolymers of PEG and PHEMA resulted in 
less fibrous encapsulation after subcutaneous implantation in rats 82 and that the use of 
dense and oriented PHEMA brushes are effective in the exclusion of proteins from the 
sensor surface 257.  
As a short-term solution to biofouling, phospholipid-derived coatings including 
phosphorylcholine-based polymers 258-259, which represent a biomimitic of the cell 
membrane of red blood cells and Nafion membranes (i.e. perfluorosulfonic acid-based 
polymers) have also been studied 251.  
Apart from these synthetic hydrogel materials, naturally derived coatings have also been 
used, such as chitosan, alginate, collagen, dextran and hyaluronic acid 260. However, their 
natural variability, immunogenic nature and difficult processability include important 
disadvantages when considering their application in implantable devices.  
As reviewed by Wisniewski et al., apart from polymer-based approaches, diamond-like 
carbon, surfactants and flow-based approaches could also be applied to reduce biofouling of 
a biosensor 251.  
 
Apart from biofouling prevention, other researchers mainly focused on the development of 
modification methods to decrease or prevent fibrous capsule formation, also called the 
foreign body capsule (FBC). In order to realize this goal, research focused on the stimulation 
of angiogenesis in close proximity of the sensor. In this respect, based on a computational 
model, Novak et al. could prove that sensor lag times are mainly dependent on the thickness 
of the FBC, whereas the attenuation of glucose that reaches the sensor surface is mainly 
determined by vessel density and capsule porosity or density 261. In other words, the 
creation of a well-vascularized capsule would result in an enhanced glucose sensor function 
because of improved glucose diffusion towards the sensor, a process which is hampered in 
case a fibrous avascular capsule is formed.  
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In order to stimulate angiogenesis around implanted glucose sensors, different strategies 
have been explored. 
Since Ward et al. could demonstrate that the transforming growth factor β (TGFβ), a 
cytokine expressed by macrophages, plays an important role in the formation of FBC around 
subcutaneously implanted devices, they attempted to block the cytokine’s action by the 
subcutaneous delivery of a TGFβ neutralizing antibody nearby the implanted sensor. 
Nevertheless, even after 28 days, they could not prove the success of this event 241. 
However, they could prove that the thickness and density of the FBC increased with the 
thickness of the implant and decreased in case of higher material porosity. These 
conclusions were conducted from the comparison between, on the one hand, porous PVA 
sponges and expanded poly(tetrafluoroethylene) (ePTFE) and on the other hand, solid PU 
and a PU multipolymer containing silicone (S) and poly(ethylene oxide) (PEO) (PU-S-PEO) 262. 
They also showed that the use of ePTFE resulted in an increased neovascularization, a fact 
which was also observed by Updike et al. They prepared an amperometric glucose sensor, 
which consisted of a GOx-loaded PU membrane, covered by a bioprotective membrane to 
prevent contact with macrophages and a ePTFE layer to enhance angiogenesis. Application 
of the latter porous membrane indeed resulted in stable subcutaneous glucose 
measurements in dogs for 5 months 263. Additionally, Koschwanez et al. demonstrated 
enhanced angiogenesis around a commercial MiniMed SOF-SENSOR (Medtronics) which was 
encapsulated with a porous PLLA membrane 264. 
Apart from varying the implant’s geometry, stimulation of angiogenesis could also be 
triggered by the local release of angiogenic factors such as vascular endothelial growth 
factor (VEGF). Herein, Ward et al. could prove that local and prolonged VEGF infusion 
resulted in high local vascular densities around a biosensor 265.  
Since the aforementioned approaches only deal with one aspect of the foreign body 
reaction, only a decreased intensity of this reaction is obtained for most studies. As a 
consequence, some researchers stressed the need for approaches, which combine different 
strategies. In this respect, Norton et al. and Patil et al. incorporated both Dex and VEGF in 
antibiofouling hydrogels to successfully lower inflammation, inhibit fibrosis and stimulate 
neovascularization in vivo 266-267. Also Ju et al. pointed out that superior host responses could 
be expected upon combining their developed porous collagen scaffold, which encapsulated 
an electrochemical glucose sensor, with anti-inflammatory drugs or angiogenic factors 268.   
 
Despite of all these interventions, the present commercially available glucose sensors, 
targeting continuous glucose monitoring, only survive for a maximum of several weeks in 
vivo, which clearly reflects the need for improved systems. 
 
1.4.6. Conclusion  
In the world of glucose sensors, the function of polymers is manifold. Different polymer 
classes have been identified, including classical thermoplastic polymers, conductive 
polymers, composites and hydrogels. In literature, their use as permselective membrane, 
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immobilization matrix of the sensing unit, glucose recognition element, electron transfer 
matrix and biocompatible coating has been described. It can be stated that each material 
class is valued because of its unique characteristic properties, such as hydrogels for their 
water swellable capacity, CP for their electron conductivity, whereas their composites, for 
example, combine the best of two worlds. Remarkably, if all above functions within glucose 
sensor applications are considered, it seems that the hydrogels are applicable in each 
functional category, which stresses the unique and versatile characteristics of this material 
class.   
 
In case in vivo use of the glucose sensor is intended, the greatest challenge still includes 
addressing and controlling the foreign body response. In this respect, a multifaceted  
approach (control of polymer geometry, drug loading, etc), would be the most effective one. 
The current PhD mainly focuses on this subject.   
 
 
1.5.   Research goals and thesis outline 
As mentioned in §1.2, the main goal of this PhD consists of the development of a packaging 
material for embedding an optical, implantable continuous glucose sensor. 
Based on the proposed concept, described in § 2.1, the packaging material should fulfill the 
following requirements:  
(1) It should offer an appropriate mechanical compatibility with subcutaneous tissue. In 
literature, the ideal bulk (i.e. mechanical and swelling) properties for an implantable 
packaging material have not yet been described. As a consequence, in the current work, a 
suitable range of bulk properties is targeted.  
(2) It should be transparent in the NIR region to enable high signal/noise glucose 
measurements. 
(3) It should be compatible with the sensor compounds. Herein, excellent adhesion between 
the polymer packaging and the sensor compounds should be pursued as well as the ability of 
the polymer packaging to act as a bidirectional diffusion barrier. 
(4) It should enable proper in vivo integration. This implies that the body reaction may not 
alter the accuracy of the glucose measurements. A suitable surface chemistry of the 
packaging material is thus required which is able to control the triggered body response. 
 
To fulfill the above-described requirements, two main goals are pursued in the current work. 
First, the development of a flexible packaging material is targeted. Since poly(methyl 
methacrylate) is known in the biomedical world as a biocompatible, FDA (Food and drug 
administration)-approved material, it was chosen as a starting material to develop more 
flexible alternatives, which could serve as a robust packaging of an optical glucose sensor. As 
a consequence, in chapter 2, an overview is given of the current use of PMMA in the 
biomedical world, followed by the screening of different MMA-based copolymer(s) 
(networks), wherein poly(ethylene glycol) (PEG) and other methacrylate-based co-
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monomers are incorporated as building blocks. Apart from an extensive screening of the 
mechanical and swelling properties of the different candidates, the optical properties in the 
NIR region, the cell cytotoxicity and the compatibility with the sensor compounds are 
investigated.  
 
Once implanted, the second goal of this work includes the induction of the desired body 
response, which is mainly determined by the sensor-tissue interface. As a consequence, a lot 
of attention is paid to the surface modification of the developed packaging materials. Since 
the developed materials are characterized by an inert character (i.e. do not contain 
chemically reactive functional groups), chapter 3 focuses on the surface activation of the 
non-functional polymer materials. Herein, two modification strategies, including the 
deposition of polydopamine (PDA) and the post-plasma grafting of 2-aminoethyl 
methacrylate (AEMA) are described and the characterization of the surface layers via 
multiple surface characterization techniques is presented.  
 
Due to the presence of surface functionalities, in a subsequent step, biofunctionalization of 
the polymer materials is enabled, i.e. the introduction of bioactive groups that enhance the 
cell interactivity of the starting materials. To this end, two strategies are followed. The first 
strategy mainly focuses on the improvement of tissue integration of the developed 
materials, in order to prevent the formation of an isolating fluid pocket around the sensor. 
To this end, a universal modification strategy based on gelatin has been developed, which 
should ensure long-term in vivo integration of the implant. In a second strategy, to further 
stimulate glucose diffusion towards the sensor, the stimulation of angiogenesis is targeted. 
To this end, the immobilization of VEGF and vascular endothial cadherin antibody (VE-cad 
AB) has been studied. Characterization of the different biofunctionalized surfaces is 
presented in chapter 4, as well as the in vitro evaluation of the different (un-)modified 
materials. Herein, the cell viability (live/dead assays) and cell adhesion properties (immuno-
assay) are studied by the fluorescent staining of different relevant cellular compounds.  
 
Next, in chapter 5, the results are presented of the in vivo experiments. In a first section,  the 
sensor fabrication with the help of an ‘in-house-built’ mould is described. Secondly, the 
in vivo evaluation of the surface modified sensor packagings is overviewed. Next, a 
description is given of the attempts made for the in vivo administration of glucose. Finally, to 
gain insight in the current sensor concept, the explanted sensors are evaluated in an in vitro 
setting.  
 
Finally, in chapter 6, the main principles of the used bulk and surface characterization 
techniques, as well as the  experimental protocols are listed. In chapter 7, the main 
conclusions and future perspectives are summed and in chapter 8, a dutch summary is 
provided. 
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2.1. Introduction 
In this chapter, focus is laid on the development of different methacrylate-based materials 
which should serve as packaging for an optical glucose sensor. To this end, poly(methyl 
methacrylate) (PMMA) was selected as a starting material, since it has already proven its 
utility for biomedical applications in the past. As a consequence, the first part of this chapter 
overviews the use and importance of PMMA, including its discovery, its applications, its 
production processes and its bulk modifications. In this way, the position of PMMA in the 
biomedical society will be demonstrated. 
 
Since the ultimate aim implies a subcutaneous implantation, the applied material should 
exhibit specific mechanical properties in addition to its biocompatibility (to be discussed in 
chapter 4). Intuitively, from the patient’s viewpoint, a certain softness and material flexibility 
would be required to assure the patient’s comfort after sensor implantation. On the other 
hand, in order to enable successful glucose measurements, all components (a.o. source, 
detector, etc.) should remain in place during the molding procedure as well as after 
implantation. As a consequence, apart from softness and flexibility, the material should also 
exhibit a certain rigidity. To this end, the chapter focuses on the development of a series of 
MMA-based copolymers and networks in an attempt to fine-tune the mechanical properties 
of PMMA for the envisaged application. Due to the lack of literature reports that determine 
a defined range of bulk properties an implantable packaging material should fulfill, we aimed 
in the current work to gain more insight into this topic by screening a range of polymers with 
divergent bulk properties. To develop such a range, two strategies were pursued, including 
(1) the integration of hydrophilic, protein-repellant poly(ethylene glycol) (PEG) in the 
polymer structure (see § 2.4) and (2) the evaluation of long-tailed hydrophobic 
methacrylates (see § 2.5). 
Since hydrophilic compounds are applied in the first strategy, the swelling behavior of the 
developed materials was also evaluated. Indeed, high swelling percentages might result in 
inferior adhesion of the polymer to the sensor surface and corrosion (see § 2.6.2) of the 
sensor compounds because of the influx of interstitial fluid. Furthermore, this influx might 
cause leaching of sensor electronic’s ions which might result in the occurrence of adverse 
body reactions such as inflammation. As a result, polymer swelling should be minimized. 
Apart from the above-mentioned physical properties, the optical properties were also 
assessed. Transparency of the different materials in the near IR-region (NIR) of the light 
spectrum is a key property, as this region is used to perform glucose measurements (see § 
2.6.1).  
In a last part of this chapter, a preliminary evaluation of the cell interactive properties is 
presented (see § 2.6.3). Since implantation is targeted, minimal cell toxicities should be 
pursued. 
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2.2. PMMA as biomedical material 
2.2.1. PMMA: a short history  
One of the most widely studied vinyl-based polymers includes poly(methyl methacrylate) 
(PMMA), an amorphous material, which is known to be very hard and brittle. When PMMA 
was discovered (1877; patented in 1933), the use of the homopolymer was centralized and 
during World War II (WWII), it functioned as aircraft windows, submarine periscopes, gun 
turrets for airplanes, etc. In the medical world, it became very popular as hard tissue 
replacement because of its biocompatibility and its ability to fulfill load bearing functions 1. 
Actually, its biocompatibility was discovered by the English ophthalmologist Harold Ridley. 
He examined WWII pilots that suffered from PMMA ocular splinters stemming from the 
windows of crashed airplanes. He observed that almost no rejection occurred and that 
healing was initiated. As a consequence, in 1949, Dr. Ridley implanted the first intra-ocular 
PMMA lens (IOL) in an attempt to cure cataract 2-3. In the meantime, in 1948, Kevin Tuohey 
produced the first hard PMMA contact lenses, which were a replacement of the glass scleral 
contact lenses already used in that time 4-6 (see figure 2.1).  
Apart from ophthalmology, PMMA also plays a crucial role in the world of orthopedics 7.  In 
1960, Sir John Charnley developed the first total hip implant, wherein PMMA functioned as 
bone cement 8. This cement interfaces the steel/PE prostheses and the human bone to 
minimize adverse body reactions 9 (see figure 2.1).    
 
 
Figure 2.1: Applications of PMMA as intra-ocular lens, contact lens and bone cement. 
 
For dentistry applications, since its early years, PMMA has also proven its utility as dental 
adhesive and resin 10. More recently, micro- and nano- PMMA spheres became popular as a 
component in vaccine formulations, as drug carrier but also as fillers for cosmetic  
surgery 11-13. Logically, in all of these fields, certain limitations were noted and continuous 
modifications had to be performed to produce improved materials. As a result, composite 
materials as well as copolymers have been developed starting from PMMA (see § 2.2.3). As 
an example, table 2.1 overviews some recent applications of PMMA, discussed in literature. 
Chapter 2 | Synthesis and characterization of  UV-curable MMA-based packaging materials  
 
70 
 
Table 2.1: Overview of recent applications of PMMA. 
Application References 
Dentistry-related applications 14-16 
Prevention of infection / biofilm formation on implants 17-19 
Orthopedic applications 20-25 
Ophtalmology 19, 26 
Particulates for drug delivery 11, 27-29 
Membrane filters 30 
Microfluidics 31-34 
Lenses (photovoltaics) 35-37 
Batteries 38-40 
Sensors 41-42 
 
2.2.2. PMMA: production processes 
Depending on the application, different polymerization processes can be applied to 
synthesize PMMA or MMA-based materials. Radical polymerizations are the ones mostly 
described in literature. These cover conventional radical polymerizations, which can be 
performed in solution or bulk, with the help of a thermal radical initiator such as 
benzoylperoxide (BPO) and Azobisisobutyronitril (AIBN) or a UV-sensitive radical initiator 
such as Irgacure 2959.  
In case well-defined molecular weights (Mw) and Mw distributions are a prerequisite, 
controlled radical polymerizations can also be performed, because these processes are 
capable to retard chain transfer and termination. In general, an initiator, catalyst and 
sometimes a chain-end stabilizer will be required 43. In order to  produce well-controlled 
PMMA, research focuses on the evaluation of different initiating systems (i.e. initiator and 
catalyst) such as the use of alkylhalides (e.g. CCl4) in the presence of ruthenium-based (e.g. 
RuCl2(PPh3)3) 
44-45, nickel based 46-48 copper-based 49-50 or aluminium-based complexes 51 or 
the use of AIBN and FeCl3 in the presence of triphenylphosphine 
50, 52. The use of functional 
initiators permits the introduction of specific end-group functionalities into the polymer 
structure 48. Furthermore, this method allows for the production of uniform and more 
complex polymer architectures such as MMA-based block copolymers 53-54, star shaped 
PMMA 55-56 and uniform stereoblock PMMA 51.  
 
A special case of living radical polymerization (LRP) includes the surface initiated LRP. Herein, 
the initiator is immobilized on a surface and the polymer chains are subsequently grown in a 
controlled way from this surface. As a result, PMMA brushes can be created on top of 
different materials such as on gold films 57-58, gold nano-particles 59-60, silicon wafers 61 and 
silica (nano)particles 62-64. As an example, these brushes may serve as etching barriers 61. 
Apart from bulk PMMA and PMMA brushes, PMMA particles can also be produced and will 
mostly function as particulate carriers for drug delivery 13. The most applied polymerization 
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technique in this field would be emulsion polymerization and the different variants are 
excellently reviewed by Bettencourt et al.11 
Next to radical polymerizations, also anionic polymerization reactions with MMA have been 
reported in literature 65-66, as well as the use of click chemistry 67. 
In this work, a radical UV-induced polymerization process was selected as the preferred 
polymer production process, as explained in paragraph 2.3. 
 
2.2.3. PMMA-based composites and copolymers 
Over the years, researchers have always tried to adjust the bulk properties of existing 
materials. In case of polymer materials, two main strategies co-exist:  
1) Production of composites: inorganic fillers are used to fine-tune the polymer 
properties 
2) Copolymerization strategy: the properties of different homopolymers are combined 
by reacting their respective building blocks. 
 
In case of PMMA-based composites, a lot of studies have been conducted in an attempt to 
improve its physical properties such as its tensile strength, its heat resistance, gas 
permeability and even its conductivity, all with a minimum loss in transparency 68. As a 
result, nanocomposites gained a lot of interest. Examples include the introduction of 
graphite-based compounds 69-71, (multi-walled) carbon nanotubes via in situ bulk 
polymerization 72-77, sulfides such as ZnS 78-79 and MoS2 
80, clays 81-84, alumina 85 and silicium-
based compounds 68, 86-87. In the medical world, a typical example could be given by 
PMMA/hydroxyapatite (HA) composites. Herein, HA, a major inorganic component of bone, 
stimulates the adhesion of PMMA cement to bone as well as the subsequent bone  
growth 88-90. Furthermore, the introduction of silver nanoparticles was studied to enhance 
the antibacterial properties of PMMA 91. 
Apart from composites, many researchers apply the principle of copolymerization to alter 
material properties. A lot of MMA-based materials have already been investigated and 
examples of comonomers include methacrylic acid 92, styrene 93 and aldehyde-functionalized 
poly(ethylene oxide) (PEO) 94. In the last case, copolymerization was facilitated by amination 
of PMMA. 
Also in the medical world, this strategy has been applied in an attempt to adjust the material 
properties of PMMA. In the context of contact lenses, MMA has been copolymerized with N-
vinylpyrrolidinone to create soft daily contact lenses which are characterized by a much 
higher oxygen permeability compared to the original hard ones 4. For IOL’s, sulfonate and 
carboxylate bearing monomers were used in an attempt to modulate fibroblast   
proliferation 95-96. Furthermore, to apply PMMA as a stent coating, it should elicit sufficient 
flexibility and elasticity. In this respect, the copolymerization of MMA and hydroxyethyl 
methacrylate  (HEMA) has already been studied 97. 
It should be noted that the use of polymer blends could include a third way of altering the 
mechanical and physical properties of a material. In case of PMMA, examples of this strategy 
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include the combination of PMMA with polyaniline 98 and polystyrene 99. Furthermore, the 
creation of interpenetrating networks could also be mentioned, such as with isocyanate-
functionalized poly(ethylene glycol) 100. 
 
 
2.3. UV-induced polymerization for the production of methacrylate-based 
polymers 
As mentioned in §2.2.2, several techniques can be used to polymerize methacrylate-based 
compounds. Herein, all polymers were produced via a radical UV-induced bulk 
polymerization reaction of which the set-up is displayed in figure 2.2. The monomer/initiator 
solution is injected in a pre-shaped silicon spacer, which is placed between two teflon foil 
covered glass plates. The release foil prevents the monomers to interact with the glass via 
hydrogen bonds and ensures a straightforward release of the produced polymers. 
 
Figure 2.2: Schematic representation of the applied UV-polymerization setup. The teflon sheets 
covering the glass plates are not shown. 
 
The UV-induced film casting technique is selected because of several key advantages 101:  
o low cost approach 
o low energy consumption 
o process feasible at ambient temperature  
o solvent-free formulations are used thus excluding a drying step  
o favourable reaction kinetics  (< 90 minutes reaction, compared to 24 hours in case of 
solution polymerization)  
o high yields are obtained, thus excluding purification procedures 
 
Furthermore, since the materials should embed optical compounds, it is also desirable to 
immediately mold the implant in the required shape, given that an appropriate mold is 
developed (see chapter 5).  
The main disadvantage of the bulk polymerization technique is the inferior control over the 
molecular weight of the final polymer obtained. In bulk, the mobility of the reacting units 
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will decrease because of an increasing viscosity of the reaction medium during 
polymerization. As a result, the active polymerizing chains become restricted in movement 
and thus the rate of termination becomes limited due to a limited diffusion of the growing 
chains. The diffusion of monomer, on the other hand is less affected by the viscosity changes 
and because of the limited termination, monomer consumption will increase rapidly. This 
autoaccelaration effect, also called Trommsdorff effect, causes a significant raise in the 
weight average molecular weight (Mw), but only a moderate increase in the number average 
molecular weight (Mn) and is thus reflected by high polydispersity values 102. For the 
envisaged application, this disadvantage is clearly surpassed by the plethora of advantages 
listed above. 
  
In order to conduct a UV-induced polymerization, a suitable photo-sensitive initiator is 
required, which is also non-toxic. Previous studies have already shown that the initiator 1-[4-
(2-hydroxyethoxy)-phenyl]-2-hydroxy-2-methyl-1-propanone (i.e. Irgacure® 2959) exhibits 
the lowest cell toxicity throughout an extensive range of mammalian cells, compared to 
alternative initiators, such as Irgacure® 651 and 184 103. As a result, Irgacure® 2959 was 
selected and applied. 
The conducted reactions follow a radical mechanism as depicted in figure 2.3, which 
illustrates the radical polymerization of a random methacrylate-based monomer using 
Irgacure® 2959 as an initiator.  
Upon UV irradiation, Irgacure® 2959 dissociates with the formation of free radicals (cfr. the 
initiation step), which react with the methacrylate-based monomers to form long polymer 
chains (cfr. the propagation step). The chain reaction terminates when two radical species 
combine or disproportionate (cfr. the termination step).  
 
In dentistry, a photopolymerization or curing is extensively used to perform dental 
restaurations and for sealant application 104-105, but also in the coating industry, the 
technique is very important for surface protection of various materials 106.  Furthermore, in 
the field of tissue engeering, photopolymerization is widely applied for the production of 
hydrogel networks to be used as tissue barriers, drug delivery systems and as cell carrier 
scaffolds to stimulate tissue regeneration 107. The use of photo-initiated polymerizations in 
the context of biomaterials has been extensively reviewed a.o. by Fisher et al 108. 
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Figure 2.3: Reaction mechanism of the polymerization of a random methacrylate-based monomer, 
initiated by Irgacure® 2959. ‘R’ is referring to a random side chain (e.g. methyl, PEG,…), whereas ‘P’ 
is referring to a polymer chain which is grown according to the above-mentioned mechanism (i.e. 
initiation and propagation). 
 
 
2.4. Development of poly(ethylene glycol)-based materials 
In a first attempt to develop a suitable packaging material for an optical glucose sensor, PEG-
containing macromonomers were selected and copolymerized with MMA. PEG is the most 
commonly applied non-ionic hydrophilic polymer and is known for its low intrinsic toxicity, 
which renders it ideal for biomedical applications. PEG-based coatings have already been 
recognized as efficient ‘non-fouling’ surfaces 109-113 while in the field of drug delivery, it has 
proven its use as an excellent shielding agent for in vivo delivery of various bioactive 
compounds including drugs and peptides 113-115. Apart from being applied as drug excipient, 
PEG is approved by the Food and Drug Administration (FDA) for its use in cosmetic    
products 116.  
In the present work, PEG is mainly selected for its protein repellent properties. As pointed 
out in chapter 1, proteinaceous fouling on the sensor surface or membrane is one of the 
main reasons why the stability and reliability of most commercially available sensors 
decreases after implantation. As a consequence, PEG-based copolymers were selected as 
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potential sensor packaging material. Variation of the PEG molecular weight, its functionality 
and composition enabled to fine-tune the final material properties. 
Paragraph 2.4.1 will report on the different starting compounds and the production of the 
selected homopolymers. Next, in the following paragraphs the different PEG-based 
copolymers will be described and their bulk properties will be evaluated.  
 
2.4.1. Characterization of the starting compounds and the homopolymers. 
Two PEG-based methacrylates were selected for the copolymerization with MMA, including 
poly(ethylene glycol) monomethyl ether monomethacrylate (PEGMA) as monomer and 
poly(ethylene glycol) dimethacrylate (PEGDMA), as crosslinker. For both compounds, the 
number of ethylene glycol (EG ) repeating units was varied (cfr. different molecular weights) 
and its effect was investigated. More specifically, for PEGMA, molecular weights of 500 
g/mol (PEGMA(500)) and 1100 g/mol (PEGMA(1100)) were studied whilst for PEGDMA, the 
molecular weights were 550 g/mol (PEGDMA(550)), 750 (PEGDMA(750)) and 1154 g/mol 
(PEGDMA(1150)). The structure and proton NMR spectra of the different starting 
compounds are displayed in figure 2.4. These NMR spectra will form the base for structure 
elucidation of the to-be-developed polymers. The different peak annotations are overviewed 
in the experimental part (see chapter 6, § 6.2.1.1).  
 
 
Figure 2.4: 1H-NMR spectra of MMA (top), PEGMA(500) (center, n=9) and PEGDMA(550) (bottom, 
n=9), recorded in CDCl3. The indices (a,b,c,…) link the protons with the corresponding peaks. 
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During the course of this work, the vinyl proton peaks were of major importance, because 
their disappearance indicated a successful polymerization/crosslinking. Completion of the 
polymerization is a prerequisite to minimize possible leaching of the starting monomers and 
potential inflammation in vivo. As a consequence, the UV irradiation time was optimized for 
each starting compound in order to ensure full conversion. Figure 2.5 summarizes the 
optimization results for MMA, PEGMA(500) and PEGDMA(550).  
 
For MMA, as anticipated, a decrease in peak area corresponding to the double bond protons 
(at 5.47 and 6.02 ppm) was obtained upon increasing the irradiation time (see figure 2.5, A). 
Furthermore, new signals arose between 0.75 and 1 ppm, representing the protons in the 
polymer backbone (indicated by arrows in figure 2.5, A). Moreover, upon polymerization, a 
shift could be observed of the peak corresponding to the methyl-ester (H3C-O-C=O) group 
from 3.53 ppm to 3.69 ppm (see spectra b and c). Figure 2.5 (A) also includes a spectrum of 
the initiator (spectrum d), Irgacure® 2959, in order to identify the additional peaks present in 
spectra b and c.  
 
Quantification of the conversion (see figure 2.5, B and chapter 5, experimental part) was 
enabled by the calculation of the following ratio: 
 
                 %100*
3/))()((
2/)(
(%)
53.369.3
02.647.5
polymerImonomerI
I
Conversion
ppmppm
ppmppm


                   (2.1)        
              
Herein, the integration in the numerator resembles the double bond protons, whereas the 
integrations in the denominator resemble the methoxy protons. As a result, the PMMA 
synthesis in the presence of 2 mol% initiator resulted in a conversion of 98% after 90 
minutes of UV irradiation. 
 
For PEGMA, irradiation times of 2, 6, 10 and 20 minutes were evaluated and after 20 
minutes, all double bond protons disappeared (figure 2.5, C). Compared to PMMA, the PEG-
based oligomer is characterized by superior conversion kinetics (figure 2.5, D), due to the 
lower viscosity of the reaction mixture. As a consequence, the UV irradiation time of the 
copolymers was set between 20 and 90 minutes, depending on the PEGMA/MMA 
comonomer ratios (see § 2.4.2).   
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Figure 2.5: A: Overlay of the 1H NMR spectra of MMA (a), PMMA after 30 minutes (b) and 90 minutes (c) 
of UV irradiation and Irgacure® 2959 (d). B: MMA conversion as a function of UV irradiation time (365 
nm). C: Overlay of the 1H NMR spectra of unreacted (a) and reacted PEGMA(500) after 6 (b), 10 (c) and 
20 minutes (d) of UV irradiation. D: PEGMA conversion percentage as a function of UV irradiation time. 
E: 1H NMR spectra of the soluble fraction obtained after soxhlet extraction in ethanol of the 
homopolymer PEGDMA(550) (a), the starting oligomer PEGDMA(550) (b) and Irgacure® 2959 (c). All 
NMR solutions were prepared in CDCl3. 
0 
20 
40 
60 
80 
100 
0 30 60 90 120 
C
o
n
v
e
r
si
o
n
 (
%
) 
UV-irradiation time (min) 
0 
20 
40 
60 
80 
100 
0 5 10 15 20 
C
o
n
v
e
r
si
o
n
 (
%
) 
UV-irradiation time (min) 
A B 
C D 
E 
Chapter 2 | Synthesis and characterization of  UV-curable MMA-based packaging materials  
 
78 
 
For PEGDMA, a similar optimization was performed. Conventional 1H-NMR spectroscopy was 
not applicable since the homopolymer of PEGDMA is crosslinked, rendering dissolution 
impossible. Furthermore, HR-MAS spectroscopy measurements was neither a valid 
alternative because of a too high crosslinking degree 117. Therefore, soxhlet extractions were 
conducted to quantify and identify the soluble fraction of the produced samples. Different 
irradiation times were again evaluated (10, 20 and 30 minutes). The results showed that 
after 10 minutes, the crosslinking reaction was completed. The soluble fraction amounted 
1.6% and mainly consisted of an excess of ‘leached-out initiator’, as evidenced by 1H NMR 
spectroscopy (figure 2.5, E).  
As a consequence, for the production of the MMA/PEGDMA copolymer networks, the UV 
irradiation time was varied between 10 and 90 minutes, depending on the PEGDMA/MMA 
comonomer ratios (see § 2.4.3).  
 
As PMMA was used as a reference material, the UV-polymerized sheets were fully 
characterized. The properties are summarized in table 2.2. 
Tensile tests confirmed the fact that PMMA acts as a strong (E-mod of ± 1600 MPa) but 
brittle (elongation of 3%) material. In literature, the E-modulus of PMMA typically varies 
between 710 MPa and 5000 MPa 118-123, while the elongation is around 3 % 121. These 
variations can typically be attributed to variations in polymer molecular weight, different 
production processes applied for sample preparation, the shape of the test specimens and 
the instrument settings. Furthermore, PMMA reveals a  hydrophobic character since almost 
no swelling was obtained (i.e. 2%). By applying a UV-induced radical polymerization, a 
molecular weight of 30000 g/mol was obtained and the polydispersity (PD= 2.9) clearly 
reflected the method of synthesis, since more controlled polymerizations result in 
polydispersities < 1.5 or even around 1.  
 
Table 2.2: Characteristics of PMMA, produced via UV-induced bulk polymerization 
Mechanical properties   
E-modulus (Mpa) 1595 ± 357 
Elongation (%) 3 ± 1 
Force at break (N) 96 ± 24 
Swelling properties   
Swelling (%) 2.0 ± 0.2 
Molecular weight   
Mn (g/mol) 30000 ± 800 
Polydispersity  2.9 ± 0.0 
 
In the upcoming paragraphs, the results of a full screening of the different copolymer 
formulations is described. The initial focus will be on the PEGMA-based copolymers (§ 2.4.2), 
followed by the PEGDMA-based networks (§ 2.4.3). Finally, combinations of the three 
starting compounds will be evaluated (§ 2.4.4). 
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2.4.2. Development and evaluation of copolymers of MMA and poly(ethylene glycol) 
monomethyl ether monomethacrylate. 
The first series of PEG-based copolymers were non-crosslinked and constituted of methyl 
methacrylate (MMA) and poly(ethylene)glycol monomethylether monomethacrylate 
(PEGMA) of different molecular weights. First, the maximum amount of PEGMA to be 
incorporated in order to produce rigid materials was determined. In case of PEGMA(500), 
solid materials were obtained if the incorporated percentage was lower than 20 mol%. As a 
consequence, 15 mol% was selected as limit. In case of PEGMA(1100), this limit was set to 7 
mol% as the incorporation of higher mol% PEGMA(1100) resulted in sticky, glue-like 
materials. This is related to the low glass transition temperature of this polymer (Tg < -60°C). 
The structure of the developed copolymers was evidenced by means of 1H-NMR 
spectroscopy. Figure 2.6 displays the spectra of a random co-polymer, together with the 
corresponding peak assignments. 
 
 
 
Figure 2.6: 1H NMR spectrum of P(MMA-co-PEGMA(500)) recorded on a 300 MHz device (A) and 
the 2D cosy NMR spectrum of the same compound, recorded on a 500 MHz device (B), both in 
CDCl3. 
 
When comparing with figure 2.4 (a), it is clear that the peak at 3.3 ppm (i.e. peak c2) 
represents the methoxy protons of the PEG-units while the signal at 4 ppm (i.e. peak d1) 
corresponds to the -CH2- protons adjacent to the ester functionality in the same PEG-
A 
B 
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segment. Based on the integrations of the peaks at 3.53 (peak c1) and 3.58 ppm (peak d3) 
and the known composition of the synthesized polymer, the one at 3.58 ppm (i.e. peak d3) 
could be assigned to the ether protons in the PEG side chain, whereas the one at 3.53 ppm 
(i.e. peak c1) could be annotated to the methyl-ester-protons of the MMA-units. To verify 
these results, a 2D cosy NMR spectrum was recorded. From figure 2.6 (B), it is evident that 
the peak at 4.05 ppm (peak d1) and the one at 3.65 ppm (d3) couple, which implies that 
both proton types are part of the same building block, being the PEG-based compound.   
 
Based on literature, it can be anticipated that an almost ideal random copolymer will be 
obtained, since the reactivity ratios of MMA and PEGMA are 0.95 and 1.05 respectively 124. 
Nevertheless, it should be pointed out that these parameters were determined for a 
conventional solution polymerization and upon applying a much lower molar ratio for 
PEGMA compared to MMA.  
 
Next, the molecular weight of the different copolymers, as well as their polydispersities were 
determined. Table 2.3 gives an overview of the copolymer compositions and the GPC results. 
Compared to PMMA (table 2.2), slightly higher molecular weights are obtained, which is due 
to the higher molecular weight of the PEG building blocks, but similar high polydispersities 
were obtained, which is again inherent to the used bulk polymerization technique. 
 
Table 2.3: Copolymer compositions which were synthesized and analyzed by GPC. 
Sample MMA(mol%) PEGMA(500)(mol%) Mn stdev DP stdev 
1 95 5 43700 700 2.8 0.03 
2 90 10 50200 1100 2.6 0.03 
3 85 15 47700 3400 2.3 0.12 
 
MMA(mol%) PEGMA(1100)(mol%) Mn stdev DP stdev 
4 98 2 42000 600 2.7 0.11 
5 96 4 44000 400 2.5 0.04 
6 94 6 48300 900 2.2 0.01 
7 93 7 50800 2400 2.0 0.12 
 
In a next step, mechanical tests were performed to study the influence of PEGMA on the 
mechanical properties of the developed materials. Figure 2.7 (B) clearly shows that an 
increased amount of PEGMA resulted in a decrease of the E-modulus. This is also visualized 
by a less steep slope of the initial linear elastic part in the stress-strain curves (Figure 2.7, A) 
and was anticipated, because of the presence of long chains in the materials developed. The 
longer side chains increase the free volume between the polymer backbones as well as their 
freedom to move. As a result, a higher flexibility of the material is obtained. Furthermore, it 
was noted that the longer the PEG chains, the more the E-modulus decreased leading to 
more elastic materials.  
The observed trend was also evidenced by the elongation potential of the materials. 
Elongations of 500 % were obtained when 15 mol% of PEGMA(400) was incorporated. On 
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the other hand, for PEGMA(1100), only 7 mol% was needed to realize elongations of 600%. 
The strength of the materials could be evaluated based on the force required for material 
failure. As expected, this force decreased with increasing molar percentages of PEGMA 
incorporated (see table 2.4).  
 
 
  
Figure 2.7: Typical stress-strain curves obtained at room temperature by tensile testing for PEGMA-
based copolymers (A). Elastic modulus as a function of mol% PEGMA incorporated. Two different 
molecular weights of the PEG chains were studied: 400 and 1000 g/mol (B).  
 
The trends observed for the mechanical properties are further supported by the glass 
transition temperatures (Tg) of the materials. In case of PMMA, a high Tg value was found 
(98°C) as anticipated based on its glassy state for the current test conditions (i.e. 
measurements at room temperature). Conversely, in case 15 mol% PEGMA(500) was 
introduced in the polymer structure, a negative value was obtained for the Tg (i.e. -20°C). As 
a consequence, the material is in its rubbery state, which is clearly reflected by the low E-
modulus and the high elongation percentage.  
 
Table 2.4: Overview of the bulk properties of the MMA and PEGMA containing copolymers. All 
tensile tests were performed at room temperature and the swelling experiments were conducted 
in water at 37°C. Furthermore, the glass transition temperature of a selection of materials are also 
presented, calculated based on the 2nd heating cycle. 
Sample MMA 
 (mol%) 
PEGMA(500) 
(mol%) 
E-mod  
(Mpa) 
Elongation 
 (%) 
Force at break  
(N) 
Swelling  
(%) 
Tg 
(°C) 
Ref. 100 0 1595 ± 357 3 ± 1 96 ± 24 2 ± 0 98 
1 95 5 436 ± 62 4 ± 2 44 ± 30 12 ± 4 59 
2 90 10 204 ± 55 170 ± 8 39 ± 9 37 ± 4 37 
3 85 15 2 ± 1 551 ± 44 10 ± 3 249 ± 27 -20 
 MMA 
 (mol%) 
PEGMA(1100) 
(mol%) 
E-mod 
 (Mpa) 
Elongation 
 (%) 
Force at break  
(N) 
Swelling  
(%) 
Tg 
(°C) 
4 98 2   537 ± 136 10 ± 12 55 ± 24 12 ± 2 57 
5 96 4 345 ± 72 64 ± 44 45 ± 8 33 ± 2 50 
6 94 6 19 ± 7 343 ± 30 14 ± 2 105 ± 4 - 
7 93 7   2 ± 0 619 ± 93 7 ± 4 107 ± 4 - 
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Apart from the mechanical properties, the swelling capacity of the materials was also 
studied. Since PEG is known to be a very hydrophilic compound, higher concentrations will 
result in higher swelling percentages, which is clearly visible in table 2.4. Furthermore, when 
comparing copolymer 1 and 5, the swelling percentage of the first polymer is twice as high 
as the latter one. Doubling the molecular weight of the PEG chain thus results in a doubling 
of the swelling capacity. 
 
2.4.3. Development and evaluation of copolymers of MMA and poly(ethylene glycol) 
dimethacrylate 
The second set of produced materials included a series of crosslinked polymers based on 
MMA and poly(ethylene glycol) dimethacrylate (PEGDMA). As stated above, dependent on 
the molar composition of the networks, UV irradiation times varying from 10 to 90 minutes 
were applied. To determine the monomer conversions, sol-gel studies were conducted in 
acetone. It can be concluded that high monomer conversions were obtained as gel fractions 
above 95% were obtained for all formulations under study (figure 2.8) 
  
 
Figure 2.8: Gel fraction as a function of the mol% and the molecular weight of PEGDMA as 
obtained through sol-gel testing in acetone.  
 
Figure 2.9 and table 2.5 provide an overview of the bulk properties of the obtained polymer 
networks. Comparison of the different E-moduli shows a similar trend for the three studied 
molecular weights of PEGDMA. Up to a certain level of PEGDMA, a decrease of the E-
modulus is obtained with an increasing PEGDMA content. Subsequently, upon exceeding this 
percentage of PEGDMA (depending on the molecular weight), a plateau value is reached. 
This phenomenon can be explained by the counteracting effect of two factors: higher 
percentages of PEGDMA result in the presence of a higher amount of long and flexible 
chains. As a result, the free volume between the polymer chains increases and more flexible 
and soft materials are obtained. Conversely, an increase of the percentage of PEGDMA 
0 
20 
40 
60 
80 
100 
5 10 15 20 30 40 50 60 
G
el
fr
a
c
ti
o
n
 (
%
) 
 PEGDMA(Mw) (mol%) 
PEGDMA(550) PEGDMA(750) PEGDMA(1150) 
Synthesis and characterization of  UV-curable MMA-based packaging materials | Chapter 2 
83 
 
results in an increase in the number of crosslinking points present in the material. These 
crosslinks determine the brittleness of the material. 
Once the plateau value is reached, both effects compensate. At that point, the introduction 
of long chains in the material will be masked by the number of crosslinks introduced. As 
anticipated, this plateau value is reached at a lower PEGDMA(1154) content (at 10 mol%) 
compared to PEGDMA(750) (at 20 mol%) and PEGDMA(550) (at 50 mol%) (see arrows in 
figure 2.9, B).  
 
 
   
Figure 2.9: Typical stress-strain curves obtained for MMA/PEGDMA networks (A). Elastic modulus 
as a function of mol% PEGDMA incorporated. Three different molecular weights of PEGDMA are 
studied: 550, 750 and 1154 g/mol (B) 
 
The decrease in E-modulus with increasing PEGDMA content can be noted in the stress-
strain curves by a decreasing steepness of the slope in the linear elastic part. Furthermore, 
higher percentages of PEGDMA result in weaker materials which is represented by a 
decreasing Fmax (figure 2.9(A)) and force at break (table 2.5).  
The presence of crosslinks also influences the elongation percentages of the materials. A 
higher amount of crosslinker or crosslinking points results in lower elongation percentages. 
The crosslinks act as anchorage points, which freeze the polymer chains in a fixed position. In 
this way, the polymer chains are not able anymore to move along each other, but instead, 
these points will introduce a certain stress into the material. As a consequence, the 
crosslinks will enhance the brittle nature of the materials.  
Next, the swelling behavior of the materials was studied. Table 2.5 clearly shows that an 
increased swelling is obtained when more PEGDMA is introduced into the material. 
Nevertheless, if the swelling percentages are compared with the ones obtained for the 
PEGMA-based materials (table 2.4), these percentages are still moderate because of the 
presence of crosslinks.  
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Table 2.5: Overview of the bulk properties of the developed copolymer networks consisting of 
MMA and PEGDMA. The table mentions the theoretical co-monomer ratios. All tensile tests were 
performed at room temperature and the swelling experiments were conducted in water at 37°C. 
Sample MMA (mol%) PEGDMA(550) (mol%) E-mod (Mpa) Elongation (%) Force at break (N) Swelling (%) 
Ref 100 0 1595 ± 357 3 ± 1 96 ± 24 2 ± 0 
8 90 10 1533 ± 144 10 ± 2 121 ± 6 7 ± 1 
9 80 20 1101 ± 74 9 ± 3 88 ± 7 10 ± 0 
10 70 30 593 ± 66 11 ± 4 67 ± 2 13 ± 0 
11 60 40 320 ± 25 21 ± 2 54 ± 4 15 ± 1 
12 50 50 142 ± 40 16 ± 3 36 ± 6 17 ± 1 
13 40 60 122 ± 7 17 ± 1 34 ± 3 19 ± 1 
 MMA (mol%) PEGDMA(750) (mol%) E-mod (Mpa) Elongation (%) Force at break (N) Swelling (%) 
14 90 10 324 ± 13 30 ± 9 70 ± 3 19 ± 2 
15 80 20 19 ± 4 42 ± 2 18 ± 1 30 ± 1 
16 70 30 19 ± 1 18 ± 2 10 ± 1 36 ± 1 
17 60 40 21 ± 2 13 ± 1 8 ± 1 43 ± 0 
18 50 50 21 ± 1 11 ± 1 7 ± 1 43 ± 1 
19 40 60 21 ± 1 8 ± 1 5 ± 1 46 ± 2 
 MMA (mol%) PEGDMA(1154) (mol%) E-mod (Mpa) Elongation (%) Force at break (N) Swelling (%) 
20 95 5 249 ± 5 105 ± 1 77 ± 2 16 ± 0 
21 90 10 7 ± 0 87 ± 7 20 ± 2 37 ± 1 
22 85 15 7 ± 0 30 ± 9 9 ± 1 56 ± 2 
23 80 20 8 ± 0 23 ± 4 7 ± 0       62 ± 2 
 
Compared to PEGMA, the introduction of PEGDMA resulted in slightly higher E-moduli (a 
minimum of 8 MPa compared to 2 MPa) and lower elongation percentages (a maximum of 
100% compared to 600%), due to the introduction of crosslinking points in the latter case. 
One remarkable result can further be highlighted. The combination of MMA with 5 mol% 
PEGDMA(1154) is characterized by a relatively high elongation percentage (± 105%) 
combined with a rather high E-modulus (± 250 MPa), which seems contradictive. The 
increased elongation can probably be explained by the higher molecular weight of the PEG 
chain, a fact which is also described in literature 125. Regarding the higher E-modulus, it can 
be noted that compared to PMMA, the addition of 5 mol% PEGDMA(1154) still resulted in a 
significant drop of this modulus (i.e. 6 times lower). Future experiments could focus on the 
thermal analysis of the developed materials to gain further insight in the obtained 
mechanical data. As an intermediate conclusion, It can be stated that the introduction of 
PEG in the polymer structure has a beneficial effect on the mechanical properties (i.e. 
enhanced flexibility compared to PMMA). Indeed, combinations of MMA and PEGMA or 
PEGDMA resulted in E-moduli ranging from 2 till 1600 MPa and in elongation percentages 
going from 3 till 600 %.  
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2.4.4. Development and evaluation of copolymers based on MMA, PEGMA and PEGDMA 
Tables 2.4 and 2.5 confirm that the introduction of PEG has a beneficial effect on the 
mechanical properties of the synthesized materials, meaning that lower E-moduli, higher 
flexibilities and higher elongations are obtained compared to PMMA itself. On the other 
hand, when the total amount of PEG is increased, the swelling of the materials increases in a 
proportional way, unless a crosslinking agent is used. In the latter case, crosslinking points 
are introduced which hamper swelling of the material. As a consequence, in a final step, 
both PEGMA and PEGDMA were used to finetune the properties of the starting material (i.e. 
PMMA). Since the molecular weight of the PEG chain also influences the swelling behavior of 
the material, the molecular weight of the crosslinker was fixed at 550 g/mol.  
Tables 2.6 (use of PEGMA(1100)) and 2.7 (use of PEGMA(500)) overview the different 
combinations under evaluation as well as their mechanical and swelling properties. The E-
moduli are plotted in figure 2.10. Similar trends as before were observed and are 
summarized below.Higher amounts of PEGMA resulted in: 
- a lower E-modulus, which implies that more flexible materials are obtained 
- higher elongation percentages, although the addition of a crosslinker limits this effect 
- a lower strength of the materials as less force is required before failure 
- higher swelling percentages, although this effect is counterbalanced by the 
crosslinker 
 
Table 2.6: Overview of the bulk properties of the copolymer networks consisting of MMA, 
PEGMA(1100) and PEGDMA(550). All tensile tests were performed at room temperature and the 
swelling experiments were conducted in milli-Q water at 37°C. 
Sample 
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(1100) 
(mol%) 
E-mod  
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
Ref 100 0 0 1595 ± 357 3 ± 1 96 ± 24 2 ± 0 
45 50 48 2 55 ± 4 14 ± 2 24 ± 3 23 ± 1 
46 50 46 4 43 ± 2 13 ± 1 18 ± 1 28 ± 0 
47 50 44 6 32 ± 1 11 ± 1 12 ± 1 32 ± 0 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(1100) 
(mol%) 
E-mod  
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
48 75 23 2 270 ± 55 22 ± 3 35 ± 23 19 ± 0 
49 75 21 4 50 ± 7 30 ± 2 27 ± 1 28 ± 1 
50 75 19 6 20 ± 1 30 ± 2 17 ± 1 34 ± 1 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(1100) 
(mol%) 
E-mod 
 (Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
51 85 13 2 445 ± 13 19 ± 8 61 ± 5 16 ± 0 
52 85 11 4 107 ± 55 53 ± 3 43 ± 2 32 ± 0 
53 85 9 6 14 ± 4 55 ± 8 17 ±3 41 ± 1 
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Table 2.7: Overview of the bulk properties of the copolymers based on MMA, PEGMA(500) and 
PEGDMA(550). All tensile tests were performed at room temperature and the swelling 
experiments were conducted in milli-Q water at 37°C. 
Sample 
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
Ref 100 0 0 1595 ± 357 3 ± 1 96 ± 24 2 ± 0 
24 50 45 5 62 ± 6 16 ± 0 25 ± 1 21 ± 0 
25 50 40 10 37 ± 1 13 ± 1 16 ± 2 24 ± 0 
26 50 35 15 29 ± 2 11 ± 0 10 ± 0 33 ± 2 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
27 75 25 0 424 ± 80 16 ± 5 92 ± 23 12 ± 1 
28 75 20 5 149 ± 12 28 ± 5 48 ± 5 15 ± 0 
29 75 15 10 49 ± 10 44 ± 4 32 ± 3 21 ± 1 
30 75 10 15 10 ± 1 42 ± 5 12 ± 2 34 ± 1 
31 75 5 20 4 ± 0 37 ± 6 3 ± 2 65 ± 3 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
32 80 18 2 491 ± 9 26 ± 2 82 ± 2 12 ± 1 
33 80 16 4 486 ± 14 24 ± 6 69 ± 3 13 ± 0 
34 80 12 8 212 ± 2 49 ± 1 49 ± 2 19 ± 0 
35 80 4 16 8 ± 0 108 ± 2 15 ± 0 44 ± 1 
36 80 2 18 2 ± 0 153 ± 5 7 ± 5 65 ± 1 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
37 85 15 0 945 ± 63 14 ± 4 111 ± 12 9 ± 0 
38 85 13 2 900 ± 39 14 ± 5 91 ± 6 9 ± 0 
39 85 10 5 453 ± 57 23 ± 7 63  ± 4 14 ± 0 
40 85 5 10 125 ± 35 86 ± 5 40 ± 6 23 ± 1 
  
 MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(Mpa) 
Elongation 
(%)  
Force at break 
(N) 
Swelling 
(%) 
41 90 8 2 1542 ± 235 11 ± 3 120 ± 19 8 ± 1 
42 90 6 4 1129 ± 124 14 ± 3 86 ± 3 9 ± 1 
43 90 4 6 1081 ± 194 10 ± 2 85 ± 12 12 ± 1 
44 90 2 8 678 ± 122 39 ± 22 69 ± 12 16 ± 1 
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Figure 2.10: Elastic modulus as a function of mol% PEGMA incorporated for the polymers consisting 
of MMA, PEGMA and PEGDMA(550). Two molecular weights of PEGMA were evaluated: 500 g/mol 
(A) versus 1100 g/mol (B). ‘x’ stands for the amount of PEGMA as indicated on the x-axis. 
 
2.4.5. Influence of PBS buffer on the polymer mechanical properties 
Previous paragraphs (2.4.2-2.4.4) have shown that all materials reveal some swelling in 
water (percentages ranging from 2% to 250%). As the materials will be implanted 
subcutaneously, material swelling will occur in vivo. To study the effect of swelling on the 
mechanical behavior, a material selection was incubated at 37°C in PBS (phosphate buffered 
saline) buffer, a phosphate buffer, mimicking the pH and ionic strength of the in vivo 
environment. The materials were evaluated for their elastic modulus, elongation and force 
at break. The selection was based on minimized water swelling percentages. In the end, 
electronic parts need to be encapsulated into the polymer material and excessive swelling 
should thus be avoided. Furthermore, high swelling could introduce mechanical stress and 
eventually cause fracture of the polymer implant. As a consequence, combinations of MMA 
and PEGMA were excluded from this study as well as the PEGDMA derivatives which were 
characterized by a longer PEG chain (i.e. PEGDMA(750) and PEGDMA(1154)). First, the 2-
component systems were evaluated (see figure 2.11) and incubation in PBS buffer resulted 
in a significant decrease of the E-modulus and force at break (p<0.05).  
 
 
Figure 2.11: E-modulus, elongation % and force at break  of materials 8, 9 and 12 (cfr. table 2.5), 
measured in dry state and after incubation in PBS buffer (pH 7.4) at 37°C. Samples which are 
statistically different are denoted by “*”. 
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The elongation percentage on the other hand increased for the lower crosslinker 
percentages (10 and 20 mol% PEGDMA), but not when 50 mol% crosslinker was introduced. 
Due to the higher amount of hydrophilic PEG, higher swelling is manifested and it is 
anticipated that because of this swelling more salts, which are present in the PBS buffer, will 
be incorporated inside the polymer network. As a consequence, these salts alter the 
brittleness of the incubated materials, which is illustrated by a decreased elongation of the 
material.    
Results of the three-component systems are summarized in figure 2.12.  
 
 
  
 
  
 
  
Figure 2.12: E-modulus (A), elongation % (B) and force at break (C) of materials 32-36 (left column, 
subscript “1”) and materials 41-44 (right column, subscript “2”), measured in their dry state and 
after incubation in PBS buffer at 37°C (pH 7.4). Samples which are statistically different are 
denoted by “*”. 
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Herein, the materials consisting of 90 mol% MMA and 10 mol% PEG (i.e. total PEG content 
consisting of PEGMA and PEGDMA) follow the expected trend. Upon swelling in PBS-buffer, 
lower E-moduli (figure 2.12, A2), higher elongation percentages (figure 2.12, B2) as well as 
lower forces at break (figure 2.12, C2) were measured. These trends are the result of the 
plasticizing effect of water. On the other hand, in case the amount of PEG is increased up to 
20 mol%, some unexpected findings arose. For materials consisting of 80/2/18 and 80/4/16 
mol% of MMA/PEGDMA(550)/PEGMA(500), a higher E-modulus is obtained for the 
incubated samples compared to the dry ones (figure 2.12, A1). This result might be explained 
by the high swelling percentages of these materials, being  65% and 44% respectively. Again, 
because of swelling, a substantial amount of salts will be incorporated inside the polymer 
structure, which influences the material’s mechanical properties. Indeed, a higher resistance 
against deformation is manifested (cfr. increased E-modulus) as well as a decreased 
elongation of the material (figure 2.12, B1) and a decreased force at break (figure 2.12, C1).  
  
2.4.6. Intermediate conclusion on the evaluation of PEG-based materials as potential 
packaging for an implantable glucose sensor 
In a first part of this research, different copolymers were produced starting from MMA and 
PEG. The materials possessed different physical characteristics and depending on the 
envisaged application, these properties can be finetuned. Their characteristics are mostly 
defined by the molar ratios of the different compounds used, the molecular weight of the 
PEG-chains and the possible use of a crosslinker.  
As stated in the introduction, when considering materials to be applied as packaging for an 
optical glucose sensor, they should meet certain characteristics. When screening the various 
result tables in previous paragraphs, various conclusions can be drawn. First, a broad range 
of materials ranging from hard (E-mod ≈ 1600 MPa) to soft (E-mod ≈ 2MPa) PEG-based 
materials could be produced. Secondly, due to the application of a hydrophilic compound, all 
polymers reveal a certain degree of swelling. It is clear that both properties counteract 
implying the need for compromises. As a consequence, the softer materials summarized in 
table 2.4 suffer from a too high swelling and are considered unsuited for the envisaged 
application. Nevertheless, for other applications including stent coatings, these materials 
could offer clear benefits (see chapter 7).  
As the present work focuses on the development of a packaging material for an optical 
glucose sensor, the network consisting of 50 mol% MMA and 50 mol% PEGDMA(550) was 
selected as most optimal material from table 2.5. This choice was made because the 
material contains a high molar percentage of PEG, but still shows limited swelling (i.e. 17%) 
due to the presence of crosslinks in the material. Furthermore, a 10-fold lower E-modulus is 
obtained and a five times higher elongation percentage, compared to PMMA.  
As a result, this material was selected as a first glucose sensor packaging candidate and was 
used as basis to fine-tune the biocompatibility (cfr. chapters 3 and 4). Alternatives comprise 
materials described in tables 2.6 and 2.7, including material 34 (80 mol% MMA/ 16 mol% 
PEGDMA(550)/ 4 mol% PEGMA(500)), material 44 (90 mol% MMA/ 4 mol% PEGDMA(550)/ 6 
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mol% PEGMA(500)) or material 28 (75 mol% MMA/  20 mol% PEGDMA(550)/ 5 mol% 
PEGMA(500)). The former two will be discussed in chapter 5, where the in vivo evaluation 
will be centralized. 
 
 
2.5. Development and characterization of butyl- , ethylhexyl- and 
laurylmethacrylate-based polymers 
In paragraph 2.2, flexible and hydrophilic copolymers were produced and screened. For the 
second strategy, flexible while hydrophobic materials have been developed. More 
specifically, different long chained comonomers were evaluated and the resulting 
copolymers were characterized by different techniques such as NMR spectroscopy and 
tensile testing. The selected monomers include n-butyl methacrylate (BuMA), 2-ethylhexyl 
methacrylate (EHMA) and lauryl methacrylate (LMA). The above-mentioned monomers have 
been selected because of their larger side chain compared to MMA. As a consequence, an 
increased free volume between the polymer main chains is anticipated along with a 
decreased glass transition temperature (Tg). A Tg below room temperature ensures that the 
polymer is in its rubbery state at phsyiological conditions and is easily deformed at 
processing and body temperature.  
In literature, alkylmethacrylate-based (co-)polymers are frequently studied. For example, 
PBuMA has already been used as a soft component in drug-eluting coatings (e.g. for stents 
a.o. the Cypher stent) 126. In the same field of drug delivery, copolymers consisting of BuMA 
and N-vinyl pyrrolidone (NVP) have also been studied 127. Furthermore, a combination of 
dextran-graft-polybutylmethacrylate has been synthesized in an attempt to enhance 
endothelialisation of materials 128 and in the field of sensors, electro-conductive films of 
PBuMA and polyaniline have been examined for their application as biosensor to detect urea 
and uric acid 129. In case of PEHMA, literature examples include the use as paper coating 130 
and the application of its monomer as a component in triblock copolymers with MMA as 
candidates for adhesives in medical tapes and labels 131.  
LMA, which contains twelve C-atoms in its side chain, is a very hydrophobic monomer and 
because of this, it has already been studied as co-monomer in the development of oil-
absorbing copolymers 132-134. In the biomedical world, it has been copolymerized with 2-
methacryloyloxyethyl phosphorylcholine (MPC) in an attempt to design polymers for in vivo 
applications such as blood-contacting devices 135. 
 
In the following paragraph, the evaluation of different monomers and their homopolymers is 
described (§ 2.5.1). Subsequently, different copolymer formulations will be screened (§ 
2.5.2-2.5.3). 
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2.5.1. Characterization of the starting compounds BuMA, EHMA and LMA and evaluation 
of the developed homopolymers  
The structure and NMR spectra of the different starting compounds are displayed in figure 
2.13. The different peak annotations are also given in the experimental                                 
part (chapter 6; § 6.2.1.2). 
 
 
 
Figure 2.13: 1H-NMR spectrum of BuMA (top), EHMA (middle) and LMA (bottom), recorded in 
CDCl3. The indices (a,b,c,…) link the protons with the corresponding peaks. 
To check for successful polymerization, the vinyl proton integrations were applied. Similar to 
the PEG-based materials, the UV irradiation time was optimized for the different 
methacrylate-based compounds under evaluation. Figure 2.14 summarizes the optimization 
results for BuMA, EHMA and LMA.  
 
In case of PBuMA, conversions of 99% were obtained after 60 minutes irradiation time. It is 
anticipated that PBuMA is characterized by a higher flexibility compared to PMMA, because 
of its larger side chains, which is reflected by the lower glass transition temperature of 
PBuMA (Tg ≈ 24°C,136), compared to PMMA (Tg ≈ 105°C). Unfortunately, simple material 
inspection showed that PBuMA acted as a very stiff and brittle material, which did not 
possess the required flexibility. As a consequence, BuMA was excluded from further study. 
 
For PEHMA, a solid while sticky material was obtained after 30 minutes, which was 
characterized by a conversion percentage above 99%. The flexible character of this polymer 
can be attributed to the low glass transition temperature which is around -10 °C. In 
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literature, this homopolymer has been described as a flexible material which possesses good 
adhesion properties at room temperature 137, which confirms the observed stickiness. 
 
 
           
Figure 2.14: Conversion percentage of BuMA (A), EHMA (B) and LMA (C) as a function of UV 
irradiation time, as determined by 1H NMR spectroscopy using sol-gel studies.  
 
It should be mentioned that for the production of PEHMA, an adjustment was made in the 
synthesis protocol. So far, all polymers were synthesized by initiation using Irgacure® 2959. 
As EHMA did not enable dissolution of this initiator, an alternative UV-sensitive initiator was 
tested, i.e. Irgacure® 651 (2,2-dimethoxy-2-phenylacetophenone). Its structure is shown in 
figure 2.15.  
 
 
       
Figure 2.15: Chemical structures of Irgacure® 651  
 
Also for LMA polymerization Irgacure® 651 was selected as initiator due to solubility reasons. 
Figure 2.14 (C) shows that after 30 minutes, already 97% of the monomer was incorporated 
into the polymer structure and after 90 minutes of UV irradiation, conversions above 99% 
were obtained. As a consequence, this UV irradiation time was set as the minimal time to 
produce the copolymers. Also in this case, the homopolymer behaved as a flexible material, 
which can again be understood by the low glass transition temperature (Tg) of this material. 
In literature, Tg’s of PLMA are reported to be approximately -53°C 138 and -65°C 139. 
 
It should be mentioned that the use of Irgacure® 651 has been reported as more toxic 
towards cells compared to the use of Irgacure® 2959 103. As a consequence, this was further 
studied and discussed in § 2.6.3. 
 
2.5.2. Development and characterization of P(MMA-co-EHMA) 
As already mentioned in the previous section, PEHMA behaves as a sticky polymer. In the 
scope of this work, this property could be detrimental towards its ease of use, such as 
difficulties that could arise during transfer between different sample containers, but more 
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importantly, the attachment of contaminants that could easily result from this stickiness. As 
a consequence, different MMA/EHMA copolymers were first visually screened, focusing on 
this specific property. 
The tested MMA/EHMA ratios are summarized in table 2.8, which shows that 80 mol% of 
EHMA can be set as a maximum to avoid stickiness of the material. On the other hand, a 
minimum of 70% is required to ensure sufficient material flexibility. Due to the brittle nature 
of the latter material, the material consisting of 80 mol% EHMA and 20 mol% MMA was 
selected as initial optimum.  
  
Table 2.8: Overview of the properties of copolymers consisting of different ratios of MMA and 
EHMA, as visually observed after production. The last column presents the E-moduli of the 
materials, as determined by tensile testing. 
MMA/EHMA ratio stickiness flexibility brittleness E-mod (MPa) 
75/25 - -- ++* / 
50/50 - - + / 
40/60 - - + 0.7 
30/70 - + + 1.1 
20/80 - + - 0.3 
10/90 + ++ - 0.1 
*
The plus sign denotes presence of the mentioned property. A higher number of +-signs indicate a relatively 
higher tackiness/flexibility of the materials. A minus sign denotes absence of the mentioned poperty. 
 
To confirm this trend and to prove the optimum of 20/80 MMA/EHMA, tensile tests were 
conducted on the different materials. From table 2.8, it is clear that compared to the PEG-
based materials, much lower E-moduli are obtained. Furthermore, an increase of the MMA 
content resulted in a slight increase of the E-modulus.  
Unexpectedly, upon storage of the produced materials during 1 day, the more flexible 
materials were transformed into very brittle ones. As a consequence, mechanical testing was 
made impossible. We anticipated that this phenomenon could be ascribed to hydrophobic 
interactions between the alkyl side chains, which induced an increased brittleness of the 
material. Due to this observation, EHMA was not further studied as potential comonomer of 
MMA, but we decided to explore a third co-monomer, lauryl methacrylate. 
  
2.5.3. Development and characterization of P(MMA-co-LMA) 
Lauryl methacrylate possesses a long linear side chain, which consists of 12 carbon atoms. 
For this reason, this monomer was evaluated as co-monomer of MMA. In a preliminary test, 
different MMA/LMA monomer ratios were evaluated and visually screened for their 
characteristics. Again, sticky while flexible materials were obtained. Both properties 
counteracted each other and as a consequence, a compromise had to be made between 
both. 
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The first visual screening resulted in the copolymer consisting of 62 mol% MMA and 38 mol% 
of LMA as the best compromise. Physicochemical analysis showed that the polymer was 
characterized by an E-modulus of ± 0.4 MPa and a swelling percentage below 1%.  
Unfortunately, the material again suffered from ageing which resulted in an increased 
brittleness over time. In order to improve the mechanical stability of the copolymers, it was 
decided to apply a crosslinker. Different amounts (1, 2 and 5 mol%) of poly(ethylene glycol) 
dimethacrylate (PEGDMA(550)), described in paragraph 2.4.3, were added to the ‘optimal’ 
composition of 62 mol% MMA and 38 mol% LMA and were evaluated.   
Since the addition of the crosslinker resulted in a decrease of the material flexibility, the 
amount of LMA needed to be increased to again obtain more flexible polymers. The 
preliminary and qualitative evaluation of different material compositions are shown in table  
2.9 and the optimal ratio which resulted in a flexible, non-sticky material consisted of 52.5 
mol% MMA, 42.5 mol% LMA and 5 mol% PEGDMA. Since this crosslinked material did no 
longer suffer from ageing, it was selected for further quantitative evaluation.  
It should be noted that addition of PEGDMA again enabled the use of Irgacure®2959 as an 
initiator. As a result, both initiators were compared to study their influence on the physical 
properties, as well as on the cell toxicity of the materials (see §  2.5.3 ). 
 
Table 2.9: First line visual screening of copolymers consisting of MMA, LMA and PEGDMA(550). 
MMA/LMA/PEGDMA(550) (mol%)  stickiness flexibility 
61.5/37.5/1 -* + 
59.5/39.5/1 + + 
57.5/41.5/1 + ++ 
54.5/45.5/1 + +++ 
54/44/2 + +++ 
52.5/42.5/5 - +++ 
*
The plus sign denotes presence of the mentioned property. A higher number of +-signs indicate a relatively 
higher tackiness/flexibility of the materials. A minus sign denotes absence of the mentioned poperty. 
 
In a first step, the optimized material was characterized by 1H-NMR spectroscopy. Since the 
material is crosslinked, HR-MAS NMR spectroscopy had to be performed. Comparison of the 
spectra of the produced polymers using both types of initiators is shown in figure 2.16. No 
clear differences were observed between both spectra and the most important observation 
involved the absence of the signals between 5 and 6.5 ppm, which confirmed a full and 
successful polymerization.  
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Figure 2.16: 1H NMR spectra of P(MMA-co-LMA-co-PEGDMA) (52.5/42.5/5), produced using 
Irgacure® 651 (a) and 2959 (b) 
 
Next, mechanical analysis was performed. During this analysis, the amount of added 
PEGDMA was further optimized and the impact of both initiator types, i.e. Irgacure® 651 and 
2959, was evaluated. Table 2.9 showed that the addition of 5 mol% of the crosslinker is a 
prerequisite to avoid material stickiness. As a result, somewhat higher amounts (7 and 10 
mol%) of PEGDMA were also tested for their effect on the mechanical and swelling 
properties of the material (see table 2.10). As anticipated, an increasing amount of 
crosslinker resulted in a slightly increased E-modulus (p>0.05), a decreased elongation 
percentage (p<0.05) and a slightly increased force at break (p>0.05). Indeed, the addition of 
a crosslinker ‘freezed’ the polymer chains to some extent, rendering the polymer less flexible 
and deformable, but more tough and rigid. The more elastic character of this new 
generation of materials was also apparent when comparing its stress-strain curve with the 
PMMA reference and the selected material from the previous section, i.e. P(MMA-co-
PEGDMA(550)) 50/50 (figure 2.17).  
The use of a different initiator only influenced the E-modulus significantly (p<0.05), whereas 
for the other properties, such as elongation, force at break and swelling, no significant 
differences were observed.  
 
Since PEG was used as a crosslinker, the material hydrophilicity could again be increased. As 
a result, the swelling percentage of these materials had to be evaluated. Table 2.10 shows 
that an increase in the crosslinker percentage is reflected in the swelling percentage. Indeed, 
swelling slightly increased upon introducing higher amounts of PEG-based crosslinker. 
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Nevertheless, the percentages were still lower than the ones obtained for PMMA (i.e. 2.0 ±  
0.2 %) and as a consequence, they could be considered negligible. 
 
Table 2.10. Overview of the bulk properties of the copolymer networks consisting of MMA, LMA 
and PEGDMA(550), using different initiators (Irgacure® 651 versus 2959). Significantly different 
results (for 1 initiator type; p<0.05) are denoted with the same letter a,b,c,… All tensile tests were 
performed at room temperature and the swelling experiments were conducted in milli-Q water at 
37°C. 
Sample MMA 
(mol%) 
LMA 
(mol%) 
PEGDMA 
(mol%) 
Irgacure® 
(type) 
E-mod 
(MPa) 
Elongation  
(%) 
Force at break  
(N) 
Swelling 
(%) 
54 52.5 42.5 5 651 3 ± 1a 116 ± 12d 10 ± 4 0.8 ± 0.3h 
55 52.5 42.5 7 651 5 ± 1 87 ± 6d 11 ± 3 1.2 ± 0.4g 
56 52.5 42.5 10 651 7 ± 1a 68 ± 9d 13 ± 3 1.7 ± 0.3g,h 
57 52.5 42.5 5 2959 6 ± 1b,c 96 ± 11e,f 11 ± 2 0.6 ± 0.2j 
58 52.5 42.5 7 2959 9 ± 3b 74 ± 8e 12 ± 2 1.1 ± 0.3i 
59 52.5 42.5 10 2959 10 ± 1c 61 ± 6f 15 ± 2 1.6 ± 0.3i,j 
 
Also for the optical absorption properties, these low swelling percentages could be 
considered as a positive result, since water includes one of the major interferents in the NIR 
detection region. Since no extensive differences were obtained in E-modulus or force at 
break, the material elongation was selected to be maximized and the swelling to be 
minimized. As a consequence, the incorporation of only 5 mol% of crosslinker was preferred. 
 
It can thus be concluded that a material was developed with increased flexibility and 
softness, but also with an improved swelling behavior compared to the PEG-based material.  
 
 
Figure 2.17: Typical stress-strain curves for PMMA, P(MMA-co-PEGDMA(550)) 50/50 and P(MMA-
co-LMA-co-PEGDMA) (52.5/42.5/5) as obtained by tensile testing.  
 
It should be noted that the materials initiated by Irgacure® 651 were characterized by a 
characteristic smell after production and during storage. Since no unreacted monomer was 
detected by HR-MAS NMR spectroscopy (figure 2.16), a soxhlet extraction was performed to 
extract and identify the nature of the non-covalently introduced fraction (i.e. the soluble 
fraction). 
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It appeared that only 2.52% of the material was extracted from the polymer network and 
that it mainly consisted of unreacted initiator as illustrated in figure 2.18. After extraction 
and drying of the samples, the smell disappeared. The results showed that unreacted 
initiator was the cause for this typical smell. It should be noted that also a small fraction of 
LMA was detected, as indicated by the arrows. Since no double bond protons were detected, 
this could refer to a leached-out PLMA fraction that was not included (i.e. covalently bound) 
inside the polymer network.  
 
Figure 2.18: 1H NMR spectra of the soluble fraction of poly(MMA(52.5)-co-LMA(42.5)-co-
PEGDMA(5)) polymerized in the presence of irgacure®651, obtained after soxhlet extraction in 
ethanol (a) and of Irgacure® 651 (b). 
 
 
2.6. Evaluation of the developed materials as packaging of glucose sensor 
electronics 
Previous sections described the optimization of the bulk properties of methacrylate-based 
polymers, intended for their application as potential packaging material for a glucose sensor. 
Apart from exhibiting excellent mechanical and swelling properties, additional success 
criteria had to be fulfilled. In the upcoming paragraphs, two additional criteria are discussed. 
First, the optical properties of the materials are discussed and secondly, their characteristics 
in forming a diffusion barrier are evaluated. Finally, some preliminary cell tests will be 
presented, to investigate the cell toxicity of the different developed materials.  
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2.6.1. Evaluation of the polymer optical properties1 
Within the current concept of a glucose sensor, near infrared light was intended to be used 
to detect glucose in the in vivo environment. Since both the laser source and the detector 
are supposed to be embedded in a polymer packaging, it was important to assess the 
spectral characteristics of the developed materials. The two wavelength regions which are 
commonly used to measure glucose are the so-called first overtone band (FOB) (1560-1850 
nm) and the combination band (CB) (2080-2325 nm) 140. For both selected materials (i.e. the 
PEG-based versus LMA-based), the absorption spectra are displayed in figure 2.19.  
 
 
Figure 2.19: Transmission in the near infrared region, recorded for 1 mm thick P(MMA-co-
PEGDMA) and P(MMA-co-LMA-co-PEGDMA). 
 
For both materials under investigation, absorption occurred around 1700 nm in the 1st 
overtone band. In the combination band, strong absorption was observed starting at 
wavelengths of 2200 nm. These absorptions could be attributed to stretching (combination + 
overtone region) and bending (combination region) vibrations of C-H bonds in the polymer 
structures 140. The results indicated that the strong absorptions could cause some issues, 
since two out of three features (2.13, 2.27 and 2.32 µm) in the combination band could not 
be accessed for glucose detection. Predictions based on multivariate analysis are typically 
more successful in case info is provided on multiple absorption bands. In the present 
research, only two features are left including one at 2.13 (CB) and 1.59 µm (FOB). 
Nevertheless, the latter corresponds with one of the least absorbing wavelength features of 
glucose (4-5 times lower compared to wavelengths in the CB). Furthermore, since the 
absorption is proportional to the path length of light (see Beer-Lambert law, chapter 1, § 
1.3.2.1), a minimal thickness of the polymer packaging should be pursued. Any signal loss 
caused by polymer absorption will affect the final sensitivity of the glucose sensor. 
Alternatively, the evanescent sensor, described by Ryckeboer et al, could offer a solution 
since this concept eliminates light absorption by the polymer packaging 141.  
                                                          
1
 In cooperation with Eva Ryckeboer, from the Faculty of Engineering Sciences and Architecture; Department of 
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2.6.2. Evaluation of the polymers as hermetic barrier2 
To evaluate the developed materials as hermetic barrier, preliminary tests were executed 
together with IMEC (‘Interuniversitair Micro-Electronica Centrum’). Hermeticity refers to the 
fact that the materials should be able to encapsulate all electronic compounds, which are 
considered non-biocompatible and the encapsulating material should function as a 2-
directional diffusion barrier. In the past, rigid Ti boxes have frequently been used to package 
implantable electronic devices, such as pacemakers 142. Of course, if the same strategy 
would be used for smaller micro-devices, a titanium packaging would enlarge the size of the 
final implant tremendously with the result of decreased user comfort. Furthermore, a lack of 
mechanical compatibility would arise between rigid titanium and the surrounding soft tissue. 
With respect to this shortcoming, tailored polymer materials could offer a distinct 
advantage. Within this scope, two of the developed polymers (i.e. P(MMA-co-
PEGDMA(550)); 50/50 (PMMAPEG) and P(MMA-co-LMA-co-PEGDMA); 55.5/45.5/5) (PLMA))  
were evaluated as potential hermetic coatings, by applying a copper (Cu) corrosion test. For 
these tests, test samples consisting of copper meanders of various line widths were covered 
with the barrier layer to be tested (i.e. the polymers under evaluation; see figure 2.20). Next, 
a glass ring was glued over the Cu meanders, creating a cavity which was filled with PBS 
buffer. The tests were performed at 37°C and at 70°C. The higher temperature was included 
to mimic stressed conditions (i.e. accelerated ageing of Copper) and to understand, whether 
or not, accelerated effects might occur. A good hermetic barrier is typically characterized by 
low corrosion of copper, which is reflected by low resistance of the Cu-meanders. For these 
tests, metallic copper (i.e. Cu0) was selected because of its sufficiently fast corrosion 
properties, its low cost, but also its omnipresence in sensor chips. 
 
 
Figure 2.20: Image of the test samples consisting of copper meanders of various line widths used 
for Cu-corrosion testing.  
 
In case PMMAPEG was used as potential hermetic layer, swelling was noticed and as a result, 
detachment from the copper samples was observed. It could be concluded that swelling of 
the materials induced inferior adhesion to the copper samples and as a result, PMMAPEG 
was identified to be insufficient as hermetic barrier. For PLMA on the other hand, no 
                                                          
2
 In cooperation with Maaike Op de Beeck from the Centre for Microsystems Technology (CMST), affiliated with 
IMEC vzw  
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swelling was observed and the resistance in copper meanders of different widths was 
measured over time in order to quantify a potential corrosion phenomenon. Figure 2.21 
clearly shows that the smaller the line width of the copper meander, the faster corrosion 
occurred. At 70°C, the 50 µm lines started to corrode after 20 hours of incubation. 
Afterwards, the resistance increased steadily towards full corrosion.  
 
 
   
Figure 2.21: Evaluation of the resistance change of PLMA protected Cu meanders of 30, 40 and 50 
µm width which are exposed to PBS buffer at 37°C (A) and 70°C (B). 
 
When comparing these results to the ones obtained for unprotected Cu-meanders (figure 
2.22, A), similar trends could be observed in case unprotected copper was measured. After 
200 hours of exposure, infinite high resistances were measured for all Cu-lines, which 
indicated that corrosive sensitive electronics must be protected from the body environment 
upon implantation. Furthermore, these results showed that the LMA-based polymer was 
permeable for moisture, rendering it a non-ideal hermetic barrier. The underlying cause for 
this observation could be an inferior adhesion between the polymer and the copper 
substrate. Alternatively, despite the material’s hydrophobic nature, these results might also 
suggest potential diffusion of water through the polymer network. 
If a polymer is used as coating for electronic devices, it is clear that an additional barrier has 
to be included to avoid diffusion of body fluids. A frequently used example of such a 
hermetic barrier is a parylene C coating, which is a vapour-deposited poly(p-xylylene) 
polymer which is frequently used as a barrier for moisture and gases and as dielectric  
barrier 143. Homogeneous coatings of this polymer can be obtained, even at room 
temperature. The barrier properties of this polymer were evaluated by IMEC (see figure 
2.22, B). The results showed that the resistance remained constant for more than 600 hours, 
indicating delayed corrosion.  
 
To conclude, the available polymers did not provide sufficient protection for both the 
implant itself against fluid penetration nor for the local tissue to avoid adverse effects upon 
implantation due to potential leaching of toxic substances from the electronics. Therefore, 
the polymer-based implant encapsulation should ideally be complemented by hermetic 
barriers such as parylene C in order to provide a bi-directional diffusion barrier insulating the 
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implanted electronics from the body. Future research should thus focus on the study and 
optimization of the adhesion between the developed polymers and the diffusion barrier. 
 
 
Figure 2.22: Evaluation of the resistance change of Cu meanders exposed to PBS buffer at 70°C: 
unprotected Cu meanders of 25, 50, 75 and 100 um width, during 200 hours (A) and parylene C-
protected (5µm) Cu meanders of 30 and 40 µm width (B). 
 
2.6.3. Preliminary cell tests: Cytotoxicity and cell interactivity of the developed materials.3 
Since the materials are intended for implantation, possible cell toxicity needs to be 
considered. In order to assess preliminary information regarding the potential cytotoxicity of 
the selected polymers, a colorimetric assay was used, applying the tetrazolium salt 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The tetrazolium salt can 
readily enter cells where it is reduced to the insoluble formazan by NAD(P)H-dependent 
oxidoreductases of metabolically active cells (see figure 2.23) 144. The yellow MTT is hereby 
converted into a purple formazan, which can be analyzed quantitatively by 
spectrophotometry. 
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Figure 2.23:  Enzymatic conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) to (E,Z)-5-(4,5-dimethylthiazol-2yl)-1,3-diphenylformazan (formazan) 
 
Prior to spectroscopic analysis, the polymer samples (n = 3) were extracted with cell 
medium. Next, different dilutions were prepared from the extraction media and added to a 
                                                          
3
 In cooperation with Heidi Declercq and Johanna Aernoudt, from the Tissue Engineering Group of the 
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96 well plate that contained human foreskin fibroblast (HFF) cells. After 2 days of incubation, 
the MTT solution was added and the cells were lysed in order to read out the absorbance. It 
should be noted that these tests were conducted according the ISO 10993 standard to gain 
initial insight in the potential of the materials and the necessity for material optimization. In 
case cell viabilities below 70% would have been obtained, the bulk materials would be 
excluded from future experiments. 
From the results (see figure 2.24) it is clear that both PMMA and PMMAPEG obeyed the 
minimum standard, as viabilities higher than 70% were obtained (figure 2.24, A). 
In case of PLMA (see figure 2.24, B), on the other hand, the undiluted and non-soxhlet-
extracted samples showed cell viabilities below 70%. Nevertheless, upon further dilution of 
the cell media, the minimum value of 70% was reached for both initiator types. This result 
suggests that the studied materials could be considered as inherently non-toxic.  
Extraction of the samples illustrated that the viability tends to increase, especially in case 
Irgacure® 2959 was used as an initiator, although no significant differences were obtained 
when comparing both conditions (extraction vs no extraction) (p>0.05). In this respect, it can 
be noted that soxhlet extraction of the prepared samples in ethanol affected the mechanical 
integrity of the materials, as illustrated by crack formation. As a consequence, the execution 
of such an extraction was not further considered.  
 
If both initiators are compared, the present data show a small preference towards the use of 
Irgacure® 651. These data thus contradict literature reports, as previous results showed that 
Irgacure® 2959 offers a good cytocompatibility and a less cytotoxic nature compared to 
Irgacure® 651 103, 145. In those studies, six different mammalian cell types were exposed to 
certain initiator concentrations (0.03 - 0.1% w/v) while Irgacure® 2959 resulted in the lowest 
toxicity. It can be concluded that the different results obtained were possibly caused by the 
different experimental approach. Nevertheless, if only the non-extracted values are 
considered, similar cell viabilities were obtained for both photo-initiators and as a 
consequence, both of them were included in the surface modification strategies (see chapter 
3).  
 
In a next step, the cell interactivity of the pristine polymers was evaluated by means of a 
live/dead assay. Herein, living cells are stained with a green color, whereas dead cells are 
washed away or stained in red. Figure 2.24, C clearly demonstrates that on PMMAPEG 
almost no cells were adhering, whereas PMMA and PLMA already showed higher cell 
densities. Nevertheless, compared to the control, more cell clusters (i.e. agglomerated cells) 
were present and the natural cuboidal shape of the human umbilical vascular endothelial 
cells (HUVECs) was not always present for the developed materials. In the current work, cell 
interactivity of the sensor packaging is targeted, because in the end, after implanting the 
materials, the creation of a fluid pocket had to be avoided. Instead, the formation of 
functional and vascularized tissue had to be pursued (see chapter 4). A proper cell 
interactivity of the materials was thus appreciated as a good indicator for the in vivo success 
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of the developed materials. To further improve the cell interactivity of the herein developed 
materials, surface modifications were performed and the discussion of these results will be 
topic of the upcoming chapters (chapter 3 and 4). 
 
 
  
 
 
Figure 2.24: MTT assays to evaluate the cell toxicity of the developed materials, i.e. PMMAPEG (A) 
and PLMA (B). In case of the LMA-based materials, both the influence of the initiator and an 
extraction step were evaluated. A live/dead assay was performed to evaluate the cell interactivity 
of the pristine polymers (C). 
 
 
2.7. Conclusion 
In the present chapter, different MMA-based copolymers have been developed and 
characterized. In case of PEG incorporation, a broad range of flexible while hydrophilic 
materials were obtained, of which the material consisting of 50 mol% MMA and 50 mol% 
PEGDMA(550) (PMMAPEG) was selected as a potential candidate for packaging a glucose 
sensor. This material was characterized by a 10-fold lower E-modulus  (142 MPa) when 
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compared to PMMA (1600 MPa), which was actually still an underestimation, as the body 
environment will cause swelling (17%) with a further decrease of the E-modulus (53 MPa) as 
a consequence. Furthermore, a second potential candidate was identified (i.e. the 3-
component system consisting of 55.5 mol% MMA, 45.5 mol% LMA and 5 mol% 
PEGDMA(550)). Compared to the swollen PEG-based material, an even lower E-modulus was 
obtained (6 MPa) together with lower swelling percentages (0.6%). For both materials, 
similar absorption behavior was obtained in the near-IR region. Because of the presence of 
absorption peaks, the polymer packaging should preferably be as thin as possible (<< 1mm) 
or even excluded from the optical path. Furthermore, it was shown that none of the 
polymers would act as a proper barrier layer. As a consequence, combination of the polymer 
packaging with a superior insulating layer such as parylene C, will be a prerequisite to ensure 
a successful operating system. In this respect, future work should definitely focus on the 
optimization of the adhesion properties between this insulating layer and the polymer 
packaging itself.  
Finally, PMMA and the PEG-based material could be considered as intrinsically non-toxic, 
since cell viabilities higher than 70% were obtained. On the other hand, the LMA-based 
materials gave rise to a slightly higher cell toxicity in case irgacure®2959 was used as initiator 
instead of Irgacure®651. Nevertheless, both initiators will still be considered during future 
experiments. 
In the upcoming chapter, both materials of choice will be subjected to different surface 
modification strategies in order to enhance their  biocompatibility. 
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3.1. Introduction 
 
Polymers such as poly(ethylene terephtalate) (PET) 1, poly(ethylene) (PE) 2, but also PMMA 3 
are characterized by inert surface properties. The latter implies that no reactive chemical 
functionalities are available on the surface to enable subsequent reactions, such as 
biofunctionalization to enhance the cell-interactive properties. In the end, as pointed out in 
the introduction, we aim at stimulating the growth of blood vessels in the neighborhood of 
the sensor 4. Since endothelial cells build up the inner blood vessel wall, attraction of this cell 
type would be beneficial. In order to obtain this goal, the immobilization of biologically 
active compounds, such as growth factors (see chapter 4) is necessary. Therefore, the 
activation of the surface by the introduction of reactive functional groups should be 
pursued.  
Previously, wet chemical modifications such as aminolysis and hydrolysis have frequently 
been applied on polymers containing functional groups which are susceptible towards these 
processes. Since PMMA contains a methylester group, aminolysis could be performed using 
a diamine derivative such as ethylenediamine, lithiated diamines or di-amino-PEG 5-10, 
whereas the introduction of carboxylic acid groups could be facilitated by hydrolysis with an 
acid or base 9, 11-12. Before, it was already proven that these amine and carboxylic acid 
functionalities permit the subsequent reactions with biosignaling molecules such as 
transferrin, insulin, fibronectin and other proteins 13-15. Since wet chemical modifications 
require the use of solvents and tend to affect the bulk of the materials, nowadays, less harsh 
and more environmental friendly methods are being evaluated which only affect the surface 
of the materials.  
In this respect, plasma treatments of polymers have been extensively studied. With respect 
to PMMA, the influence of different plasma treatments has already been evaluated, 
including oxygen 16-17, argon 18-21 and air 22-23 plasma. These literature reports indicate that a 
plasma treatment results in surface oxygen enrichment and in an increased hydrophilicity of 
the substrate. For PMMA, a decrease in water contact angle of 30° has been obtained when 
treating it with Ar-plasma (going from 75° to 45°), whereas oxygen plasma results in even 
lower contact angles (down to 2°) 16, 24.  
Even though it has been proven that a plasma treatment as such can induce an increased cell 
response 16, 25, it can be desirable to introduce specific chemical functionalities on the 
surface, which enable subsequent and permanent immobilization of biologically active 
compounds. In this respect, plasma has been frequently applied as a tool to graft such 
specific functionalities. Examples include graft polymerization of acrylamide or acrylic acid 
onto poly(ethylene) 26 or PMMA films 27-28 and post-plasma grafting of 2-aminoethyl 
methacrylate onto PCL 29.  
Apart from plasma-based modifications, alternative solventless modification techniques 
exist including photografting, ozone oxidation and high energy radiation. In the first case, 
upon UV-irradiation and in the presence of an initiator, radicals are created on the polymer 
surface, which can subsequently react with monomers, carrying the desired functionalities. 
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Using this approach, PEG monoacrylate and acrylamide were previously immobilized onto 
PMMA polymer sheets 30-31. In case of ozonization, surface peroxides, carbonyl and carboxyl 
functionalities are introduced, enabling subsequent reactions such as the immobilization of 
PEG 32. In case of high energy radiation such as electron beams, degradation of PMMA is 
highly manifested and mainly results in chain scission with the formation of radicals or active 
ions, which are chemically reactive and which may result in subsequent crosslinking 33-34.   
 
Alternatively, surface modification can also be realized by the deposition of a functionalized 
coating. In literature, different deposition principles are described such as Langmuir Blodgett 
deposition 35, self-assembled monolayers 36 or layer-by-layer deposition 37. Since all of these 
methods suffer from their non-versatile nature, the use of polydopamine was more recently 
proposed by Messersmith et al as a universal surface functionalization strategy 38-40. By a 
simple immersion step in alkaline conditions, the polymer can be applied onto a wide range 
of materials, including ceramics, metals and polymers 41. In a subsequent step, this activating 
layer enables the subsequent biofunctionalization of the materials (see chapter 4). 
 
The previous chapter indicated that the developed materials lack cell interactivity. As a 
consequence, the immobilization of biologically active compounds is required to enhance 
the cell response. Since the selected polymers are inert (i.e. do not contain reactive chemical 
functionalities), activation is necessary to subsequently link biomolecules such as antibodies 
and growth factors in a covalent way (see chapter 4). The biomolecules used in this work are 
built-up of aminoacids, implying that their main reactive groups consist of amines and 
carboxylic acids. As a consequence, complementary functional groups have to be 
immobilized onto the material surfaces to enable coupling. To this end, two strategies were 
elaborated. In a first strategy, amine-based functionalities were introduced by means of 
post-plasma grafting of 2-aminoethyl methacrylate (AEMA) (§ 3.3.2). These amine functions 
enable the reaction with carboxylic acids present in the biomolecules. The strategy was 
selected based on a previous successful report, describing the biofunctionalisation of PCL 
scaffolds 29. In a second strategy, because of its universal and versatile character (as 
described above), polydopamine (PDA) (§ 3.3.2), a marine-based adhesive, was selected as 
activating coating. Furthermore, since plasma activation was used prior to functionalization, 
the upcoming paragraph will focus on this topic. Herein, the effect of different plasma gasses 
on the material properties was studied. The final selection of plasma gas was based on 
available literature reports and on the obtained results (see further).   
 
Based on their superior mechanical and swell properties (see chapter 2), one PEG-based 
material was selected (P(MMA-co-PEGDMA), referred to as PMMAPEG), as well as one LMA-
based material (P(MMA-co-LMA-co-PEGDMA), referred to as PLMA). For the latter case, two 
different initiators (i.e. Irgacure® 2959 and irgacure®651) were evaluated in the previous 
chapter, but only minor differences were obtained during evaluation of the bulk properties 
of the materials (i.e. PLMA(2959) and PLMA(651)). Whether the initiator selection will 
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influence the surface modification and properties of the materials, will be investigated in the 
current chapter. Figure 1 overviews the different surface modification strategies that will be 
discussed in the current chapter. 
 
 
Figure 3.1: Overview of the different surface modifications that will be discussed in the current 
chapter. First, a plasma treatment was conducted as a pre-activation step. Next, surface 
functionalization was targeted via post-plasma grafting of AEMA (strategy 1) or PDA (strategy 2: 
protocol Ipl and IIpl). For the latter strategy, straightforward immersion of the polymer substrates 
in the DA solution was also evaluated (protocols I and II). The different protocols will be further 
explained in the upcoming paragraphs. The scheme also mentions the polymer substrates which 
were used during the different modification steps. 
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3.2. Plasma activation of the polymer surfaces 
In 1929, Langmuir introduced the term plasma, which is also referred to as the fourth state 
of matter, in addition to the solid, liquid and gaseous state 42. It can be defined as a ‘gaseous’ 
or fluid-like mixture consisting of ions, electrons, radicals and neutral particles such as atoms 
and molecules. Since some of the particles are in an excited state, relaxation to the ground 
state typically results in the emission of photons, which is responsible for the characteristic 
illumination of a plasma reactor (cfr. the purple color in figure 3.2, A).  
Generally, two types of plasma can be distinguished, including thermal equilibrium and non-
thermal non-equilibrium plasmas. In the former type, high temperatures are applied in order 
to equally distribute the energy amongst all particles present in the plasma. Since polymers 
do not withstand such high temperatures (up to 20000 K), the latter type is preferred to 
treat polymer-based biomaterials 43. In literature, different ways are described to generate a 
non-thermal or cold plasma including the use of glow discharge, microwave discharge, 
corona discharge and dielectric barrier discharge (DBD) 43-44. Herein, a cylindrical dielectrical 
discharge plasma reactor was used of which the schematic set-up is displayed in figure 3.2 
(B). 
 
 
Figure 3.2: A: Plasma reactor showing the illumination caused by the emitted photo-electrons and 
B: the schematic representation of the used DBD set-up, which consists of the gas cylinder (1), a 
mass flow controller (2), a plasma chamber (3), a pressure gauge (4), a valve (5) and a pump (6). 
 
As already indicated in the introduction, compared to wet chemical treatments, plasma 
treatment is characterized by a number of advantages including its solvent-free nature, its 
applicability onto different material geometries and its surface specific application, meaning 
that the bulk properties of the treated material remain unaltered. On the other hand, the 
greatest disadvantage of this plasma technique is ‘ageing’, which is the disappearance of the 
plasma effect as a function of time 45.  
It should be mentioned that the application of plasma may also result in etching of the 
surface, because of the bombardment with ions from the plasma. As a result, the surface 
roughness might be altered due to the release of small fragments. Depending on the 
application, this fact may be advantageous or unwanted 44. 
A B 
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To create a plasma, different gasses can be selected, including Ar, O2, N2 and CO2 
46. In this 
work, the application of Ar and O2 plasma treatment was mainly focused on, although, in 
cooperation with Prof. Rino Morent (Department of Applied Physics, University of Ghent), 
the effect of other plasma gasses such as air and nitrogen were also studied. The preliminary 
results that originated from this collaboration are represented at the end of this paragraph.  
 
In a first step, argon was evaluated as a plasma activating gas for the PEG and LMA-based 
materials. Static contact angle measurements (SCA) clearly showed that a plasma treatment 
converts the hydrophobic LMA-based surfaces into more hydrophilic ones (Figure 3.3, A), as 
represented by a decrease in water contact angle. In case Irgacure® 2959 was used, an initial 
decrease of the contact angle value was followed by a plateau value (i.e. ~50°) when longer 
plasma treatment times were applied (i.e. 60 seconds).  
For PLMA(651), a clear minimum in contact angle was reached when executing the plasma 
treatment for 30 seconds (± 40°), whereas a treatment time of 60 seconds caused the 
contact angle to increase (± 56°). It is however clear that for treatment times exceeding 60 
seconds, similar contact angle values were obtained compared to PLMA(2959) (i.e. 50°).  
A similar trend could be observed when PMMAPEG was used as a substrate material (Figure 
3.3, B). After 30 seconds of plasma treatment, the lowest contact angle was observed (i.e. 
20°) which is a 50° decrease compared to the blank value of 70°.   
 
From literature, it is known that the functional groups which are introduced by a plasma 
treatment, are not stable over time and that treated surfaces tend to re-orient over time 45. 
To evaluate this ageing phenomenon, plasma-treated samples were exposed to ambient air 
for a certain period of time and were again evaluated by SCA measurements. Figure 3.3 (C 
and D), clearly show that the SCA of all material surfaces increased as a function of time. In 
case of PMMAPEG (Figure 3.3, D), the contact angle was slightly increased after 30 minutes 
of air-exposure, but even after 4 hours, this increase was limited to only 8 degrees. For the 
LMA-based materials (Figure 3.3, C), the ageing behavior was again dependent on the type 
of initiator used. In case of irgacure® 651, a further decrease of the SCA was observed, even 
after 20 minutes of air exposure. This suggests a slower but further introduction of oxygen-
containing functional groups onto the polymer surfaces. Thereafter, the SCA increased up to 
68°. In case irgacure® 2959 was used as an initiator, ageing occurred immediately and after 4 
hours, the SCA increased with 13°, reaching a value of 55°. For both materials (i.e. 
PLMA(651) and PLMA(2959)), the initial contact angle of 89° was not restored implying that 
the surface wettability is well maintained for all three materials evaluated.  
These results indicated that no real time constraints were needed for the subsequent post-
plasma modification step in aqueous media. Nevertheless, in order to minimize losses of the 
plasma treatment effect, all samples were typically immersed ‘immediately’ in the solution 
applied for the modification reactions. Additionally, in literature it has been described that 
the immersion of plasma-treated samples in an aqueous environment maintains the 
hydrophilicity of the samples and thereby reduces the effect of ageing. This means that the 
Surface activation and functionalization of methacrylate-based polymers | Chapter 3 
119 
 
aqueous modification solutions show affinity towards the incorporated polar groups, forcing 
them to stay on the surface rather than forcing them into the bulk of the material 47. 
 
 
  
 
  
Figure 3.3: Static contact angles of Ar plasma-treated PLMA samples (A) and PMMAPEG samples 
(B) as a function of plasma treatment time. Furthermore, the static contact angles as a function of 
ageing time are displayed for Ar-plasma treated PLMA (C) and PMMAPEG samples (D). 
 
To study the effect of an oxygen plasma treatment, PLMA(2959) was selected and the effect 
was compared with the results obtained for an argon plasma treatment (see figure 3.4). The 
results showed that the application of an oxygen plasma resulted in similar contact angles 
compared to the argon plasma treatment. One minute of plasma treatment resulted in a 
SCA of 53°, irrespective of the applied gas. With respect to ageing, it is clear that after 
oxygen plasma treatment, no further decrease of the SCA was observed, but a slight increase 
was immediately manifested (p>0.05). The results also showed that the plasma effect was 
slightly better maintained after oxygen plasma treatment compared to argon plasma. 
Indeed, after 4 hours of air exposure, the SCA remained 60° after O2 plasma treatment, 
whereas for Ar plasma a value of 70° was already obtained.   
In figure 3.4 (C), an overview is given of the O2 and Ar plasma effects for the three different 
materials under evaluation, using a plasma exposure time of 1 minute. As previously 
discussed, a similar SCA was obtained for PLMA(2959) whereas for PLMA(651), a significantly 
lower SCA was obtained after argon plasma treatment compared to oxygen plasma 
treatment (i.e. a difference of 14°). A similar effect was found for the PEG-based material 
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and compared to oxygen plasma, a 20° lower SCA was obtained upon application of argon 
plasma. These results point out that the plasma-effect is highly substrate dependent. 
 
 
  
 
  
Figure 3.4: Comparison of Ar- and O2 plasma treated PLMA(2959) samples: effect of plasma 
treatment time (A) and the ageing effect (B). Panel C makes the comparison between the blank 
and a 1 minute argon and oxygen plasma treatment and this for the three substrate materials 
under investigation. Conditions which were significantly different (p<0.05) are denoted by the 
same letters a,b,c,… Panel D shows IR mapping measurements performed on PLMA(2959). The 
annotated peaks show the appearance of OH- (3500-3200 cm-1) and C=O functionalities (1665 
cm-1).  
 
It is generally accepted from literature data that an O2 plasma treatment results in the 
introduction of -COOH and -OH functionalities on the substrate surface whereas for Ar 
plasma treatment, the creation of free radicals is predominant. In the latter case, upon air 
exposure, these radicals can react with air species thereby introducing mainly oxygen and 
some nitrogen on the material surface 48. In the present work, the presence of these 
functional groups was demonstrated by IR mapping on the surface (Figure 3.4, D). For both 
plasma gasses, a broad signal could be distinguished around 3500-3200 cm-1 (pointed by an 
arrow), which can be attributed to –OH functionalities. Furthermore, in case of argon plasma 
treatment, a new peak arose around 1665 cm-1 (pointed by an arrow in figure 3.4, D) which 
can be attributed to the introduction of -C=O containing functionalities. 
In general, the observed decreases in SCA after plasma treatment can be explained by the 
introduction of these functional groups. In this respect, XPS analyses could have been 
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performed to gain more information on the nature of these functionalities. Further 
elucidation of the latter could offer interesting insight for future research.  
As mentioned in the beginning of this paragraph, a preliminary study was conducted with 
alternative plasma gasses, including nitrogen gas and air and a comparison was made with 
the results obtained for argon plasma treatment. As a case study, PMMAPEG was subjected 
to the different plasma treatments and the SCA values were compared (see figure 3.5, A). 
Regardless of the chosen gas, a significant decrease in contact angle was obtained after 
plasma treatment. Air and argon induced a similar effect, whereas nitrogen influenced the 
hydrophilicity to a greater extent. To understand the cause of this effect, the elemental 
composition of the nitrogen-treated surfaces was studied. Preliminary XPS analysis (see 
figure 3.5, B) revealed that a nitrogen plasma treatment resulted in the introduction of a 
substantial amount of nitrogen-containing species, which are in all probability responsible 
for the increased hydrophilicity. Maximum amounts of 6 and 7 % of nitrogen were 
introduced after respectively 0.5 and 2 minutes of plasma treatment.  
Because of the presence of amine functions in case of N2 plasma treatment, the direct 
biofunctionalization of the surfaces could also have been considered. Nevertheless, this 
route was not further explored in the current work. 
 
 
 
Figure 3.5: Static contact angle of air, argon and nitrogen plasma treated PMMAPEG samples as a 
function of plasma treatment time (A). Percentage of nitrogen introduced on the nitrogen-plasma 
treated samples (B). 
 
 
3.3. Post-plasma grafting of 2-aminoethyl methacrylate 
Apart from surface activation, functionalization of the surface was required to enable 
subsequent immobilisation of biomolecules (see chapter 4). In a first strategy, amine-based 
functionalities were introduced via a post-plasma grafting procedure. Herein, 2-aminoethyl 
methacrylate (AEMA) was selected as grafting monomer to introduce primary amines as 
reactive units. Since we aim at an activation of the polymer surface by the introduction of 
radicals, argon gas was selected to perform the plasma pre-treatment step.  
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Figure 3.6 (A) summarizes the grafting procedure which consists of two steps. First, a plasma 
treatment is applied on the polymer sheets to activate the surface by the introduction of 
radicals (see discussion in § 3.2). Upon exposure to ambient air, the created radicals 
immediately react with atmospheric oxygen and as a consequence, oxygen-rich 
functionalities are introduced on the polymer surface, such as peroxides. Based on the 
mechanistic model of Suzuki et al 26, UV-induced radical cleavage of these peroxides would 
facilitate the post-plasma grafting step. Although many literature reports refer to the above-
mentioned model 26, 29, 49-50, recent electron spin resonance (EPR) studies have demonstrated 
that UV irradiation is producing radicals not only on the functional groups introduced by 
plasma, but also continuously on the polymer chain itself 51.  
Independent of the exact grafting mechanism, upon grafting of AEMA, primary amine 
functions were introduced on the surface, enabling subsequent biofunctionalization (see 
chapter 4).  
 
The presence of the primary amine functions could be evidenced by XPS measurements. As 
demonstrated in figure 3.6 (B), nitrogen was introduced on all surfaces after the AEMA 
grafting step. Since no nitrogen was present on the blank materials, these values were clear 
evidence of the successful immobilization. Nevertheless, it should be noted that the 
reproducibility (a minimum of 2 samples, measured at three different locations were 
included in these data) of the grafting technique was rather poor, as demonstrated by the 
high standard deviations. Furthermore, if one sample was considered of one specific 
condition, no homogeneous coatings were obtained. Places without successful modification 
(i.e. of 0% N) were detected and for some samples, even places of 5-6% of nitrogen were 
observed. It appeared that PLMA(651) resulted in the most reproducible grafting results. 
Generally, compared to the work of Desmet et al 29, the obtained nitrogen percentages were 
rather small, since for the grafting on PCL, nitrogen percentages of 6 % were reached for the 
same grafting conditions and for all samples. These differences clearly prove that the success 
of this grafting method is substrate dependent. Since the optimum value to enable the 
subsequent immobilization of biomolecules is unknown, it could be anticipated that a lower 
immobilization degree of AEMA could still be sufficient to realize this goal. 
Based on these XPS measurements, an ‘optimal’ plasma treatment time was selected for 
each material. It should be noted that, due to the high standard deviations, no significant 
differences in atomic nitrogen percentage or N/C ratio were obtained when comparing the 
three different plasma activation times. Nevertheless, the plasma treatment time was still 
selected based on a maximized nitrogen percentage (mean values) and a maximized N/C 
ratio . In case of the PEG-based material, this maximum was reached for a treatment time of 
30 seconds, whereas for the PLMA-based materials, 12 seconds was selected for future 
experiments.  
In a next step, static contact angle measurements (SCA) were performed to further evidence 
the successful immobilization of AEMA. Figure 3.6 (C) shows that a significant difference was 
obtained between the SCA values of the plasma-treated samples and the AEMA-grafted 
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surfaces (p<0.05). More specifically, a significant increase of 41°, 11° and 27° was found for 
respectively PMMAPEG, PLMA(2959) and PLMA(651). After AEMA grafting, it could be 
anticipated that similar contact angles would be obtained, due to the presence of identical 
surface functionalities. Indeed, for the LMA-based materials, no significant difference was 
obtained in SCA after AEMA grafting (p>0.05), but for PMMAPEG, a significant difference 
was obtained when comparing its SCA (±61°) with the ones obtained for PLMA(651) (±76°). 
In literature, a SCA of 50° was reported for AEMA-grafted PCL samples 29. As explained 
above, the grafting technique resulted in a poor reproducibility for the current materials and 
as a consequence, the SCA measurements are still influenced by the underlying substrate. 
Furthermore, a different surface roughness of the materials could also have a substantial 
effect on these SCA measurements.  
 
 
 
 
  PMMAPEG PLMA(651) PLMA(2959) 
Plasma time (s) N (at%) N/C N (at%) N/C N (at%) N/C 
12 1.6 ± 1.8 0.027 ± 0.027 1.3 ± 0.3 0.020 ± 0.004 1.4 ± 1.8 0.020 ± 0.026 
30 3.2 ± 3.0 0.047 ± 0.042 1.0 ± 0.2 0.016 ± 0.003 0.9 ± 0.5 0.012 ± 0.006 
42 2.5 ± 2.5 0.039 ± 0.038 1.2 ±0.2 0.019 ± 0.004 1.2 ± 0.4 0.015 ± 0.006 
 
 
Figure 3.6: A: Post-plasma grafting technique of 2-aminoethyl methacrylate onto a polymer 
substrate. B: Atomic percentages and N/C ratio’s of the AEMA grafted samples. C:  Contact 
angles for the blank, argon plasma-treated and AEMA-grafted PMMAPEG and PLMA materials. 
Conditions which are significantly different (p<0.05) are denoted by the same letters a,b,c,…  
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3.4. Surface functionalization with polydopamine 
In addition to AEMA functionalization of the surfaces via a post-plasma grafting technique, 
the application of a polydopamine coating as activating sublayer has also been studied. In 
literature, a lot of attention has been paid to this adhesive coating. In the upcoming section, 
a short summary is provided on the background of this polymer coating and the various 
adhesion mechanisms reported on to date. Next, the characteristics of the deposited PDA 
layers are overviewed for the two substrate materials, including PMMAPEG (§ 3.4.2.1) and 
PLMA (§ 3.4.2.2). 
 
3.4.1. Background on polydopamine 
During the last decades, increasing research efforts have been focussing on the study of the 
adhesive capabilities of gecko’s and marine organisms of which mussels, barnacles and tube 
worms comprise common examples 38-40, 52. In case of mussels, the so-called MAP’s (i.e. 
mussel adhesive proteins) play a central role during the adhesion process and because of 
these MAP’s, mussels are able to attach to virtually all types of inorganic and organic 
surfaces under water. Sequencing of these proteins has revealed the significant presence of 
two compounds 52-53: 
 
1. L-3,4-dihydroxyphenylalanine (DOPA), a catechol containing amino acid that is 
formed by post-translational modification of L-tyrosine. Depending on the protein 
studied, concentrations ranging from a few mol% up to 27 mol% are contained in 
these MAPs 54. 
HO
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Figure 3.7: Chemical structures of L-tyrosine and L-DOPA 
 
2. Lysine amino acids which are mostly located next to the DOPA residues. 
 
H2N
OH
O
H
NH2
 
Figure 3.8: Chemical structure of L-lysine 
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Apart from covalent crosslinking which results in solidification of the adhesive, the DOPA 
residues are believed to be primarily responsible for chemisorption to surfaces under water 
via covalent and non-covalent interactions 41, 52, 55-56. Once the adhesive strength of this 
catechol-containing residue became clear, a lot of research started to mimic this behavior by 
synthesizing biomimetic copolymers, containing these DOPA residues in order to modify 
material surfaces 39, 52-53, 57-62. Examples include co-polypeptides consisting of L-Lysine and 
DOPA to form moisture resistant coatings 52, the introduction of DOPA into the structure of 
Pluronic materials to form in-situ bioadhesive hydrogels 57, the production of DOPA end-
functionalized PEG polymers to obtain non-fouling surfaces 58-59, 61, 63-64 and the production 
of poly(dopamine methacrylate-co-2-methoxyethyl acrylate)62. Furthermore, new 
bifunctional initiators were developed to initiate a surface-initiated atom transfer radical 
polymerization (SI-ATRP) of methyl methacrylate-based macromonomers. Bifunctional refers 
to the presence of an alkyl bromine to activate surface-initiated polymerization (SIP) and to 
the presence of a catechol function to allow surface anchoring of the initiator 60. 
Apart from these more complex mimetics, Lee et al introduced dopamine, also known as a 
neurotransmitter and hormone, as the smallest alternative to nature’s adhesive protein 
which combines both the catechol and amine function already mentioned above 65       
(figure 3.9). As pioneers, Lee et al applied this molecule as a self-polymerizing monomer to 
coat multiple surfaces such as metals (e.g. Au, Ag, Pt, Pd Cu, stainless steel and nitinol), 
oxides (e.g. SiO2, Al2O3,…), semiconductors (e.g. GaAs), ceramics (e.g. glass) and synthetic 
polymers (e.g. polystyrene) 41. The polydopamine (PDA) coating activates the surfaces, 
thereby enabling the subsequent grafting of polymer adlayers and biomolecules (see also 
chapter 4) 66. Ever since, many research groups have investigated the potential of this 
coating to be applied on different substrates. Typical examples include titanium 59, silicon 
oxide 67 and its microparticles 68, stainless steel 69, carbon nanotubes 70, silanated aluminum 
oxide membranes 71 and different polymers including polydimethylsiloxane (PDMS) 61, poly-
-caprolactone (PCL) 72, polyethylene (PE), poly(vinylidene fluoride) (PVDF), 
polytetrafluoroethylene (PTFE) 73 and polycarbonate (PC) 66. Interestingly, the results of 
those studies indicated that the melanin-based polymer induced a positive effect on cell 
viability, attachment and spreading on the range of materials evaluated 72, 74-76. 
 
HO
HO
NH2
 
Figure 3.9: Chemical structure of dopamine 
 
From literature, it is clear that researchers agree on the universal character of PDA and on its 
applicability as linker to immobilize other polymers, biomolecules or linkers. On the other 
hand, on the deposition behavior and structure of the PDA layers, some disagreement still 
exists to date. In the following paragraphs, a brief overview will be given on the existing 
literature regarding the reaction mechanism and structure of PDA.   
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To date, the exact polymerization mechanism remains unknown, but literature often refers 
to a reaction route resembling melanin formation 41, 77. Melanins comprise a group of 
phenolic pigments and their formation is better known as melangonesis which is a 
biochemical process occurring in the skin to protect animals and humans from solar   
damage 78. The mechanism of melanin synthesis is described by the Rapor-Mason pathway 
and consists of two main phases:  
1) the conversion of tyrosine into indolequinones  
2) polymerization of these quinones into melanin 
Figure 3.10 summarizes the steps in this mechanism in greater detail and makes a 
comparison with the polymerization mechanism of dopamine proposed by Lee et al.  
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Figure 3.10: Pathway for melanogenesis 78 and polydopamine formation 41. 
Surface activation and functionalization of methacrylate-based polymers | Chapter 3 
127 
 
The greatest difference between both reaction schemes is the involvement of enzymes 
which catalyze several steps in case of melanogenesis. In case of dopamine, no enzymes are 
involved but oxidative conditions such as alkaline media and the presence of oxidants such 
as air-oxygen, ammonium persulfate or Cu2+ will be the prerequisite to enable the different 
oxidation steps 79-80. In both cases, 5,6-dihydroxyindole (DHI) is formed which is suggested to 
be the main compound during polymerization, together with its quinone derivative 41, 78, 81. 
Also other groups speculated or confirmed that intramolecular cyclization of 
dopaminequinone occurs with the formation of indole derivatives 69, 82. Multistep reactions 
involving these indoles result in the formation of insoluble black to brownish melanin-like 
PDA particles which aggregate in solution, but at the same time, a tightly adherent PDA 
coating is formed on the immersed substrates 77.  
 
According to Bernsmann et al, both processes are independent, which means that particles 
in solution do not adhere to the substrates during immersion, but instead, PDA films are 
formed because of the interaction of monomeric species with the material’s surface 67. They 
proposed a radical process similar to aniline oxidation in which radicals absorb at the surface 
and initiate subsequent polymerization 83. Definitive proof of this mechanism was not 
delivered but also other research groups supported this idea 77 or at least confirmed the 
presence of radicals in the PDA structure 82, 84-85. They also concluded that a regular supply of 
freshly, non-oxidized dopamine molecules is needed to enable continuous growth of the 
PDA layer and to obtain a controllable layer thickness 86 67. Lee et al proposed that in case of 
inorganic surfaces such as metals, the catechol derivative of dopamine is forming strong but 
reversible coordination bonds whereas on organic surfaces, covalent bond formation is 
established by the quinone derivative 87-88. 
 
Apart from the deposition mechanism, also the structure of PDA remains a point of 
discussion. Intuitively, the structure of PDA could consist of a linear linkage of dopamine 
units, resulting in a structure as represented in figure 3.11 (a). Nevertheless, as already 
mentioned before, 5,6-dihydroxyindole and 5,6-indolequinone have already been identified 
as very important building blocks of PDA. Generally, agreement exists about this fact, but 
there still remains disagreement about how these units are linked and organized and 
whether these are the only compounds involved. A first group of researchers strongly 
believes in the covalent character of this polymer, in which different tautomers of the indole 
and quinone compounds play a major role during the reaction (see figure 3.12) 81, 89. In their 
opinion, PDA clearly resembles a melanin-like structure as displayed in figure 3.11 (b), but 
uncertainty exists about the number of repeating units. For eumelanins, the formation of 
dimers and trimers has already been suggested 85. Conversely, others determined the 
formation of tetramers and pentamers as the favorable ones 90.  
Liebscher et al even proposed a PDA structure consisting of dopamine, DHI and indoledione 
units with different degrees of (un)saturation, which are linked by C-C bonds between their 
benzyl groups (see figure 3.11, c) 84, 91 . 
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Contrary to these models, Dreyer et al did not find spectroscopic evidence for aryl-aryl 
coupling between the dopamine monomers and instead of a covalent polymer, they 
suggested a non-covalent organization of cyclized dopamine monomers. Figure 3.11 (d) 
displays the proposed structure of PDA in which strong, non-covalent intra- and interchain 
interactions exist, including hydrogen bonding, charge transfer and π-stacking 82. More 
recently, it has been suggested that a combination of covalent and non-covalent linkages 
exist in the PDA structure. Hong et al identified a self-assembled trimer consisting of a 
(dopamine)2/DHI complex (figure 3.11, e), which is tightly entrapped inside of a covalently 
bound polydopamine structure 82. The presence of free dopamine in the polymer was also 
evidenced by others 81, 92.  
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Figure 3.11: Proposed structures of PDA according to the polycatecholamine model 41 (a), the 
eumelanin-type model 78 (b), the poly(indole-dopamine) model 84 (c), the non-covalent 
organization model 82 (d), the formation of a (dopamine)2/DHI complex 
93 (e) and the formation of 
a (DHI)2/PCA trimer 
94 (f). 
 
Other studies agree on the fact that covalent linkages are very important during the initial 
steps of PDA built-up but also that non-covalent interactions become significant at later 
stages 91, 95. Liebscher et al identified the charge transfer interactions between the quinone 
and catechol units as the prevalent inter-chain interactions, assisted by some hydrogen 
bonding 84. On the other hand, according to Arzillo et al, PDA consists of oligomers which are 
attached to each other to form aggregates which are organized in 2D planar sheets via π-
stacks 95. Additionally, evidence has been found that these planar sheets of varying 
dimensions organize in onion-like nanostructures 96.  
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Figure 3.12: Tautomers of 5,6-dihydroxyindole and 5,6-indolequinone 81, 89 
 
It should be noted that the-above mentioned structural information about PDA is mainly 
deduced from PDA aggregates which were formed in solution. More recently, Ding and co-
workers focused on the structural characteristics of deposited PDA-films for different 
starting concentrations of the dopamine (DA) solution. They concluded that the film 
thickness increased with the concentration but once a concentration of 1 g/l was applied, a 
decreased layer thickness was obtained. Furthermore, based on results obtained with TOF-
SIMS, they were able to disprove all the previously mentioned models presented in figure 
3.10 and suggested the presence of pyrrolecarboxylic acid (PCA) moieties, which are derived 
from oxidative degradation of indole units. From their results, the (DHI)2/PCA trimer 
complex was identified as the major building block of PDA film formation (figure 3.11, f) 94.  
 
It is clear that the PDA structure is very complex and that probably none of the models 
described in literature completely covers the true structure of this polymer to date. As a 
consequence, PDA can be described as a very heterogeneous material and future research 
will have to shed light on this topic. 
 
Despite the uncertainty about its chemical structure, PDA possesses interesting 
characteristics and as a result, it has been applied for a broad range of applications. Apart 
from its application as adhesive coating, it is also used for the production of PDA 
nano/microcapsules which can be used as a reservoir for functional agents 68, 97. 
Furthermore, PDA has been used as universal biomineralization route to assist 
hydroxyapatite crystallization on different scaffold materials 98-100. In the world of 
chromatography, it is used as coating for capillary columns to determine auxins 101 and in the 
world of batteries, it functions as a coating for separators to improve properties such as 
electrolyte wetting and ionic conductivity 102.  
In the present work, PDA is used as an activating sub-layer to enable the subsequent 
immobilization of biomolecules such as gelatin, antibodies and growth factors (see chapter 
4). In a first part, the different deposition protocols are discussed followed by an in depth 
characterization of the deposited PDA layers.  
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3.4.2. PDA immobilization protocols and characterization 
PMMA, PMMAPEG, PLMA(651) and PLMA(2959) were subjected to a PDA surface 
modification step. As described in the experimental part (see chapter 6), different 
immobilization protocols were used. Protocol I resembles the original deposition protocol as 
described by Lee et al 41. Protocol II includes an additional step as the samples were first 
immersed in Tris buffer (pH 8.5), followed by the addition of dopamine (DA) in powder form. 
In order to evaluate the possibility to further improve the adhesion of polydopamine and the 
materials developed, both protocols were also combined with an oxygen plasma pre-
activation step (referred to as Ipl and IIpl). The deposited layers were characterized by 
applying a range of characterization techniques including static contact angle (SCA) 
measurements, X-ray photoelectron spectroscopy (XPS), profilometry measurements, 
atomic force microscopy (AFM) and scanning electron microscopy (SEM) of which the results 
are discussed in the up-coming paragraphs. 
 
3.4.2.1. PMMA and PMMAPEG as substrate materials for PDA deposition 
The different deposition protocols were tested on PMMA and PMMAPEG, in order to select 
one of the protocols for the subsequent material biofunctionalization (see chapter 4). 
Herein, PMMAPEG should be considered as the main material of interest as this material was 
intended to function as the eventual glucose sensor packaging. PMMA was included in the 
study as reference material. In § 3.4.2.2, a similar optimization will be described for the 
PLMA-based materials. 
In order to assess the atomic composition of the sample surfaces after PDA deposition, XPS 
measurements were performed. The recorded atomic nitrogen percentages indicated that a 
successful immobilization of PDA was accomplished for all samples, regardless of the 
protocol used (figure 3.13, A and B). For PMMAPEG, protocol I and protocol IIpl resulted in 
the highest nitrogen percentages (i.e. 5 ± 0.8 % for both protocols) and therefore, they 
present the preferred protocols.  
Based on the O/C ratio, the data revealed that, for PMMA, no significant difference was 
obtained (p>0.05) between the blank and the different surface-modified samples (figure 
3.13 C). The latter suggested the deposition of a very thin PDA film through which the 
substrate material could still be detected. Furthermore, it was anticipated that the O/C value 
of the PMMA blank would approach the theoretical value of 0.40. The deviation in signal 
observed for the theoretical (0.40) and experimental blank (0.30) might suggest carbon 
contamination during sample handling or chain migration and orientation, resulting in higher 
carbon percentages at the surface.   
In case of PMMAPEG (Figure 3.13, D), an excellent agreement was found between the 
theoretical (0.45) and the experimental value (i.e. 0.46) for the blank. Furthermore, as 
anticipated, deposition of PDA resulted in a significant decrease of the O/C ratio (p<0.05), 
although, compared to the theoretical value of 0.25, only protocol I approached this value.  
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Undoubtedly, the observed changes in the chemical composition of the surface also 
influenced their wettability. Therefore, static contact angle measurements were performed 
to complement the previously described results. Figure 3.13 (E) clearly shows that, 
irrespective of the used protocol, the deposition of PDA gave rise to a significant decrease in 
static contact angle compared to the blank materials (p<0.05) (from 70-85° for the blank 
materials to 40-50° for the PDA coated ones). These data are in good agreement with 
literature as Lee et al reported contact angles for PDA-coated PTFE and PC of 49° and 42° 
respectively 41. Statistical analysis showed that no significant difference was obtained for 
both materials when comparing protocol I and II. On the other hand, a significant influence 
could be observed in case protocol II was combined with a plasma pre-activating step 
(p<0.05). This might suggest a different orientation or composition of the formed PDA layer. 
Yet, if plasma treatment would induce such an effect, a significant difference would also be 
expected when comparing the results obtained for protocol I with and without a plasma pre-
activation step. As this difference is not observed, no clear evidence of this plasma-effect 
could be delivered at this stage.  
 
Based on XPS and SCA analyses, a successful PDA deposition on both PMMA and PMMAPEG 
was shown. Furthermore, based on the observed atomic nitrogen percentages and the 
match between the experimental and the theoretical O/C ratios as obtained from XPS, 
protocol I was selected as the preferred PDA deposition method. Interestingly, compared to 
the other protocols, protocol I also offered the advantage to be more time efficient. 
 
In literature, it has been shown that the deposited amount of PDA is a function of the 
incubation time and that after 24 hours, a 50 nm thick layer is deposited 41. As a 
consequence, this variable was also optimized for the selected deposition protocol. After 24 
hours of incubation, indeed the highest amount of nitrogen was detected on the PMMAPEG 
surface (i.e. N/O = 0.30) (Figure 3.13F). For PMMA, a similar optimization was performed and 
again after 24 hours, the amount of PDA was maximized (N/O = 0.29). 
 
Further characterization of the PDA-modified samples with SEM revealed the presence of 
clusters (i.e. aggregates of grape-like shaped particles) on the surfaces (figure 3.14). 
Intrigued by this observation, a comparison was made between the pristine polymers and 
the plasma treated ones. In this way, we hoped to get a better insight in the above-
mentioned plasma-effect. When comparing pristine PMMA (SCA 85°) with the plasma-
treated one (SCA ≈ 0°), the size of the largest clusters decreased from 6.5 µm to 
approximately 2 µm. Similarly, for PMMAPEG, the largest clusters sized 4 µm on the blank 
material (SCA 75°), while after a plasma treatment (corresponding with a SCA of 43°), this 
value decreased to 1.3 µm. These data suggest that plasma treatment results in a decreased 
cluster size, which is probably induced by a closer contact between the substrate and the 
dopamine solution, resulting in an increased probability for cluster formation to occur 
concomitant with a higher number of clusters deposited (cfr. cluster nucleation sites).  
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Figure 3.13: Atomic nitrogen percentages of blank and PDA-coated PMMA (A) and PMMAPEG (B) 
materials and the O/C ratio of the same PDA-coated PMMA (C) and PMMAPEG (D) samples, as 
determined by XPS. Panel (E) displays the static contact angles (SCA) determined for the blank and 
PDA-coated PMMA and PMMAPEG samples, applying different immobilization protocols. The value 
indicated by ‘#’ refers to a contact angle approaching 0°. Panel (F) demonstrates the effect of PDA 
deposition time on the N/O ratios of PMMAPEG surfaces as obtained by XPS measurements.  
Samples which are significantly different within one graph are marked with the same letter 
(a,b,c,…) (p<0.05). For the SCA measurements, all PDA-modified samples are significantly different 
compared to their respective blank (p<0.05). 
 
In literature, PDA coatings have already been described as showing a granular morphology 
on a gold surface 81, to uniform with covalently bound PDA on poly(vinylidene fluoride) 
(PVDF) 77 and on epoxy resins, showing a granular cover layer containing additional 
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aggregates with a diameter of 0.5-5µm and 100-450 nm respectively 103. Furthermore, Giol 
et al noticed that dependent on the applied protocol, specific surface topographies were 
obtained on poly(ethylene terephtalate) (PET) 104. Additionally, plasma pretreatment 
resulted in a more homogeneous PDA spreading, a finding which was also supported by Xie 
et al 105. 
 
 
Figure 3.14: SEM images1 of PMMA blank (a), PDA coated PMMA applying protocol I (b) and 
plasma + protocol I (c), PMMAPEG blank (d) and PDA coated PMMAPEG applying protocol I (e) and 
plasma + protocol I (f). For each coated material, several clusters are indicated and one zoom 
(indicative, produced via graphical software) is pointed by the arrows. 
 
The cluster formation was further evidenced by AFM measurements. For the plasma-treated 
PMMAPEG samples, grain-like structures were visualized in the surface plots (figure 3.15, C). 
On the other hand, in the absence of the plasma treatment, a more cloud-like structure was 
observed (figure 3.15, B). This observation supported the SEM images, as smaller clusters 
were also observed in case a plasma treatment was applied.  
In case of PMMA, upon application of the selected protocol (i.e. protocol I), a decrease in 
surface roughness manifested, going from an RMS value of 88 nm for the blank down to 45 
nm for the PDA-coated samples (figure 3.16, A). It is clear that for the PMMA samples, a high 
surface roughness was obtained for the blank materials which can be explained by the use of 
a release foil during the production of the samples. Upon PDA deposition, the surface 
‘valleys’ were filled to some extent (figure 3.16, B), which explained the observed decrease 
in RMS value.   
 
 
 
                                                          
1
 All SEM images were realized in cooperation with Dr. David Schaubroeck, from the Centre for Microsystems 
Technology (Cmst) ; Department of Electronics and information systems. 
Chapter 3 | Surface activation and functionalization of methacrylate-based polymers  
 
134 
 
 
 
 
Figure 3.15: Surface plots recorded with AFM for blank PMMAPEG (RMS 0.576 nm) (A), PDA- 
coated PMMAPEG applying protocol I (RMS 4.459 nm) (B), PDA-coated PMMAPEG applying 
plasma+protocol I (RMS 4.814 nm) (C) 
 
 
 
Figure 3.16: Panel A displays the AFM surface plots of the blank (left) and PDA coated PMMA 
(right), applying protocol I. Panel B clearly shows how the surface valleys contain PDA clusters. 
A B 
C 
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A 
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3.4.2.2. PLMA as substrate material for PDA deposition 
After optimization of the deposition protocol for PMMA and PMMAPEG, both PLMA(651) 
and PLMA(2959) were evaluated as substrate materials for PDA immobilization. Based on 
their hydrophobic nature, which is mainly reflected by their low swelling percentage (<0.5%), 
a plasma pre-treatment was in this case beneficial to activate the surface and enhance its 
surface wettability. For these materials, protocol I and the combination of this protocol with 
a plasma pre-treatment step (Ipl) were evaluated. Two plasma gasses including oxygen and 
argon gas, were used to study the enhancement of the PDA deposition. In the end, based on 
the previous findings, we anticipated that the hydrophilicity of the substrate will be crucial 
to enhance contact with the dopamine solution.  
 
XPS measurements were performed to gain insight in the elemental composition of the 
deposited PDA layers. The presence of nitrogen in the elemental composition again 
confirmed the immobilization of this layer (figure 3.17, A). Furthermore, the use of a plasma 
pre-activation step resulted in significantly higher nitrogen percentages compared to 
protocol I (p<0.05) while the highest nitrogen percentages (up to 6%) were obtained when 
oxygen was used as plasma gas. It also became clear that significantly higher amounts of 
PDA were deposited onto PLMA(2959) compared to PLMA(651), especially in case a plasma 
pre-treatment step was applied.  
Apart from the atomic nitrogen percentages, the O/C ratios, represented in figure 3.17 (B), 
were also evaluated. In case Irgacure®2959 was applied, no significant differences were 
obtained, whereas for PLMA(651), significant differences were obtained between the plasma 
treated samples and both the blank and the samples treated using protocol I. Herein, the 
theoretical O/C value of dopamine (0.25) was best approached by the oxygen plasma 
treated samples (0.29 for PLMA(651) and 0.27 for PLMA(2959)). Based on the XPS data, the 
latter protocol was selected as the optimal one. Again, the optimal deposition time was 
determined to be 24 hours (N/O= 0.28). 
Next, static contact angle measurements were performed to evaluate the wettability of the 
different surfaces. The results (see figure 3.17, C and D) show that treatment of the blank 
materials with oxygen or argon plasma resulted in a significant decrease of the contact 
angle. In addition, the most pronounced effect was obtained for the argon plasma treatment 
(see also § 3.2).  
All PDA coated samples showed a significant difference compared to their respective blanks, 
which again proved the successful immobilization. Only for the PLMA(651) samples which 
were pre-treated by Ar-plasma, a significant difference in SCA after PDA deposition was not 
observed (p>0.05).   
In case Irgacure® 2959 was used as an initiator, similar contact angles were obtained for the 
different PDA deposition protocols, compared to those obtained for PMMA and PMMAPEG 
(between 40 and 50°). For PLMA(651), slightly higher contact angles were obtained (up to 
55°). However, only in case of Ar plasma treatment, a significant difference was obtained 
between both PLMA(651) and PLMA(2959) after PDA deposition. Comparison of the 
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different PDA deposition protocols applied on PLMA(651), showed a significant difference in 
case protocol I was compared with plasma(O2)+protocol I. This observation might suggest a 
different structure or orientation of the PDA layer in case oxygen plasma was applied, but no 
clear evidence was found for this. Based on the maximized atomic nitrogen percentage, the 
plasma(O2)+protocol I was selected as the preferred PDA deposition protocol. 
Overall, it could be concluded that the selection of initiator does affect the outcome of 
surface functionalization, although, only in a limited manner (maximum difference of 2% of 
nitrogen and less than 10° in SCA value).  
 
 
   
 
   
Figure 3.17: Atomic nitrogen percentage (A) and O/C ratios (B) determined by XPS of the blank and 
PDA-coated PLMA(651)  and PLMA(2959) (via protocol I (I) and in combination with an O2 (Ipl(O2)  
or an Ar plasma pre-treatment step (Ipl(Ar))). Static contact angles measured for PLMA(2959) (C) 
and PLMA(651) (D) are also presented. Samples which are significantly different are marked with 
the same letter (a,b,c,…) 
 
Again, SEM was used to visualize the clusters formed on the material surfaces. Similar to 
PMMA and PMMAPEG, the application of a plasma treatment onto PLMA(651) resulted in 
the formation of smaller clusters, which was probably due to a lower contact angle of the 
underlying surfaces (figure 3.18, A). In case of the blank material (CA 90°), the largest 
clusters sized 9 µm. Conversely, for the O2-plasma treated samples (CA 68°), the largest 
clusters only sized 4 µm. For the Ar-plasma treated samples (CA 54°), this value even 
dropped to 2 µm.  
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Figure 3.18: SEM images of PLMA(651) (A) and PLMA(2959) (B): blank (a), PDA coated, protocol I 
(b), O2 + protocol I (c) and Ar + protocol I (d). For each coated material, several clusters are 
indicated and one zoom (indicative, produced via graphical software) is indicated with arrows. 
A 
B 
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Upon comparing different materials, it became clear that comparable cluster sizes were  
obtained because of similar contact angles. Indeed, comparison of the largest cluster size 
obtained for the PMMAPEG blank (CA 69°) and the O2-plasma treated PLMA samples (CA 
68°), revealed a comparable cluster size (i.e. 4 µm).  
 
If one material is considered, the cluster size definitely decreased with a decreasing contact 
angle. However, this observation was contradicted when evaluating the PLMA(2959) 
materials (Figure 3.18, B). Herein, the largest clusters (7 µm) were observed on the argon-
treated samples (CA 61°), followed by the oxygen treated samples (4 µm; CA 71°) and the 
blank material (2 µm, CA 89°), a trend which is exactly the opposite of the previously 
observed ones. It can thus be concluded that the PDA cluster formation is not solely 
controlled by the surface contact angle. 
 
 
3.5. Conclusion 
In a first part of this chapter, a plasma treatment has been evaluated for its surface 
activating effect. The results showed that both argon and oxygen were able to lower the 
contact angle of the different substrate materials due to the introduction of oxygen 
containing groups. Furthermore, the use of a nitrogen gas plasma  enabled the introduction 
of nitrogen functionalities on the surface of the materials and this approach could offer 
future opportunities to allow for surface biofunctionalization. 
In the next step, two functionalization routes were explored. First, the UV-induced post-
plasma grafting of 2-aminoethyl methacrylate was studied. For both the LMA-based 
materials and PMMAPEG, successful grafting was shown. However, compared to literature 
results, the amount of immobilized AEMA was only limited. Based on the XPS results, the 
optimal Ar plasma treatment time was considered to be 30 seconds for PMMAPEG, whereas 
for the PLMA materials, this time was set at 14 seconds.  
In the second case, polydopamine was evaluated as activating sublayer and regardless of the 
underlying substrate and the used protocol, successful immobilization was accomplished for 
both PMMAPEG and PLMA. The presence of the layer was confirmed by XPS as indicated by 
the presence of nitrogen on the surface, through SEM and AFM because of the visualization 
of clusters and via SCA measurements, as shown by the changed wettabilities. Based on the 
obtained nitrogen content present on the surface and the best agreement between the 
theoretical and the experimental O/C surface ratio’s, the optimal PDA deposition protocol 
could be selected for each material, being protocol I in case of PMMAPEG and Ipl(O2) for the 
LMA-based materials. 
For the latter material, the effect of the initiator selection on the subsequent surface 
functionalization was evaluated. In case of the post-plasma grafting of AEMA, no clear 
influence was noticed. Conversely, in case of PDA deposition, the use of irgacure® 2959 
resulted in a slightly higher nitrogen content on the surface (+2%), although no differences 
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were found in surface wettability. Due to this difference, it was decided to exclude 
PLMA(651) from the biofunctionalization studies, to be discussed in chapter 4. 
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4.1.  Introduction 
Surface biofunctionalization differentiates from surface activation in the sense that 
modification of the material is performed in order to introduce a biological function. In this 
work, the introduction of a biological function aims at controlling the cell-interactivity of the 
developed materials. Even more, we aim at enhancing the vascularization around the 
implant.  
To realize the former goal (i.e. enhancement of cell-interactivity), an often applied strategy 
involves the immobilization of proteins constituting the extra-cellular matrix. A very relevant 
protein in this respect is gelatin, which is derived from collagen by an acid or an alkaline 
treatment. In the former case, Gel A is obtained which is characterized by an iso-electric 
point (IEP) of 7-9, whereas in the latter case Gel B is formed which possesses an IEP of 4.7-
5.3. The difference in IEP is the result of the different pre-treatment applied. Gelatin is a well 
known compound in the food industry, where it is used in desserts, confectionary, as 
clarification agent in beverages, but also in meat 1. In the pharmaceutical field, it is applied in 
tablets, drug capsules and emulsions, but also in photography, gelatin-based emulsions have 
been used substantially in the past, prior to the current digital era 2-3. In the biomedical 
industry, gelatin is frequently used as injectable microspheres for drug delivery 4-6, as matrix 
for protein release 7 but also as hydrogel-based wound dressing with the aim to realize skin 
regeneration 8-10. Herein, gelatin B (Gel B) from bovine skin was selected and evaluated as 
biofunctional coating to enhance cell adhesion and proliferation of the implant materials 
developed, with the final aim of tissue integration. It should be noticed that a full 
immunological study has already been performed by Sirova et al indicating that Gel B is 
superior over Gel A from an immunological perspective 11. With respect to the proposed 
glucose sensor design (see chapter 1), tissue integration includes a pre-requisite to allow for 
contact between the interstitial fluid (that contains glucose) and the sensor itself. In the end, 
the formation of a fluid pocket needs to be avoided, since this would result in the isolation of 
the glucose sensor from the body (see also chapter 5). This first biofunctionalization strategy 
(i.e., tissue integration approach; see figure 4.1) will be topic of § 4.2.   
 
During the course of the current work, it was realized that the stimulation of blood vessel 
growth in the vicinity of the sensor could further enhance the success of the eventual 
sensor. In the end, the formation of a foreign body capsule at the site of sensor implantation 
would be disadvantageous as this capsule is characterized by a hypo-vascular nature. As a 
consequence, the permeation of glucose molecules would again be limited which is 
detrimental for the sensor function. Indeed, Kreutzer et al have already shown that an 
increased blood vessel density at the site of sensor implantation improves the in vivo glucose 
sensor function 12. 
To stimulate the process of new blood vessel formation from existing ones (i.e. the second 
goal of this chapter), also known as angiogenesis, different approaches can be followed.  
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First, researchers have tried to increase the vessel density through the local release of 
angiogenic factors, such as basic fibroblast growth factor (bFGF) and vascular endothelial 
growth factor (VEGF) 13. bFGF was recognized as the first angiogenic factor which enabled 
the proliferation of endothelial cells (EC) 14. Later on, VEGF was identified as a more specific 
mitogen of EC which stimulates the migration of these cells to form tubular structures  in 
vitro 15. Other families of growth factors (i.e. indirect angiogenic factors) have been used to 
stabilize and mature the newly formed capillaries, for example, by the recruitment of 
smooth muscle cells. Examples include platelet derived growth factor (PDGF), angiopoietin 
and transforming growth factor β (TGF-β) 15-16. Due to their complementary effects, interest 
has grown to develop systems enabling the delivery of multiple (direct and indirect) 
angiogenic factors 17.  
Irrespective of the factor release targeted (single vs multiple), polymers have always played 
a crucial role in the process. Local release is necessary to avoid angiogenesis at unwanted 
sites, whereas controlled release ideally should avoid the detrimental effects which are 
associated with prolonged exposure of tissue towards these factors, including severe 
vascular leakage and reduced blood pressure 18. Typical natural polymer matrices used for 
growth factor loading for tissue regeneration purposes include heparinized alginate scaffolds 
19, fibrin 20, chitosan 21-22, collagen and gelatin 23-24, whereas the synthetic alternatives are 
offered by polyesters synthesized starting from lactide and glycolide (PLGA) and PEG 
hydrogels 16. Growth factors are mainly physically embedded into the polymer scaffolds, 
aiming at a sustained and slow release, which is controlled by the degradation speed of the 
scaffold as well as the growth factor-polymer interactions. In this way, the polymer scaffold, 
which offers mechanical support, is systematically replaced by vascularized functional tissue. 
Other studies focused on the covalent immobilization of growth factors. According to Shen 
et al, immobilization of VEGF in a collagen-based scaffold resulted in an increased viability of 
endothelial cells compared to the ones containing soluble VEGF 25. Furthermore, it has 
already been suggested that immobilized VEGF could transduce cell signals for a longer time 
compared to soluble VEGF, which only has an in vivo half-life of 3 minutes due to 
internalization and cellular inactivation 26. According to the authors, this observation opens 
perspective for the in vivo blood vessel formation. The positive effect of immobilization onto 
VEGF activity was also proven by Ito et al 27 and Chiu et al 26, but also for other growth 
factors, a similar effect was observed 28-29.   
Since, in this work, the targeted glucose sensor is intended for long term implantation 
purposes, degradation of the polymer packaging would be an undesired feature. As a 
consequence, based on the observed positive effect of VEGF immobilization, herein, a 
similar approach was followed and the covalent immobilization of VEGF was studied as the 
first approach within the second biofunctionalisation strategy (see figure 4.1 and § 4.3). 
In a second approach to promote vascularization, the mobilization of endothelial progenitor 
cells (EPC) towards the site of implantation was targeted. These EPC typically differentiate 
into mature endothelial cells and restore endothelial function after vascular injury. Herein, 
identification of a specific and exclusive surface marker for EPC has formed the main 
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challenge. The Bio-engineered GenousTM stent, provided by OrbusNeich, applies CD34 as 
marker. To bind circulating EPC, monoclonal murine anti-human CD34 antibodies have been 
coupled on a 316L stainless steel (SS) coronary stent 30. Nevertheless, Lim et al questioned 
the specificity of this surface marker, since other CD34 positive cells could differentiate into 
inflammatory cells and smooth muscle cells. As an alternative, VE-cadherin was proposed as 
the ideal surface marker for EPC, as this marker is only expressed on late EPC and mature 
endothelial cells, but not on early EPC or other leukocytes. It was proven that immobilization 
of anti-VE-cadherin antibodies (VE-cad AB) onto a SS stent did enhance re-endothelialization 
of a stent, which is the first step towards angiogenesis 31. As a consequence, the 
immobilization of VE-cad AB onto the developed polymeric packaging materials was also 
studied in this work (see figure 4.1 and § 4.3). 
In a last and third approach, both VEGF and VE-cad AB’s are combined to study a potential 
combined effect between both of them (see figure 4.1). 
 
In the following paragraphs, the immobilization strategies are discussed and the successful 
immobilization of the biomolecules is presented. Furthermore, their influence on the cell-
interactivity of the materials is described1. Improvement of the latter property was 
interpreted as a first indication for their in vivo success to stimulate tissue integration (1st 
strategy) and vascularization (2nd strategy). 
 
 
Figure 4.1: Two biofunctionalization strategies have been applied and compared. The first 
generation strategy includes a Gel B immobilization to stimulate tissue integration (studied on 
PMMA and PMMAPEG). In a second strategy VEGF, a growth factor (approach 1), VE-cad AB 
(approach 2) and their combinations (approach 3) are immobilized to stimulate vascularization of 
the future implant (studied on PMMAPEG and PLMA). For the second strategy, biofunctionalization 
was performed on both AEMA (only studied in case of PLMA) and PDA activated substrates 
(studied on both PLMA and PMMAPEG).  
 
 
                                                          
1
 All live/dead assays were perfomed in cooperation with Heidi Declercq and Johanna Aernoudt, from the 
Tissue Engineering Group of the Department of Basic Medical Sciences, under supervision of Prof. Maria 
Cornelissen. The immune-assays and confocal fluorescence microscopy measurements were conducted in 
cooperation with Prof. Winnok De Vos from the Faculty of Bioscience Engineering; Department of Molecular 
Biotechnology. 
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4.2. The enhancement of tissue integration via Gel B biofunctionalization  
4.2.1. Surface immobilization of bio-active biopolymers onto PDA-coated surfaces 
Messersmith et al, the pioneers of the PDA-coating, recognized this method as a versatile 
platform to enable subsequent coupling reactions using biologically active compounds 32. 
Since the exact structure of PDA is still unclear, the exact coupling mechanism remains 
unknown, but it has been suggested that catechol and quinone functions, present in the PDA 
coating, react with nucleophiles such as amines and thiols via a Michael-type addition or a 
Schiff-base reaction 32. Regardless of the exact mechanism, the successful immobilization of 
different biologically active compounds have already been demonstrated by different 
research groups, of which some examples are summarized in table 4.1.  
 
Table 4.1: Literature examples of the immobilization of biologically active compounds onto PDA 
coated substrates. 
Substrate material Biological compound Aim Ref.* 
PE*, DLC* 
Bovine serum albumin 
(BSA) 
Blood compatibility improvement 33-34 
Cu, TiOx, PC, cellulose Trypsin Proof of immobilization strategy 
35 
PE/PU* Heparin Blood compatibility improvement 36-37 
Glass 
Lysozyme, myoglobin,  
a-lactalbumin 
Fundamental study 38 
Ti VEGF Revascularization/bone healing 39 
Gold electrode Anti-SRB* antibodies Selective immunosensor 40 
NiTi alloy VEGF Endothelialization of vascular implant 41 
PLCL* VEGF/bFGF/RGD Endothelialization of vascular implant 42-43 
SS* 316L VEGF/mPEG-NH2 
Improve biocompatibility of metal 
devices 
44 
Au, glass, Pt, In, SnO2, 
LCP*  
Poly-D-lysine Neural interface design 45 
*
Abbreviations: PE: Polyethylene; DLC: Diamond like carbon; PU: Polyurethane; SRB: sulfate-reducing bacteria; 
PLCL: poly(L-lactide-co-ε-caprolactone); SS: Stainless steel; LCP: liquid crystal polymer; Ref.: References 
 
In the present work, the PDA platform was also used to enable subsequent 
biofunctionalization of the developed materials. As pointed out in the introduction, in a first 
strategy, an improved cell-interactivity of the implant materials was targeted by means of 
Gel B immobilization. In a second strategy, a more specific body response was targeted, 
being the recruitment of endothelial cells towards the implant with the final aim to induce 
angiogenesis. To this end, VEGF and VE-cad AB were coupled onto PDA-functionalized 
polymer substrates (see § 4.3).  
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4.2.2. Immobilization of Gel B as biofunctional compound 
Gel B from bovine skin was selected and evaluated as biofunctional coating to enhance cell 
adhesion and proliferation of the materials developed. In a first step, PMMAPEG was 
selected as substrate material to evaluate the success of the Gel B immobilization (§ 4.2.1.1). 
Herein, PMMA was included as reference. In vitro studies were conducted to evaluate the 
cell-interactivity and proliferation of the Gel B coated materials and a comparison was made 
with the blank and PDA coated samples (§ 4.2.1.2).  
 
4.2.2.1. Surface characterization of the immobilized Gel B layer 
Immobilization of Gel B onto the selected materials was facilitated by first activating the 
surfaces using PDA. The results presented in chapter 3, illustrated that PDA was successfully 
immobilized onto the selected polymers. Next, based on previous research 46, three Gel B 
concentrations, including 0.5, 1 and 2 w/v% were evaluated.  
XPS measurements revealed that for PMMA, all three concentrations resulted in a 
homogeneous coating, as no significant differences (p>0.05) were obtained when comparing 
the N-content present on the surface (figure 4.2, A). However, when considering PMMAPEG, 
a significant difference was obtained when comparing the lowest (i.e. 0.5 w/v%) and the 
intermediate (i.e. 1 w/v%) concentration. As a consequence, 1 w/v% was selected for further 
sample preparation, as this represents the minimum concentration required to realize 
homogeneous coatings on both material types.  
The successful Gel B immobilization was confirmed by comparison of the C1s carbon detail 
peaks of the PDA and Gel B coated materials. As shown in figure 4.2 (B and C), deconvolution 
of these peaks resulted in three different carbon signals, indicating different chemical 
environments (i.e. C=O, C-O/C-N and C-C/C-H). These figures suggest that deposition of Gel B 
resulted in an increase in carbonyl (C=O) functionalities (figure 4.2, C) compared to the PDA 
deposition. This can be ascribed to the presence of amide linkages in the gelatin backbone. 
The presence of Gel B was further evidenced by contact angle measurements as shown in 
figure 4.2 (D). For both material types, PMMA and PMMAPEG, a significant (p<0.05) 
decrease in contact angle was observed when comparing the PDA and Gel B coated samples 
(from 50° to 20° and 28° for PMMA and PMMAPEG respectively). 
 
As an important intermediate conclusion, it can be stated that two polymers with different 
mechanical properties (see chapter 2) but with a comparable surface chemistry are 
obtained. The comparable surface chemistry implies that both materials are characterized by 
similar surface wettabilities (both after PDA and GelB deposition) and atomic compositions. 
Nevertheless, two more parameters should be evaluated prior to in vitro testing: the surface 
roughness and the stability of the deposited layers. 
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Figure 4.2: Panel A: Percentage of nitrogen determined by XPS for the PDA and Gel B modified 
PMMA and PMMAPEG samples. Three different Gel B concentrations were evaluated: 0.5, 1 and 2 
w/v%. Panel B and C represent the carbon detail peaks obtained through XPS which reveal the 
different chemical environments when comparing a PDA (B) and a Gel B (C) modified surface 
(Herein, PMMA). Panel D shows the static contact angle values for the different surface 
modifications applied whilst panel E compares the root mean square (RMS) values obtained 
through profilometry for the blank, PDA coated and Gel B coated PMMA and PMMAPEG samples. 
Conditions marked by the same letters a,b,c,…are significantly different (p< 0.05). In figures A and 
D, all Gel B coated samples were significantly different compared to the PDA coated ones (not 
marked). 
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Previously, it has been demonstrated that surface roughness influences cell behavior 47. In 
case of PMMA, it has been shown that the use of concave patterned films results in 
significantly increased cell densities compared to flat surfaces 48. As a consequence, the 
surface roughness of the different (un-)modified materials was evaluated by profilometry. 
Figure 4.2 (E) clearly demonstrates that for both materials, no significant difference was 
obtained between the different surface modifications (p>0.05). In case both material types 
are compared, a significant difference was obtained in RMS value for the blank materials and 
the PDA coated ones (p<0.05), whereas for Gel B, regardless of the material, a similar surface 
roughness was observed. As a consequence, the observed differences (for blank and PDA 
functionalized materials) should be considered when interpreting the upcoming cell data.  
 
Since implantation of the materials is targeted, it is essential to evaluate the stability of the 
PDA and Gel B layers in simulated in vivo conditions. To this end, the modified PMMA and 
PMMAPEG samples were incubated in PBS buffer at 37°C and as a function of incubation 
time, the decrease in atomic nitrogen percentage was measured. For both PMMA (figure 
4.3, A) and PMMAPEG (figure 4.3, B), stable PDA layers were obtained since after incubation 
no significant decreases in atomic nitrogen percentage were measured (p > 0.05). On the 
other hand, after 24 hours of incubation, the Gel B modified PMMA and PMMAPEG samples 
respectively resulted in a 2 and 4 % decrease in atomic nitrogen percentage compared to the 
non-incubated samples (p < 0.05). Notwithstanding this decrease, the atomic nitrogen 
percentages remained significantly higher compared to the PDA modified samples, which 
proves the presence of the Gel B  layer. For longer incubation times (i.e. 48 hours and 1 
week), similar results were obtained compared to the samples which were incubated for 24 
hours, meaning that the Gel B layers can be assumed stable after this initial incubation time. 
Furthermore, after 24 hours of incubation, equal nitrogen percentages are detected for both 
PMMA and PMMAPEG (i.e. 8-9 % N). 
 
 
  
Figure 4.3: Stability testing of the PDA and PDA/Gel B modified PMMA (Panel A) and PMMAPEG 
materials (Panel B). The decrease in atomic nitrogen percentage was evaluated as a function of 
incubation time in PBS buffer at 37°C, using XPS.  
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4.2.2.2. In vitro evaluation of the  Gel B modified samples 
As previously mentioned, the developed implant materials are intended for long term 
implantations, implying eventual tissue integration. As a consequence, the in vitro cell-
interactivity is a prerequisite. 
Therefore, to gauge the cytocompatibility of the various materials under investigation, a 
semi-quantitative live/dead assay with human foreskin fibroblasts (HFF) was conducted. The 
data revealed that for the pristine surfaces, HFF attached to the PMMAPEG blank (estimated 
viable cell density of 1%) to a lower extent compared to the PMMA blank (estimated viable 
cell density of 6%) (figure 4.4, A). Using PMMA as a substrate material, deposition of a PDA 
layer showed a significant positive effect (p<0.05) on the fibroblast cell attachment 
(estimated viable cell density of 12%), in line with earlier findings, although to a lower  
extent 42, 49-51. This was not the case for PDA-modified PMMAPEG (estimated cell viability of 
2%), plausibly due to the cell-repellant properties of PEG. In the past, many studies focused 
on the production of antifouling surfaces applying PEG as antifouling polymer 52. In this 
context, PEG grafts are mainly used to realize this aim. As a result, copolymer networks 
containing these PEG moieties might also induce a similar effect, as shown by the low 
cellular adhesion (see figure 4.4, A). However, it was anticipated that PDA deposition would 
render these materials cell-interactive. Indeed, it has already been suggested that an 
increased cell-interactivity of PDA coated materials results from the adsorption and 
subsequent covalent immobilization of serum proteins via Schiff-base formation and/or 
Michael-type addition without altering their biological function 51.   
From our findings, it is obvious that the applied PDA coating on PMMAPEG is insufficient to 
overrule the decrease in thermodynamic stability of the serum proteins induced by PEG 53-54. 
It can be anticipated that this perturbation of the serum protein’s native structure prevents 
specific interactions occurring between the adsorbed proteins and cells and as a result, also 
cell adhesion 51. Furthermore, these results suggest that cells still sense the underlying PEG-
substrate, probably because of a low PDA layer thickness. Investigation of this causal effect 
could therefore be topic of future work. 
Upon surface decoration of the PDA functionalized polymers using gel B, a more prominent 
effect was accomplished on the cell growth as evidenced by higher cell densities (>90 % for 
both PMMA and PMMAPEG) accompanied by superior cell spreading (see figure 4.4, A). 
To acquire more detailed information on the attachment and spreading potential of 
fibroblasts, cytoskeletal cellular components were visualized (figure 4.4, B) including the F-
actin fibers and focal adhesion (FA) points. Being responsible for cell shape, the actin 
cytoskeleton provides a direct proxy for cell spreading. The focal adhesion points, on the 
other hand, represent cellular connections with the extracellular matrix and thereby provide 
information about the cell adhesion properties. In brief, cells with larger actin-stained 
surface area and more focal adhesion points are better attached to the surface 55. Bearing 
this in mind, the projected area and relative number of focal adhesion points per cell were 
quantified (figure 4.4, C). 
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As represented in figure 4.4 (C), higher cell areas (determined at the level of 1 cell) were 
obtained for the Gel B coated samples, although, for PMMA the differences were not 
significant (p>0.05) compared to the blank and PDA coated samples. For PMMAPEG on the 
other hand, a significantly increased cell area was observed for the Gel B coated samples 
when compared to the other test conditions (p<0.05). This increased cell area can be 
understood as an improved cell spreading on the Gel B coated samples. Furthermore, 
comparison of the two substrate materials showed that a significantly lower cell area was 
obtained for the PDA coated PMMAPEG samples compared to the PMMA coated ones 
(p<0.05). This again points in the direction of a PDA layer thickness which is insufficient to 
disguise the underlying substrate. Apart from the consequential protein repellant properties, 
a lower surface roughness of the PDA-coated PMMAPEG materials, as demonstrated            
in § 4.2.2.1, might also be a cause for the observed difference in cell area 56.  
Apart from cell growth, cell attachment was studied by determining the number of focal 
adhesion points, counted for each cell. The results showed that in the series PMMA < PDA-
coated PMMA < Gel B coated PMMA, the number of focal adhesions increased, although not 
significantly, as depicted in figure 4.4 (C) (p > 0.05). As a consequence, this result confirmed 
a small, yet positive effect on cell attachment when applying PDA as an activating layer. In 
previous research, a similar, yet more pronounced (i.e. a 14-fold increase in the overall cell 
area for the PDA coated materials) trend has already been observed 51. It can be concluded 
that these results correspond with the live/dead results. Furthermore, in order to maximize 
cell adhesion and spreading, Gel B can be considered as the preferential coating for PMMA, 
as illustrated in figure 4.4 (A, B and C). 
The PMMAPEG materials showed a somewhat different behavior. When comparing 
PMMAPEG and PMMAPEG-PDA, no statistical difference was obtained between the number 
of focal adhesion points present on the surfaces and for both conditions almost no focal 
adhesions were observed (figure 4.4, C). As a consequence, the application of PDA was 
insufficient to enhance cell adhesion.  
Inferior cell adhesions were also clearly visualized by a spherical cell shape present on the 
blank and PDA-coated PMMAPEG materials (figure 4.4, B). Gel B immobilization on the other 
hand resulted in a natural rhombic-like shape of the attached cells, comparable to the cell 
shape obtained in case of the PMMA surfaces. This visual observation was also supported by 
quantification of the cell circularity, since significant differences were obtained when 
comparing the PDA and Gel B coated PMMAPEG samples. As a consequence, also for 
PMMAPEG, Gel B coatings can be considered as the preferential ones.  
In previous work, the application of PDA and gelatin was studied by Sook et al on PCL-based 
materials. They tested PCL, PCL-PDA and PCL-gelatin to assess the bio-interactivity towards 
human umbilical vein endothelial cells (HUVECs). Their results illustrated that the PDA-
coated samples resulted in higher cell viabilities and adhesion compared to the gelatin 
modified samples 50.  
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Figure 4.4: panel A: Live dead assay with propidium iodide (red color, dead cells) and calcein AM 
stained (green color, living cells) using HFF cells. Panel B: Immunostaining assay with HFF cells. 
Stainings are performed to visualize the actin filaments (red), the nuclei (blue) and the focal 
adhesions (green). Panel C: Cell Area, cell circularity and number of focal adhesion points obtained 
for the different material conditions. Samples marked by the same letters (a,b,c,…) were 
statistically different (p<0.05).  
A B 
C 
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In the present work, an opposite trend was observed. However, it should be noted that 
herein gelatin was covalently bound to the PDA layer while in the study of Sook et al, gelatin 
was physically adsorbed onto the PCL fibers without applying the PDA primer layer. In this 
respect, Desmet et al. also confirmed that physisorption of gelatin onto PCL resulted in 
inferior cell-interactivity compared to chemically coupled gelatin 57. Nevertheless, the 
improvement in cell-interactivity after PDA deposition was not as prominent herein 
compared to their study 50. The latter clearly implies that apart from the considered cell 
type, the substrate material also influences cell behavior to a great extent despite a similar 
surface chemistry.  
 
To further prove the universal character of the PDA/ GelB coating strategy, a preliminary 
live/dead assay was conducted on the same set of (un)modified materials, but upon the 
application of a second cell type, i.e., HUVECs. Figure 4.5 clearly demonstrates how the 
application of Gel B again results in an enhanced cell density as reflected by the higher cell 
densities compared to the blank and PDA-coated samples. It can be noted, however, that 
herein the application of a PDA coating does enhance the cell interactivity, although, to a 
lesser extent compared to the combined PDA/GelB immobilization.  
 
 
Figure 4.5: A live/dead assay was performed, using HUVECs. Dead cells are stained with propidium 
iodide (red) and living cells are stained with calcein AM (green). 
 
From these in vitro results, it can be concluded that the combination of PDA activation and 
Gel B functionalization results in similar cellular responses, irrespective of the 
physicochemical properties of the underlying substrate. Hence, it can be stated that a 
universal surface modification strategy was developed. 
 
4.2.2.3. Effect of substrate mechanical properties on cell response, using Gel B as a model 
From literature, it is well known that matrix stiffness influences cell behavior 58-59. In this 
respect, cells not only exert forces on the underlying substrate, but they also experience 
tension from their environment on which they respond through alterations in their 
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cytoskeleton organization, adhesion, protein expression, post-translational modifications, 
differentiation properties and cell-cell interactions 59-61. It should be mentioned that these 
responses are cell-type dependent. In this context, increased proliferation with rise in 
substrate rigidity is common across many cell types, such as neurons, osteoblasts, vascular 
smooth muscle cells and fibroblasts 59. Also endothelial cells behave similar to fibroblasts in 
the sense that increased substrate rigidity will result in increased cell spreading. 
Furthermore, for these cell types, it was demonstrated that soft materials (E-mod = 0.5 kPa) 
stimulate the existence of cell-cell contacts, whereas more rigid ones (E-mod = 33 kPa) 
enhance cell-substrate adhesion 62. 
In order to study the influence of the mechanical properties on cell behavior, a range of PEG-
based materials (see chapter 2), characterized by different elasticity moduli were selected  
and compared for their cell-interactive properties. The material composition together with 
the corresponding E-moduli and the surface composition of the selected materials are 
represented in table 4.2. Different mechanical properties were obtained by varying the PEG 
chain length (550 vs 750 g/mol) or by varying the molar composition (linear PEG vs PEG 
cross-linker). As a control, materials 1 and 3 (see table 4.2 for their exact composition) were 
included, because of their similar E-moduli. Material 5, on the other hand, was included to 
study the effect of a substantially lower E-modulus. 
To render the selected materials cell-interactive, the PDA/Gel B coating, as described above, 
was applied. Regarding the experimental setup, two assumptions could be made. First, if the 
PDA/Gel B coating is indeed characterized by a universal character, it is expected that 
regardless of the different mechanical properties, a similar cell response would be provoked. 
Secondly, if a difference in cell response would be observed between materials 1 to 4, it can 
be anticipated that the latter is due to differences in the mechanical properties of the 
substrate materials, as similar compositions were selected (90 mol% MMA and 10 mol% 
PEG).   
Prior to the in vitro assay, the success of the PDA and Gel B immobilization onto the 
materials was confirmed using XPS.  
 
Table 4.2: Overview of the chemical composition and the E-moduli of the selected PEG containing 
materials. The atomic nitrogen percentages, as determined by XPS, after PDA deposition and Gel B 
immobilization are also shown. Herein, the standard deviations, shown between brackets, are a 
measure of the homogeneity of the coatings applied on the sample surfaces. 
Material 
MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGDMA(750) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(MPa) 
NPDA (at%) 
(stdev) 
NGelB (at%) 
(stdev) 
1 90 10 0 0 1533 5 (0.2) 10 (0.4) 
2 90 0 10 0 324 4 (0.2) 9 (0.4) 
3 90 8 0 2 1542 5 (0.6) 10 (0.7) 
4 90 2 0 8 678 5 (0.4) 9 (0.2) 
5 50 40 0 10 37 5 (0.1) 7 (0.4) 
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It can be concluded from table 4.2 that PDA deposition resulted in a similar nitrogen content 
for the different material surfaces (i.e. ±5%). In case of Gel B immobilization, the different 
materials also resulted in a similar nitrogen content (i.e. ±10% N) which resembled the 
values as described higher (§4.2.1.1). An exception was observed for material 5, since only 
7% of nitrogen was detected after Gel B immobilization. Whether the somewhat higher 
swelling degree (i.e. 24% cfr a maximum swelling of 16%) is responsible for this fact, should 
be further investigated.   
 
Evaluation of the live-dead images, presented in figure 4.6 (A), showed that after 1 day of 
cell contact, all materials, except material 5, resulted in high cell densities. However, for 
materials 2 and 4, areas of lower cell density were also observed (not shown). This 
observation suggests a preferred HUVECs cell growth onto more rigid materials, an 
observation which was also made in literature, although, in the latter case rigid materials 
were characterized by an E-modulus of 30 kPa 59. After 7 days, confluent cell layers were 
observed on all materials, although material 5 again showed lower cell densities compared 
to the other materials. Furthermore, more dead cells were observed for this material. If 
material 1 and 3 are compared, more dead cells were present on the latter. Since both 
materials are characterized by similar elasticity moduli, it cannot be excluded that the 
introduction of PEGMA into the material’s composition is responsible for this phenomenon. 
Since material 5 contains the highest amount of PEGMA(500), it can also be questioned 
whether the difference in cell behavior is caused by a difference in mechanical properties or 
by the presence of a higher amount of PEGMA. Additionally, for material 5, a third cause 
could be the less efficient Gel B immobilization (cfr. 7% N versus 10% N for the other 
materials).  
In order to obtain more information about cell adhesion, the focal adhesion (FA) points were 
stained and quantified. Figure 4.6 (B) shows a representative confocal image for the 
different substrate materials, as well as the boxplots, which represent the distribution of the 
number of FA counted for different cells on a substrate material. Visual observation of the 
FA shape showed that for all material compositions, stable, elongated focal adhesions were 
obtained. In literature, a similar observation was made for acrylamide-based gels. In this 
study, more rigid substrates (E-mod of 30-100 kPa) resulted in mature elongated focal 
adhesions, whereas on more flexible substrates (   1kPa), the FA appeared as more diffuse 
dot-like structures 63. When comparing these E-moduli to the values in our study, it is clear 
that all materials reveal an E-mod > 100 kPa (i.e. all materials in this study) and thus they can 
be considered as rigid substrates, which are characterized by an organized F-actin stress 
fiber structure 60. A comparison with literature results describing similar cell types and 
materials characterized by an E-mod > 40 MPa would have been more relevant, but these 
are lacking in the current state-of-the-art. Furthermore, it should be noted that the 
mechanical analysis procedures generally described in literature are in great part different 
from the techniques applied herein (e.g. the use of rheology 64 or indentation tests 65 versus 
tensile testing in the current study).  
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Figure 4.6: Panel A: Live dead assay with propidium iodide (red color, dead cells) and calcein AM 
stained (green color, living cells) HUVEC cells. Panel B: Immunostaining assay with HUVECs. 
Stainings are performed to visualize the actin filaments (red), the nuclei (blue) and the focal 
adhesions (green). The boxplots representing the FA distributions are also shown. 
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Apart from substrate stiffness, the presence of Gel B, will also influence cell adhesion. In this 
respect, a previous study has shown that a decreased density of collagen type I onto 
polyacrylamide gels resulted in decreased cell-matrix adhesions but in increased cell-cell 
connections 66. Since Gel B immobilization resulted in a similar surface composition (cfr. XPS 
results) for the different materials, except for material 5, this variable could be considered as 
a constant. 
Quantification of the number of focal adhesion points showed that materials 4 (median FA = 
236), 2 (median FA= 207) and  3 (median FA = 198) resulted in the highest median number of 
focal adhesion points, as compared to material 1 (median FA = 126) and 5 (median FA = 124). 
Nevertheless, based on statistical analysis, it could be concluded that the focal adhesion 
distribution is the same across the different material categories (p>0.05).   
This last conclusion again highlights the universal character of the PDA/Gel B modification. 
 
 
4.3. The enhancement of vascularization via the immobilization of VEGF and 
VE-cad AB 
In the previous paragraph, Gel B was evaluated as cell-interactive coating, in order to 
estimate its potential for tissue integration. As pointed out in the introduction, the 
stimulation of angiogenesis and vascularization (i.e., strategy 2 in figure 4.1) could further 
increase the glucose sensor success and therefore, the immobilization of VEGF (approach 1), 
VE-cad AB (approach 2) and their combinations (approach 3) were studied together with 
their in vitro response. In order to immobilize the angiogenic factors, both of the surface 
activation strategies, discussed in chapter 3, were considered. Dependent on the pre-
activation step, i.e., PDA vs. AEMA activation, a different protocol was required for the 
immobilization of the biological components. As a consequence, the characterization results 
are discussed accordingly in § 4.3.1 (PDA-based) and § 4.3.2 (AEMA-based). 
Apart from PMMAPEG, the LMA-based packaging (referred to as PLMA) was also included in 
this study.  
 
4.3.1. Immobilization of VEGF and VE-cad AB onto PDA-modified surfaces 
4.3.1.1. Preliminary experiments to determine the required angiogenic factor concentration   
Prior to immobilization and full characterization of the immobilized compounds, the 
angiogenic factor concentration was selected for both VE-cad AB and VEGF.  
In case of antibody immobilization, the applied concentrations reported in literature highly 
depend on the targeted application 40, 67-72. In the specific case of VE-cadherin AB, only few 
studies have been conducted and as a consequence, a concentration range was evaluated by 
means of radiolabeling experiments2. To this end, VE-cad antibodies were radiolabeled with 
                                                          
2
 All radiolabeling experiments were conducted in cooperation with Ken Kersemans, from the Department of 
Pharmaceutical Analysis, the Laboratory of Radiopharmacy, under supervision of Prof. Filip De Vos. 
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the iodine isotope I125 according to the procedure described in chapter 6 (§ 6.1.10 and § 
6.2.3.5). Furthermore, since the amino acid composition of VE-cad AB remains unknown to 
date, the evaluation of a concentration range was also beneficial to evaluate the feasibility 
of radiolabeling experiments. Figure 4.7 (A) clearly shows that upon increasing the AB 
concentration, an increased radio-active signal was obtained for both the blanks and the 
PDA coated surfaces. As a consequence, proof was delivered that tyrosine and/or histidine 
were present in the AB amino acid sequence and that iodination through electrophilic 
aromatic substitution could be considered a suitable technique for further characterization 
of the AB-modified surfaces (see next paragraph).  
 
It is clear from figure 4.7 (A) that the highest radio-activity was obtained in case a starting 
solution of 4 µg/ml was used. As a consequence, the concentration was set at 4 µg/ml for all 
future experiments.   
A preliminary stability test showed that incubation of the AB-modified samples in PBS-buffer 
(37°C) resulted in a slight decrease in signal, but overall, the modification could be assumed 
stable over the studied time frame (i.e. 48 hours, see figure 4.7, B). These preliminary data 
indicated that the immobilization of VE-cad AB was successful and that an in depth study 
could be initiated in this respect. The results of this study will be discussed in the upcoming 
paragraphs. 
 
 
  
Figure 4.7: I125 radio-activity from VE-cad antibody (AB) deposited onto the blank and the PDA 
coated PMMAPEG material, as a function of the initial AB concentration (The measured radio-
activity of the 0.2, 0.4, 1, 2 and µg/ml stock solutions was respectively 1, 2, 6, 12, 24 and 49 µCi)  
(A). The stability of the deposited AB layer was tested as a function of time, upon incubation of the 
AB-modified (4 µg/ml) samples in PBS buffer at 37°C (B).  
 
In case of VEGF immobilization, the concentration of the starting VEGF solution was selected 
based on the most relevant literature reports, describing the covalent immobilization of 
VEGF with the aim of improving vascularization around an implant. In this respect, Shen et al  
immobilized VEGF into a collagen scaffold via EDC-chemistry 73  using 500 ng/ml and 1 µg/ml 
VEGF solutions. They showed that both VEGF concentrations promoted the penetration and 
proliferation of endothelial cells within the scaffolds, which could lead to an in vivo 
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vascularized scaffold 25. The same research group also proved that the use of 1 µg/ml 
resulted in tube formation in vitro and in an increased blood vessel density by conducting an 
in vivo chicken chorioallantoic membrane (CAM) assay 26. Furthermore, Shin et al applied a 
similar concentration of VEGF (1.3 µm/ml) onto PDA functionalized poly(L-lactide-co-ε-
caprolactone) (PLCL) films. They demonstrated an enhanced proliferation and migration of 
HUVECs 42. Based on these data, a VEGF concentration of 1 µg/ml was selected to perform 
the modification in the current study. 
 
4.3.1.2. Characterization of the AB and VEGF functionalized surfaces    
In order to study and quantify the amount of immobilized AB and VEGF, XPS measurements 
and radiolabeling experiments were conducted. 
Table 4.3 displays the XPS results of the angiogenic factor functionalized substrate materials. 
Comparison of both materials (PMMAPEG vs PLMA) did not result in significant differences 
in the N/C ratios in case the same surface modification was considered (p > 0.05). For both 
PMMAPEG and PLMA, a significantly higher N/C ratio was obtained after AB and/or VEGF 
immobilization, when compared to the PDA functionalized blanks, offering a prominent 
proof of successful angiogenic factor immobilization.  
 
It was anticipated that the AB and VEGF immobilized surfaces would result in similar or 
lower N/C values compared to the pristine AB and VEGF materials. This trend was followed 
for the AB functionalized PDA surfaces (N/C < 0.177), but the VEGF modified PDA surfaces 
resulted in significantly higher N/C ratios compared to the ones obtained for pristine VEGF 
(N/C = 0.110). It should be mentioned that for VEGF immobilization, the supplier’s protocol 
stipulated that bovine serum albumin (BSA) had to be dissolved in the modification buffer to 
assure the stability of VEGF. As a consequence, the increased N/C ratios for the VEGF 
functionalized surfaces were possibly biased by the addition of this nitrogen containing 
compound. As mentioned in the introduction (§4.2, table 4.1), the covalent linkage of amine 
functions in BSA with the o-benzoquinone of dopamine has been demonstrated      
previously 36. Furthermore, since BSA may also influence cell behavior, this factor should be 
considered when interpreting the up-coming cell data. It is known that surface adsorbed 
albumins offer non-fouling properties, which intervene with cell adhesion 74. 
 
Apart from XPS, radiolabeling experiments were conducted to determine the amount of AB 
and/or VEGF which was deposited onto the surface. It should be mentioned that for the 
VEGF functionalized samples, no BSA interference could occur in this case, since VEGF was 
selectively labeled with 125I.  
 
For both materials, high aspecific adsorptions of AB and VEGF were measured, as shown in 
table 4.3. Herein, comparable amounts of antibody were deposited on both PMMAPEG and 
PLMA, whereas in case of VEGF, significantly higher adsorptions were determined for 
PMMAPEG. This phenomenon of aspecific adsorption could already be deduced from the 
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XPS measurements, since nitrogen was detected on most of the blank surfaces after AB or 
VEGF incubation. This topic will be further discussed in the upcoming paragraph. Further 
comparison of PMMAPEG and PLMA showed that all biofunctionalization strategies (i.e. AB 
vs VEGF vs combined AB/VEGF immobilization) resulted in significantly higher depositions 
for PMMAPEG compared to PLMA (p<0.05), which can be declared by the higher swelling 
properties of the former material.  
 
When there is focused on one material, the following observations could be made: 
In case of PMMAPEG, the successful AB immobilization was confirmed, since significantly 
higher amounts of AB were deposited onto the PDA functionalized surfaces (±80 ng/cm2) 
compared to the blank (± 22 ng/cm2) (p<0.05). VEGF immobilization, on the other hand 
resulted in a significantly higher amount on the blank sample (634 ng/cm2) compared to the 
PDA activated one (± 507 ng/cm2). As a consequence, due to the high aspecific adsorption, 
the covalently linked fraction is potentially masked, making it difficult to judge the success of 
VEGF immobilization at this stage.  
 
In case of PLMA, PDA activation resulted in higher amounts of AB (29 ng/cm2) and VEGF (286 
ng/cm2) compared to deposition onto the blank materials (16 and 174 ng/cm2 respectively) 
and although a significant difference was only measured in case of the VEGF-functionalized 
samples (p<0.05), the immobilization could be considered successful.   
 
Table 4.3: Atomic composition of the biofunctionalized PMMAPEG and PLMA surfaces. A 
comparison is made with the experimental composition of the pristine proteins. The amount of AB 
and VEGF deposited onto the different material surfaces, as determined by radiolabeling 
experiments is also displayed. Significantly different conditions (p<0.05) are denoted by the same 
letters a,b,c,… 
Material Modification O (at%) C(at%) N (at%) N/C Mass (ng/cm
2) 
PMMAPEG - 29 (±1) 63 (±1) 0 0 - 
PLMA - 22 (±0) 70 (±1) 0 0 - 
AB - 22 (±2) 62 (±1) 11 (±0) 0.177 (±0.005) - 
VEGF - 33 (±1) 59 (±1) 7 (±0) 0.110 (±0.006) - 
PMMAPEG AB 31 (±0) 64 (±1) 0 (±0) 0 (±0) 22 (±7) 
a 
  VEGF 30 (±1) 66(±0) 1 (±0) 0.010 (±0.005) 634 (±73)
  c,d 
  PDA 21 (±2) 73 (±1) 5 (±1) 0.070 (±0.010) - 
  PDA AB 23 (±1) 65 (±1) 9 (±1) 0.132 (±0.009) 79 (±4) 
a,b 
  PDA VEGF 22 (±1) 65 (±1) 10 (±1) 0.154 (±0.021) 507 (±48) 
c,e 
  PDA AB VEGF 22 (±0) 65 (±1) 10 (±1) 0.160 (±0.009) 186 (±3)
 f  
PLMA AB 22 (±1) 71 (±1) 1 (±0) 0.019 (±0.004) 16 (±1) 
  VEGF 22 (±1) 70 (±1) 1 (±0) 0.017 (±0.005) 174 (±7) 
d,g 
  PDA 20 (±0) 74 (±0) 6 (±0) 0.076 (±0.004) - 
  PDA AB 21 (±0) 69 (±1) 9 (±1) 0.136 (±0.010) 29 (±11) 
b 
  PDA VEGF 20 (±0) 69 (±1) 10 (±0) 0.143 (±0.003) 286 (±12) 
e,g 
  PDA AB VEGF 21 (±1) 68 (±1) 10 (±1) 0.142 (±0.010) 56 (±4) 
f 
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Finally, if both AB and VEGF are immobilized onto the PDA coated surfaces, a lower 
angiogenic factor mass was determined for both materials (186 and 56 ng/cm2 for 
respectively PMMAPEG and PLMA), compared to the sum of the individually immobilized 
factors (586 and 315 ng/cm2 for respectively PMMAPEG and PLMA). It can be concluded that 
both factors influence each other and that competition exists during immobilization. 
 
4.3.1.3. Stability study of the AB and VEGF functionalized surfaces    
To study the stability of the AB and/or VEGF functionalized samples, the radio-labeled 
samples were incubated in PBS buffer at 37°C and were evaluated after 24 hours and 10 
days. It was anticipated that upon incubation, the non-specifically bound AB and VEGF 
fraction would (partially) be removed from the surface, whereas the covalent fraction would 
act as a stable layer. 
From the previous paragraph, it was concluded that significantly higher amounts of AB and 
VEGF were detected onto the PDA functionalized PMMAPEG surfaces compared to the PDA 
modified PLMA ones. This difference can possibly be explained by the higher swelling of 
PMMAPEG, which induces increased AB or VEGF absorption. Indeed, a 24 hours incubation 
of the AB and VEGF modified PMMAPEG samples resulted in respectively a 22 and 15% 
decrease of angiogenic factor mass, whereas in case of PLMA, the decrease was limited to 
respectively 7 and 4% (see figure 4.5, B and C). Furthermore, after 10 days of PBS incubation, 
the average decrease in angiogenic factor mass was again higher for PMMAPEG (i.e. 45% 
compared to the initial mean value) compared to PLMA (i.e. 26% compared to the initial 
mean value). 
This trend was also confirmed for the combined AB/VEGF functionalized samples, since 
PMMAPEG resulted in a 46% decrease of angiogenic factor mass, whereas for PLMA this 
decrease was again limited to 21%. 
 
Overall, it can be stated that the material composition is highly influencing the stability of 
the immobilized angiogenic factors. Furthermore, it can be stated that high aspecific 
adsorptions are manifested for both materials. Moreover, for PMMAPEG, a certain degree of 
absorption is also observed. The fraction of non-covalently bound factors can be regarded as 
a positive aspect, since during the first 10 days after implantation, a sustained release of 
angiogenic factors could be anticipated. As pointed out in the introduction of the current 
chapter, the positive effect of a controlled VEGF release on the vascularization process has 
already been proven 15. Whether or not a similar effect could be anticipated for VE-cad AB 
release remains unclear and could be the subject of future research. In general, future 
research should ideally include a detailed in vivo assessment of this release. 
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Figure 4.8: Stability study of the AB (Panel A) and VEGF (Panel B) modified PMMAPEG and PLMA 
surfaces by incubation of the samples during 24 hours and 10 days in PBS buffer at 37°C. Samples 
modified with both AB and VEGF are divided over both panels.  
 
4.3.1.4. In vitro evaluation of the biofunctionalized PDA-based surfaces. 
First, a qualitative live-dead assay was conducted using HUVEC. Figure 4.9 summarizes the 
results for both PLMA and PMMAPEG after 1 and 7 days. When comparing the blank 
materials, it is clear that for both time points, more cells adhered onto the LMA-based 
material compared to the PEG-based one. This can again be attributed to the protein 
repellant nature of PEG, as previously discussed (see §4.2.2.2).  
For the PDA modified materials, a 24 hour cell incubation resulted in less dead cells for PLMA 
compared to PMMAPEG, which again shows that a PDA coating is not able to completely 
disguise the protein-repellant properties of PEG. Nevertheless, it can again be stated that 
HUVECs appear less susceptible towards the non-fouling properties of PEG, compared to HFF 
(cfr. figure 4.5). After 7 days of cell incubation confluent cell layers were observed for both 
materials, which shows that the PDA coated materials are more cell compatible compared to 
the blank materials.  
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Figure 4.9: Live dead assay after 1 day and 7 days of cell incubation on the surface modified PDA-
functionalized materials, including PLMA and PMMAPEG. Living cells are stained with calcein AM 
(green), dead cells with propidium iodide (red). Scale bare: 500 µm, for all figures. 
 
Further biofunctionalization of the materials with VEGF and/or VE-cad AB clearly resulted in 
higher cell densities compared to the PDA-activated surfaces. Again, after 7 days, confluent 
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cell layers were evident for both material types. Since proliferation of the cells is manifested, 
a first proof is delivered that VEGF and/or AB functionalization of the surfaces results in an 
enhanced cell interactivity and cell viability. However, the assays do not allow to 
differentiate between the different surface functionalization strategies. As a consequence, 
immuno-staining assays were conducted. 
 
Prior to this discussion, attention should be drawn to the VEGF and antibody-incubated 
blank materials. During radiolabeling experiments, it seemed that high amounts of VE-cad 
AB and VEGF adsorbed non-specifically onto the blank PMMAPEG and PLMA materials. Since 
almost no living cells were detected especially on the PMMAPEG surfaces, not even after 7 
days of incubation, it can be concluded that the AB and growth factors are present in a non-
active state. In the end, radiolabeling experiments could demonstrate the presence of AB 
(i.e. 40 and 20 ng/cm2 for respectively PMMAPEG and PLMA) and VEGF (i.e. 300 and 220 ng/ 
cm2 for respectively PMMAPEG and PLMA) even after 10 days of PBS incubation. 
In literature, similar conclusions were previously drawn in case of hydrophobic model 
surfaces. Wiseman et al could prove that antigen binding is not facilitated in case the 
deposited amount of antibody is lower than 100 ng/cm2, because of a flat-on orientation of 
the AB (see § 4.2.4) 75. As a consequence, PDA functionalisation is required to bind the 
antibodies and growth factors in their active state.  
 
Immuno-staining of HUVECs, seeded on different surface-modified materials, resulted in  
confocal images as displayed in figure 4.10 (A). It is again very clear that both blank materials 
lack cell adhesive properties, as represented by a rather stretched or even bolded cell shape. 
Compared to the blank samples, the PDA-functionalized materials resulted in the 
attachment of a higher amount of cells, which are characterized by a superior non-bolded 
cell shape. The latter result is in line with the live/dead assay as it again points out that 
HUVECs are less susceptible towards PEG’s repellant nature compared to HFF cells (§4.2.2.2).  
In case of AB and/or VEGF immobilization, nicely cuboidal-shaped HUVECs were visualized 
on top of the surfaces. Nevertheless, in case of VEGF immobilization, more stretched cells 
were observed together with lower cell densities compared to the AB functionalized ones 
(data not shown). Even though the latter observation was not clear from the live dead assay, 
visual observation of the confocal images already predicted a small preference towards the 
presence of VE-cad AB’s on the surface. To test this hypothesis, a quantitative analysis of the 
focal adhesion points was performed of which the results are presented in boxplots in figure 
4.10 (B). Again, cells with more focal adhesion points can be interpreted to be superiorly 
attached to the surface. 
In case the same surface modification was considered, it can be concluded that PMMAPEG 
and PLMA did not result in significantly different amounts of focal adhesion points (p>0.05). 
It can thus be concluded that the studied biofunctionalization strategies result in cell 
responses which are independent of the nature of the underlying substrate. 
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If one material is considered, first PLMA, a significantly lower amount of focal adhesion 
points was obtained for the blank material (median FA=39), compared to the AB 
functionalized samples (median FA = 93) and the ones carrying a combination of VEGF and 
AB (median FA = 116) (p<0.05). If only VEGF was immobilized (median FA = 68), such a 
difference with the blank was not obtained, which points in the direction of our hypothesis 
(i.e. preference of HUVECs towards AB functionalized surfaces).  
 
 
 
Figure 4.10: Confocal images of HUVECs, seeded onto (non-)biofunctionalized PLMA and 
PMMAPEG materials, for 2 days. Herein, nuclei, F-actin fibers and focal adhesion points are 
respectively stained in blue, red and green (scale bare = 20 µm) (A). Distribution of the focal 
adhesion points, counted per cell for the blank and PDA functionalized PLMA and PMMAPEG 
materials. Conditions which are significantly different are denoted by the same letter a, b, c,… (B)   
 
 
A 
B 
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Comparison of the different surface modifications indicated a significantly lower number of 
focal adhesions for the PDA coated surfaces (median FA = 63) compared to the condition 
where both VEGF and AB were immobilized (median FA = 116) (p<0.05). A similar conclusion 
could be made for the VEGF functionalized samples  and the combination of AB and VEGF. If 
only AB was immobilized, no significant difference was obtained with the VEGF 
functionalized surfaces, nor with the combined AB/VEGF functionalized samples (p>0.05). As 
a consequence, for PLMA, it can be concluded that the combination of AB and VEGF is 
preferred to maximize cell adhesion, followed by the immobilization of AB as such. 
Immobilization of VEGF or the application of a single PDA coating is however least preferred 
if the stimulation of HUVEC adhesion is targeted. 
 
For PMMAPEG, a similar evaluation was conducted and herein, a significantly higher amount 
of focal adhesion points was obtained for the combined AB and VEGF immobilized samples 
(median FA= 78), compared to the blank (median FA = 25) (p<0.05). The same applied for the 
comparison between the PDA (median of 27) coated samples and the VEGF/AB 
functionalized ones. However, in case the AB functionalized samples (median of 51 FA) and 
the VEGF functionalized ones (median of 41 FA) were compared with the PDA coated 
samples and the AB/VEGF functionalized samples, no significant difference could be found 
(p>0.05). As a consequence, a similar conclusion as for the LMA-based material could be 
made, being that the combination of AB and VEGF is preferred to stimulate HUVEC adhesion.  
 
As a result, it was suggested that a combined, maybe synergetic effect would be provoked by 
the immobilization of both angiogenic factors. To study this phenomenon in more detail, a 
separate experiment was conducted. Herein, contrary to previous experiments, for each 
condition (AB, VEGF or AB/VEGF), the same total angiogenic factor concentration of 4 µg/ml 
was used for immobilization, as well as a fixed protocol (see chapter 6). In this way, a 
concentration effect or a protocol-related effect could be ruled out as variable from the 
experimental set-up.  
Figure 4.11 clearly shows the cuboidal shaped HUVECs present on the different AB and/or 
VEGF functionalized surfaces. Furthermore, when the number of focal adhesion points was 
compared for the different samples, a significant difference was observed between the AB 
immobilized samples and the combined VEGF/AB functionalized ones (p<0.05).  
 
Comparison of the VEGF and AB functionalized samples did however not result in significant 
differences. Since the only variable in the experimental setup was given by the nature of the 
angiogenic factors, it is clear that if both AB and VEGF are present on the surface, both 
factors carry responsibility for the increased cell adhesion. Furthermore, since the initial and 
individual concentrations of VEGF and AB in the combined angiogenic factor solutions were 
lower (2 µg/ml) compared to the solutions used for single angiogenic factor deposition (4 
µg/ml), it can be concluded that a combined effect does exist between both VEGF and VE-
cad AB, which stimulates HUVEC adhesion. 
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Figure 4.11: Evaluation of the combined effect of VE-cad AB and VEGF, which are immobilized onto 
PDA coated PLMA networks. 
 
When translating these results into an in vivo situation, several assumptions can be made. In 
case no angiogenic factors would be immobilized, cell tests have shown that almost no 
adhesion of cells is manifested and as a consequence, it is suggested that the in vivo 
integration of the implant will be less efficient. This topic will be further studied in chapter 5 
where the in vivo results are discussed. Conversely, upon immobilization of VEGF or VE-cad 
AB, enhanced cell adhesion was detected, implying that better body integration might be 
expected. To prove the latter statement, different experiments should be conducted for the 
different strategies. In case of single VE-cad AB immobilization, the attraction of circulating 
endothelial progenitor cells (EPCs) is targeted in the in vivo situation. After differentiation 
into mature endothelial cells, they will be able to contribute in the formation of new ‘de 
novo’ blood vessels via a process called vasculogenesis (see figure 4.12, A). To prove this 
assumption for the currently developed materials, further testing in vitro and in vivo will be 
necessary. To be more precise, experiments with EPCs should be conducted to evaluate their 
viability, and differentiation capability in case of contact with the herein developed 
materials. 
In case of single VEGF immobilization, stimulation of angiogenesis was mainly targeted, a 
process wherein a new blood vessel is formed from an existing one (see figure 4.12, B). 
During this process, first, degradation of the basal membrane of the existing blood vessel will 
occur and ‘tip’ cells will form. These ‘tip’ cells consist of endothelial cells which contain long 
and mobile filopedia which will stretch and migrate in the direction of pro-angiogenic 
signals, such as VEGF, which are in this case immobilized on the implants. As a result, a 
sprout  will form, which is the first important step towards new blood vessel formation (see 
figure 4.12, B). Further in vitro (e.g. migration studies) and extensive in vivo evaluations (e.g. 
the chick chorioallantoic assay (CAM)) will be needed to prove this theory.  
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Furthermore, upon combining VEGF and VE-cad AB on the surface of the implant, it can be 
suggested that a combined in vivo effect might exist. In this context, Gavard et al proved that 
upon VEGF stimulation, endocytosis of VE-cadherin, an endothelial cell surface marker, was 
stimulated 76. Due to the internalization of VE-cadherin, cell-cell contacts are broken and 
thereby the endothelial barrier function is disrupted, which is needed for the initiation of 
angiogenesis (cfr. sprouting). Since in this work, VE-cad antibodies are immobilized, VE-
cadherin bearing endothelial cells are likely to become recruited towards the implant and 
upon interaction with the immobilized VEGF, a similar mechanism could be induced, thereby 
enhancing the generation of new blood vessels via angiogenesis. Again, in vivo experiments 
should be conducted to prove the latter theory. 
 
 
Figure 4.12: Formation of new blood vessels via vasculogenesis (i.e.‘de novo’) (A) or angiogenesis 
(via sprouting of an existing blood vessel) (B). The figure also shows the final maturation step 
during new blood vessel formation (C).77 
 
4.3.2. Immobilization of VEGF and VE-cad AB onto AEMA-modified surfaces 
Apart from PDA functionalization, primary amines were introduced onto the implant 
materials via a post-plasma grafting strategy, as described in chapter 3 (§ 3.3).  Herein, it was 
proven that the post-plasma grafting of AEMA resulted in a relatively low nitrogen content 
on the surface (i.e. around 1%). As a consequence, due to the high cost of the biological 
compounds, only one material was selected to evaluate the different biofunctionalization 
protocols (i.e. PLMA(2959)), because of its superior physicochemical properties compared to 
PMMAPEG (see chapter 2).  
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4.3.2.1. Immobilization strategy   
As a result of the post-plasma grafting of AEMA, primary amine functions were immobilized 
onto the substrate material, as evidenced by XPS (1% N). To enable the subsequent 
immobilization of AB or growth factor, carbodiimide coupling chemistry was applied to 
induce a nucleophilic attack of the surface amine functions towards an activated carboxylic 
acid group of the growth factor or antibody. As depicted in figure 4.13, this process 
comprised several steps. First, the carboxylic acid moiety of the AB or VEGF is activated by 
reaction with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). Hereby, an excellent 
leaving group is generated due to the formation of an activated o-acylisourea intermediate. 
Nucleophilic attack of this activated compound by the surface amine functionalities finally 
results in covalent linkage of the AB or growth factor via an amide bond. The main 
advantage of this chemistry is its applicability in water, which enables direct bioconjugation 
in aqueous conditions. However, since hydrolysis of the activated intermediate includes the 
main competing reaction (see figure 4.13), the coupling reaction should happen fast. In this 
respect, the stability of the reactive intermediate can be increased by using N-
hydroxysulfosuccinimide (sulfo-NHS) 78-80.  
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Figure 4.13: Coupling of VE-cad AB or VEGF to AEMA functionalized surfaces using EDC-chemistry, 
in the presence or absence of sulfo-NHS. 
 
Because of the higher hydrolysis resistance of the sulfo-NHS activated intermediate, Staros 
et al proved that higher yields could be obtained for the linkage of glycine and a 
metalloprotein 78. On the contrary, Vashist et al noticed that the crosslinking of antibodies 
with 3-aminopropyltriethoxysilane (APTES)- functionalized surfaces at a pH 7.4 was 
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enhanced in case EDC was used instead of EDC/sulfo-NHS 81. Due to this finding, both 
conditions (i.e. use of EDC and EDC/sulfo-NHS) were evaluated in the present work. Apart 
from mechanism-based selections, variations in reaction conditions are also common in 
literature reports, such as the choice of buffer and pH. Generally, it is accepted that the EDC 
coupling reaction proceeds best in MES buffer at a more acidic pH (pH 4.5), although 
phosphate-based buffers with a neutral pH (pH 7.2) can also be used but might result in a 
lower coupling efficiency. In case NHS ester chemistry is used, the reaction will preferably 
proceed at neutral to more basic pH conditions (pH 7.2-9). Considering the practical 
constraints herein (modification of small sample surfaces), both reactions are conducted in 
the same buffer, at equal pH. Based on literature examples, two different buffers were 
selected, including an acidic MES buffer (pH of 6) 79, 82 and a neutral PBS buffer                     
(pH of 7.4) 81, 83. 
 
4.3.2.2. Characterization  of the AB and VEGF functionalized surfaces    
To evaluate the different protocols, XPS measurements were performed to study the 
elemental composition of the surface before and after angiogenic factor immobilization 
(table 4.4). It can be noted that compared to the AEMA functionalized surfaces (1% N), 
significantly higher nitrogen percentages were obtained after VEGF and/or AB 
immobilization (> 3% N), which is a direct proof for their presence on the surface. 
Furthermore, it was again anticipated that the N/C ratio of the VEGF and AB modified 
surfaces should again result in similar or lower values compared to pristine AB (N/C= 0.17) 
and VEGF (N/C = 0.11). This prediction was followed for all samples. Since BSA was again 
present in the VEGF modification buffer, much higher ratios could have been expected in 
this case (cfr. the PDA-based experiments).  
 
If the different immobilization protocols are compared, it is clear that both for the AB and 
VEGF immobilization, MES buffer is preferred, since lower nitrogen percentages and N/C 
ratios were detected in case the modification was performed in PBS buffer. This can possibly 
be explained by the respective pH values of the two buffers, being 6.1 for MES and 7.4 for 
PBS. It is suggested that the crosslinking reaction proceeds best in more acidic conditions, 
which is in agreement with literature reports 83, as discussed earlier. Furthermore, similar 
results were obtained in case EDC was used and when EDC was combined with sulfo-NHS. 
This also follows the expectations, because the benefit of using sulfo-NHS could not be 
judged from these characterization results, but will follow from a stability test (see later on).  
It can be mentioned that some degree of aspecific adsorption is again manifested, because if 
no EDC crosslinker was used, an increase of 1% (in case of AB) and 3% (in case of VEGF) in 
atomic nitrogen was observed, compared to the AEMA grafting only. Nevertheless, 
compared to the test samples wherein an EDC crosslinker was used, these values remain 
significantly lower (p<0.05). It should again be stressed that due to the presence of BSA in 
the VEGF modification buffer, it is not clear from these results whether the increase in 
nitrogen percentage is caused by VEGF, BSA or a combination of both. 
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Table 4.4: Atomic composition of the AB and/or VEGF biofunctionalized PLMA surfaces, as 
determined by XPS. Different immobilization protocols are compared, including variations in 
coupling agent and buffer (see text for the detailed discussion). The deposited masses of AB and/or 
VEGF  are shown in the last column, as determined by radiolabeling experiments. 
Material Modification 
Coupling 
agent 
Buffer O (at%) C(at%) N (at%) N/C Mass (ng/cm
2
) 
AB - - - 22 (±2) 62 (±1) 11 (±0) 0.177 (±0.005) - 
VEGF - - - 33 (±1) 59 (±1) 7 (±0) 0.110 (±0.006) - 
PLMA - - - 22 (±0) 70 (±1) 
- 
- - 
PLMA AEMA - PBS 25 (±1) 71 (±1) 1 (±0) 0.014 (±0.003) - 
  AB - PBS 22 (±1) 71 (±1) 1 (±0) 0.019 (±0.004) 15 (±1) 
  VEGF - PBS 22 (±1) 70 (±1) 1 (±0) 0.017 (±0.005) 161 (±2) 
PLMA AEMA AB - PBS 26 (±0) 65 (±1) 2 (±0) 0.031 (±0.007) 21 (±4) 
  AEMA AB EDC PBS 27 (±2) 64 (±1) 3 (±2) 0.046 (±0.028) 28 (±3) 
  AEMA AB EDC MES 28 (±1) 64 (±2) 4 (±1) 0.068 (±0.011) 24 (±4) 
  AEMA AB EDC/NHS PBS 25 (±1) 65 (±1) 3 (±1) 0.050 (±0.009) 26 (±2) 
  AEMA AB EDC/NHS MES 27 (±1) 66 (±1) 4 (±0) 0.056 (±0.006) 21 (±2) 
PLMA AEMA VEGF / PBS 24 (±1) 65 (±3) 3 (±2) 0.053 (±0.031) 511 (±44)
 a,b,c,d 
  AEMA VEGF EDC PBS 26 (±1) 63 (±2) 4 (±0) 0.057 (±0.007) 397 (±11)
 a,e,f 
  AEMA VEGF EDC MES 26 (±1) 66 (±2) 5 (±1) 0.076 (±0.009) 277 (±37) 
b,e,g 
  AEMA VEGF EDC/NHS PBS 25 (±1) 66 (±2) 3 (±1) 0.048 (±0.020) 419 (±20) 
c,g,h 
  AEMA VEGF EDC/NHS MES 26 (±1) 66 (±1) 6 (±0) 0.085 (±0.006) 275 (±23) 
d,f,h 
PLMA AEMA AB VEGF EDC MES 26 (±1) 63 (±1) 4 (±0) 0.055 (±0.003) 164 (±12) 
 
Next, radiolabeling experiments were performed to determine the immobilized AB and 
VEGF mass. The results confirmed the successful immobilization of VEGF and AB via each of 
the studied crosslinking mechanisms. Indeed, significantly higher amounts of AB and VEGF 
were measured onto the AEMA and EDC pre-treated samples compared to the AB and VEGF 
incubated blank samples (p<0.05). Furthermore, similar amounts of AB and VEGF were 
observed on the AEMA-coated samples compared to the PDA-coated samples (cfr. table 4.3). 
 
In case of AB immobilization, comparison of the different AEMA-based deposition protocols 
did not result in significantly different AB masses present on the surface. It was expected 
that the addition of EDC (and NHS) would have resulted in a significantly higher amount of 
immobilized AB. However, due to high aspecific adsorptions, it was difficult to differentiate 
between the non-specifically and covalently bound portion.  
 
Also in case of VEGF immobilization, high aspecific adsorption of VEGF onto the AEMA 
functionalized surfaces had manifested, since if no crosslinker was used, a significantly 
higher amount of immobilized VEGF was obtained (p<0.05). It can further be noted that in 
the presence of EDC, intermolecular crosslinking of VEGF could compete during surface 
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immobilization of VEGF. Comparison of the different EDC-chemistry based protocols showed 
that, coupling in PBS buffer was preferred over the use of MES buffer, since significantly 
higher amounts of VEGF were detected in the former case (± 400 ng/cm2 with PBS vs ± 276 
ng/cm2 with MES) (p<0.05). This conclusion clearly contradicts the XPS results. Nevertheless, 
since the latter XPS results were biased by the presence of BSA (i.e. part of the nitrogen 
signal originates from BSA), the radiolabeling experiments were considered more 
trustworthy.  
 
Comparable to the immobilization onto the PDA modified surfaces, dual factor 
immobilization resulted in lower, almost half of the deposited AB and VEGF (i.e.164 ng/cm2), 
compared to the sum of their individually deposited masses (±300 ng/cm2). It can again be 
concluded that both factors influence each other and that competition possibly exists during 
immobilization. 
 
4.3.2.3. Stability study of the AB and VEGF functionalized surfaces    
To study the stability of the immobilized angiogenic factors, the different surface modified 
samples were incubated in PBS buffer at 37°C and evaluated by radiolabeling experiments as 
a function of time. It was anticipated that upon incubation of the AB and VEGF modified 
samples, the systems without applied cross-linker would result in significantly higher 
decreases in deposited angiogenic factor mass compared to the EDC-crosslinked samples. 
Furthermore, it was expected that the application of NHS would result in significantly lower 
releases upon incubation, since NHS stabilizes the reactive intermediate (see figure 4.13), 
which is susceptible towards hydrolysis.  
In case of the former assumption, figure 4.14 clearly shows that a similar decrease is 
obtained for the different crosslinker-treated samples and the ones which were not treated 
with a crosslinker. This suggests that, even if covalent linkage would have occurred upon 
application of EDC as a crosslinker, substantial amounts of aspecific adsorption could still 
occur. The latter suggestion could be further motivated by the limited amount of 
immobilized AEMA (i.e. only 1% of N detected compared to 6% in literature 84, see chapter 
3). 
Regarding the second assumption, upon PBS incubation, slightly lower decreases were 
obtained in AB and VEGF masses in case NHS was used as stabilizer, nevertheless, these 
decreases were not significant (p>0.05) compared to the other immobilization protocols. 
This observation shows the limited effect of NHS addition for the current experimental set-
up or confirms an initial limited covalent linkage of the angiogenic factors to the surface.  
If the absolute deposited masses are compared after 24 hours and 10 days of incubation, a 
significantly higher (p<0.05) amount of immobilized AB was retained for the EDC crosslinked 
samples (in PBS) (i.e, 20 ng/cm2) compared to the blank (i.e. AB incubated AEMA samples 
without crosslinker; 17 ng/cm2). 
In case of VEGF immobilization, the same protocol (i.e. EDC crosslinking in PBS, in the 
absence of NHS) resulted in the highest mass retention after incubation, compared to the 
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other crosslinker-based protocols. Nevertheless, compared to the blank (VEGF incubated 
AEMA samples without crosslinker), these amounts remained significantly lower (p<0.05).  
If these results are compared with the ones obtained for the PDA activated samples (see § 
4.3.1), it can be concluded that the success of AB and VEGF immobilization onto the PDA 
modified samples was more pronounced compared to the AEMA activated ones. In the 
former case (i.e., PDA activation) higher amounts of angiogenic factors were immobilized 
compared to simple incubation of the blank materials in AB and VEGF solutions. As a 
consequence, covalent linkage was assumed in case of PDA activation. On the other hand, 
for the application of AEMA, such increases were not demonstrated, since simple incubation 
of the AEMA-modified samples into the angiogenic factor solution resulted in similar or even 
higher deposited angiogenic factor masses compared to the crosslinker-based (i.e. EDC) 
immobilizations. As a consequence, instead of covalent interactions, a preference towards 
aspecific adsorption was suggested. To judge the impact of this fact, cell tests had to be 
performed to evaluate the activity of the immobilized factors. 
Similar to the angiogenic factor functionalized PDA samples, the detected sustained release 
could again offer interesting opportunities in the in vivo environment. 
 
 
 
 
 
Figure 4.14: Stability study of the AB (panel A) and VEGF (panel B) modified PLMA surfaces by 
incubation of the samples during 24 hours and 10 days in PBS buffer at 37°C.  
 
 
 
 
0 
5 
10 
15 
20 
25 
30 
35 
AB (PBS) AB EDC (PBS) AB EDC (MES) AB EDC/NHS 
(PBS) 
AB EDC/NHS 
(MES) 
M
a
ss
 A
B
 (
n
g
/c
m
2
) 
Modification 
0 h 
24 h 
240 h 
0 
100 
200 
300 
400 
500 
600 
VEGF (PBS) VEGF EDC (PBS) VEGF EDC 
(MES) 
VEGF EDC/NHS 
(PBS) 
VEGF EDC/NHS 
(MES) 
M
a
ss
 V
E
G
F
 (
n
g
/c
m
2
) 
Modification 
0 h 
24 h 
240 h 
-21% 
-25% 
-30% -21% 
-27% 
-19% 
-18% 
-18% 
-16% 
-16% 
A 
B 
Surface biofunctionalization | Chapter 4 
177 
 
 
 
4.3.2.4. In vitro analysis of the angiogenic factor functionalized AEMA-based surfaces 
Similar to previous in vitro evaluations, a live dead assay at day 1 and day 7 was performed 
to study the cell viability of HUVECs when seeded on PLMA with different surface 
modifications. Figure 4.15 summarizes the results obtained in case different coupling 
protocols were used to attach the angiogenic factors onto the AEMA functionalized surfaces. 
Based on a visual evaluation of the cell densities present after 24 hours, it could be 
concluded that almost no cells were present on the blank material and that the cell density 
was increased due to the application of an AEMA coating. Covalent immobilization of AB via 
EDC or EDC(NHS) chemistry in MES buffer resulted in higher cell densities, whereas in PBS, 
the cell number was much lower. Since quantification via radiolabeling revealed equal 
amounts of AB for the different immobilization protocols (see table 4.4), it is suggested that 
linkage in MES buffer resulted in a more active state of the AB. 
 
In case of VEGF immobilization, after 24 hours of cell incubation, lower cell densities were 
observed compared to the AB functionalized surfaces, irrespective of the coupling protocol. 
The lower cell densities could possibly be attributed to the presence of BSA, which was 
added to the modification buffer. Similar to the PDA functionalized samples, competition will 
have occurred during immobilization on the AEMA coated samples and as a consequence, 
both VEGF and BSA were present on the surface. From previous studies with hepatocytes, it 
appeared that the cell adhesion, proliferation and viability significantly decreased when 
immobilizing BSA 33. Therefore, also for HUVECs, a similar effect might be responsible for 
these lower cell densities, although further studies would be needed to elucidate the exact 
role of both components. 
Despite of these differences seen after 24 hours, 7 days after cell seeding, both the AEMA 
functionalized and VEGF or AB factor containing surfaces resulted in confluent cell layers, 
meaning that all surfaces are characterized by a good cell compatibility. Furthermore, the 
HUVECs were characterized by their natural cuboidal shape, although this was less obvious 
in case antibodies were immobilized in PBS buffer.  
As expected, the blank material resulted in a low cell compatibility, since cells did not 
proliferate and even after 7 days, low cell densities were still observed. 
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Figure 4.15: Live dead staining of HUVECs, seeded on the AEMA functionalized PLMA surfaces. Both 
VEGF and VE-cad AB are coupled with AEMA using EDC-chemistry. 
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To study the cell attachment on the PLMA surfaces in a more detailed way, immuno-assays 
were conducted to determine the amount of focal adhesion points present in the attached 
cells. From the confocal images in figure 4.16, a similar trend (compared to the live dead 
images) was seen for the obtained cell densities when comparing the different deposition 
protocols, implying that VEGF immobilization resulted in lower cell densities compared to 
the AB immobilized surfaces. Furthermore, the cuboidal cell shape was much more 
pronounced in case AB’s were immobilized. VEGF immobilization resulted in more 
elongated, stretched cells.  
 
In the next step, the number of focal adhesion points was quantified of which the results are 
presented in the boxplots of figure 4.16. AB functionalization (median FA between 70 and 
80) resulted in a significantly higher amount of focal adhesion points compared to the blank 
(median FA= 13) (p<0.05), although, in case the coupling was conducted in PBS, such a 
difference was not obtained (median FA = 57) (p>0.05). When the different modification 
protocols were compared, no significant differences were observed and similar results were 
obtained compared to the positive control, which is a cell adhesive reference (p>0.05).  
In case of VEGF immobilization, only a significant difference was obtained between the blank 
(median FA = 13) and in case the immobilization was performed with EDC, in MES buffer 
(median FA = 77). Comparison of the different VEGF immobilization protocols (median FA 
between 57 and 77) did not result in a significantly different number of focal adhesion 
points, also not compared to the cell adhesive control (79) (p>0.05).  
Based on these cell adhesion results, it can be concluded that all immobilization protocols 
are suitable to maximize cell adhesion and this applies to both AB and VEGF. 
On the other hand, if all in vitro results are considered, it can be concluded that the highest 
cell densities and the most natural cell morphology was obtained in case VE-cadherin 
antibodies were immobilized onto the PLMA surfaces and if MES was used as immobilization 
buffer. This follows the expectation, since more acidic conditions are generally preferred (pH 
4.5) to perform the EDC coupling reaction. As a consequence, the used MES buffer in this 
work approaches this condition most (pH 6) 83.  
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Figure 4.16: Distribution of the focal adhesion points, counted per cell after 2 days of cell contact 
for the blank and AEMA functionalized PLMA materials. Conditions which are significantly different 
are denoted by the same letter a, b, c,…   
 
It can also be mentioned that the application of AEMA as such resulted in similar positive 
and equal cell responses. It should be clear that even though such positive cell responses 
were obtained for a single AEMA coating, the specific function of VE-cad AB and VEGF (see 
§4.1) will be essential to stimulate angiogenesis in an in vivo environment.   
 
Similar to the PDA functionalized surfaces, it was tested whether the existence of a 
combined effect of AB and VEGF could be confirmed in this case. To this end, a similar 
experiment was conducted during which a fixed angiogenic factor concentration (4 µg/ml) 
and immobilization protocol (EDC/MES) was applied. Figure 4.17 shows the nicely cuboidal 
shaped HUVECs in case AB and AB/VEGF were immobilized. For the VEGF functionalized 
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surfaces, next to the anticipated cuboidal shaped cells, some cell clusters were also visible. 
Quantification of the focal adhesion points resulted in a higher median for the combined 
AB/VEGF functionalization (median FA =235), compared to the single AB (median FA = 192) 
or VEGF(/BSA) (median FA = 188) functionalized surfaces. However, statistical testing 
showed that the obtained differences were not significant (p>0.05). It can be concluded that 
based on this study, no statistical evidence for a combined angiogenic factor effect could be 
found.   
 
 
Figure 4.17: Evaluation of the combined effect of VE-cad AB and VEGF, which are immobilized onto 
AEMA coated PLMA networks. 
 
To further study the impact of angiogenic factor immobilization on the cell behavior in an in 
vitro setting, future studies should focus on gene expression, during which genes related to 
adhesion, migration and endothelial function could be quantified. Examples include the Von 
Willebrand Factor (VWF), VEGFR, VEGFA, ICAM1 and ICAM2 which are factors that all 
contribute to angiogenesis 85. Furthermore, two-dimensional angiogenesis assays as well as 
cell migration assays could be performed. In this respect, Gellynck et al (Tissue Engineering 
Group, UGent) already performed some preliminary tests showing that an increased AB 
concentration resulted in an increased blood vessel length and that a concentration of 4 
µg/ml gave rise to an improved migration of HUVECs 86. A similar evaluation could also be 
performed for the other angiogenic factors, including VEGF as well as the combined 
AB/VEGF immobilization strategy. 
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4.3.3. Study into the orientation of the immobilized antibodies 
In the previous sections, successful immobilization of VE-cad AB was proven. It can however 
be questioned how these antibodies are oriented on the polymer surface. Antibodies are Y-
shaped structures, which carry two Fab binding sites (antigen binding fragments) and an Fc 
region (fragment crystallizable region) (figure 4.18, A). In case antibodies are adsorbed onto 
surfaces, different orientations can occur, including the Fab-up, Fc-up, side-on and flat-on 
orientation 75, 87. In case of covalent immobilization of the AB, different orientations will also 
be obtained due to the dispersion of the AB reactive groups (i.e. amines and carboxylic acid 
functions) throughout its overall structure. Optimal function of the antibody is guaranteed in 
case the Fab region is oriented towards the body environment. In other words, ideally, the 
AB should be attached onto the material surface via its Fc region. In this way, the Fab 
binding site will be maximally available to bind the endothelial cell’s VE-cadherin. To study 
the orientation of the immobilized antibodies onto PLMA and PMMAPEG, radiolabeling 
experiments were conducted with two distinct secondary antibodies (antigens in this case). 
The first one specifically binds the Fab binding sites of VE-cadherin AB, whereas the second 
one the Fc region. In other words, a successful oriented immobilization of AB should be 
reflected in the results by a higher amount of bound anti-Fab secondary AB and a lower 
amount of anti-Fc secondary AB.  
Apart from the PDA and AEMA (EDC)-based AB immobilization strategies, an alternative 
immobilization route, which should allow for oriented AB immobilization was included in the 
current study. This route, as depicted in figure 4.18 (B), consisted of four different steps. 
After introduction of primary amines onto the surface via the post-plasma grafting of AEMA 
(step 1), the amines were reacted with a (succinimidyl-6-hydrazino-nicotinamide) 
heterobifunctional crosslinker (S-Hynic) to introduce hydrazide functions on the surface 
(step 2). Next, carbohydrate moieties, which are exclusively present in the Fc part of the 
antibody were oxidized to aldehyde functionalities, using sodium periodate (NaIO4) (step 3). 
In this last step, there is aimed at breaking the carbon-carbon bond between two adjacent 
hydroxyl functions in the sugar unit. Herein, it is important to use a NaIO4 solution with a 
concentration higher than 10 mM. Lower concentrations will only result in the selective 
oxidation of sialic acid residues 83. Finally, to couple the AB with the surface, the reactive 
surface hydrazide functionalities were reacted with the aldehyde functions of the oxidized 
AB (step 4). 
 
The results (figure 4.18, C and D) showed that in case of PMMAPEG, high aspecific 
adsorptions of anti-Fab and anti-Fc VE-cad AB were manifested onto the blank material and 
to a higher extent compared to PLMA. For all PMMAPEG modifications, a higher amount of 
anti-Fc secondary AB was detected compared to the anti-Fab one, although, for the PDA 
functionalized surfaces, this difference was not significant. For the AEMA functionalized 
surfaces, significantly higher amounts of anti-Fab and anti-Fc secondary VE-cad AB’s were 
detected compared to the PDA functionalized ones. This suggests a higher availability of the 
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AB binding sites in case the AB is immobilized via an AEMA-based coupling. The same 
conclusion could be made for the AEMA modified PLMA samples. 
 
 
 
 
 
 
   
Figure 4.18: AB orientation onto polymer surfaces (A). Modification strategy towards controlled 
antibody orientation (B). Evaluation of the AB orientation onto PDA and AEMA functionalized 
PMMAPEG (C) and PLMA (D) surfaces.  
 
For PMMAPEG, the application of the oriented AB immobilization strategy did however not 
result in a significant preference towards anti-Fab secondary AB binding. On the contrary, it 
appeared that all the modifications resulted in a preferred Fc-up orientation of the 
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immobilized AB’s. In case of PLMA, the EDC-crosslinked AB’s resulted in the highest amount 
of Fab-up immobilization (p<0.05). Furthermore, no distinct preference towards anti-Fab 
secondary AB bonding was experienced in case the oriented AB immobilization was 
executed. In case of PLMA, the Fc-up/Fab-up AB distribution is approximated by 50%/50%, 
whereas for PMMAPEG less than 30% of the AB’s were present in the desired Fab-up 
orientation.  
It can be concluded that the availability of the AB binding sites can still be improved. As a 
consequence, the evaluation of improved or alternative AB binding strategies could be the 
topic of future research.  
 
 
4.4. Conclusion 
In the present chapter, the biofunctionalization of PDA and AEMA functionalized surfaces 
was established.  
First, a universal modification strategy was developed which enhances the cell-adhesive 
properties of implant materials. To this end, the combination of PDA and gelatin B was 
applied onto PMMA and a PEG-based methacrylate material, which is characterized by a ten-
fold lower E-modulus. Application of this bi-layer system revealed similar cell-interactivities 
irrespective of the underlying substrate material’s (physico)chemistry. Furthermore, both 
PMMAPEG and PMMA required a gelatin B adlayer on the PDA-modified samples to yield 
similar cell adhesion properties. Furthermore, if PDA/Gel B was applied onto different 
PMMAPEG-based materials with varying elasticity moduli, similar numbers of cell focal 
adhesions were obtained, which again stresses the universal character of this coating. 
 
In the second part, VE-cad AB and VEGF were immobilized onto PDA and AEMA 
functionalized surfaces. In the former case, successful immobilization of both AB and VEGF 
was accomplished, as proven by XPS and radiolabeling experiments. Maximized HUVEC 
adhesion was obtained in case both angiogenic factors were immobilized and it was proven 
that a combined effect existed between both factors.  
In case of AEMA-functionalized surfaces, similar conclusions could be drawn, although for 
the latter, the occurrence of a positive combined effect was not evident. In case of single 
angiogenic factor immobilization, increased cell densities and cell adhesions were observed 
if AB’s were immobilized as compared to VEGF, although no statistical confirmation could be 
delivered for this finding. Based on XPS and radiolabeling measurements, no unambiguous 
preference could be observed amongst the different EDC-based immobilization protocols 
and it was suggested that for all conditions, the aspecific adsorption of the angiogenic 
factors masked the covalent linkage of these factors.  
As mentioned earlier, future studies could focus on 2D angiogenesis and migration assays or 
gene expression during which different factors controlling angiogenesis (such as VWF, VEGF 
and ICAM 1), could be evaluated and quantified, in order to better simulate and understand 
the in vitro and in vivo response. Furthermore, the release of angiogenic factors over time, 
Surface biofunctionalization | Chapter 4 
185 
 
due to the aspecific ad- and absorptions, should be further investigated in an in vitro and in 
vivo setting. 
 
Based on an orientation study of the immobilized antibodies, it could be concluded that AB 
immobilization onto AEMA-functionalized surfaces resulted in an increased accessibility of 
the AB towards antigen binding, compared to antibodies immobilized onto PDA. If 
PMMAPEG was used as a substrate material for oriented AB immobilization, less than 30% of 
the antibodies were Fab-up oriented, whereas for PLMA, this amount was increased towards 
50%. Based on these results, successful orientation of the antibody was not yet 
accomplished. Nevertheless, further investigation of the AB orientation dependent cell 
behavior would be an interesting topic for future research studies. 
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5.1. Introduction 
The previous chapter has indicated that surface biofunctionalization of the polymer 
packaging with growth factors and especially antibodies induced a positive in vitro cell 
response, which was reflected by high cell viabilities and cell adhesion characteristics. Due to 
this promising outcome, it was justified to further characterize the materials for their in vivo 
behavior. To this end, an appropriate animal model needed to be selected. Spontaneous 
diabetes occurs in many animal species. In addition, upon the application of experimental 
methods such as the administration of alloxan or streptozotocin, many animals can be made 
diabetic. Previously, both spontaneous and experimental animal models have been used to 
study the etiologies, complications, treatments and prevention of diabetes 1. Examples of 
such animal models include rats, mice, dogs, rabbits and hamsters 1-3. In the current work, 
based on the sensor design which includes rather large sensor implants (a maximum of 2 cm 
in ф and 6 mm thickness), small animal models such as rats and hamsters could not be 
considered. As a consequence, bigger mammals had to be chosen. Since goats are 
appreciated as social animals and as ‘easy to handle’, they were selected as the preferred 
animal model.  Nevertheless, for the in vivo evaluation of the developed materials and their 
surface modifications, rats were also included in this work. 
Since we aimed at developing a glucose sensor which operates for longer implantation 
times, all goat implantation experiments were conducted for a minimum of 1 month. 
Previously, the subcutaneous implantation of an enzymatic glucose sensor resulted in 
successful long-term in vivo glucose measurements. Herein, with the help of a 
radiotransmitter, glucose values were recorded for a sensor life time of 3-5 months in dogs 4. 
Furthermore, in pigs, these values could be recorded for longer than 1 year 5. Nevertheless, 
in humans, the currently applied glucose sensors such as the GlucoDay, a microdialysis-
based sensor, enable continuous glucose measurements for a period of only 48 hours 6-7.  
This fact clearly shows the need for new continuous glucose sensors, which operate for 
longer periods in an in vivo setting. In this work, the use of an optical sensor design is 
evaluated for the latter purpose.  
In the upcoming paragraphs, the production of the implantable sensors will be discussed, 
followed by the in vivo evaluation of the developed blank and biofunctionalized 
methacrylate-based packaging materials1. Herein, special attention is paid to the induced 
tissue response and vascularization around the implanted materials. In a last step, the sensor 
design will be evaluated in an in vivo and in vitro setting for its glucose detection capacity.  
It should be mentioned that, from a polymer perspective, only the PMMAPEG-based 
materials were evaluated in the forthcoming in vivo experiments. Interestingly, the PLMA-
                                                          
1
 All implantations in goats were performed by Lieven Vlaminck, from the Department of Surgery and 
Anaesthesiology of Domestic Animals. The rat implantation studies and histological evaluations, on the other 
hand were performed by Greet De Smet, Lise De Moor and Karolien Gellynck, at the Tissue Engineering Group 
of the Department of Basic Medical Sciences, under supervision of Prof. Maria Cornelissen. All optical, 
evaluations during the in vivo studies were performed by Ronny Bockstaele, the project leader of GlucoSens. 
Furthermore, he also guided the protein and glucose analyses, in cooperation with Prof. Joris Delanghe, a 
clinical chemist at UZ (University hospital) of Ghent.  
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based materials could also have offered a good (or even superior) alternative, but at the 
time of the planned in vivo experiments, these materials were not yet available. For the 
same reason, only the PDA surface activation and VE-cad AB biofunctionalization strategy 
were included in the in vivo assays.  
 
 
5.2. Development of a UV-transparent mold for the production of dummy 
and fiber-embedded donut-shaped implants  
As introduced in chapter 1, the sensor design requires a donut-shaped sensor packaging.  
Since the polymer packaging is developed via photo polymerization, a UV-transparent mold 
had to be designed and applied. Due to the more complex shape of the final mold compared 
to the polymerization set-up discussed in chapter 2, no teflon release foil could be used to 
assure the release of the polymers after production. As a consequence, an appropriate UV-
transparent material that does not react with the MMA-based material had to be used. Since 
plexiglass and polycarbonate did not perform as desired, zeonex®, a cyclic olefin-based 
polymer was selected (transparent disks in figure 5.1 A) for all mold designs. 
In case dummy, fiber-less donuts needed to be produced, a mold design as presented in 
figure 5.1 was used (referred to as mold design 1). Herein, the donut-shaped central cavity 
was created by the assembly of two UV-transparent zeonex® discs and a stainless steel (SS) 
ring, which determined the outer diameter of the donut (i.e. 15 mm). The inner diameter of 
the donut was determined by a small stainless steel tube which was mounted between the 
two zeonex discs (figure 5.1, A and B). To fix the different parts, they were pressed inside a 
brass ring and tightened with two screw rings (figure 5.1, C). To inject the monomer/initiator 
solution in a proper way, syringes were mounted in both needles. Herein, the first syringe 
was used to inject the solution, whereas the second needle/syringe was used to remove air 
from the central cavity in a controlled way. After injection and UV irradiation, donut-shaped 
samples with an outer diameter of 15 mm and a thickness of 5 mm could be created. 
Depending on the diameter of the used SS tube, the diameter of the central cavity could be 
adjusted (1 vs. 3 mm). 
 
 
Figure 5.1: Assembly of a UV-transparent mold for the production of a dummy donut-shaped 
polymer packaging (mold design 1) 
 
A B C 
Central 
cavity 
SS  
tube 
Brass 
ring 
Screw 
rings 2 cm 2 cm 2 cm 
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In case optical glass fibers needed to be embedded inside the polymer packaging, a different 
mold design had to be used. Figure 5.2 displays the different parts, constituting this mold 
(figure 5.2, A), the assembly of the mold (figure 5.2, B-D) and the final encapsulated fiber-
containing implant (figure 5.2, E). Again, the central cavity of the donut-shaped implant was 
created by two zeonex® discs, which were separated by a stainless steel ring. Since fibers 
were included, space needed to be created and therefore the stainless steel ring was 
transversely cut. The inner diameter of 1 mm was in this case created by a SS pin which was 
fixed inside the zeonex® windows. In the latter design, everything was clamped by two metal 
rings, which also contained enough fiber space and which were tightened with screws (figure 
5.2, D).  
 
 
 
 
 
 
Figure 5.2: Assembly of a UV-transparent mold for the production of a donut-shaped polymer 
packaging, incorporating optical fibers (A-E). A cross-section of the embedded fiber construct (mold 
design 2) is also shown (F). Mold design 3 is identical to design 2, except for the use of PES 
membranes which cover the central cavity (mold design 3) (G). In this case, a metal roundel and 
metal perforated support were used respectively above and under the membrane as mechanical 
support. 
A B 
C D E 
F 
membrane 
G 
2 cm 
2 cm 
Metal roundel 
Metal support 
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Injection of the monomers and curing were conducted similarly as in the previous setup. It 
should be mentioned that all fibers and/or electronics, that needed to be encapsulated in 
the polymer packaging, first needed to be mounted and aligned onto a separate metal 
carrier. Otherwise, fixed positions of these compounds could not be guaranteed during the 
molding process. Furthermore, the fibers itself had to be protected by a poly(urethane)-
based catheter, to prevent fiber fracture or damage. Application of mold design 2 resulted in 
implants with an outer diameter of 2 cm and a thickness of 6 mm. Due to this design, the 
optical light path typically consisted of 0.5 mm polymer material, followed by 1 mm air or 
tissue (i.e. in case of implantation) and finally again 0.5 mm polymer, before reaching the 
second fiber. The cross-section of the final molded implant is displayed in figure 5.2, F.  
 
Since a central cavity was created in the previous mold designs, potential tissue in-growth 
and/or the influx of biological compounds such as cells and proteins might result in optical 
losses during glucose measurements. To study this effect, a third mold design was also 
included. Herein, circular polyethersulfone (PES) membranes with a molecular weight cut off 
at 10 kDa and a diameter of 10 mm were included 8-9. Using this approach, low molecular 
weight glucose (180 Da) was able to diffuse through the membrane to reach the sensing 
cavity, but tissue in-growth or the influx of interfering biological compounds such as serum 
albumin (Mw = 67 kDa) could be prevented 10-12. A schematic representation of the mold 
design is shown in figure 5.2 (G). 
The production of the donuts was performed with the same mold components as 
represented in figure 5.2 (A). Additionally, to offer mechanical strength to the included 
membranes, perforated metal plates (8 mm ф, 0.5 mm thickness, 1 mm ф pores) were used 
as lower supports, whereas a metal roundel (10 mm outer ф, 5 mm inner ф and 0.3 mm 
thickness) was placed on top of the membrane. An additional advantage of this sensor 
design (mold design 3) included the absence of polymer in the optical path of the light beam.  
 
 
5.3. Determination of the optimal implantation site: an exploratory in vivo 
study.  
During a first implantation round, three different polymer formulations were implanted (2 
replicates per polymer formulation) at 3 different implantation sites in three different goats. 
In this way, each goat was carrying 18 samples, including 6 per implantation side. The 
selection of the polymer networks was based on the availability of the developed packagings 
and on their difference in mechanical and swelling properties. An overview of the different 
formulations under investigation is given in table 5.1. Concerning the implantation site, 
subcutaneous (i.e. under the skin), intramuscular (i.e. inside a muscle) and retroperitoneal 
(just outside the celiac) implantations were studied and evaluated. On the other hand, 
intravenous (i.e. inside a blood vessel) implantations were excluded from this study because 
of safety and practical reasons. To be more precise, if a long-term continuous glucose sensor 
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would be implanted in a human blood vessel, clotting, bleeding and infection could be 
anticipated, which would be detrimental for the patient 13. On the other hand, since glucose 
measurements in whole blood are the clinical standard, the construction of a calibration 
model for the interpretation of optical glucose spectra is very straightforward, because of its 
availability in literature. In case of glucose measurements in ISF, the biological fluid under 
investigation in this study, the interpretation can be more difficult. Nevertheless, it has 
already been shown that a clinically significant correlation exists between glucose 
concentrations in blood and the interstitial fluid (ISF). To be more precise, time lags of 0 
(steady-state situation), 8-10 (assumed as acceptable), but also of 30 minutes have been 
reported and the differences are mainly due to different collection methods, experimental 
designs and different ISF collection sites14-17. The correlation can thus be assumed as unique 
for each sensor system and should be evaluated in detail for each example. Also in the 
present work, this challenge had to be tackled and an unambiguous calibration model which 
correlates the spectral ISF data with a glucose concentration, had to be developed. The latter 
was, however, beyond the scope of the current work. These aspects were tackled by co-
workers at the KU (Catholic University) Leuven (under supervision of Prof. Saeys) 18. 
 
Table 5.1: Overview of PMMAPEG formulations implanted in goats 
Material 
MMA 
(mol%) 
PEGDMA 
(mol%) 
Mn (PEGDMA) 
(g/mol) 
E-mod 
(MPa) 
Swelling 
(%) 
PMMAPEG 1 50 50 550 142±40 17±1 
PMMAPEG 2 50 50 750 21±1 43±1 
PMMAPEG 3 85 15 550 1053±51 12±0 
  
PMMAPEG dummy donuts (i.e. fiber-less donuts) were produced using mold design 1 (figure 
5.1). The samples were implanted in three healthy, female milk goats and divided over the 
three implantation sites selected. After four weeks of implantation time, the donuts were 
explanted and the tissue clumps containing the samples were evaluated. The results showed 
that all samples were surrounded by a connective tissue layer. Based on the morphology of 
the cells and the extracellular matrix, two distinct types of these capsules could be 
distinguished (figure 5.3 A). In the first case (capsule 1), a sharp delineation was observed 
between the connective tissue capsule and both the implant and the surrounding tissue. As 
a consequence, the donut-shaped samples could be considered as separated from the 
capsule. Capsule type 1 clearly resembled a capsule characteristic for the final stage of the 
tissue repair process, meaning that particularly quiescent fibroblasts (i.e. fibrocytes) were 
present in the tissue. These fibrocytes are morphologically different from their active 
counterparts and are typically small, spindle-shaped cells containing a small, dark nucleus. A 
last characteristic of this type 1 capsule includes the presence of collagen fibres, which were 
visualized after hematoxylin and eosin (H&E) staining (pink color, figure 5.3, A). 
In the second case (capsule 2), the connective tissue clearly resembled tissue corresponding 
to the active stage of the tissue repair process. Herein, a more ‘ruffled’ edge could be 
observed between the donut implant and the tissue. Furthermore, a more smooth transition 
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existed between the connective tissue capsule and the surrounding tissue, without clear 
delineations. The tissue consisted of active fibroblasts characterized by an abundant 
cytoplasm, a large oval pale-staining nucleus with fine euchromatic chromatin and a large 
nucleolus. After H&E staining, the tissue behaved less eosinophilic, which refers to a lower 
collagen content present in the extracellular matrix (ECM). It can be concluded that the type 
2 capsule was more integrated and more preferred compared to the first one. 
 
 
 
 
Figure 5.3: Panel A: Two types of capsule formation were observed. In case of capsule type 1, more 
eosinophilic fibrocytes were observed and a clear-cut border was present at the donut-capsule and 
capsule-tissue interfaces. On the other hand, for capsule type 2, more basophilic fibroblasts were 
observed, a more ruffled border was present and the capsule-tissue interface showed a smooth 
transition. Panel B: Distribution of the explanted samples (i.e. donuts) regarding the type of 
capsule surrounding them. In the left figure, the influence of the biomaterial composition is shown, 
whereas in the right graph, the influence of the implantation site is evaluated 19. 
 
Apart from this general distinction, the different PMMAPEG materials were compared with 
regard to the type of encapsulating connective tissue. Figure 5.3 (B) shows that PMMAPEG 3 
gave rise to the lowest amount of ‘connective tissue capsule 2’ (only 6%), followed by 
PMMAPEG 2 (17%) and PMMAPEG 1 (22%). 
A 
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Based on this finding, PMMAPEG 1 was selected as the preferred PMMAPEG sensor 
packaging. Based on its physicochemical properties (see table 5.1 and chapter 2), this choice 
was further evidenced. Indeed, this material gave the best compromise between mechanical 
properties (i.e. relatively low E-modulus) and swelling behavior (i.e. low swelling %). 
Concerning the implantation site, figure 5.3 (B) shows that subcutaneous implantation was 
preferred due to a lower amount of ‘capsule 1’ formation. Furthermore, from a surgical 
viewpoint, this selection was further supported. During the explantation process, it 
appeared that several of the retroperitoneal implants were migrated towards more caudally 
located places near the pelvic area. It is hypothesized that these migrations were caused by 
movement of the goat and by intestinal activity. Moreover, due to the invasive nature of 
these retroperitoneal implantations, its omission was more than justified.  
 
Regarding the intramuscular implantation, some of the donuts were nicely integrated inside 
the muscular tissue, while others did not show any integration at all. It can be anticipated 
that muscle movement was responsible for this finding. As a consequence, due to the 
accessibility and its more reproducible nature, reflected by the appearance of mostly 
vascularized connective tissue, subcutaneous implantation was selected as the preferred 
implantation site.   
 
 
5.4. In vivo evaluation of the surface modified PMMAPEG-based packaging 
material  
In the next step, the pristine and surface-modified PMMAPEG materials (see chapter 3,         
§ 3.4.2 and chapter 4, § 4.2.2) were implanted to evaluate the effect of the surface 
functionalization on the in vivo response. To this end, the nature of the tissue surrounding 
the implants was evaluated and particular focus was attained on the presence of blood 
vessels. VE-cad antibodies were immobilized to induce neo-vascularization around the 
implant. As a result, it could be anticipated that an increased amount of blood vessels would 
surround the biofunctionalized samples. Several experiments in goats and rats were 
conducted and will be discussed in the upcoming paragraphs. 
   
5.4.1. In vivo biological experiments in goats 
Similar to the exploratory in vivo study, donut-shaped dummy (cfr. no photonic or electronic 
components included) PMMAPEG implants were evaluated. More specifically, blank, PDA-
modified and PDA/VE-cad AB modified (see chapter 4, §4.2.1) samples were implanted 
subcutaneously in three goats. In addition, VE-cad AB functionalized Gel B surfaces were 
included in this study. The latter combination was not fully characterized and was not 
mentioned in chapter 4, but at the moment of this first implantation study, it was decided by 
the GlucoSens partners that this condition could be considered as valuable. For the latter 
condition, the antibodies were immobilized onto Gel B via physisorption. Radiolabeling 
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experiments indicated that lower amounts of AB were immobilized onto GelB (173 ng/cm2), 
compared to PDA (287 ng/cm2). In vivo comparison of the latter two conditions allowed to 
study the effect of the used immobilization strategy on the body response.  
Half of the samples were explanted after 1 month, the other half after 3 months 
implantation. Histological evaluation of the tissue surrounding the implants revealed that no 
visual differences could be observed between the different surface modifications (PDA vs 
PDA/VE-cad AB). However, if the blank samples were compared with the surface modified 
ones (figure 5.4), a more dense connective tissue could be observed for the blank samples, 
resembling capsule 1 (figure 5.3, A). Surface modification, on the other hand, generally 
resulted in superior integration, with less dense connective tissue and a smoother transition 
between tissues, which clearly resembled capsule 2 (figure 5.3, A).  
 
 
Figure 5.4 : Histological evaluation of the connective tissue surrounding the explanted unmodified 
(A and C) and modified (B and D) donut samples after 1 month (A and B) and 3 months (C and D) 
implantation. The position of the implant is indicated via ‘implant’. 
 
Nevertheless, it should be mentioned that the results depicted in figure 5.4 were not 
apparent for all samples. What is more, most of the samples were associated with capsule 
type 1, irrespective of the implantation time and the surface modification applied.  
It should also be noted that, based on the presence of macrophages and lymphocytes, only 
minor inflammation was observed around 17% of the implants. 
 
As pointed out in chapter 4, VE-cad AB’s were immobilized on the PMMAPEG surfaces to 
enhance neo-vascularization via vasculogenesis. To evaluate the success of this approach, 
the number of blood vessels in the vicinity of the sensor were counted. Several criteria had 
to be met before a capillary was taken into account. In this respect, the presence of a red 
blood cell, an endothelial cell and a lumen were evaluated. If two of the three criteria were 
met and if the diameter of the blood vessel was not larger than 10 µm, the observed 
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structure could be classified as a capillary. Figure 5.5 (A) shows some typical examples of 
such capillaries.  
 
 
 
Figure 5.5: Panel A: Histological section (H&E staining) of the tissue surrounding the implant. Based 
on the three criteria, referred to in the text, the capillaries (indicated by arrows) could be counted. 
Panel B and C: Mean capillary density of the tissue surrounding the blank and modified PMMAPEG 
implants after 1 month (B) and after 3 months (C) implantation (left panel). The distribution of the 
data is represented by boxplots (right panel) 19. 
 
The result of the evaluation of the different histological slices for the amount of capillaries is 
shown in figure 5.5 (B and C). After one month of implantation, no significant differences 
were observed for the amount of capillaries when comparing the different surface 
modifications applied. Furthermore, similar results were obtained for the blank, non-
modified materials. After three months, based on the median capillary number, higher 
A 
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amounts were counted in the vicinity of the VE-cad AB (i.e. 111/mm2) functionalized 
surfaces, compared to the GelB/AB (i.e. 86/mm2) and PDA functionalized surfaces (i.e. 
83/mm2). The latter two cases even resulted in a lower amount of capillaries compared to 
the blank control (i.e. 88/mm2). Nevertheless, due to the high variation in the data 
distribution (see standard deviations in figure 5.5, C), none of these differences were 
statistically significant (p > 0.05).  
The obtained results were in good correlation with the radiolabeling data (see higher). 
Indeed, the highest micro-vessel density was observed for the VE-cad AB modified samples, 
using PDA as functionalization platform. Based on these results, it seemed that the use of 
Gel B as intermediate layer did however not improve vascularization. Since the AB’s were 
immobilized via physisorption, an enhanced availability could be anticipated. However, the 
obtained results showed that this effect was not manifested.  
 
5.4.2.  In vivo biological experiments in rats 
In addition to the goat experiments, in vivo experiments using rats as experimental model 
were also performed. Since small disk samples (6 mm ф, 1 mm thickness) were applied in 
this set-up, rats could be used as animal model. 
In a preliminary experiment, disks of non-modified, PDA and PDA/VE-cad AB- (4 and 40 
µg/ml) modified PMMAPEG, were implanted for 28 days. After histological processing and 
staining with haematoxylin-eosin, the number of capillaries was counted in ten 100 µm/100 
µm squares and converted to the number of capillaries/mm². Herein, the same criteria were 
applied to recognize blood capillaries, as indicated above (see figure 5.5, A).   
In the series blank < PDA-coated < PDA/AB-coated, a slight increase in the number of 
capillaries was observed (figure 5.6), although, the increases were not significant (p > 0.05). 
The lower standard deviation in case of AB immobilization seemed to reveal a higher 
reproducibility for the capillary count. The application of a higher concentration of antibody 
(40 µg/ml) did, however, not augment the amount of capillaries surrounding the implant. On 
the contrary, a higher concentration even resulted in a significant decrease of the capillary 
count (p < 0.05). This result might be attributed to density related effects. 
Based on these preliminary results, an extensive study using normal and Goto-Kakizaki rats 
was performed. The latter family of rats is a non-obese Wistar substrain which develops type 
2 diabetes mellitus in life and which shows a congenital vascular impairment. In this study, 
20 normal and 20 diabetic rats were used. Each rat contained 3 PMMAPEG-based disks, 
including a blank, a PDA coated sample and a PDA/VE-cad AB functionalized sample. To 
investigate the tissue reactions and capillary formation over time in both rat species, 
explantations were done 2 days, 5 days, 10 days and 25 days post-implantation. This implies 
that for each time point, 5 replicates were analyzed per condition (i.e. blank, PDA, PDA/VE-
cad AB modified). Prior to discussing the results of capillary formation, inflammation and 
connective tissue formation around the implants were first evaluated.  
 
Chapter 5 | In vivo evaluation of a biofunctionalized methacrylate-based packaging  
 
202 
 
 
Figure 5.6: Preliminary in vivo test with rats. Evaluation of the number of capillaries surrounding 
the implanted materials after 4 weeks of implantation. 
 
5.4.2.1. Evaluation of inflammation and connective tissue capsule formation 
Similar to the goat implantation study, implantation of the test samples could evoke a body 
response (also see chapter 1). As previously described, this response implies that 
inflammation will occur and that over time, a fibrous capsule will develop around the 
implant.  
In a first step, the inflammation of the implanted disks was studied. After 2 and 5 days, 
inflammation was observed by the visualization of granulocytes and macrophages. The 
reaction appeared equal for all conditions and it seemed that the inflammation was reduced 
as a function of time. Nevertheless, more inflammation was observed for the diabetic rats 
compared to the normal ones. In literature, similar observations have already been 
described for the subcutaneous 20 and the intraperitoneal 21 implantation of polyether-
polyurethane sponge discs in normal and diabetic rats.  
Next, the connective tissue capsule surrounding the implanted samples was evaluated for its 
thickness (figure 5.7). Interestingly, after 2 days, no capsule was observed yet, whereas after 
5 days, measurement of the capsule thickness could be performed. Upon surface 
modification, the thickness of the connective tissue capsule decreased for both the diabetic 
and normal rats, but only for the normal rats a significant difference was obtained in case 
the blank (19 µm) was compared with the AB functionalized samples (15 µm) (p<0.05). After 
10 days of implantation, similar thicknesses were obtained for the different surface 
modifications and this for both the normal and the diabetic rats. It can be mentioned that 
for both the normal and diabetic rats, the lowest capsule thickness was respectively 
observed for the AB functionalized surfaces (33 µm) and the control (27 µm), although, 
compared to the other test conditions, these differences were not significant (p>0.05). A 
similar trend was observed after 25 days. For both the normal and the diabetic rats, the 
thickest capsule was observed around the PDA coated samples (49 µm vs. 59 µm), followed 
by the AB functionalized samples (48 µm vs. 59 µm) and the controls (39 µm vs. 43 µm).  
As a function of time, the capsule thus increased for both groups of rats. Statistically, for the 
normal rats, a significantly thicker capsule was observed after 10 days compared to 5 days of 
implantation for each condition (control, PDA and AB functionalized). The same applied in 
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case the capsules after 5 and 25 days were compared, but comparison of day 10 and day 25, 
only resulted in a significant difference for the PDA functionalized samples. In case of 
diabetic rats, comparison of the capsule after 5 and 25 days and after 10 and 25 days, 
resulted in a significantly thicker capsule for the longer implantation times and this for all 
test conditions (p<0.05).  
Based on the data obtained after 5 and 25 days of implantation, it could be concluded that 
generally a thicker capsule was formed in case the samples were implanted in diabetic rats, 
compared to the normal rats. Nevertheless, this difference was only significant in case of 
PDA modification. Previous research conducted by Oviedo-Socarrás et al showed an 
opposite tend since the thickness of the fibrogenic capsule surrounding implants in diabetic 
rats (169 ± 11 µm) appeared to be significantly lower compared to the thicknesses obtained 
from samples in non-diabetic rats (295 ± 19 µm) 21. Based on their experiments, they 
concluded that increased TNF-α (tumor necrose factor, a cytokine) levels were responsible 
for fibroblast apoptosis. As a consequence, decreased collagen levels were deposited by 
these cells, which explains the decreased fibrous capsule formation 20. In the current study, a 
clearly different trend was observed. Furthermore, much thinner capsules were measured 
for both the diabetic (170 µm vs. 28 µm) and non-diabetic rats (300 µm vs. 33 µm) . This 
clearly proves that the type of material (polyether-polyurethane sponge discs vs. PMMAPEG-
based materials) also influences the eventual body reaction.  
 
 
Figure 5.7: Analysis of the thickness of the connective tissue capsule after 5, 10 and 25 days of 
implantation in normal and diabetic rats. Conditions which are significantly different are denoted 
by similar letters a, b, c,… The X-axis indicates the codes of the applied surface modification. All 
error bars are a measure for the standard deviation, obtained after measurement of 5 replicates 
per condition and time point. 
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5.4.2.2. Evaluation of capillary formation 
Apart from the fibrous capsule, the capillary formation was evaluated for the different 
surface modifications and the different implantation times. Herein, to count the number of 
capillaries, the same criteria were used as previously described (see § 5.4.1). It should be 
noted that no statistical analysis was performed on the obtained results due to the limited 
dataset (n=2) under investigation. Nevertheless, based on figure 5.8, some qualitative trends 
could be deduced. As a function of time, the number of capillaries increased for both groups 
of rats. The highest amount of capillaries was obtained for the AB functionalized samples, 
although, the results at day 5 contradicted this finding. At this timepoint, similar results were 
obtained for the different test conditions. At day 25, for both the normal and diabetic rats, a 
higher amount of capillaries was present around the AB functionalized samples (22 vs. 17) 
compared to the PDA functionalized (15 vs. 10) and the blank test condition (10 vs. 9). This 
finding indirectly delivered the proof that VE-cad antibodies are indeed able to attract EPC, 
as described by Lim et al thereby enhancing neo-vascularization 22. From the previous 
comparison, it is also clear that samples implanted in diabetic rats gave rise to the formation 
of a lower number of capillaries compared to the normal rats. These findings are in line with 
the work of Oviedo-Socarrás et al, who reported on the polyether-polyurethane sponge  
discs 20. They also found a lower number of blood vessels in the fibrovascular tissue from 
diabetic rats compared to the vessel numbers around implants from non-diabetic animals. 
These lower capillary numbers are most likely related to a lower number of circulating 
endothelial progenitor cells (EPC) which is characteristic for diabetics. It has already been 
demonstrated that diabetes related hyperglycemia can induce alterations to EPC, meaning 
that the number of EPC is reduced and that their function is impaired. As a consequence, 
their proliferation, adhesion and vasculogenesis is reduced. EPC originate from the bone 
marrow and can be mobilized into the peripheral circulation in response to tissue ischemia 
and cytokines such as VEGF and stromal-derived-factor-1α (SDF-1α) to contribute to 
endothelial repair and neovascularization at injury sites. Since diabetes is also responsible 
for a depleted production of SDF-1α, lower mobilizations of EPC from the bone marrow are 
enabled and as a consequence, lower vascularization is observed in diabetic rats 23-24. 
A second explanation can be found in the mechanism of diabetic retinopathy, a disease 
which originates from an increased vascular permeability due to alteration of the blood-
retinal barrier. It was shown that diabetes is indeed responsible for this blood-retinal barrier 
breakdown by the proteolytic breakdown of VE-cadherin, which is responsible for 
endothelial cell-cell contact. As a consequence, the quantities of soluble VE-cadherin in the 
body of diabetics might be increased. Since in the present work antibodies against VE-
cadherin were immobilized onto the implanted materials, competition might have occurred 
between the soluble VE-cadherin and the circulating EPC for antibody binding. The lower AB 
availability for EPC could therefore be responsible for the lower degree of vascularization in 
diabetic rats when compared to the healthy ones 25. 
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Figure 5.8: Number of capillaries counted around the implanted (non-)modified PMMAPEG 
samples, implanted in both healthy and diabetic rats. The evaluation was performed 2, 5 and 25 
days post-implantation. The X-axis indicates the codes of the applied surface modification. All error 
bars are a measure for the standard deviation, obtained after measurement of 2 replicates per 
condition and time point. 
 
5.4.2.3. Evaluation of capillary formation in VE-cad AB functionalized 3D scaffolds: a proof of 
principle  
During previous experiments, the formation of a dense connective tissue capsule was 
observed for both the blank and the modified samples. Furthermore, a trend towards 
increased vascularization was observed in case VE-cad AB’s were immobilized on the surface 
implant, but statistical confirmation could not be delivered. As a consequence, in order to 
evaluate and to prove the hypothesis that VE-cad AB’s induce vascularization to a greater 
extent compared to PDA and non-modified samples, 3D printed porous PCL scaffolds, 
bearing identical surface chemistry were studied in vivo. The selection of porous scaffolds 
originates from previous work conducted by Koschwanez et al. They applied a porous 
polylactide coating on the surface of the commercialized MiniMed SOF-SENSOR 
(Medtronics) and they observed different tissue reactions between the sensors that 
contained a smooth surface versus a porous one. To be more precise, they observed 
threefold more blood vessels around the porous structures, combined with three times less 
collagen development, which resulted in a decreased thickness of the formed fibrous 
capsule 26. 
In this work, 3D printed PCL scaffolds (6 mm ф, 1 mm thickness) with pores of 250 µm 
diameter were produced and implanted in three healthy and three diabetic rats. The same 
conditions as in the previous experiments were included in the study being blank, PDA-
coated and PDA/AB-functionalized PCL scaffolds. For each sample condition, a duplicate was 
implanted per rat. In this way, samples could be explanted in duplicate at three time points, 
allowing for a preliminary and morphological analysis of the tissue integration and capillary 
formation after 4, 7 and 14 days of implantation. 
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After 4 days of implantation, no capillaries were observed between the struts of the plotted 
PCL scaffolds. Some tissue in-growth could already be observed and some inflammation was 
also occurring. Around the scaffold, no clear connective tissue capsule was observed (figure 
5.9, A-C).  
 
 
Figure 5.9: H&E staining of histological sections of PCL scaffolds. Tissue inside the scaffold, 
between the PCL struts and the surrounding tissue are visualized. 
 
After 7 days of implantation, clear differences were observed between the different surface 
modifications. It appeared that the blank PCL scaffolds were better integrated compared to 
day 4 while still no connective tissue capsule was formed. Furthermore, in some areas 
between the struts, capillaries were spotted (figure 5.9, D). In case PDA was applied as 
coating, more blood vessel structures were detected compared to the blank (figure 5.9, E) 
and in case AB’s were immobilized, blood vessels were present in all areas between the PCL 
struts (figure 5.9, F). In the latter case, also around the implant, a lot of capillaries were 
formed, even at the material border. After 14 days of implantation, the blank materials were 
nicely integrated in the surrounding tissue. Between the PCL struts, more capillaries were 
present at day 14 compared to the same condition at day 7. However, the blood capillaries 
were only present in certain areas (figure 5.9, G and 5.10, A). In case of PDA deposition, 
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more blood vessels were present compared to the blank, with less empty areas that did not 
contain blood vessels (figure 5.9, H and 5.10, B). In the presence of VE-cad AB, a lot of blood 
vessels were visualized, including the formation of many small capillaries (figure 5.9, I and 
5.10, C). Again, around the implanted samples, blood vessels were observed till the border 
of the material (figure 5.10, D).  
 
Based on these preliminary results, it can be concluded that the combination of a porous 
material structure and VE-cad AB functionalization indeed offers possibilities to provoke 
enhanced vascularization. Furthermore, the use of such a porous structure seems to result in 
a decrease or even the absence of a dense connective tissue capsule. As a consequence, for 
future designs of a glucose sensor packaging, the use of a porous coating, containing VE-cad 
AB should definitely be considered. Furthermore, the addition of dexamethasone as anti-
inflammatory compound, could further decrease the inflammatory response and fibrosis 
around the implants 26. Nevertheless, in the latter case, caution is needed as these drugs 
could also influence the immune system in a negative way (see also chapter 1, § 1.4.5). 
 
 
Figure 5.10: Anti-desmine staining of tissue inside the blank (A), PDA-coated (B) and AB- 
functionalized (C) PCL scaffolds, explanted at day 14. In case VE-cad AB was applied on the surface, 
blood vessels could be observed around the scaffold, even at the border of the implant (D, H&E 
staining at day 7, capillaries are indicated by the arrows) 
 
 
5.5. Evaluation of the applied sensor design  
During previous in vivo experiments, the main focus was on the evaluation of the chemical 
composition and the surface modification of the PMMAPEG-based packaging materials. 
Apart from that, the sensor design itself also had to be evaluated for its glucose sensing 
potential. To this end, the current glucose sensor concept (see figure 1.3) was tested for its 
optical glucose sensing capacity in vivo. In this work, two approaches were followed to 
determine glucose quantities and to evaluate the glucose sensor concepts. In a first 
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approach, optical transmission spectra through tissue were measured in vivo with the help 
of embedded optical fibers (§ 5.5.1). In the second approach, a commercial microdialysis 
probe, which is normally operational for 48 hours in vivo, was embedded inside the 
PMMAPEG packaging to see whether glucose measurements could be prolonged using the 
current sensor design and surface modifications (§ 5.5.2).  
  
5.5.1. In vivo glucose measurements via an optical fiber-based design 
5.5.1.1. Experimental set-up and in vivo optical measurements 
In a first attempt to optically measure glucose quantities in vivo, an external light source and 
detector were connected to an implanted sensor via optical fibers. The sensor itself 
consisted of a PMMAPEG packaging which housed the optical fibers. Both fibers were 
separated by a 1 mm central cavity through which tissue and the ISF were measured. It is 
clear that in this approach, optical fibers passed through the skin of the animal (figure 5.11) 
and as a consequence, the fibers needed to be protected by a biocompatible polyurethane 
tubing (Braun). In this study, two variants of the sensor were fabricated. The first variant 
enabled direct measurement of the tissue and ISF in the central cavity and these were 
fabricated according to mold design 2 (see figure 5.2, § 5.2). For the second device, 
membranes were used to cover the central cavity in order to filter the ISF that would finally 
make contact with the optical beam. To this end, a commercially available PES membrane 
was selected and included in the mold design (cfr. mold design 3, figure 5.2, § 5.2). To insert 
the sensors in the animals, two incisions were made at a distance of 10 cm. A cavity was 
created subcutaneously and the sensor was inserted from one side. Before the insertion, the 
sensor was packed in a sterile drain, which was removed after the insertion. After the 
implantation, a metal box and protective jacket were mounted on the animal to protect the 
fibers and the wound of the animal (figure 5.11, B).  
 
 
Figure 5.11: Panel A: Experimental setup to measure glucose in vivo. Two variants of the sensor 
were implanted, in the absence and presence of a membrane covering the central 1 mm hole (i.e. 
variant 1 and 2 respectively). Panel B: Real-life picture of the experimental set-up. A zoom is 
presented of the metal box surrounding the implanted sensors (B). 
 
A B 
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During the implantation period, optical measurements could be performed over a period of 
weeks. For the (membrane-containing) sensors, transmission spectra between 1500 and 
1700 nm (first overtone band) could be recorded. Figure 5.12 (A) shows the spectra recorded 
with sensor variant 1 (without membranes). Herein, large variations were obtained in the 
optical output, which represents a large disturbance of the optical beam due to the presence 
of tissue inside the measurement cavity. After 3 weeks of implantation, a more stable signal 
was obtained which indicates that the central cavity was homogeneously filled. Overall, the 
variations in optical signal could not be related to spectral information of the tissue. In case a 
membrane was used to cover the central cavity (sensor variant 2), transmission spectra, 
represented in figure 5.12 (B), were typically obtained. During the first days after 
implantation, the central cavity of the sensor remained empty and as a consequence, no 
absorption could be distinguished. After 10 days, the spectrum changed to the absorption 
spectrum of water, which indicated that the cavity under the membrane was filled. Also in 
this case, variations in the signal were observed, but again these suffered from a feature-less 
nature. In conclusion, the optical transmission of the implanted sensors were insufficiently 
reproducible over time in order to perform further analysis or to develop a model for 
glucose concentration measurements. 
 
  
Figure 5.12: Transmission spectra of the sensor without membranes, implying that the optical 
beam is in direct contact with the tissue. The codes M63, M90,… refer to the codes given to each 
explanted donut. Furthermore, the day of explantation (e.g. 8 aug) is also mentioned (A). 
Transmission spectra of the sensor with membranes filtering the sample prior to contact with the 
optical beam (B). 
 
From a practical point of view, a lot of sensors suffered from fiber failure as a result of 
external forces. Examples included movement of the mechanical protection box or fiber 
breakage due to movement of the goat. Furthermore, some of the fibers appeared broken 
close to the sensor. This indicated that the construction of a polymer tube surrounding the 
bare glass fiber was not reliable and did not offer sufficient protection. As a consequence, 
for future experiments, enforcement of the polymer cladding would be beneficial. In 
parallel, setups with only one fiber entry would also be preferred. In the current setup, 
failure of one fiber already rendered the complete sensor useless for optical transmission 
experiments. Finally, the protection box on the body of the animals could be further fixated 
A B 
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using additional tape bandages or an alternative position on the body could also be 
considered. 
 
It can be concluded that the use of optically aligned fibers to measure glucose quantities is 
not optimal due to a lack of robustness of this system. Nevertheless, from the experiments it 
also became clear that the use of membranes is preferred to avoid great optical variations 
due to optical losses generated by tissue, grown inside the sensor cavity. 
 
5.5.1.2. Visual evaluation of the explanted sensors 
A dense and strong connective tissue capsule was formed around the sensors. What is more, 
even the 1 mm central cavity of the membrane-less sensors was filled with the same tissue. 
This observation confirms the observations made during the optical measurements (§ 
5.5.1.1). Compared to the observations, described in paragraphs 5.3 and 5.4, the fiber- 
based sensors were characterized by inferior tissue integration and resulted in a tissue 
capsule which was much thicker and dense (see figure 5.13, B) compared to the fiber less 
implants (see figure 5.13, A). It was anticipated that these differences were caused by the 
movement of the optical fibers surpassing the skin of the animal, thereby influencing the 
healing process. In case of the membrane-based sensors, fluid was present underneath all 
membranes, an observation that could again be confirmed by the optical in vivo 
measurements. It is also worth noting that one of the goats developed an infection around 
the implanted donuts. Evaluation of the connective tissue showed an even thicker tissue 
layer, which clearly demonstrates the adverse body reaction (see figure 5.13, C). 
It was also observed that most sensors contained cracks and that inside these cracks, clear 
in-growth of tissue was observed, which indicated that the cracks were probably formed in 
an early stage after implantation. This observation could be linked to the swelling capacity 
and the crosslinking density of the PEG-based materials. Furthermore, due to the 
incorporation of metal parts, the presence of crosslinks, in combination with material 
swelling, resulted in the creation of high stresses inside the sensor and as a consequence, 
several sensors appeared broken after explantation (see figure 5.13, B). Moreover, the 
mechanical impact of the movement of the goat was underestimated.  
The adverse effects of material swelling were also confirmed during hermeticity testing (see 
chapter 2). Herein, delamination was observed between the cupper substrates and the 
polymer coating.  
The in vivo results showed that swelling (even 17%) and a high crosslinking density (50 mol% 
PEGDMA) was detrimental to obtain a robust sensor. In this respect, the LMA-based 
material, described in chapter 2, could offer a superior alternative, due to its lower swelling 
capacity (<1%) and crosslinking density (2 mol% PEGDMA). 
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Figure 5.13: Figure A shows the vascularized tissue, surrounding a VE-cad modified fiber-less 
PMMAPEG sensor. Figure B shows a more dense connective tissue that is surrounding a broken 
PMMAPEG fiber-based sensor. Figure C shows the connective tissue that was found around an 
infected sensor.   
 
5.5.2. In vivo glucose measurements via an embedded commercial microdialysis probe 
Previous experiments indicated that as a function of time, fluid was diffusing through the 
membrane into the central cavity of the membrane-containing sensor setup. To study the 
glucose content of this fluid, a micro-dialysis probe was integrated into the sensor design 
and subsequently implanted subcutaneously in goats.  
To this end, a CMA-7 micro dialysis probe (Aurora Bioscience) was selected, which is a flow-
through dialysis probe which is in contact with its environment via a cuprophane membrane. 
A reference fluid is pumped through the probe via the percutaneous tubings and in this way 
analytes are able to diffuse from the environment through the membrane in the probe. In 
this way, analytes can be measured online, which is a frequently used technique for follow-
up during surgical operations. Herein, the measurement of the glucose content present in 
the central cavity of the sensor, is targeted. 
To embed the dialysis probe inside the glucose sensor design, a new molding piece had to be 
developed (see figure 5.14, A), containing a free space to mount the probe inside the 
packaging. The outer disks were produced individually, according to the principle described 
in mold design 1 (§ 5.2, figure 5.1). After production of the different items, they were glued 
together with a cyano-acrylate based glue (Loctite 4161, Henkel). Herein, no metal carrier 
was applied to mechanically support the membranes and all sensors were modified with 
PDA and functionalized with AB, in order to stimulate angiogenesis around the sensor. Again, 
C 
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the sensors were implanted subcutaneously in goats. The presence of the sensors could be 
easily verified with ultrasound measurements, as shown in figure 5.14, (B). Based on the 
curvature of the membranes, it is clear that the latter experienced pressure from the body 
environment. Both concave and convex curvatures were observed for different sensors, but 
all membranes remained intact during implantation. 
 
In order to collect the fluid inside the sensor probe, a micro dialysis pump was used to direct 
the glucose-containing reference fluid outside the body, where glucose was measured via a 
hexokinase-based glucose assay (figure 5.14, C).  
For most sensors, the overall glucose yield was low, since most of the tubes of the micro-
dialysis probes failed due to mechanical stresses. Only one sensor remained operational, but 
also in that case, only low glucose values were measured. After two months of implantation, 
no glucose was measured any longer. To understand the low yield of the operating sensor, 
the explanted sensors were further tested in an in vitro environment. Discussion of these 
results will be topic of the upcoming paragraph (§ 5.5.3).  
 
 
 
     
Figure 5.14: Molding piece to create the central disc, which contains open space to mount the 
commercial dialysis probe. Again, two membranes were applied to cover the central cavity of the 
sensor (not shown) (A). Ultrasound image of a sensor implanted in the goat. The membranes are 
clearly visible, as well as the probe (red arrow) (B). Sampling of the fluid under the membranes was 
done using a micro-dialysis pump (C). 
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5.5.3. Further evaluation of the membrane-based sensor design 
From § 5.5.1, it became clear that measurements through tissue are difficult due to high 
optical losses. As a consequence, the use of membranes is a prerequisite to enable accurate, 
low noise measurements. In this respect, further characterization of the used membrane 
set-up was required to further elucidate the in vivo situation. Therefore, in a first step, 
dummy membrane sensors were implanted and the liquid collected under the membrane 
was analyzed. In this way, insight was provided in the filtering effect of the applied 
membrane. In a second step, the robustness of the membrane was analyzed after 
explantation. Implantation might have altered the physical properties of the membrane and 
in this respect, the change in diffusion properties of the explanted membranes was studied.   
 
5.5.3.1. Dummy membrane-containing sensors to evaluate the filtering effect of the applied 
membrane 
During the first experiment, dummy membrane-containing sensors were produced as 
demonstrated in figure 5.15 (A). Similar to the production of the ‘microdialysis-probe-
containing-sensor’, all parts constituting the sensor, were molded individually. Next, PDA 
surface modification was conducted and in a last step, all different parts were glued together 
including the PES membrane with a molecular weight cut-off of 10 kDa. After ethylene oxide 
sterilization, the AB functionalization was performed, in order to prevent potential 
alterations in the AB’s activity or function. 
Prior to production, two medical device adhesives were tested including a cyanoacrylate-
based glue (Loctite 4161, Henkel) and an epoxy-based-glue (Loctite M-31 CL Hysol, Henkel). 
Based on qualitative tensile and incubation tests, the cyano-acrylate based glue was selected 
as the preferred one. 
For this implantation round, apart from the original PMMAPEG material (PMMAPEG 1), two 
other compositions were included to evaluate their in vivo response (PMMAPEG 4 and 5). 
The different material compositions and their physico-chemical properties are again 
summarized in table 5.2. It is clear that the selected materials were characterized by a 
slightly lower swelling, but also by a less brittle nature, as reflected by the lower crosslinker 
quantities present in the materials (= mol% PEGDMA). In this way, the impact of the 
mechanical properties on sensor survival could be evaluated. 
 
Table 5.2: Composition and physico-chemical properties of the PMMAPEG-based dummy 
membrane sensors. 
Material MMA 
(mol%) 
PEGDMA(550) 
(mol%) 
PEGMA(500) 
(mol%) 
E-mod 
(MPa) 
Elongation 
(%) 
Force at 
break (N) 
Swelling 
(%) 
PMMAPEG 1 50 50 0 142 ± 40 16 ± 3 36 ± 6 17 ± 1 
PMMAPEG 4 80 16 4 486 ± 14 24 ± 6 69 ± 3 13 ± 0 
PMMAPEG 5 90 4 6 1081 ± 194 10 ± 2 85 ± 12 12 ± 1 
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Again, all donuts were implanted subcutaneously in goats. Upon explantation of the donuts,  
2 months post implantation, a good wound healing was observed and a nice thin, 
vascularized tissue layer was surrounding the different implants. In this case, no dense layer 
of connective tissue was observed, as described in § 5.5.1.2, but similar results were 
obtained compared to descriptions in § 5.3. It should be mentioned that the tissue closest to 
the membrane was characterized by a red color (figure 5.15, B). It can be anticipated that 
the observed blood was a remainder of the implantation process, which could not be 
removed by the body during the healing process.  
Except for 1 sensor, which was PMMAPEG 1-based, all sensors remained intact after 
explantation. This indirectly proved that the ideal glucose sensor packaging should be 
characterized by low(er) swelling and a non-brittle nature (cfr. higher force at break and 
elongation percentage).   
Visual observation of the explanted membranes showed some yellow discoloration after 
removing the tissue (Figure 5.15, C) and the central opening, under the membrane was 
completely filled with liquid. This liquid could be isolated (figure 5.15,D) (generally 40-50uL 
from each donut), but to enable analysis of the liquid content, samples had to be pooled 
prior to analysis. The protein content could be determined via SPE gel electrophoresis and 
was compared with the protein content that was observed for the liquid present on the 
outside of the sensor.  
 
  
Figure 5.15: Figure A shows the design of the dummy membrane sensors.  After explantation, a 
nice tissue layer was created around the sensors with some reddish coloration close to the 
membrane (B). The membrane was characterized by a yellow color (C). Figure D displays the fluid 
extractions from the sensor while figure E shows the SPE gel electrophoresis results obtained after 
2 months of implantation. Herein, the protein profiles are compared for the inner and outer sensor 
liquid.  
 
A B C 
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This comparison showed that some filtering could be noticed for most (except 1) of the 
PMMAPEG-based donuts (see figure 5.15, E). Nevertheless, compared to the PDMS donuts 
(protein content = 42 mg/dl) which were also included in this study as hydrophobic 
counterpart, the observed filtering effect was much lower (protein content inside PMMAPEG 
samples = 829-1812 mg/dl). The latter could be attributed to the swellable nature of the 
materials, which facilitated protein influx at the different material interfaces.  It should be 
noted that during explantation, one broken sensor was yielded and as a consequence, for 
this sensor, a similar protein profile was obtained for the inner fluid compared to the 
external sensor fluid. 
 
Apart from the protein content, glucose quantities were determined via a hexokinase-based 
glucose assay and UV-VIS spectrometry. The results showed that for some sensors the 
glucose values inside the sensor were much lower (4-18 mg/dl) compared to the reference 
value determined from the liquid surrounding the sensor (20-30 mg/dl). Due to this 
observation, the change in diffusion properties of the implanted membrane before and after 
implantation became a subsequent item to be evaluated.  
 
5.5.3.2. Evaluation of the explanted membranes: a diffusion experiment 
In previous experiments, glucose values lower than expected, were recorded in the fluid 
present in the central cavity of the sensor. As a consequence, the properties of the used 
membranes were further investigated. To this end, diffusion experiments were conducted. 
Figure 5.16 (A)  displays the diffusion setup which consists of two chambers. The left one 
was filled with a stirring glucose solution whereas the right one contained pure water. 
Between the two compartments, the subject under analysis (a membrane or an explanted 
donut) was clamped and brought in contact with the fluids present in the compartments. In 
this way, diffusion of glucose could occur from the left towards the right compartment, 
surpassing the subject under investigation. Every 30 minutes, a 40 µl test sample was 
removed from the water-containing container and analyzed with a commercial Accu-check 
glucose sensor (Figure 5.16, B).  
 
 
                             
Figure 5.16: Images of the used diffusion setup (A) and the Accu-check read out system (B). 
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Diffusion of glucose through the explanted membranes resulted in an increased glucose 
value as a function of time. Indeed, after 3.5 hours of diffusion, concentrations of 97 mg/dl 
and 138 mg/dl were measured for respectively sensor 1 and 2 (Figure 5.17, A). Nevertheless, 
these values were significantly lower when compared to the ones obtained for the pristine 
membranes (275 mg/dl) (figure 5.17, B). These results thus showed that alterations were 
induced in the membrane diffusion behavior. To study the cause of this change, several 
diffusion experiments were conducted. First, the influence of the glue was tested on the 
diffusion properties of the membrane. Since the membranes were glued between the 
polymer disks, the glue could have potentially blocked the pores of the membranes due to 
capillary forces. To evaluate this assumption, the diffusion of glucose through a PES 
membrane glued between two polymer discs with a cyano-acrylate based glue, was tested. 
During the first 2.5 hours, no glucose was measured and after 4 hours, the concentration 
was still limited to 16 mg/dl. On the other hand, if the glued samples were incubated for 9 
days in PBS buffer (37°C), much higher concentrations were detected (124 mg/dl), which 
were comparable to the concentrations obtained for the explanted membranes (Figure 5.18, 
C). As a consequence, the cyano-acrylate based glue indeed blocked the pores. In addition, 
as a function of time and upon incubation in PBS buffer, glucose diffusion was again 
facilitated. This finding suggests that no optimal adhesion exists between the glue and the 
different materials (i.e. the PMMAPEG material and the membrane) or that the curing 
parameters of the glue still need to be optimized.  
As mentioned in the previous paragraph, a second epoxy-based glue was also considered for 
the sensor assembly. Although this glue was not selected due to inferior adhesion 
properties, it was also evaluated for its influence on glucose diffusion through the glued 
membrane constructs. Figure 5.17 (D) shows that similar concentrations were detected prior 
to and after incubation of the test structures (± 270 mg/dl). Furthermore, the obtained 
concentrations were similar to the values obtained for the blank pristine membranes. Pore 
blockage is thus glue-dependent, yet, for the adhesion of PMMAPEG, further optimization is 
required to realize functional membrane integration inside the sensor design.  
Apart from glue-dependent alterations, the lower glucose concentrations in figure 5.17 (A), 
could also be caused by the in vivo residence time. As mentioned in figure 5.15 (C), the 
explanted membranes showed a yellowish discoloration. This observation suggested the 
deposition of proteins during the implantation period, which is a well-known phenomenon 
in literature 27-29. More specifically, biofouling has been recognized as the main 
counteracting cause for the successful development of long-term implantable         
biosensors 11, 30 .    
To prove the presence of proteins on the explanted membranes, a qualitative coomassie 
blue staining was performed as represented in figure 5.17 (E). This dye binds non-specifically 
to virtually all proteins and an increased blue intensity can thus be correlated with protein 
presence. Compared to the pristine membrane, a more intense blue color was observed for 
the explanted membranes, which indicates the presence of proteins on the latter surface. 
Furthermore, XPS-analysis confirmed this finding, because a higher N/C ratio was obtained 
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for the explanted membranes compared to the pristine membrane and the composition of 
the glue (Figure 5.17, F). These results were anticipated, since proteins contain a substantial 
amount of nitrogen in their amino acid structure.  
 
 
 
 
 
 
  
Figure 5.17: Diffusion of glucose through the explanted membranes (A), pristine blank membranes 
(B), membranes glued between 2 polymer discs, using a cyano-acrylate based glue (C) and an 
epoxy-based glue (D). In case of C and D, a comparison is made between the diffusion behavior of 
the glued structures before and after incubation in PBS buffer at 37°C. Panel E displays the 
coomassie blue stained explanted and blank membranes, whereas panel F shows the N/C ratio’s, 
determined by XPS for the blank membranes, the glue and the explanted membranes. 
 
To summarize, if a membrane-based PMMAPEG sensor is implanted subcutaneously, the 
glucose diffusion rate will be influenced by two factors. First, upon implantation, glucose 
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diffusion will be limited due to blockage of the membrane pores by the applied cyano-
acrylate-based glue. As a function of time, partial disassembly of the sensor might occur, 
because of an inferior adhesion between the glue and implant material, thereby establishing 
glucose diffusion. Secondly, due to a body-induced reaction, biofouling will occur and as a 
consequence, glucose diffusion will again be delayed. It is clear that the manufacturing 
process of the membrane-based sensors requires further optimization. In this respect, 
alternative glues could be evaluated. Alternatives could be given by the MED-series provided 
by NuSil, as they cure in contact with most materials common for biomedical assemblies 31. 
Furthermore, the use of fibrin glue could also be evaluated. Previously, it has been used 
extensively in plastic and reconstructive surgery in skin grafts, but also to attach PMMA 
intra-ocular lenses (IOL) to the sclera bed in the eye 32-33. 
 
Regarding the applied membrane, different alternatives could also be studied such as 
polyacrylonitrile (PAN), polycarbonate (PC), cuprophane or cellulose acetate-based 
membranes 28, 34.  
Transport properties of analytes towards the sensor will also be influenced by the thickness 
of the applied membrane. In this respect, the currently used PES membrane was 
characterized by a thickness of 200 µm, which might explain the slow in vitro diffusion of 
glucose, as represented in figure 5.16 (B). In electrochemical sensors, the applied 
membranes are mostly characterized by smaller thicknesses (< 100 µm) 4.  
Furthermore, instead of using pristine polymer membranes, surface modification of the 
membranes could also be considered. In this respect, Wei et al have already performed PDA 
modification of PES membranes to subsequently biofunctionalise them. They have proven an 
improved blood compatibility of the membrane, but the influence of the modification on the 
diffusion behavior of the membrane was not included in their study 35. As a consequence, 
this was studied in the current work for the PDA-VE-cad AB modified membranes.  
This phenomenon was studied with the help of a diffusion setup (figure 5.16, A), as 
described previously. Herein, a pristine and PDA-modified PES membrane was clamped 
between the two diffusion cell compartments and rhodamine 6G was used as dye to study 
the diffusion properties of the membranes. As illustrated in figure 5.18 (B), PDA modification 
altered the diffusion properties in a tremendous way. As a consequence, the PDA 
modifications of all membrane-based sensors had to be done prior to the sensor assembly. 
Alternatively, other surface modifications of the membrane could be considered for future 
experiments in order to reduce biofouling. Previously, Ma et al. (2007) have applied a 
polyvinyl alcohol (PVA) coating to enhance the membrane’s antifouling properties 36. In this 
respect, the plasma deposition of acrylic acid, followed by RGD peptide immobilization with 
the help of a hydrophilic spacer arm could also be considered 37. In general, plasma 
treatment of PES membranes includes a frequently used method to improve the 
membrane’s hydrophilicity 8. 
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Figure 5.18: Effect of PDA functionalization on the diffusion properties of a PES membrane. A 
rhodamine 6G solution was used as test liquid. 
 
 
5.6. Conclusions and future perspectives 
In this chapter, different in vivo experiments were conducted in order to understand the 
needs of a suitable glucose sensor design.  
First, it was demonstrated how an in-house-made mold enabled the production of donut-
shaped implant materials. Next, a relevant and representative implantation side was 
selected to evaluate the different glucose sensor packagings and designs. Based on surgical 
implications (including site accessibility and reproducibility) and the occurrence of better 
integrated connective tissue capsules, subcutaneous implantation was preferred over 
intramuscular and retroperitoneal implantations. 
Subsequently, different surface modified (i.e. blank, PDA and AB modified) implants were 
implanted and evaluated for their in vivo response. Minor inflammation was observed for a 
minority of the implanted samples. Generally, compared to the blank materials, a better 
tissue integration was observed for the surface modified materials, but no clear differences 
in morphology of the connective tissue could be observed between the mutual 
modifications. Nevertheless, higher amounts of capillaries were counted around the AB-
modified samples, which were implanted both in goats and rats, but at this stage, no 
statistical evidence could be delivered for this phenomenon. The enhanced implant 
vascularization was further proven during a qualitative evaluation of porous AB-
functionalized PCL scaffolds. These scaffolds  gave rise to a clear enhancement of the 
vascularization and resulted in a tremendous decrease of fibrous encapsulation. As a 
consequence, for future sensor designs, the incorporation of a porous coating, bearing VE-
cad AB’s, should definitely be considered. 
 
Concerning the sensor design, it was proven that in-vivo measurements of optical spectra 
using optical fibers to connect the sensors to external light sources and detectors was not 
successful. More specifically, the yield of the sensor was low as most of the optical fibers 
were broken due to the mechanical stress imposed by the movement of the animals. For 
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some sensors, the transmission spectra could be measured, but the transmission through 
tissue appeared to be too variable and therefore not feasible. 
As a result, a PES membrane with a molecular weight cut-off of 10 kDa was included in the 
sensor design in order to filter the interstitial fluid which is in contact with the optical fibers. 
Optical transmission measurements became more stable compared to the non-membrane-
based design, but even then the transmission remained too variable to build a multivariate 
analysis model.   
 
Overall, the manufacturing approach of the membrane-based sensors requires further 
optimization. More specifically, because of pore blockage by the cyano-acrylate-based glue, 
an alternative adhesive needs to be selected to enable a robust assembly of the sensor. 
Furthermore, based on the low diffusion rate of the current membrane, superior 
alternatives could be considered. Variations in membrane thickness or the use of a surface 
modified membrane could for example be tested. The latter approach would also enable a 
reduction in biofouling and an enhancement of the membrane’s biocompatibility. 
 
Despite of the remaining optimization needs, it can be concluded that first and important  
steps were taken towards the development of an implantable optical glucose sensor. 
 
 
5.7. References 
1. Mordes, J. P., and Rossini, A. A. (1981) Animal models of diabetes, The American journal of 
medicine 70, 353-360. 
2. Rees, D., and Alcolado, J. (2005) Animal models of diabetes mellitus, Diabetic Medicine 22, 
359-370. 
3. Haghdoost, I. S., Ghaleshahi, A. J., and Safi, S. (2007) Clinicopathological findings of diabetes 
mellitus induced by alloxan in goats, Comparative Clinical Pathology 16, 53-59. 
4. Updike, S. J., Shults, M. C., Gilligan, B. J., and Rhodes, R. K. (2000) A subcutaneous glucose 
sensor with improved longevity, dynamic range, and stability of calibration, Diabetes Care 23, 
208-214. 
5. Gough, D. A., Kumosa, L. S., Routh, T. L., Lin, J. T., and Lucisano, J. Y. (2010) Function of an 
implanted tissue glucose sensor for more than 1 year in animals, Science Translational 
Medicine 2, 42ra53-42ra53. 
6. Varalli, M., Marelli, G., Maran, A., Bistoni, S., Luzzana, M., Cremonesi, P., Caramenti, G., 
Valgimigli, F., and Poscia, A. (2003) A microdialysis technique for continuous subcutaneous 
glucose monitoring in diabetic patients (part 2), Biosensors & Bioelectronics 18, 899-905. 
7. Poscia, A., Mascini, M., Moscone, D., Luzzana, M., Caramenti, G., Cremonesi, P., Valgimigli, F., 
Bongiovanni, C., and Varalli, M. (2003) A microdialysis technique for continuous 
subcutaneous glucose monitoring in diabetic patients (part 1), Biosensors & Bioelectronics 
18, 891-898. 
8. Zhao, C., Xue, J., Ran, F., and Sun, S. (2013) Modification of polyethersulfone membranes–a 
review of methods, Progress in Materials Science 58, 76-150. 
9. Zhang, J., Wang, Q., Wang, Z., Zhu, C., and Wu, Z. (2014) Modification of poly (vinylidene 
fluoride)/polyethersulfone blend membrane with polyvinyl alcohol for improving antifouling 
ability, Journal of Membrane Science 466, 293-301. 
In vivo evaluation of a biofunctionalized methacrylate-based packaging | Chapter 5 
221 
 
10. Gunasingham, H., Teo, P. Y., Lai, Y.-H., and Tan, S.-G. (1989) Chemically modified cellulose 
acetate membrane for biosensor applications, Biosensors 4, 349-359. 
11. Wisniewski, N., and Reichert, M. (2000) Methods for reducing biosensor membrane 
biofouling, Colloids and Surfaces B-Biointerfaces 18, 197-219. 
12. Uehara, H., Kakiage, M., Sekiya, M., Sakuma, D., Yamonobe, T., Takano, N., Barraud, A., 
Meurville, E., and Ryser, P. (2009) Size-selective diffusion in nanoporous but flexible 
membranes for glucose sensors, ACS nano 3, 924-932. 
13. Jaremko, J., and Rorstad, O. (1998) Advances toward the implantable artificial pancreas for 
treatment of diabetes, Diabetes Care 21, 444-450. 
14. Olesberg, J. T., Cao, C. S., Yager, J. R., Prineas, J. P., Coretsopoulos, C., Arnold, M. A., Olafsen, 
L. J., and Santilli, M. (2006) Optical microsensor for continuous glucose measurements in 
interstitial fluid - art. no. 609403, In Optical Diagnostics and Sensing VI (Cote, G. L., and 
Priezzhev, A. V., Eds.), pp 9403-9403, Spie-Int Soc Optical Engineering, Bellingham. 
15. Collison, M. E., Stout, P. J., Glushko, T. S., Pokela, K. N., Mullins-Hirte, D. J., Racchini, J. R., 
Walter, M. A., Mecca, S. P., Rundquist, J., Allen, J. J., Hilgers, M. E., and Hoegh, T. B. (1999) 
Analytical characterization of electrochemical biosensor test strips for measurement of 
glucose in low-volume interstitial fluid samples, Clinical Chemistry 45, 1665-1673. 
16. Sternberg, F., Meyerhoff, C., Mennel, F. J., Mayer, H., Bischof, F., and Pfeiffer, E. F. (1996) 
Does fall in tissue glucose precede fall in blood glucose?, Diabetologia 39, 609-612. 
17. ThomeDuret, V., Reach, G., Gangnerau, M. N., Lemonnier, F., Klein, J. C., Zhang, Y. N., Hu, Y. 
B., and Wilson, G. S. (1996) Use of a subcutaneous glucose sensor to detect decreases in 
glucose concentration prior to observation in blood, Analytical Chemistry 68, 3822-3826. 
18. Goodarzi, M., Sharma, S., Ramon, H., and Saeys, W. (2015) Multivariate calibration of NIR 
spectroscopic sensors for continuous glucose monitoring, Trac-Trends Anal. Chem. 67, 147-
158. 
19. Gellynck, K., Kodeck, V., Van De Walle, E., Kersemans, K., De Vos, F., Declercq, H., Dubruel, P., 
Vlaminck, L., and Cornelissen, M. (2015) First step toward near-infrared continuous glucose 
monitoring: in vivo evaluation of antibody coupled biomaterials, Experimental Biology and 
Medicine 240, 446-457. 
20. Oviedo Socarras, T., Vasconcelos, A. C., Campos, P. P., Pereira, N. B., Souza, J. P. C., and 
Andrade, S. P. (2014) Foreign Body Response to Subcutaneous Implants in Diabetic Rats, Plos 
One 9. 
21. Oviedo-Socarras, T., Vasconcelos, A. C., Barbosa, I. X., Pereira, N. B., Campos, P. P., and 
Andrade, S. P. (2014) Diabetes alters inflammation, angiogenesis, and fibrogenesis in 
intraperitoneal implants in rats, Microvascular Research 93, 23-29. 
22. Lim, W.-H., Seo, W.-W., Choe, W., Kang, C.-K., Park, J., Cho, H.-J., Kyeong, S., Hur, J., Yang, H.-
M., Cho, H.-J., Lee, Y.-S., and Kim, H.-S. (2011) Stent Coated With Antibody Against Vascular 
Endothelial-Cadherin Captures Endothelial Progenitor Cells, Accelerates Re-
Endothelialization, and Reduces Neointimal Formation, Arteriosclerosis Thrombosis and 
Vascular Biology 31, 2798-U2141. 
23. Westerweel, P. E., Teraa, M., Rafii, S., Jaspers, J. E., White, I. A., Hooper, A. T., Doevendans, P. 
A., and Verhaar, M. C. (2013) Impaired Endothelial Progenitor Cell Mobilization and 
Dysfunctional Bone Marrow Stroma in Diabetes Mellitus, Plos One 8. 
24. Yiu, K.-H., and Tse, H.-F. (2014) Specific Role of Impaired Glucose Metabolism and Diabetes 
Mellitus in Endothelial Progenitor Cell Characteristics and Function, Arteriosclerosis 
Thrombosis and Vascular Biology 34, 1136-1143. 
25. Navaratna, D., McGuire, P. G., Menicucci, G., and Das, A. (2007) Proteolytic degradation of 
VE-cadherin alters the blood-retinal barrier in diabetes, Diabetes 56, 2380-2387. 
26. Koschwanez, H. E., Yap, F. Y., Klitzman, B., and Reichert, W. M. (2008) In vitro and in vivo 
characterization of porous poly-L-lactic acid coatings for subcutaneously implanted glucose 
sensors, Journal of Biomedical Materials Research Part A 87A, 792-807. 
Chapter 5 | In vivo evaluation of a biofunctionalized methacrylate-based packaging  
 
222 
 
27. Ward, W. K. (2008) A review of the foreign-body response to subcutaneously-implanted 
devices: the role of macrophages and cytokines in biofouling and fibrosis, Journal of Diabetes 
Science and Technology 2, 768-777. 
28. Wisniewski, N., Klitzman, B., Miller, B., and Reichert, W. (2001) Decreased analyte transport 
through implanted membranes: Differentiation of biofouling from tissue effects, Journal of 
biomedical materials research 57, 513-521. 
29. Wisniewski, N., Moussy, F., and Reichert, W. M. (2000) Characterization of implantable 
biosensor membrane biofouling, Fresenius Journal of Analytical Chemistry 366, 611-621. 
30. Gifford, R., Kehoe, J. J., Barnes, S. L., Kornilayev, B. A., Alterman, M. A., and Wilson, G. S. 
(2006) Protein Interactions with subcutaneously implanted biosensors, Biomaterials 27, 
2587-2598. 
31. NuSil. (2014) medical implants, adhesives; Retrieved July 20  (2015) from 
http://nusil.com/en/productsearch#life-sciences?segment=MedicalImplant. 
32. Currie, L. J., Sharpe, J. R., and Martin, R. (2001) The use of fibrin glue in skin grafts and tissue-
engineered skin replacements: A review, Plastic and reconstructive surgery 108, 1713-1726. 
33. Agarwal, A., Kumar, D. A., Jacob, S., Baid, C., Agarwal, A., and Srinivasan, S. (2008) Fibrin 
glue–assisted sutureless posterior chamber intraocular lens implantation in eyes with 
deficient posterior capsules, Journal of Cataract & Refractive Surgery 34, 1433-1438. 
34. Clark, L. C., and Duggan, C. A. (1982) Implanted electroenzymatic glucose sensors, Diabetes 
Care 5, 174-180. 
35. Wei, Q., Li, B., Yi, N., Su, B., Yin, Z., Zhang, F., Li, J., and Zhao, C. (2011) Improving the blood 
compatibility of material surfaces via biomolecule‐immobilized mussel‐inspired coatings, 
Journal of Biomedical Materials Research Part A 96, 38-45. 
36. Ma, X., Su, Y., Sun, Q., Wang, Y., and Jiang, Z. (2007) Enhancing the antifouling property of 
polyethersulfone ultrafiltration membranes through surface adsorption-crosslinking of poly 
(vinyl alcohol), Journal of Membrane Science 300, 71-78. 
37. Di Carlo, B. V., Gottifredi, J. C., and Habert, A. C. (2011) Synthesis and characterization of 
composite membrane by deposition of acrylic acid plasma polymer onto pre-treated 
polyethersulfone support, Journal of Materials Science 46, 1850-1856. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Chapter 6 
 
 Experimental section 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 | Experimental section                        
224 
 
6.1. Overview of applied techniques 
Previous chapters have reported on substantial characterization of both the bulk of the 
materials and their surface properties, using different experimental techniques. The 
upcoming paragraphs summarize the principles thereof. The specifications and experimental 
details elaborated throughout this work are summarized in a subsequent part. 
 
6.1.1. Nuclear Magnetic Resonance spectroscopy 
The synthesized materials were structurally evaluated by conventional proton nuclear 
magnetic resonance (1H-NMR) spectroscopy. Using this technique, each proton covalently 
bound in a chemical structure, results in a characteristic resonance signal present in the 
recorded spectrum because of its characteristic spin. Depending on the chemical 
environment (i.e. the neighbouring atoms) of the proton, the position of the signal is 
alterred, yet remains characteristic for a specific environment.  
In order to apply conventional 1H-NMR spectroscopy, dissolution of the polymer in a 
deuterated solvent such as CDCl3, is a prerequisite. In this work, apart from non-crosslinked 
materials, crosslinked polymer networks were also synthesized which are insoluble in any 
solvent. As a result, these were not suitable for conventional 1H-NMR spectroscopy analysis. 
In addition, measurements in the dry state would not provide a suitable alternative since this 
would result in considerable line broadening because of the presence of dipolar interactions, 
chemical shift anisotropy (CSA) and magnetic susceptibility effects 1-3. Conversely, if the 
network can be swollen in a deuterated solvent, both solvatation of the polymer chains and 
the chain mobility are increased. As a consequence, magic angle spinning (MAS) NMR 
spectroscopy can be used as a characterization technique for crosslinked, swellable 
networks. To this end, the sample is rapidly rotated at the magic angle of 54.7° relative to 
the static magnetic field (figure 6.1) in order to remove the line broadening effects. This 
technique thus allows to record NMR spectra of semi-solid samples, with more narrow 
signals as a result. 
 
 
Figure 6.1: Scheme showing the concept of magic angle spinning. Within the main magnetic field 
(B0), a sample (gray) is rotating with a high frequency. The rotation axis is tilted by 54,7° (i.e. the 
magic angle, θm) with respect to the direction of B0. 
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6.1.2. Tensile testing 
In order to evaluate the mechanical properties of the synthesized materials, tensile tests 
were conducted. To this end, dog bone shaped specimens (figure 6.2, A) with a length of L0 
(the gauge length) were stretched using a constant elongation rate. As a result, stress strain 
curves were generally recorded as depicted in figure 6.2 (B), which represents an amorphous 
material in the glassy state. Different regions can be distinguished in the plot. More 
specifically, region 1, which is the linear part of the curve, is the elastic region which follows 
Hooke’s law, implying that the stress is proportional to the strain. As a consequence, 
deformations applied in this region are reversible. In region 2, a deviation from linearity can 
be noticed, which is due to visco-elastic effects and pseudo-plastic deformations. The 
maximum is defined as the yield stress. Immediately after the maximum (region 3), a drop in 
the stress occurs which is associated with the phenomenon of ‘necking’. Herein, a decrease 
in cross-sectional area is created at a certain point along the length of the material which 
consequently propagates throughout the sample. Because of this propagation, upon 
increasing strength, an almost constant stress value is obtained (cfr. region 4) since the 
surface area of the cross-section decreased. The polymer chains align in the direction of the 
applied force and due to this ‘cold drawing’, the material is irreversibly deformed. In the final 
part (i.e. region 5), the stress is again increased upon increasing strain (i.e. strain hardening). 
At a certain point, a maximum orientation in the sample is realized, which results in a higher 
resistance against deformation which will finally induce rupture 4. 
 
Figure 6.2: Dog bone shaped specimen with L0 = 25 mm, used for tensile testing (A). A theoretical 
stress strain curve for an amorphous material in the glassy state (B). 
 
In the present work, the technique was mainly used to compare different formulations with 
respect to their flexibility and elasticity. As a consequence, the E-modulus of the different 
materials could be determined by measuring the initial slope of the elastic part of the 
recorded stress (σ, MPa)- strain (ε, in %) curves (equation 2.1).  
 
                                                                                  .E                                                               (6.1) 
    
A B 
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Starting from the force F (expressed in Newton (N)) and the length of the sample before (L0) 
and after elongation (Le), the stress and the strain could be calculated as:  
 
                                                                                  
0
A
F
                                                               (6.2)   
                                                                           
0
0
0
L
LL
L
L
e



                                                     (6.3)     
Herein, A0 resembles the initial surface area on which the force is applied. Referring to figure 
6.2 (A), this surface can be calculated from the cross-section of the center part of the dog 
bone shaped material: 
                                                                                 baA .0                                                                (6.4) 
 
Apart from the elasticity modulus, the elongation percentage as well as the force at break 
were evaluated to respectively judge the ‘stretchability’, the brittleness and the strength of 
the different materials. 
 
6.1.3. Swelling tests 
In case one of the building blocks is characterized by hydrophilic character, it is very useful to 
quantify the swelling potential of the final materials. Given the scope of this project, swelling 
could have a detrimental effect on the working efficiency of the final sensor. Based on the 
initial dry mass (m0) and the mass after swelling (mt), the swelling percentage could be 
calculated, as pointed out in equation 6.5. 
 
                                                    %100*(%)
0
0
m
mm
Swelling t

                                                    (6.5) 
If unreacted species are present inside the polymer network, upon incubation, they will 
leach out from the polymer network and form the sol fraction. Based on the dry mass of the 
samples after swelling (me), the gel and sol fractions could be calculated (equations 6.6 and 
6.7). 
                                                         %100*(%)
0
m
m
fractionGel e                                               (6.6)
 
                                                   fractiongelfractionSol  %100(%)                                     (6.7) 
Knowledge of the gelfraction is important, because the leachable fraction might be the cause 
of potentially toxic effects induced during in vitro and in vivo testing. Obviously, purification 
of the polymers could address this issue. 
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6.1.4. Static Contact Angle measurements  
The hydrophobic or hydrophilic nature of a material can be determined through the 
assessment of a static contact angle (SCA), which is a measure of the material wettability. 
If a liquid drop is deposited onto a solid surface, three different interfacial forces come into 
play, including the solid-liquid (γSL), the liquid-vapour (γLV) and the solid-vapour (γSV) 
interfacial tensions. After deposition, a mechanical equilibrium will exist between the 
different forces and this equilibrium will determine the value of the contact angle (θ). The 
relationship between the different properties at equilibrium is dictated by Young’s equation, 
as indicated in figure 6.3. 
 
 
Figure 6.3: Definition of the static contact angle (θ), according to Young’s equation. 
 
For high contact angle ( > 90°) values, the water droplet tends to ball up, since low affinity 
exists between the solid surface and the liquid. In case of low contact angles ( < 90°), the 
water droplet will spread due to higher affinities between the two substances. If  = 0°, 
complete wetting of the surface is obtained 5. 
 
6.1.5. X-ray Photo-electron Spectroscopy  
XPS is a powerful technique to determine the atomic composition of a polymer surface for 
an information depth of about 7 nm. Furthermore, information on the binding states of 
these elements, their oxidation numbers and chemical functionalities can be deduced. 
To obtain this information, a solid sample is irradiated with soft X-rays under high vacuum 
conditions. Typically for XPS, Mg (1253.6 eV) and Al-Kα (1486.6 eV) rays are used. 
Upon interaction with the surface, there is a certain probability that an electron from one of 
the inner shells or valence bands is excited and thereby ejected (figure 6.4). The emitted 
photoelectrons are detected and their number is expressed as a function of their binding 
energy. Based on the knowledge of the energy of the initial X-ray irradiating the surface (hν) 
and the detected kinetic energy of the emitted photo-electrons (Ekin), the binding energy (Eb) 
of the latter  can be calculated via :                
    
                                                                             Eb= hν - Ekin-Ф                                                         (6.8) 
 
Herein, Ф represents an instrument constant, which is determined via device calibration. 
Since the binding energy of an electron is element-specific, information about the elemental 
composition (except H and He) of the surface can be obtained via this technique. 
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Furthermore, the binding energy will also be determined by the chemical environment of 
the studied atom. Due to differences in electronegativity between neighboring elements, 
shifts in the binding energy are represented. As a consequence, electron-withdrawing 
neighboring atoms will be characterized by higher binding energies, whereas electron-
releasing neighbours are characterized by lower binding energies. Using peak deconvolution, 
the different environments of an atom can be distinguished and their relative ratios can be 
calculated 5. 
 
 
 
 
 
 
 
Figure 6.4: Emission of a photo-electron from the inner shell of an atom, due to the interaction of 
X-rays with matter. 
 
6.1.6. Scanning Electron Microscopy  
Scanning electron microscopy (SEM) is a microscopic technique which applies an electron 
gun to generate a high energy electron beam (5-100 keV). This beam is focused and rastered 
on a specimen to retrieve topographical and elemental information of a sample surface 
(Figure 6.5, A). Interaction of the accelerated primary electrons with the sample surface 
results in the production of different signals, due to the existence of different interactions. 
Depending on the depth of information (100 nm - 50 µm), different signals arise, each 
providing unique information about the sample (figure 6.5, B).  
Secondary electrons and backscattered electrons are commonly used for imaging purposes. 
Herein, information about the sample morphology and topography is provided by detection 
of the secondary electrons, whereas backscattered electrons are mainly used to illustrate 
contrasts in composition of multiphase samples. Secondary electron-based images are 
created by a spatial reconstruction of the electron’s intensity on a phosphor screen or a 
charged coupled device (CCD) detector. 
The emission of secondary electrons is also accompanied by the emission of X-rays due to 
the relaxation of electrons that move from a higher energy state in the atom to a lower one. 
These X-rays are characteristic for each element and thereby, information is provided about 
the chemical composition of the sample surface. 
Since electrons are used to generate a SEM-image, the studied samples should be 
characterized by electron-conducting properties. Most polymers are non-conductive and 
therefore, a thin conductive coating, typically  gold, is applied on these samples. 
Compared to light microscopy, SEM imaging is characterized by a superior lateral resolution 
and depth of field 5-7. 
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Figure 6.5: Instrumentation of a SEM device (a). Depending on the depth of information, different 
signals can be detected, each providing unique information about the studied sample (b) 
 
6.1.7. Profilometry measurements  
In order to study the topography of samples, profilometry measurements can be conducted. 
In case of contact profilometry, a finely pointed tip is moved over the sample. Herein, 
vertical movements of the stylus are converted into numerical information. It is a very 
reproducible technique, which provides a two-dimensional description of the surface. This 
technique only allows characterization of surface features which are larger than the stylus 
point diameter (µm size). Due to measuring, distortions of the surface topography might be 
manifested. In case the latter would impose major issues, non-contact profilometry 
measurements can also be conducted. In this case, no tip is used, but a laser beam is focused 
onto the sample surface. Light reflections are recorded and transformed into numerical 
information. 
 
6.1.8. Atomic Force Microscopy (AFM) 
Apart from profilometry, AFM can be used to obtain high resolution topographical 
information from the surface. In this case, a fine pyramidal siliciumnitride tip is mounted 
onto a flexible cantilever, which is attached to a piezo tube. When the tip is brought into 
close contact with the sample surface, interaction forces (such as van der Waals interactions 
and electrostatic forces) will be created between both the tip and the sample (atoms). 
Because of these interactions, the cantilever will undergo a deflection, which is detected by 
a photodiode. The latter is enabled through the use of a laser beam, which is reflected off a 
mirror present on the cantilever arm. Data arising from these measurements are then used 
as an input signal for a measuring system.  
Again, the tip shape and diameter will determine the spatial resolution of the 
measurements. Compared to profilometry, much smaller diameters are applied. 
Furthermore, AFM can be considered less destructive compared to profilometry. 
AFM measurements can be conducted in different modes including the contact, the non-
contact and the tapping mode. In the first case, the tip is in contact with the sample and the 
A B 
Chapter 6 | Experimental section                        
230 
 
repulsive interaction forces are recorded, which are caused by an overlap between the 
electron clouds of the tip and surface. A disadvantage of this mode includes its more 
destructive nature, although less severe, compared to profilometry.  
For both the non-contact and tapping mode, the cantilever is oscillating. In the former case, 
the cantilever remains close to the sample at all times (5-15 nm distance), without physical 
contact. Herein, imaging results from the detection of longer distance interactions, as 
mentioned above. In the latter case, at the lowest point of the oscillation cycle, the 
cantilever tip actually gets in contact with the sample. The force interaction of tip and 
surface influences the amplitude of oscillation and the amplitude change is translated into 
topographical information. The tapping mode combines the high resolution of the contact 
mode and the non-destructive nature of the non-contact mode. 
 
 
Figure 6.6: Representation of the AFM measurement principle (A) and the different measurement 
modes (B). 
 
6.1.9. Infrared spectroscopy 
Infrared spectroscopy is a standard technique used in organic chemistry for structure 
analysis, but also as an analytical technique to study the purity of compounds. Herein, 
organic molecules are exposed to infrared radiation and in case the light energy matches the 
energy of a specific molecular vibration, absorption occurs. Both the energy of the light and 
the amount of light absorption are molecule-specific and allow for structure elucidation. 
Typically, IR measurements are performed in the mid-IR region (4000-400 cm-1), but in this 
work interest also went to the NIR region (12820-4000 cm-1), since in the final glucose sensor 
setup, glucose will be measured in this wavelength range. 
A 
B 
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In case IR surface mapping was conducted on the samples investigated (cfr. § 6.2.2.5), 
attenuated total reflectance (ATR) is measured instead of light absorption. To this end, an 
optically dense crystal with a high refractive index is applied. The IR beam is directed onto 
the crystal at an angle which exceeds the critical angle for internal reflection. This 
reflectance results in an evanescent wave that extends beyond the surface of the crystal into 
the sample held in close contact with the crystal. Due to the interactions of the IR beam with 
the sample, absorption of IR energy will occur and as a consequence the evanescent wave 
will be attenuated. Based on the attenuations, measured by the detector, the IR spectrum is 
generated 8.  
 
6.1.10. Radiolabeling experiments 
Radiolabeling of proteins and other molecules with a radio-active element is a frequently 
used method in assays, localization and for imaging applications. Typical examples of  radio-
active markers in biological studies are 14C, 32P, 35S, 3H, 125I en 131I. 
Since iodination includes a common method of adding a tracer with high specific activity to a 
protein of interest, this method was also used in this work to label VEGF and VE-cad AB. As 
mentioned above, two radio-active isotopes of iodine are commonly used. The decay of 131I 
is characterized by - and -emission, whereas for 125I , the decay is characterized by 
electron capture, followed by  -emission. Herein, 131I emits 3-10 times more energetic 
electromagnetic  rays compared to 125I. As a consequence, higher detection sensitivities are 
obtained in case the former marker is used. Nevertheless, because of its higher safety, its 
less damaging nature and its longer half-life (60 days cfr. 8 days for 131I), 125I can be 
considered as the most suitable isotope to label biological compounds such as ABs and 
growth factors 9-10. 
Two methods are frequently used to perform the iodination of biological compounds. In the 
direct method, labeling of the biomolecule is directly done in the presence of an oxidizing 
agent. The indirect method makes use of an intermediate compound, which is labeled and 
subsequently used to label the molecule of interest. In the current work, the direct method 
is applied, which requires the presence of an oxidizing agent. Various oxidizing agents have 
already been reported such as N-chlorotoluenesulfonamide (Chloramine-T) and the complex 
lactoperoxidase/H2O2 
10. In this work, Iodogen is used as oxidizing agent to permit the in-situ 
formation of an electrophilic radio-active iodine species (figure 6.7) 11-12. This electrophilic 
halogen species permits reaction with molecules which contain activating groups such as 
activated aryl functions including aniline derivatives and phenols. As a consequence, in case 
of VEGF and VE-cad AB, the presence of tyrosine and histidine in their amino-acid sequence 
is a prerequisite to enable electrophilic aromatic substitution of the electrophilic iodine. 
Herein, tyrosine can incorporate two iodine-atoms whereas for histidine this number is 
limited to one (figure 6.7). Furthermore, to allow for the iodination reactions, neutral or 
more alkaline conditions should be established. At physiological pH, mainly tyrosine will be 
targeted, whereas at pH>9, also histidine will become susceptible towards iodination. 
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Nevertheless, in the latter case, the histidyl reactivity will also be influenced by other factors, 
such as the protein structural properties 13. Finally, in case of acidic conditions, the protein 
will lose its activity, which should be avoided at all times. In this work, iodination of tyrosine 
was targeted. 
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Figure 6.7: The formation of an electrophilic 125I species with the help of IODO-GEN. Via 
electrophilic aromatic substitution, the radio-active marker is introduced in tyrosine and histidine 
amino acids, present in the VEGF and AB structure. 
 
6.1.11. Fluorescence microscopy. 
When a molecule is irradiated with high energy light, this energy will be absorbed by the 
molecule, thereby becoming excited and move from the ground state to a higher energy 
level. Subsequently, relaxation will occur with light emission as a consequence. Due to 
vibrational energy losses, the molecule will emit a photon of lower energy (i.e. with a higher 
wavelength) when going back from the excited to the ground state. This physical 
phenomenon, called fluorescence, is the basis for fluorescence microscopy imaging 
techniques. 
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In this work, two different principles of fluorescence microscopy are used including widefield 
microscopy and confocal fluorescence microscopy (figure 6.8). 
 
Figure 6.8: Schematic representation of the widefield and confocal fluorescence imaging process 14. 
 
In conventional fluorescence microscopy, light of a specific wavelength (or a defined band of 
wavelengths), often in the ultraviolet, blue or green regions of the visible spectrum, is 
produced by passing multispectral light from an arc-discharge lamp or other source (e.g. a 
mercury or xenon source) through a wavelength selective excitation filter (not shown in 
figure 6.8). Next, the light is guided towards a dichromatic mirror which reflects the selected 
(shorter) wavelengths through the microscope’s objective, in order to illuminate the sample 
with intense light. If the specimen is fluorescent, the emission light gathered by the objective 
passes back through the dichromatic mirror (transmits light of longer wavelength) and is 
subsequently filtered by a barrier (or emission) filter (not shown in figure 6.8), which blocks 
the unwanted excitation wavelengths. In this case of epifluorescence, the objective is used 
by both the illuminating light and the fluorescing light, in conjunction with a dichromatic 
mirror. In case of reflected light microscopy, a beamsplitter is used instead of a dichromatic 
mirror. 
 
In contrast to widefield microscopy, where the entire specimen is illuminated, confocal 
microscopy  only illuminates one specific spot in the sample at a time. In order to create 
images, one or more focused laser beam lights are scanned across the specimen. The images 
produced by scanning the specimen in this way are called optical sections. Apart from point 
illumination, the technique also makes use of a spatial pinhole in front of the detector to 
restrict the light reaching the detector to only the focal plane. This technique is 
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characterized by an improved optical resolution and contrast and it allows to collect serial 
optical sections of thicker specimens (so-called z-stacks) 14-15. 
 
 
6.2. Experimental methods 
Apart from various experimental techniques, various methods and protocols were 
elaborated and applied to obtain the results presented in chapters 2-5. This section 
summarizes the various applied methods as applied per chapter. 
 
6.2.1. Chapter 2: Development of a flexible PMMA-based packaging for an optical glucose 
sensor. 
6.2.1.1. Production of PMMA- and PEG-based copolymers   
Methyl methacrylate (MMA; Sigma Aldrich) was distilled prior to use. Poly(ethylene glycol) 
monomethylether monomethacrylate (PEGMA) with molecular weights of 500 and 1100 
g/mol and poly(ethylene glycol) dimethacrylate (PEGDMA) with molecular weights of 550, 
750 and 1154 g/mol (Sigma Aldrich) were applied as received. In order to produce polymer 
sheets, an initiator (i.e. Irgacure 2959, BASF) / monomer solution (2 mol% compared to the 
amount of monomer double bonds) was injected in a pre-shaped silicone spacer (James 
Walker), which was placed between two teflon foil (Holders technology) covered glass 
plates. Subsequently, the samples were UV-irradiated at both sides (UV-A, 365 nm, 13 
mW/cm2, distance UV-lamps: 3 cm). Optimization of the UV irradiation times was performed 
by the evaluation of polymer samples obtained after different UV irradiation times by 1H 
NMR spectroscopy (Bruker 300 MHz spectrometer). In case of PMMA, samples were 
dissolved in CDCl3 whereas for PEGDMA, a soxhlet extraction of 24 hours in ethanol had to 
be performed in order to study the polymer networks. Determination of the conversion 
percentage of PMMA was enabled by comparing the proton integrations of the monomer 
double bonds (δ = 5.98 ppm and 5.44 ppm) with the sum of the O-CH3 polymer and 
monomer protons (δ =3.53 ppm and 6.69 ppm respectively). In case of PEGMA, similar 
calculations were performed, but for PEGDMA, full conversion was assumed when the 
disappearance of the double bond protons in the soluble fraction was attained.  
The various NMR peak annotations of the starting monomers are given below: 
 
MMA: 1H NMR (CDCl3;300 MHz): δ = 6.02 ppm (1H,s, H2C=C-), δ 5.47 ppm (1H,s, H2C=C-), δ = 
3.69 ppm (3H, s, CH3-O-), δ = 1.83 ppm (3H, s, CH3-C=CH2);  
PEGMA: 1H NMR (CDCl3;300 MHz): δ = 6.02 ppm (1H,m, H2C=C-), δ 5.47 ppm (1H,m, H2C=C-), 
δ = 4.19 ppm (2H, t, -C=OO-CH2-CH2-), δ = 3.64 ppm (2H, t, -C=OO-CH2-CH2-), δ = 3.54 ppm 
(28 H, m, -O-CH2-CH2-O-), δ = 3.44 ppm (2H, m, CH2-O-CH3), δ = 3.27 ppm (3H, s, -O-CH3), δ = 
1.84 ppm (3H, s, CH3-C=CH2). 
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PEGDMA: 1H NMR (CDCl3;300 MHz): δ = 6.02 ppm (1H,s, H2C=C-), δ 5.47 ppm (1H,m, H2C=C-
), δ = 4.19 ppm (4H, t, -C=OO-CH2-CH2-), δ = 3.64 ppm (4H, t, -C=OO-CH2-CH2-), δ = 3.54 ppm 
(13H, m, -O-CH2-CH2-O-), δ = 1.84 ppm (6H, s, CH3-C=CH2) 
 
6.2.1.2. Production of BuMA, EHMA and LMA-based copolymers 
n-Butyl methacrylate (BuMA) and 2-ethylhexyl methacrylate (EHMA) monomers were 
purchased from Sigma Aldrich and purified by distillation. Lauryl methacrylate (LMA; Sigma 
Aldrich) was used as received. Polymer production was performed similar to the PEG-based 
materials, although apart from Irgacure® 2959, Irgacure® 651 (BASF) was also evaluated (see 
chapter 2). Optimization of the UV irradiation times was again performed by the evaluation 
of the polymer samples obtained after different UV irradiation times by 1H NMR 
spectroscopy (Bruker 300 MHz spectrometer). Herein, determination of the conversion 
percentages was enabled by comparing the proton integrations of the unreacted 
methacrylate protons (δ≈ 6 ppm and 5.5 ppm) with the sum of the  O-CH2 polymer and 
monomer protons (δ ≈ 4.05 - 4.12 ppm). Again, in case a crosslinker was added to the 
polymer formulation, the conversions were evaluated from the soluble fractions, as 
obtained via soxhlet extraction. The different NMR peak annotations of the starting 
monomers are indicated below: 
 
BuMA: 1H NMR (CDCl3;300 MHz): δ = 6.03 ppm (1H,m, H2C=C-), δ 5.47 ppm (1H,m, H2C=C-), 
δ = 4.09 ppm (2H,t, -O-CH2-), δ = 1.88 ppm (3H, t, CH3-C=CH2), δ = 1.6 ppm (2H, quin, O-CH2-
CH2), δ = 1.34 ppm (2H, sex, CH2-CH3), δ = 0.89 ppm (3H, t, CH2-CH3) 
EHMA: 1H NMR (CDCl3;300 MHz): δ = 6.08 ppm (1H,m, H2C=C-), δ 5.52 ppm (1H,m, H2C=C-), 
δ = 4.05 ppm (2H, dd, -O-CH2-), δ = 1.93 ppm (3H, t, CH3-C=CH2), δ = 1.61 ppm (1H, m, CH2-
CH-CH2), δ = 1.43-1.30 ppm (8H, m, -CH2-CH2-CH2-CH3 and –CH-CH2-CH3), δ = 0.9 ppm (6H, 
m, CH2-CH3) 
LMA: 1H NMR (CDCl3;300 MHz): δ = 6.07 ppm (1H,m, H2C=C-), δ 5.51 ppm (1H,m, H2C=C-), δ 
= 4.12 ppm (2H,t, -O-CH2-), δ = 1.92 ppm (3H, t, CH3-C=CH2), δ = 1.65 ppm (2H, quin, O-CH2-
CH2), δ = 1.25 ppm (18H, m, -(CH2)9-CH3), δ = 0.86 ppm (3H, t, CH2-CH3) 
 
6.2.1.3. Soxhlet extraction 
All soxhlet extractions were performed for a minimum of 24 hours with 
ethanol as extraction solvent. Figure 6.9 demonstrates the 
experimental setup. A weighed sample was placed in the soxhlet 
chamber. Upon heating of the extraction solvent (ethanol), it is 
evaporated and slowly fills the soxhlet chamber. As soon as the 
chamber is completely filled, it is emptied via a siphon arm, in a 
continuous way, allowing to slowly release and enrich the soluble 
fraction from the solid sample. 
After extraction, the solid sample was dried in a vacuum oven (40°C) 
Figure 6.9: Soxhlet 
extraction setup 
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and based on the weight before and after extraction, the percentage of soluble fraction 
could be determined. Furthermore, identification of the soluble fraction is facilitated, by 
evaporating the solvent, which is collected in the round bottom flask, and by dissolving the 
rest fraction in CDCl3. In this way, structure analysis could be performed using 
1H-NMR 
spectroscopy.          
  
6.2.1.4. Gel Permeation Chromatography 
The molecular weights and molecular weight distributions (expressed by PD, the 
polydispersity) of the non-crosslinked polymers were determined via gel permeation 
chromatography (GPC) (Waters 2695), equipped with a refractive index detector (Waters 
2414). Separations were performed on a mixed D column (60 cm in length, 5 µm particle 
size; Polymer Laboratories), combined with a PLgel (5 µm) guard column. Chloroform was 
used as eluens with a flow of 1 ml/min. Prior to sample injection, all polymer solutions (10-
20 mg/ml in chloroform) were filtered with 0.45 µm Chromafil®Xtra PTFE 45/25 filters 
(Macherey Nagel). PMMA standards with different molecular weights (5000, 20000, 50000 
and 150000 g/mol; Sigma Aldrich) were used for calibration. 
 
6.2.1.5. Tensile tests 
A universal tester 10-KM (Hounsfield Test Equipment Ltd), equipped with a load cell of 100 
and 1000 N was used for mechanical analysis. All measured specimens were dog bone 
shaped (25 mm in gauge length and 4 mm in width, according to ISO 37-2). The sample 
thickness was assessed using a caliper and was averaged at 1 mm. The unidirectional tension 
speed was 25 mm/min. For each composition, 10 measurements were performed and 
averaged. The elastic modulus (MPa), the elongation (%) and force at break (N) were 
recorded using the QMAT software. 
When the influence of PBS buffer was studied on the mechanical properties, similar dog-
bone shaped materials were incubated for 48 hours in PBS-buffer (10 mM, pH 7.4) at 37°C, 
prior to measurement.  
 
6.2.1.6. Swelling experiments 
To determine the swelling percentage of the materials, three disc-shaped samples (d = 1 
mm) per condition were freeze-dried and weighed (initial mass, m0). Subsequently, the 
samples were incubated for 24 hours in deionized water at 37 °C. After swelling, the samples 
were again weighed (mt) and swelling degrees were calculated using equation 6.5 (§ 6.1.3). 
When evaluating the polymer production of crosslinked materials (§ 2.3.3), an appropriate 
solvent had to be selected which is able to dissolve the building blocks. In case of 
MMA/PEGDMA copolymer evaluation, acetone was used and the swelling experiments were 
conducted in a similar way as described above.  
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6.2.1.7. NIR optical measurements 
NIR measurements were conducted with an Agilent 680 Series FTIR (Agilent Technologies 
Belgium, Diegem, Belgium). Herein, the samples were fixated in the sample compartment 
and NIR-light (12820-4000 cm-1) was transmitted through the samples. Measurements were 
processed by Resolutions Pro software (Agilent Technologies Belgium, Diegem, Belgium). 
 
6.2.1.8. Hermeticity testing 
Test samples consisting of copper meanders of various line widths (30, 40 and 50 µm) were 
covered with a PMMAPEG or PLMA network. The polymer coating was applied on the test 
samples in a similar way as the polymer sheets were produced. The setup is displayed in 
figure 6.10. A 250 µm thick spacer with a rectangular central cavity was taped over the 
region of the test sample that contained the cupper lines. A needle was inserted inside the 
spacer to allow for monomer injection and finally, the spacer was covered with a small teflon 
foil covered glass plate. Upon UV irradiation,  the cupper meanders were covered by a 250 
µm thick polymer layer.   
 
 
Figure 6.10: Polymerization set-up to coat the cupper lines, present in the test sample. 
 
Next, a glass ring was glued over the Cu meanders, creating a cavity which is filled with PBS 
buffer (10 mM, pH 7.4) and the test samples were incubated at 37°C or 70°C. Every 3 hours, 
for a period of 800 hours, the resistance was measured for the various cupper line widths. 
 
6.2.1.9. Cytotoxicity testing. 
Cytotoxicity was evaluated according to the ISO10993 part 5 standards of extraction tests 
with MTT (3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT, Merck 
Promega) as a detection molecule. Human foreskin fibroblasts (HFF) (American Type Culture 
Collection, ATCC) were cultured (37°C, 5% CO2) in a DMEM High Glucose GlutaMAX-medium 
supplemented with fetal bovine serum, L-glutamine, sodium pyruvate and penicillin-
streptomycin (Gibco, Life Technologies, Ghent, Belgium). From an ethylene oxide sterilized 
polymer sheet, 0.5 g was cut and placed in 1 mL of HFF culture medium at 37°C. The 
extraction medium was diluted after 8 days (1:1) with HFF culture medium and then placed 
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on top of a monolayer of HFF. After 24 hours, the medium was discarded and replaced by 
200 ml of a 0.5 mg/ml MTT containing medium, followed by an incubation for 4 hours at 
37°C. The MTT-solution was discarded and replaced by 200 ml of lysis-buffer (0.1% of Triton 
TM-X-100 [Fluka, Sigma-Aldrich, Bornem, Belgium] in isopropanol/0.04M HCL [Chem-Lab, 
Zedelgem, Belgium/UCB, Brussels, Belgium]), and incubated for 30 min at 37°C. Absorbance 
was measured at 570 nm with KCjunior software on a Universal Microplate Reader EL800 
(BIO-TEK Instruments Inc., Bad Friedrichshall, Germany). The viability was calculated as 
percentage of the control (i.e. no polymer extract was added).  
 
In case of the LMA-based materials, the polymer samples were only incubated for 24 hours 
at 37°C in HFF medium. Different dilutions were prepared from the extraction medium, 
being 1/1, 1/4 and 1/8, before incubating cells for 48 hours in the diluted media. 
 
6.2.2. Chapter 3: Surface activation and functionalization of methacrylate-based polymers 
6.2.2.1. Plasma treatment 
Plasma treatment of polymer sheets or discs was conducted with a cylindrical dielectrical 
discharge plasma reactor, Model Femto, version 3 (Diener Electronic, Germany). The O2 or 
Ar gas pressure (Air liquide) was kept at 0.8 mbar and the applied power was 100 W.  
In case plasma experiments were conducted at the Department of Applied Physics, a home-
made device was used. Herein, the experimental set-up consisted of two circular copper 
plates (diameter of 7 cm) covered with glass plates, which acted as dielectric barrier. The 
distance between the glass plates was 7 mm and the electrodes were placed within a 
cylindrical enclosure made of PVC (inner diameter: 25 cm, height: 25 cm). After placing the 
polymer sample on the lower glass plate, the chamber was evacuated below a pressure of 2 
kPa. The plasma chamber was subsequently flushed for 3 minutes with plasma gas at a rate 
of 5.2 slm (standard liters per minute) while keeping the pumping system switched on. After 
3 minutes of flushing, the vacuum pump was turned off and the chamber was filled with 
helium, argon or oxygen gas (Air Liquide) at a rate of 5.2 slm. When atmospheric pressure 
(101 kPa) was reached, the plasma chamber was pumped down to 5 kPa while the gas flow 
was decreased to 0.2 slm. Subsequently, the AC power source was turned on while the 
pressure in the discharge chamber was maintained at 5 kPa by slightly pumping during 
plasma treatment 16.  
 
6.2.2.2. Post-plasma grafting of AEMA 
Grafting of AEMA onto the polymer surfaces consisted of two steps. First, the samples were 
treated with Ar plasma for 0.2 (optimum for PLMA), 0.5 (optimum for PMMAPEG) or 0.7 
minutes. Subsequently, the activated polymer samples were placed in a quartz 6-well plate 
and immersed in a 1M aqueous 2-aminoethylmethacrylate (AEMA, Polysciences) solution. 
The latter is obtained by dissolving AEMA in degassed de-ionized water. Next, the 6-well 
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plate was covered with a quartz glass plate and irradiated by UV-light (λmax = 350 nm) for 1 
hour to enable grafting. Afterwards, the samples were rinsed with de-ionized water (3 times 
water exchange) and incubated overnight to remove unreacted AEMA. Finally, the samples 
were dried under a gentle stream of nitrogen gas and stored in a dessicator until the next 
modification step or analysis.  
 
6.2.2.3. Surface functionalization with polydopamine.  
In case of PMMAPEG modification, the deposition of polydopamine was established by 
applying and comparing two different protocols. The first protocol was described earlier by 
Lee et al 17. Using this protocol (protocol I), the samples were incubated for 24 hours in a 2 
mg/ml dopamine.HCl (DA) (Sigma Aldrich) solution in Tris buffer (10-3M, pH 8.5; prepared 
from Trizma base, Sigma Aldrich). Protocol II includes an additional step as the samples were 
first immersed in Tris buffer (pH 8.5), followed by addition of the dopamine.HCl salt               
(2 mg/ml). In order to evaluate the possibility to further improve the adhesion of 
polydopamine onto the developed materials, both protocols were also combined with an 
oxygen plasma pre-activation step (1 minute, 0.8 mbar), referred to as plasma + protocol I 
(Ipl) and plasma + protocol II (IIpl).  
In case of PLMA, protocol I was evaluated in combination with a plasma pretreatment step. 
Herein, two gasses were selected including Ar and O2 gas (both 1 minute, 0.8 mbar). 
 
6.2.2.4. SCA measurements 
To determine the wettability of the modified surfaces, a SCA 20 Instrument (Dataphysics), 
equipped with a light source and high speed video system with CCD cameras was used. To 
determine the static contact angles of the (non-)modified polymer surfaces, the sessile drop 
method was used and for each material and condition, three samples were measured and 
for each sample, a minimum of three drops was recorded. For each drop, the static contact 
angle was determined 5 seconds after the first contact with the surface using the circle 
fitting of the imaging software SCA20 (version 2.1.5).  
 
6.2.2.5. IR mapping 
IR mapping was conducted with a Perkin Elmer Spotlight 400 FTIR Imaging System in 
combination with a Spectrum 100 FT-IR Spectrometer. The wavenumber of the light was 
varied between 744 and 4000 cm–1. Since IR-mapping was used, the IR-light beam was 
scanned over the polymer surface to obtain different spectra on different locations of the 
material. One sample per test condition was analyzed and a spectrum was recorded for 
three different spots on the surface. 
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6.2.2.6. XPS measurements 
To determine the elemental compositions, an ESCA S-probe VG monochromatised 
spectrometer equipped with an Al Ka X-ray source (1486 eV) was used.  
Survey scans were recorded on three spots of each sample and the elemental composition 
of the top surface could be determined by calculating the peak areas in the obtained 
spectra. A minimum of two samples per test condition were measured. Furthermore, by 
measuring carbon details, insight on the type of chemical bonds between carbon and other 
elements on the surface, could be obtained. 
 
6.2.2.7. AFM measurements 
The surface roughness of the samples was characterized using atomic force microscopy 
(AFM). The images were obtained under ambient test conditions with a multimode scanning 
probe microscope (Digital Instruments, USA) equipped with a Nanoscope IIIa controller. 
After recording 50 µm scans in tapping mode with a silicon cantilever (OTESPA, Veeco), 
surface roughness analysis was enabled using the Nanoscope software version 4.43r8. 
 
6.2.2.8. SEM measurements  
SEM analysis was performed on a JEOL JSM-5600 instrument. The instrument was used in 
the secondary electron mode (SEI) at an acceleration voltage of 20 kV. Prior to analysis, all 
samples were coated with a thin gold layer (ca. 20 nm) using a plasma magnetron sputter 
coater. Images were recorded at three different surface areas of each sample. 
 
6.2.2.9. Statistical analysis 
The average and standard deviations were calculated for each condition tested and 
statistical differences were determined via a one way ANOVA-test in the 95% confidence 
interval, followed by a Sidak post hoc test, for multiple comparisons. IBM SPSS Statistics 
Version 20 (IBM Corporation, New York, United States) software package was used as 
statistical software and two values were considered significantly different when p < 0.05. 
Error bars represent the standard deviations in all graphs. 
 
6.2.3. Chapter 4: Surface biofunctionalization to enhance the cell interactivity of 
methacrylate-based materials 
6.2.3.1. Immobilization of a Gel B Layer 
The deposition of Gel B (Rousselot) onto PMMAPEG was established by first applying a 
polydopamine coating using protocol I. Next, the samples were incubated overnight at 40°C 
in a gelatin B solution, by dissolving the appropriate amount of Gel B (0.5, 1 or 2 w/v%) in 
Tris buffer (10-3M, pH 8.0). After incubation, the samples were rinsed with milliQ water and 
gently dried with N2 gas. 
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6.2.3.2. Immobilization of angiogenic factors onto PDA-modified surfaces 
Disk-shaped samples (0.8 or 1 cm in diameter, 1 mm thick) were punched from a PMMAPEG 
or PLMA polymer sheet. Prior to AB and/or VEGF immobilization, the sample surfaces were 
modified with PDA. In case of PMMAPEG, protocol I was applied whereas for PLMA, the 
same protocol was combined with an oxygen plasma pre-treatment step, as described 
previously. Next, the samples were placed in a 48 well plate and incubated overnight at 
37°C, in 200 µL of the angiogenic factor solution. In case recombinant human vascular 
endothelial growth factor 165 (VEGF-165, Thermo Scientific) was immobilized, a solution of 1 
µg/ml was prepared in Tris buffer (10-3M, pH 8.5). Herein, the buffer was enriched with 
bovine serum albumin (BSA, Roche Diagnostics, 0.01 g/ml), as prescribed by the VEGF 
supplier. In case vascular endothelial cadherin antibody (BV9) (VE-cad AB, Santa Cruz 
Biotechnology) was immobilized, a 4 µg/mL solution was prepared in PBS buffer (pH 7.4). 
After incubation, all samples were rinsed three times with PBS buffer in order to remove 
unreacted VEGF or AB.  A similar procedure was conducted on the blank materials, without 
PDA coating. 
When both angiogenic factors were immobilized simultaneously on the sample surface, the 
concentrations of 1 µg/ml VEGF (in Tris buffer) and 4 µg/ml VE-cad AB (in PBS) were 
maintained, meaning that the overall angiogenic concentration was set to 5 µg/ml. 
In case the synergetic effect of the two factors was studied, identical concentrations and 
immobilization conditions were used. Herein, VEGF-immobilized samples (4 µg/ml in Tris 
buffer pH 8.5) and AB-immobilized samples (4 µg/ml in Tris buffer pH 8.5) were compared 
with VEGF/AB immobilized samples with a total angiogenic factor concentration of 4 µg/ml 
(Tris buffer pH 8.5). 
 
6.2.3.3. Immobilization of angiogenic factors onto AEMA-modified surfaces 
Disk-shaped samples (0.8 or 1 cm in diameter, 1 mm thick) were punched from a PLMA 
polymer sheet. Prior to AB and/or VEGF immobilization, the sample surfaces were treated 
with Ar plasma during 0.2 minutes, followed by AEMA grafting as described elsewhere (see § 
6.2.2.2.). 
Next, for the immobilization of VEGF and AB, EDC chemistry was applied. To this end, the 
disk-shaped samples were placed in a 48 well-plate and incubated in 200 µl of AB or VEGF 
solution. Next, 10 µl of a 0.5 mg/ml 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, 
Sigma Aldrich) solution was added and reacted for 4 hours at room temperature. In case the 
sulfo-NHS mediated strategy was followed, after EDC-addition, 10 µl of a 0.7 mg/ml N-
hydroxysulfosuccinimide (sulfo-NHS, Sigma Aldrich) solution was also added. After 4 hours of 
reaction time, all samples were rinsed with PBS buffer and incubated overnight at 37°C in 
order to remove the unreacted species. 
The VEGF and AB solutions were prepared in two different buffer types, being PBS buffer (10 
mM, pH 7.4) and MES buffer (50 mM, pH 6.1; prepared from 2-(N-
morpholino)ethanesulfonic acid (MES) hydrate, Sigma Aldrich) until concentrations of 
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respectively 1 and 4 µg/ml were obtained. Again, in case of VEGF immobilization, BSA was 
added to the buffer solution (0.01 g/ml). 
Similar to the PDA immobilization, when both AB and VEGF were immobilized, the 
concentrations of 1 µg/ml VEGF (MES buffer) and 4 µg/ml VE-cad AB (MES buffer) were 
maintained, meaning that the overall angiogenic concentration was set to 5 µg/ml. In case 
the synergetic effect was studied between both factors, VEGF-immobilized samples (4 µg/ml 
in MES buffer, pH 6.1) and AB-immobilized samples (4 µg/ml in MES buffer, pH 6.1) were 
compared to VEGF/AB immobilized samples with a total angiogenic factor concentration of 4 
µg/ml (MES buffer, pH 6.1). 
In case of oriented AB immobilization, the AEMA coated samples were immersed in a 0.42 
mg/ml succinimidyl-6-hydrazino-nicotinamide (S-Hynic; DivBioScience, the Netherlands) 
solution for 2 hours at room temperature. To this end, 1 mg of S-hynic was dissolved in 200 
µl DMF and diluted with PBS buffer (pH 8) to obtain the desired concentration of 0.42 
mg/ml. In the meantime, in order to oxidize the carbohydrate functions of the AB, 60 µl of a 
10 mg/ml sodium periodate (NaIO4, Sigma Aldrich) solution was added to 250 µl of VE-cad 
AB (200 µg/ml) and reacted for 30 minutes. After reaction, the AB was purified with a PD-10 
desalting column (packed with Sephadex™ G-25 Medium; GE Healthcare, Belgium), 
according to the prescribed supplier protocol and purified AB (14.3 µg/ml) was obtained and 
diluted (to 4 µg/ml). Finally, after 2 hours of S-Hynic incubation, the samples were rinsed 
three times with PBS buffer and incubated for 1 hours in 200 µl of the oxidized AB solution.   
  
6.2.3.4. SCA and XPS measurements 
All SCA and XPS measurements were conducted similarly as described in §6.2.2.4 and 
§6.2.2.6. 
 
6.2.3.5. Profilometry measurements  
Profilometry measurements were conducted with a stylus contact profilometer (Dektak 8) 
and were taken electromechanically by moving the sample under a diamond-tipped stylus 
with a radius of 2.5 µm. A high-precision translation stage moved the sample under the 
stylus according to the user-programmed scan length (7 mm), translation speed (35 µm/sec) 
and stylus force (3 mg). As the stage moved across the sample, surface variations caused the 
stylus to be translated vertically. The resultant vertical motion of the stylus is then translated 
into height variation information by dedicated computer algorithms. For each material and 
test condition, three measurements were recorded over a scan length of 7 mm with a 
resolution of 0.12 µm and the RMS surface roughness was determined over the same length. 
Averages of the three measurements were calculated, as well as the related standard 
deviations. Calculation of the RMS value for each scanned line was performed by applying 
the formula,  
N
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with Zavg the average height (Z) value within the measured area (7 mm); Zi being the current 
Z value and N the number of points recorded within the scanned area. 
 
6.2.3.6. Radiolabeling experiments 
Radio-iodination of VE-cad AB and VEGF was performed as described by Pierce 
Biotechnology Inc. (Rockford, IL, USA) 18. Iodogen (1,3,4,6-tetrachloro-3a,6a-
diphenylglycouril, Pierce, USA) was dissolved in chloroform to a concentration of 2 mg/ml 
and 100 μl was added to a 1.5 ml conical vial. Chloroform was evaporated under a gentle N2 
flow at room temperature, hereby coating the Iodogen onto the inner surface of the vial. 
The Iodogen coated vials were stored in a dessicator at 5°C prior to use.  
To a Iodogen coated reaction vessel, the required volume of the AB/VEGF stock solution was 
added, immediately followed by the addition of 100 µl of a 0.01 M PBS buffer (pH 7) and 10-
20 μL radio-iodide solution in 0.05 N NaOH (125I; GE/Amersham Health, Eindhoven, The 
Netherlands). This mixture was incubated at ambient temperature under slight shaking for 
15 minutes. The overall radiochemical purity (RCP) was determined using iTLC-SG 
chromatographic strips (Gelman Sciences) and citrate-buffer (0.068 M citrate, pH 7.4) as 
eluent. The concentration of AB and VEGF in the final solution was adjusted to suit the 
experimental conditions, specified elsewhere (see § 6.2.3.2 and 6.2.3.3) and the specific 
activities were calculated accordingly.  
Next, disk-shaped samples (1 cm diameter, 1 mm thick) were incubated in 200 µl of the 
radiolabeled VEGF and AB solutions according to the immobilization protocols, described 
elsewhere (see § 6.2.3.2 and 6.2.3.3). After incubation, the samples were rinsed in PBS and 
the radioactivity was measured with a Geiger Muller teller. 
In case of the AB orientation study, secondary antibodies were radiolabeled, including anti-
mouse IgG (Fab specific) FITC-conjugated (Sigma Aldrich) and IgG (Fc specific) FITC-
conjugated. The same procedure as described above was used. The AB modified samples 
were finally incubated overnight at 37°C in 200 µl of a 80 µg/ml solution of secondary AB in 
PBS. 
 
6.2.3.7. Cell culture and cell seeding 
Two types of cell culture were used: fibroblasts and human umbilical vein endothelial cells 
(HUVECs).  
Human foreskin fibroblast (HFF-1) cells were cultured in DMEM glutamax medium 
supplemented with 10% fetal calf serum (FCS, Gibco Invitrogen), 2 mM L-glutamine (Sigma-
Aldrich, Belgium), 10 U/ml penicillin, 10 mg/ml streptomycin (Gibco Invitrogen) and 100 mM 
sodium-pyruvate (Gibco Invitrogen). Cells were cultured at 37 °C in a humidified atmosphere 
containing 5% CO2. The medium was changed 2 times a week. Normal duman dermal 
fibroblasts (NHDFs, Promocell) were cultured in advanced DMEM (Gibco, Invitrogen, USA), 
supplemented with 2 % fetal bovine serum (FBS) and 1% penicillin/streptomycin/glutamin.  
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HUVECs were cultured in endothelial growth medium 2 (EGM-2, Clonics®, Lonza), at 37°C. 
This medium was composed of endothelial basal medium (EBM-2) and SingleQuots™ 
(Clonics®, Lonza) containing several supplements and growth factors. The concentration of 
growth factors and supplements in 500 ml basal medium was: 0.5 ml human epidermal 
growth factor (hEGF), 2 ml human recombinant fibroblast growth factor (hFGF-β), 0.5 ml 
vascular endothelial growth factor (VEGF), 0.5 ml insulin-like growth factor (R3-IGF-1), 0.2 ml 
hydrocortisone, 0.5 ml ascorbic acid, 0.5 ml heparin, 10 ml FBS and 0.5 ml 
gentamicine/amfotericine (GA-1000).  
Prior to cell seeding, all samples were sterilized by ethylene oxide treatment (cold cycle, AZ 
Sint-Jan, Brugge, Belgium). All biological compounds (Gel B, VE-cad AB and VEGF) were 
subsequently immobilized under sterile conditions. 
 
Cell seeding for the in vitro evaluation of PDA/Gel B coated samples. 
HFF-1 cells were seeded with a density of approximately 30000 cells/cm2 in 24-well culture 
dishes. Cell adhesion at day 1 was evaluated after live/dead staining. NHDFs of passage 
number 12 were seeded on top of the films with a cell density of approximately 5000 
cells/cm². Cytoskeletal organization was evaluated after 2 days of incubation by 
immunolabeling and confocal microscopy. 
 
Cell seeding for the in vitro evaluation of the substrate mechanical properties 
HUVECs of passage 7 were seeded on top of the PEG-based samples with a cell density of 
20000 cells/cm2. Cell adhesion at day 1 and 7 was evaluated by a  live/dead assay. 
Cytoskeletal organization was evaluated after 2 days of incubation by immunolabeling and 
confocal microscopy. 
 
Cell seeding for the in vitro evaluation of VEGF and AB functionalized materials 
HUVECs of passage 5-10 were seeded on top of the PEG-based samples with a cell density of 
10000 cells/cm2. Cell adhesion at day 1 and 7 was evaluated by a  live/dead assay. 
Cytoskeletal organization was evaluated after 2 days of incubation by immunolabeling and 
confocal microscopy. 
 
6.2.3.8. Live dead assay 
To visualize cell distribution on the polymer discs, a live/dead staining was performed. After 
rinsing the films, the supernatant was replaced by 1 ml PBS solution supplemented with 2 µl 
(1 mg/ml) Calcein AM (Anaspec, USA) and 2 µl (1 mg/ml) propidium iodide (Sigma). Cultures 
were incubated for 10 minutes at room temperature, washed and evaluated by fluorescence 
microscopy (Type U-RFL-T, Olympus, XCellence Pro software, Aartselaar, Belgium). 
Evaluations were done 1 day and/or 7 days post cell seeding. 
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6.2.3.9. Immunolabeling assay 
Actin filaments and focal adhesion points were (immuno-)labeled. All steps were performed 
at room temperature and a washing step consisted of 3 times 5 minutes washing in PBS 
buffer, unless stated otherwise. After removal of the medium, the cells were washed briefly 
with PBS and fixed in 4 % buffered paraformaldehyde solution for 20 minutes at room 
temperature. After washing the samples, the cells were permeabilized with a 0.5 % Triton X-
100 in PBS solution for 5 minutes. Subsequently, cells were blocked with a 50 % FBS solution 
in PBS for 1 hour, washed, incubated with the primary antibody, mouse anti-paxillin 
(Milllipore, Overijse, Belgium; 1:1000 diluted in 50 % FBS in PBS) for 1 hour and washed 
again. Afterwards, the cells were incubated with the secondary antibody AlexaFluor 488 goat 
anti-mouse IgG (A11001, Life Technologies, Merelbeke, Belgium) for 30 minutes and 
washed. Next, the cells were stained with a phalloidin-rhodamine (Life Technologies) 
solution (1:100 diluted in PBS) and a 1 µg/ml DAPI solution (Life Technologies, Merelbeke, 
Belgium) for 10 minutes and washed again. The samples were mounted on a cover slide 
prior to microscopy measurements. All immunolabeling experiments were performed in 
duplicate.  
The samples were investigated by means of a Nikon A1r confocal microscope mounted on a 
Nikon Ti Body (Nikon Instruments, France) and magnified with a 40x Plan Fluor oil objective 
(numerical aperture 1.3). In order to obtain a representative image of each test condition, 
three separate regions were randomly acquired per sample. 
 
6.2.3.10. Confocal image processing 
Image processing was performed in Fiji (http://fiji.sc), a packaged version of ImageJ freeware 
(W.S. Rasband, U.S.A. National Institutes of Health, Bethesda, Maryland, USA, 
http://rsb.info.nih.gov/ij/, 1997–2014). The focal adhesion points were quantified by means 
of a custom-designed image processing pipeline, which is essentially based on a high-content 
analysis workflow described earlier 19 and available upon request. In brief, the analysis 
consists of a few image preprocessing steps, followed by hierarchical segmentation of nuclei, 
cells and focal adhesion points (FA) to allow region-specific analysis of objects. First, image 
hyperstacks are projected according to the maximum axial pixel intensity and corrected for 
lateral illumination heterogeneity and background signals by means of a pseudo-flat field 
correction, which consists of dividing the image by a duplicate image smoothened with a 
Gaussian blur of large radius (sigma = 50). A subsequent local contrast enhancement 
balances for more subtle intensity fluctuations. Next, nuclear regions of interest (ROIs) are 
segmented in the DAPI channel after filtering with a Gaussian kernel of small radius (sigma = 
3), automatic thresholding according to Otsu’s algorithm and watershed-based separation. 
Cellular boundaries are then delineated by combining a segmentation of the median filtered 
Phalloidin channel, using the Triangle autothresholding algorithm, with a Voronoi tesselation 
on the nuclear ROIs (Boolean AND operation). Finally, FA are specifically enhanced in the FA 
channel by means of a Laplacian operator and binarized using the Triangle autothresholding 
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algorithm. Segmentation of FA can be further refined by cell-dependent peak selection, 
which is based on preserving only those objects (presumed FA) for which the average signal 
surpasses a threshold (typically defined as the average signal + 1 x std of the FA channel in 
the cell ROI). This feature avoids detection of noise pixels and allows for accurate 
segmentation of FA in cells with varying background fluorescence. The resulting ROIs were 
used for analyzing shape (area, aspect ratio circularity) and intensity metrics of objects larger 
than a predefined size (> 5 pixels) on the original image.  
 
6.2.3.11. Statistical analysis 
For all experiments, except the cell tests, statistical differences were determined via a one 
way ANOVA-test in the 95% confidence interval, followed by a Sidak post-hoc test for 
multiple comparisons. In case of cell-data, the average values of various parameters such as 
number of focal adhesions and circularity were statistically compared by means of a non-
parametric Kruskal-Wallis test. IBM SPSS Statistics Version 20 (IBM Corporation, New York, 
United States) software package was used as statistical software. The boxplots were 
generated with R statistical freeware (The R Development Core Team) 20. Two values were 
considered significantly different when p < 0.05. Error bars represent standard deviations.  
 
 6.2.4. Chapter 5: in vivo evaluation of a biofunctionalized methacrylate-based packaging 
for an optical glucose sensor 
6.2.4.1. Production of donut-shaped implants 
All implants were produced according to one of the three mold designs discussed in chapter 
5 (§ 5.2). In case of mold design 2, where optical fibers were included in the implants, the 
fibers first needed to be mounted on a separate metal carrier. In this respect, it can be 
mentioned that a single mode to single mode fiber setup was selected. Prior to molding, 
optical fibers with glass ferrules (1.8 mm, Thorlabs) were fit in two holes of a metal carrier 
and were optically characterized. From these measurements, it was clear that the sensor to 
sensor variation of the coupling efficiency was quite large, which implied that the optical 
overlap between the two fibers was not optimal. This was probably related to stresses inside 
the carrier because of drilling of the holes. Next generation carriers should be built 
differently to avoid these current problems. After molding, the biocompatible PUR tubing 
(Braun) was introduced to the carrier and an optical connector was spliced to the fibers.  
 
6.2.4.2. Goat implantation procedure  
All in vivo studies were approved by the Ethics Committee of the Faculty of Veterinary 
Medicine, Ghent University. All animal care did comply with the EC guidelines for the care 
and use of laboratory animals.  
Adult female goats (Saanen milk goats) with ages between 3 and 6 years and a mean body 
weight between 50 and 70 kg were used. The goats were housed in groups with continuous 
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access to food and water. Twelve hours pre-operatively, the goats were deprived of food 
and received medication (Neopen® 1 ml/20 kg subcutaneously [Intervet, Merck & Co., Inc, 
Brussels, Belgium] and Ketofen 10%® 2.2 mg/kg intramuscularly [Merial, Velserbroek, the 
Netherlands]) to assure relevant blood values during surgery. Before surgery the goats were 
premedicated using xylazine (Proxylaz®, 0.2 mg/kg IM [Prodivet, Eynatten, Belgium]). 
Anesthesia was induced with ketamine (Ketamine 1000®, 1.1 mg/kg [Ceva Santé Animale, 
Naaldwijk, the Netherlands]) and midazolam (Dormicum®, 0.03 mg/kg [Roche, Woerden, 
Belgium]) and maintained after tracheal intubation with an O2 in isofluorane-mixture (Isoflo® 
[Abbott Lab, Wavre, Belgium]). Routine monitoring (ECG, pulsoximetry, capnography, direct 
blood pressure, and arterial blood gasses) was performed. Ringer’s lactate solution (5 
ml/kg/h [Baxter]) was administered intravenously during the anesthetic period. All animals 
received peroperative antibiotics (Neopen® 1 ml/20 kg subcutaneously) and non-steroidal 
anti-inflammatory drugs (NSAID, Ketofen 10%® 2.2mg/kg intramuscular). Post-operatively, 
antibiotic treatment was continued for 5 days and NSAIDs were given for 3 days.  
After induction of anesthesia, the animals were placed in lateral recumbency. The skin was 
sharply incised and the correct implantation depth was achieved through further blunt 
dissection before implant positioning. Incisions were sutured (if needed in several layers) 
with resorbable sutures (Maxon 2/0 skin, Vicryl 2/0 muscle [Ethicon, Johnson & Johnson 
Medical N.V./S.A., Diegem, Belgium]) and protected with a sterile self-adhesive bandage. 
When all samples were implanted, the goat was transported to the recovery box. The goats 
were closely monitored in the post-operative period.  
In the first experimental setup, called the exploratory in vivo study, which was intended to 
aid design optimization, implantation site, and packaging evaluation, three goats were used. 
In each goat, 18 donut-shaped PMMAPEG implants were tested. These implants consisted of 
PMMAPEG 1, 2 and 3 of which half of the implants had an internal diameter of 3 mm, the 
other half, an inner donut diameter of 6 mm. Each material was implanted subcutaneously 
(para lumbar fossa), retroperitoneally (ventral abdominal area), and intramuscularly (gluteus 
muscle region) on both flanks of the animal. Animals were euthanized after 1 month and the 
donuts were harvested with surrounding tissue for histological analysis. 
During the second experimental setup, the effect of the surface modifications was studied. 
Based on the results obtained in the first experiment, PMMAPEG 1 was selected and only 
subcutaneous implants were performed. Herein, the materials were surface modified with 
PDA, PDA/VE-cad AB and PDA/GelB/VE-cad AB, as described previously (§ 6.2.2.3, 6.2.3.2 
and 6.2.3.1 respectively). Non-modified materials were included in the study as a control. 
Again donut-shaped materials were implanted in both flanks of each animal. In total, 3 
samples were produced per test condition and per time point of explantation and divided 
over three goats. The animals were kept alive for three months. Materials were harvested 
after 1 and 3 months for histological processing and analysis. 
The third experimental setup was intended to evaluate the in vivo measurement of glucose 
via optical fibers. 10 sensors, comprising 5 membrane-based sensors and 5 membrane-less 
sensors, were implanted subcutaneously in 5 goats via a similar implantation procedure as 
Chapter 6 | Experimental section                        
248 
 
described before. To insert the sensor, two incisions were made at approximately 10 cm 
distance. A cavity was created in the subcutaneous area under the skin and the sensor was 
inserted from one side. Prior to insertion, the sensor was packed in a sterile drain, which was 
removed after the insertion. After the implantation, a metal box and protective jacket were 
mounted on the animal to protect the fibers and the surgical site of the animal. Due to 
practical issues, no surface modifications were conducted on this set of implants. 
During the fourth experimental setup, intended to further study the membrane-based set-
up, two types of samples were implanted. The first group consisted of CMA-7 micro-dialysis 
probe, incorporated into a PMMAPEG packaging (described in § 5.5.2). Two sensors were 
surface modified with PDA/VE-cad AB, whereas the other two weren’t. The implantation 
procedure was similar as described in the beginning of this paragraph. The second group of 
samples consisted of 6 dummy membrane sensors (described in § 5.5.3). Three different 
compositions were studied and two replicates per composition were implanted 
subcutaneously, as described above. Explantations were done 1 and 3 months post the 
implantation date. 
Prior to implantation, all implants were sterilized by ethylene oxide treatment (cold cycle, AZ 
Sint-Jan, Brugge, Belgium and at Maria Middelares, Gent, Belgium) and all biological 
compounds (Gel B, VE-cad AB and VEGF) were subsequently immobilized under sterile 
conditions. 
 
6.2.4.3. Rat implantation procedure 
During a first experiment, to further study the impact of surface modification on the in vivo 
response of the glucose sensor packaging, rat experiments were conducted. Herein, 20 
female normal rats (Wistar rats)  and 20 female diabetic rats (Goto-Kakizaki rats) were used. 
In each rat, three PMMAPEG 1 disks (6 mm diameter and 1 mm thickness) were implanted 
subcutaneously in the back of the rats. Three conditions were studied: blank samples, PDA 
coated ones and disks modified with PDA/VE-cad AB. Anesthesia was induced via the 
inhalation of 5% isofluran (Isoflo®, Abbott Lab), mixed with O2 and was maintained during 
the surgery with 1 to 1.5 % isofluran. Next, the back of the rat was shaved and disinfected 
with Hibitane Plus® (Mönlycke Health Care). Incisions were made and after insertion of the 
polymer disks, these were sutured with resorbable sutures (Vicryl 4-0; Ethicon). The skin was 
again disinfected with Hibitane Plus® and as a painkiller, Temgesic (Reckitt Benckiser) was 
administered subcutaneously. Explantation of the discs and the surrounding tissue was 
conducted after 2, 5, 10 and 25 days from both the normal and diabetic rats. 
 
In the course of a second experiment, porous PCL scaffolds (6 mm diameter, 1 mm thickness 
and 250 µm pores) were produced with a 3D-printer (Bioscaffolder®, SYS+ENG) and surface 
modified with PDA and PDA/VE-cad AB. In this case, 6 samples (2 per condition) were 
implanted subcutaneously in the back of each rat, via the same implantation procedure as 
described above. In total, 6 female rats (Wistar rats) were used. the discs were explanted 
after 4, 7 and 14 days. 
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6.2.4.4. Histological analysis of the explanted samples 
Preparation of the sections 
Donuts from the goats or disk-shaped samples from the rats, with their surrounding tissue, 
were placed in 4% (para)formaldehyde for 24 h at 4°C. They were dehydrated, embedded in 
paraffin and 7 µm sections were cut from the donut-type goat materials on a SLEE cut 4060 
microtome (SLEE medical GmbH, Mainz, Germany). In case of the disk-shaped samples, 
explanted from the rats, 5 µm sections were cut with a microtome (Model 2040, Reichert-
Jung). Sections in the middle of the implanted materials were analyzed.  
 
Staining and analysis of the sections 
Sections were stained with hematoxylin & eosin (H&E) (Hematoxylin from VWR, Leuven, 
Belgium and Eosin-Y w/Phloxine (Microm, Thermo Fisher, Walldorf, Germany) to screen and 
study the morphology of the surrounding tissue. The staining was performed with an 
automated staining device (HMS 740 Robot-Stainer, MICROM international) and comprised 
following steps: 3 x 5 minutes incubation in toluene (UltraClear), 2 x 2 minutes isopropanol, 
2x2 minutes alcohol 96%, 2 minutes tap water, 1 minute milliQ water, 15 seconds 
haematoxyline (VWR®), 2 minutes tap water, 1 minute clarifier I (Thermo-scientific), 1 
minute tap water, 1 minute bluing reagent (Thermo-scientific), 1 minute tap water, 1 minute 
milliQ water, 30 seconds eosine + phloxine (Thermo-scientific), 2 minutes tap water, 2 x 2 
minutes alcohol 96%, 2x 2 minutes isopropanol, 2 x 2 minutes toluene, followed by 1 minute 
incubation in a fresh bath of toluene. 
To evaluate the samples, a Jeneval light microscope (Carl Zeiss NV-SA, Zaventem, Belgium) 
was used. Furthermore, in case of the rat experiments, the thickness of the connective tissue 
capsule could be studied in this way. For each section, the thickness of the capsule was 
determined for the four edges surrounding the implant. Herein, the measurement was done 
at the position where the capsule appeared thickest. The average of these four values was 
calculated and used. 
 
To study the number of capillaries in the sections, the H&E slides were scanned under a 20x 
or 40x objective using an Olympus BX51 microscope, and captured using dotSlide software 
(Olympus, Aartselaar, Belgium). Eighteen square fields per image (100 µm x 100 µm) 
surrounding the tissue-implant surface were manually selected, and the total number of 
capillaries was manually counted. The criteria applied for designating a capillary were 
explained in § 5.4.1. 
 
In case of the rat experiments, pericytes, which surround mature capillaries and which 
contain desmine, were stained to further visualize them. To this end, after deparaffinization 
and an antigen retrieval pre-treatment, sections were demarcated with Dakopen (Dako) and 
rinsed with PBS-buffer, followed by a pre-treatment with 3% H2O2 solution (VWR®). Blocking 
was done for 30 minutes with a mixture of 10 ml PBS, 5% Normal Rabbit Serum (NRS) 
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(X0902, Dako), 1% BSA (Roche diagnostics) and 0.2% Tween (VWR®). Next, the sections were 
incubated for 2 hours in the primary antibody solution of anti-desmine (M0760, Dako, 1/200 
dilution), washed with PBS (2 x 5 minutes) and incubated for 1 hour in the secondary 
antibody solution, which is a biotinylated rabbit anti-mouse antibody (E0413, Dako; 1/200 
dilution). After rinsing with PBS (2 x 5 minutes), streptavidine-peroxidase (P0397, Dako) was 
added. Next, the samples were again rinsed with PBS (2 x 5 minutes) and Tris buffer (1 x 5 
minutes). To render the substrate chromogenic, a mixture of 0.06% 3,3’-diaminobenzidine 
tetrahydrochloride (DAB, D5637, Sigma Aldrich) and 0.03% H2O2  in Tris-buffer was added for 
10 minutes and subsequently rinsed with water for 10 minutes. 
 
6.2.4.5. SPE gel electrophoresis 
Liquid samples for SPE gel electrophoresis analysis were obtained during the explantation 
process. After removing the tissue from the implant material, the liquid present on top of 
the implant was collected and is referred to as the external fluid. Next, one membrane was 
removed from the donuts and the fluid present underneath was also collected and is 
referred to as the internal fluid. SPE gel electrophoresis was performed on both liquids with 
a commercially available agarose gel electrophoresis kit (Protur HiSi kit from Analis, Namur, 
Belgium). 
6.2.4.6. Diffusion experiments 
A 10 g/l D-glucose (Anhydrous, 96%, sigma Aldrich) solution was prepared and added in the 
right compartment of an in-house-built diffusion device, as shown and described in § 5.5.2.2. 
The left compartment was filled with milli-Q water (Millipore) and between the 
compartments, the test subject (membrane or donut-implant) was clamped and in this way 
contacted with the two involved stirring fluids. Both compartments were made of double-
layered glass, which allowed to work at thermostatic temperatures, in this case 37°C, via a 
water flow supplied from a thermostatic bath. 
As a function of time, samples (40 µl) were taken from the right compartment to determine 
the amount of glucose which diffused through the membrane or donut. Glucose quantities 
were determined via test strips and a commercialized glucometer (Accu-Chek Aviva, Roche). 
To this end, a test strip was mounted inside of the glucometer and one droplet of glucose 
solution was placed on the test strip, which enabled reading of the glucose concentration 
from the device.   
 
6.2.4.7. Statistical analysis 
Statistical significance for capillary counts were assessed by one-way ANOVA with Tukey’s 
post-hoc test for multiple comparisons. In case the values were not normally distributed 
according to the Shapiro-Wilk normality test, a Kruskal-Wallis non-parametric test was 
performed to determine statistical significance. The threshold for significance was p < 0.05. 
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The error bars represent the standard deviation. Statistical analyses were performed using 
IBM SPSS Statistics Version 20 (IBM Corporation, New York, United States) software package. 
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7.1. Discussion and future perspectives 
The goal of the present research included the development of a flexible, biocompatible 
methacrylate-based packaging material for an implantable optical glucose sensor, which is 
intended for long-term continuous glucose monitoring (CGM). In this work, different steps 
have been elaborated, as summarized in  figure 7.1.  
 
 
Figure 7.1: The development of a flexible methacrylate-based packaging material towards an 
implantable, optical glucose sensor: the different steps that should be performed in order to 
realize this goal. Ronny Bockstaele is greatly acknowledged for providing the concept of this figure 
 
In a first step, all optical components should be mounted on a pre-assembly carrier to assure 
optical alignment. In the current work, optical fibers were still used and it was shown that 
some difficulties were associated with this concept. Due to external forces, fiber failure was 
apparent for most of the implanted sensors, despite the use of a biocompatible 
polyurethane tubing to protect the optical fibers. Future designs should encounter this 
problem e.g. by applying a more stiff tubing, by using only one fiber entry and/or by 
optimizing the eventual protection on the animals themselves. For the latter, the protection 
box could be fixed more tightly or could also be mounted on the back of the goats. Using this 
approach, the implants and fibers will be less attainable for the animals. It can further be 
highlighted that the concept of using optical fibers is only a preliminary set-up, since at the 
final approach, a wireless sensor is pursued. Nevertheless, this intermediate concept is 
required to evaluate the overall feasibility. 
After assembly of the different optical components, the sensor is ready to become 
encapsulated in a polymer packaging. As indicated in chapter 1, the packaging material 
should fulfill certain characteristics. First, a certain flexibility and softness of the packaging 
were targeted. In this respect, the most ideal mechanical properties a subcutaneous 
packaging should show, were attempted to become identified. To this end, upon application 
of poly(ethylene glycol) monomethylether monomethacrylate (PEGMA) and/or 
poly(ethylene glycol) dimethacrylate (PEGDMA), a broad range of MMA-based copolymers 
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was developed (see chapter 2) with E-moduli ranging from 10 to 1600 MPa. To evaluate the 
impact of the E-modulus on the cell behavior, different materials, characterized by various E-
moduli, were selected and treated with a similar surface chemistry. Nevertheless, the 
different E-moduli could not be differentiated on a cellular level (see chapter 4). Whether 
the mechanical properties were responsible for this fact or the applied surface chemistry, 
should be the topic of future research. Although it was not possible to identify the ideal 
range of packaging E-moduli, it can be anticipated that E-moduli in the range of those of skin 
(100 kPa-100 MPa 1), could offer excellent candidates. In this respect, the developed PLMA-
based material (55.5 mol% MMA, 45.5 mol% LMA and 5 mol% PEGDMA(550)) could be an 
interesting candidate (E-mod = 6 MPa). Nevertheless, this material was not yet studied in an 
in vivo setting, since it was only available at the end of the current PhD. Based on the 
mechanical properties of the PMMAPEG-based materials, also within this range, a selection 
could be made, but due to the high swelling of these materials (up to 250%), a somewhat 
higher E-modulus (E-mod = 142 MPa) was selected as potential glucose sensor packaging 
(i.e. combining 50 mol% MMA and 50 mol% PEGDMA), since it formed the best compromise 
between the E-modulus and swelling (17%). Regarding this latter property, it was also 
questioned how much swelling would be tolerated in the final sensor concept. Based on the 
experiments conducted with the PMMAPEG-based material (associated with a swelling of 
17%), it was concluded that swelling should be eliminated to the greatest extent possible, 
especially in case of highly crosslinked materials. The in vivo experiments showed that some 
of the implanted donuts were broken inside the goats which was attributed to stresses 
created due to a combination of high swelling and crosslinking degree (50 mol% of 
crosslinker) of the studied material. Furthermore, because of swelling, poor adhesion of the 
PMMAPEG polymer onto the metal substrates was demonstrated during hermeticity testing. 
It can be noted that the PLMA-based material could again offer a superior alternative, since 
its swelling was limited to only 0.6%, which is even less than PMMA itself (i.e. 2%). 
Regarding the optical properties of the materials, a minimized swelling would further limit 
the interference of water during the NIR optical measurements of glucose. Nevertheless, 
optical evaluation of the PMMAPEG and PLMA-based materials in the near-IR region showed 
that too high absorptions were present to allow for sensitive glucose measurements. Future 
research should thus focus on the alternative glucose sensor concept, i.e. the evanescent 
glucose sensor as described by Ryckeboer et al 2 (also see figure 7.2).  In this concept, the 
polymer material is excluded from the light path.  
Finally, the packaging material should preferably act as a hermetic barrier, in the sense that 
it should prevent contact of body fluids with the electronics and contact of leached 
electronic species with the body. Both materials, PMMAPEG and PLMA were evaluated and 
turned out to be unsuitable for this purpose, thus future experiments should further 
elaborate on the optimization of the latter property. For short term implantations (i.e. 
months), the combination with parylene C could be evaluated while long term implantations 
(i.e. years) could include the application of ALD (Atomic Layer deposition) to form an 
intermediate layer between the electronics and the polymer. 
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Apart from the PLMA-based material, also other polymers could in the future be evaluated 
as glucose sensor packaging, as long as they fulfill the above-mentioned criteria (i.e. E-mod 
between 100 kPa and 1000 MPa; swelling close to 0%, transparency in the near IR would be 
recommended, fulfillment of a hermetic barrier layer would be a plus). In this context, 
Kodeck et al already explored the use of PDMS (E-mod= ± 1 MPa), but due to ageing of the 
bulk material (the E-modulus increased as a function of time), further optimization is 
necessary. It can be noted that determination of the impact strength of the developed 
materials could also give valuable information. Indeed, upon impact, it should not break 
inside the body.  
 
In a third step, after encapsulation of the sensor compounds in the polymer packaging, the 
surface properties of the packaging material had to be tailored. Initial cell tests (see chapter 
2) showed that the bulk materials lack cell-interactivity. Since tissue encapsulation and 
vascularization around the sensor are required, excellent cell compatibility is needed. If inert 
materials would be selected, no cells or proteins would adhere in an in vivo setting and as a 
consequence, isolation of the implant from the body would be the result. This would also 
imply that no glucose would diffuse towards the sensor resulting in inaccurate glucose 
measurements. However, upon implantation of a sensor, a foreign body response will 
typically occur, associated with aspecific protein adsorption as well as random cell 
attachment. In the current work, we aimed at controlling this foreign body reaction by 
attracting the desired cell type, through surface biofunctionalization.  
Prior to biofunctionalization, activation of the surface (step 3 in figure 7.1 and chapter 3) had 
to be established, since no chemical functionalities were available to immobilize these bio-
molecules. To this end, two strategies were evaluated, including the deposition of a 
polydopamine (PDA) coating and the immobilization of 2-aminoethyl methacrylate (AEMA) 
via post-plasma grafting. For both PMMAPEG and PLMA, the conditions were optimized and 
for the latter hydrophobic material, the use of an O2 plasma treatment seemed beneficial to 
maximize PDA deposition. It was shown that the use of PDA resulted in homogenous and 
reproducible coatings, whereas for the AEMA grafting, this was not the case. In this 
perspective, the use of PDA could be considered as the most promising. Furthermore, the 
application of a nitrogen plasma as pre-activation step could also offer future opportunities, 
since preliminary experiments showed the presence of nitrogen groups (up to 7%) on the 
surface. If the subsequent immobilization of bio-active compounds such as VEGF or VE-cad 
AB would be enabled via this strategy, it would offer a reagent-less, less time-consuming and 
cheaper alternative. 
 
For the biofunctionalization of the materials (step 4 in figure 7.1 and chapter 4), different 
approaches were evaluated in an in vitro setting. In a first strategy, a universal modification 
strategy was developed to enhance the cell interactivity of polymer materials, via the 
anchorage of a thin gelatin layer onto the PDA modified substrates. The universal character 
was proven since increased cell densities and cellular focal adhesion points were observed 
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for both the PDA/gelatin modified PMMAPEG and PMMA samples. For the first material, this 
includes a remarkable result, since PEG is recognized as a protein-repellant and non cell-
interactive polymer, yet gelatin was able to mask these properties. Since cell-interactivity 
was established via the immobilization of a combined PDA/Gel B layer, first steps were taken 
to assure contact between the sensor and the surrounding body environment by means of 
tissue integration. The latter fact was however not proven in an in vivo setting and could be 
included in future experiments. In future research, the use of recombinant gelatin could also 
be explored, since it could offer enhanced immunological properties compared to bovine 
skin derived gelatin. 
During the course of this research, it was however realized that tissue integration as such 
would not suffice. In the end, blood glucose has to be supplied towards the sensor and as a 
consequence, angiogenesis should preferably be stimulated in the vicinity of the sensor. In 
this respect vascular endothelial growth factors (VEGF), vascular endothelial cadherin 
antibody (VE-cad AB) and their combinations were anchored onto the AEMA and PDA 
modified PMMAPEG and PLMA-based surfaces. In this work, successful immobilization was 
demonstrated and the number of focal adhesions, counted for each adhering HUVEC was 
the highest for the combination of VEGF and AB. Furthermore, in case PDA was used as 
activating sublayer, it was proven that the immobilization of both angiogenic factors resulted 
in a positive combined effect, as represented by the significantly increased cell adhesion 
properties of the materials. These results thus gave a first in vitro indication of successful 
and desired cell (i.e. HUVECs) attachment. Nevertheless, to prove the potentially stimulated 
angiogenesis, future experiments should be conducted. In this respect, the culture of 
endothelial progenitor cells (EPC) onto the substrates and the evaluation of their 
differentiation potential into mature endothelial cells could also provide valuable 
information. Furthermore, since in the in vivo environment, multiple cell types will be 
present, co-culture studies could also be conducted, e.g. in the presence of fibroblasts. The 
latter cell type secretes matrix components that could act as scaffold and enable endothelial 
cells (EC) to form tubules with a lumen. Furthermore, it has already been demonstrated that 
EC behave differently in a tubular structure in the presence of accessory cells such as 
pericytes and smooth muscle cells 3. It would thus be interesting to also include these cell 
types in future in vitro assays.  
 
Chapter 4 further demonstrated that part of the immobilized growth factors and antibodies 
were released over time. Extensive studies exploring the impact of this observation would be 
an interesting topic for future research. Indeed, the beneficial effect of a controlled and slow 
release of growth factors such as VEGF was already proven. Also in the present work, further 
elaboration on a method to render the release controllable, e.g. by the encapsulation of 
VEGF-containing microspheres inside the packaging material (see figure 7.2, B) could be 
promising. Furthermore, the in vivo lifetime of the biomolecules should be evaluated in 
detail. 
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As mentioned in step 4 of figure 7.1, prior to biofunctionalization, a sterilization step should 
be included to enable implantation of the sensor. In this work, the influence of sterilization 
was not included yet but its effect on the material properties should definitely be included in 
future research. The ethylene oxide sterilization process could influence the reactivity of the 
activation layers (i.e. PDA and AEMA) and thus the success of the biofunctionalization. 
Furthermore, in case of incomplete coverage of the material surface by the activation layer, 
the unmodified spots could also be characterized by altered surface properties and e.g. act 
as more hydrophilic substrates. This could increase the amount of aspecific adsorption of the 
biomolecules.   
 
In a last part of this work (chapter 5), a selection of the developed (un-)modified materials as 
well as the glucose sensor concept were evaluated in an in vivo environment.  
Herein, blank, PDA and PDA/VE-cad AB modified PMMAPEG samples were implanted in 
goats. The most promising condition, i.e. the combined immobilization of VEGF and AB, was 
not included in this study, because it was only developed at the end of this PhD. It was 
observed that subcutaneous implantation resulted in the development of a fibrous capsule 
around all of the donut-shaped implants. The highest mean capillary formation around the 
implant was found for the PDA/VE-cad AB functionalized samples, although no statistical 
evidence could be delivered. Since the evaluation of capillary formation is rather 
complicated on 2 D surfaces, future experiments could focus on alternative test approaches. 
These could include the chorioallantoic membrane assay (CAM) in a chicken embryo, which 
is a low cost and more straightforward method compared to mammalian models. 
Furthermore, this test could be used to further evaluate the impact of material optimization 
(e.g. concentration of VEGF, AB,…) onto the process of angiogenesis. Other in vivo models 
include implantation in the avascular cornea of rabbits or the dorsal skinfold chamber.  
Nevertheless, for all of these assays, porous material structures are required. In this work, 
preliminary tests have been performed with porous PCL scaffolds which were surface-
treated with the PDA/VE-cad AB coating and it was demonstrated that enhanced 
vascularization and a decreased thickness of the fibrous capsule was formed compared to 
the unmodified PCL samples after implantation in rats.  Furthermore, the use of a  porous 
structure also seemed to have a positive influence on the results (i.e. decreased thickness of 
the fibrous capsule and an increased number of blood vessels). The future glucose sensor 
concept could thus consider the use of such a porous polymer structure (see figure 7.2). 
Finally, future research could also focus on the evaluation of potential tumor formation. 
Since tumor formation is characterized by the process of uncontrolled angiogenesis, 
angiogenesis around the glucose sensor should occur in a controlled manner, without 
rendering it pathological. To initiate this cancerous state, preneoplastic cells should be 
maintained in the vicinity of the sensor. These cells would be an interesting marker to 
include in future assays. Nevertheless, it should also be emphasized that the rarity of human 
foreign body associated tumors suggests that cancer-prone cells are rather infrequently 
associated with the foreign body reactions towards implanted human medical devices 4. 
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During the in vivo experiments, the sensor design was also evaluated. It was concluded that 
glucose measurements through tissue via an optical fiber setup was impossible. As a 
consequence, coverage of the central cavity of the donut shaped sensor with a membrane 
was necessitated. Since biofouling of the applied  PES membrane was demonstrated as well 
as its slow diffusion kinetics, further improvements should be considered during future 
work. Furthermore, an improved or adjusted assembly of the different sensor compounds 
should be investigated, as already discussed earlier in the current chapter.  
For future in vivo experiments, goats could still be used as a representative animal model, 
especially in case the evaluation of the final glucose sensor is pursued. Nevertheless, for 
further optimization concerning polymer selection and  biofunctionalization strategies, 
normal and diabetic rats would be preferred as they enable a faster screening. 
 
Based on all previous considerations, a first indication for a future assembly of the 
evanescent glucose sensor is indicated in figure 7.2 (A). Herein, the impermeable layer could 
represent a parylene C coating or an ALD layer. From a technical perspective, future 
challenges include the incorporation of the membrane into the polymer packaging as well as 
ensuring  good adhesion between the polymer and the impermeable layer. 
 
  
 
                
Figure 7.2: The future sensor concept as proposed by Ryckeboer et al 2 (A) and the adjusted version 
based on the performed research (B). 
 
B 
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If the above mentioned conclusions would be integrated, the sensor concept could be 
adjusted according to figure 7.2 (B). Herein, the sensor components are again coated with an 
impermeable ALD layer, followed by their incorporation into a porous PLMA scaffold. Herein 
the scaffold could be modified with VE-cad AB (and/or VEGF) and could incorporate VEGF-
loaded microparticles to enable their controlled release. This approach would be technically 
more challenging, since the application of a porous polymer packaging would ask for more 
advanced techniques such as 3D printing. The latter technique would also require alternative 
production methods for the PLMA starting material. Also in this case, integration of the 
membrane and sufficient adhesion properties of the different layers could pose some 
difficulties.  
 
It can be concluded that first steps were taken in the development of an implantable glucose 
sensor packaging. Furthermore, new challenges are identified and could be the topic of 
promising forthcoming research.  
 
 
7.2. Future opportunities 
Apart from their application as glucose sensor packaging, some of the developed materials 
could also be considered as stent coating material. In this area of research, there is still a 
need for new coatings that cover the stent before and after expansion and which are able to 
reduce thrombosis and restenosis, once implanted in the human vein 5-7.  
In this respect, some of the non-crosslinked, PEG based materials (cfr. chapter 2, table 2.3) 
offer great potential due to their high elongation percentages (up to 600%). Preliminary 
tests1 already showed a uniform coverage of the stent by dipcoating it in a polymer solution. 
Figure 7.3 clearly shows how the stent’s surface topography disappears after coating with a 
PEG-based material. Nevertheless, further optimization is required (cfr. concentration of the 
polymer solution, speed of dipcoating, solvent choice, etc.) to control and optimize the layer 
thickness and to avoid an excess of material in the stent bridges (indicated by the circle in 
figure 7.3).   
Concerning the biocompatibility of the stent, re-endothelialization of the outer side of the 
stent is required and as a consequence, the application of the above-described 
biofunctionalization strategies (VEGF, AB immobilization) could also be applied in this case.  
On the other hand, the inner side of the stent contacts the blood stream, so a protein-
repellant coating should ideally be applied in order to avoid thrombosis and restenosis of the 
stent. In this respect, the non-modified PEG-materials could also be examined, because 
based on this work and other studies, the anti-biofouling character of PEG has already been 
demonstrated.  
 
                                                          
1
 In cooperation with Matthieu De Beule, from the Faculty of Engineering and Architecture, Department of 
Electronics and Information Systems. 
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Figure 7.3: A stainless steel stent was coated with a polymer layer consisting of 94 mol% MMA and 
6 mol% PEGMA(1100) (i.e. material 6 in chapter 2), via dipcoating (50 mm/min) from a polymer 
solution (5 wt% in THF). 
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8.1. Inleiding 
Uit cijfers van de internationale diabetes federatie (IDF) bleek dat er wereldwijd in 2013 
meer dan 382 miljoen mensen leden aan diabetes en er wordt verwacht dat dit aantal zal 
verdubbelen tegen 2035 1. Diabetes is een ziekte die gekenmerkt wordt door een afwijkende 
glucose huishouding. Bij een gezonde patiënt zullen te hoge bloed glucose waarden 
(hyperglycemie) bestreden worden door de aanmaak van insuline, maar in het geval van 
diabetici is het lichaam ofwel niet in staat insuline aan te maken (diabetes type I) of niet in 
staat om adequaat te reageren op de aanmaak van dit hormoon (diabetes type II) 2. Het is 
een niet-geneesbare ziekte, maar het is reeds bewezen dat een strikte en continue opvolging 
van de bloed glucose waarden zou resulteren in gereduceerde medische kosten doordat de 
patiënt in staat zou zijn om normale glucose waarden te handhaven, wat verder ook de kans 
op complicaties (zoals oog-, nier-, zenuw- en vasculaire ziekten) doet verminderen. Het 
spreekt voor zich dat de ontwikkeling van glucosesensoren bij diabetes management een 
cruciale rol speelt. 
 
Vandaag de dag bestaat er reeds een hele reeks glucosesensoren die zeer stabiel, accuraat 
en gevoelig zijn in vitro, maar indien implantatie wordt beoogd om continue monitoring toe 
te laten, daalt hun betrouwbaarheid en stabiliteit dramatisch na een aantal dagen als gevolg 
van o.a. aspecifieke proteïne-adhesie 3.  
In het kader van huidig doctoraatswerk werd een glucose sensor ontwikkeld, bestaande uit 
een ‘single chip’ optische, nabij infrarood (NIR) gebaseerde sensor, die een ‘silicon 
photonics’ geïntegreerde spectrometer bevat, alsook een NIR lichtbron, met als doel lange-
termijn en continue opvolging van glucose mogelijk te maken. Het principe van de sensor 
wordt geïllustreerd in figuur 8.1 en komt neer op de detectie van glucose in de centrale 
opening van het donut-vormig implantaat.  
 
  
 
Figuur 8.1: NIR-gebaseerde glucose sensor, die verpakt is in een donutvormig biocompatibel 
polymeermateriaal. 
Aangezien de implantatie van de sensor beoogd wordt, is er nood aan de ontwikkeling van 
een flexibele en biocompatibele verpakking, wat het uiteindelijke doel vormt van huidig 
doctoraatswerk. 
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8.2. Ontwikkeling van een methacrylaat-gebaseerd verpakkingsmateriaal 
Voor de ontwikkeling van het verpakkingsmateriaal werd uitgegaan van poly(methyl 
methacrylaat) (PMMA), een materiaal dat gekarakteriseerd wordt door zijn 
biocompatibiliteit. In het verleden werd het reeds aangewend voor meerdere biomedische 
toepassingen zoals lenzen, heup-, bot-, en tandimplantaten 4-6. Aangezien de subcutane 
implantatie van het verpakkingsmateriaal beoogd wordt, is een zekere flexibiliteit van de 
verpakking vereist om het comfort van de patiënt te verzekeren. Bovendien is een beperkte 
zwelling van de verpakking nodig om delaminatie van de verpakking en de sensor 
componenten te vermijden. Bijgevolg werden verschillende MMA-bevattende copolymeren 
geproduceerd via een UV-geïnduceerde fotopolymerisatie (zie figuur 8.2) met behulp van 
Irgacure® 2959 of 651 als foto-initiator. De bekomen materialen werden geëvalueerd voor 
hun mechanische en zweleigenschappen.  
 
Figuur 8.2: UV-polymerisatie set-up. In de originele opstelling werd ook teflon aangebracht op de 
glasplaten om het polymeer vlot te kunnen verwijderen.  
 
In een eerste strategie werd MMA gecombineerd met proteïnen afstotende poly(ethyleen 
glycol) gebaseerde reagentia, waaronder poly(ethyleen glycol) monomethylether 
monomethacrylaat (PEGMA) en poly(ethyleen glycol) dimethacrylaat (PEGDMA). Door het 
moleculair gewicht van de PEG keten te variëren alsook de samenstelling van het polymeer, 
werd een reeks polymeren gesynthetiseerd met uiteenlopende mechanische (E-moduli 
variërend van 10 tot 1600 MPa) en zwellingseigenschappen (zwellingspercentages variërend 
van 2 tot 250%). Het beste compromis tussen mechanische eigenschappen en zwelling werd 
vertoond door PMMAPEG, bestaande uit 50 mol% MMA en 50 mol% PEGDMA(550). 
Bijgevolg werd dit materiaal als eerste kandidaat verpakkingsmateriaal geselecteerd.   
 
In een tweede strategie werd een hydrofoob materiaal ontwikkeld, bestaande uit 55.5 mol% 
MMA, 45.5 mol% lauryl methacrylaat (LMA) and 5 mol% PEGDMA(550). Ten opzichte van de 
PEG-gebaseerde materialen werd een nog lagere E-modulus (6 MPa) bereikt, alsook een 
verwaarloosbare zwelling (0.6%) (zie figuur 8.3). Bijgevolg werd dit materiaal (PLMA) als 
tweede kandidaat geselecteerd. Voor deze laatste kan er nog opgemerkt worden dat de 
keuze van initiator (Irgacure®2959 versus Irgacure® 651) geen significante invloed had op de 
mechanische of zwellingseigenschappen van het uiteindelijke materiaal. Desalniettemin 
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werd deze variabele meegenomen om zijn invloed na te gaan op de oppervlakmodificatie 
resultaten.  
 
 
Figuur 8.3: Weergave van een typische trek-rek curve (links) alsook de zwellingseigenschappen van 
de geselecteerde materialen PMMAPEG en PLMA (rechts). PMMA fungeerde als referentie. 
 
Additionele testen toonden aan dat beide materialen voldoende optische transparantie in 
het NIR golflengtegebied vertoonden en een minimale celtoxiciteit (< 30%). Daarentegen 
vormden zij geen voldoende diffusiebarrière om corrosie van de onderliggende electronica 
tegen te gaan, wat impliceert dat in het finale sensor concept, een additionele coating, zoals 
paryleen C, zal moeten worden aangewend.   
  
 
8.3. Activatie van de polymeeroppervlakken 
In een tweede luik van dit onderzoek werd de focus gelegd op de optimalisatie van de 
biocompatibiliteit van de materialen door het uitvoeren van oppervlakmodificaties. Om 
biofunctionalisatie mogelijk te maken, dienen de inerte materiaaloppervlakken in eerste 
instantie geactiveerd te worden, wat betekent dat functionele, reactieve groepen ingevoerd 
worden. 
In dit werk werden twee ‘activatie-routes’ verkend, waaronder de ‘post-plasma grafting’ van 
2-aminoethyl methacrylaat (AEMA) en de depositie van een polydopamine (PDA) laag.  
In geval van ‘AEMA grafting’ werden twee opeenvolgende stappen uitgevoerd. De eerste 
stap omvatte een plasmabehandeling m.b.v. Ar gas. Hierdoor werd in de tweede stap, de 
UV-geïnduceerde grafting van AEMA mogelijk gemaakt (zie figuur 8.4). De bekomen 
resultaten illustreren dat plasma behandeling een sterke daling van de contacthoek tot 
gevolg had, doordat zuurstof bevattende functionaliteiten ingevoerd werden op het 
oppervlak. Verder toont figuur 8.4 de succesvolle grafting van AEMA aan door de 
aanwezigheid van een stikstofpiek, bepaald via X-stralen foto-electron spectroscopie (XPS), 
alsook door een stijging van de contacthoek t.o.v. de plasma behandelde stalen. Aangezien 
geen significant verschil werd aangetoond tussen de twee PLMA gebaseerde materialen, 
werd PLMA(651) geëlimineerd uit de vervolgstudie. 
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Figuur 8.4: Schematische voorstelling van de ‘post-plasma grafting’ techniek van AEMA. De 
contacthoeken van de blanco, Ar-plasma behandelde en AEMA gecoate stalen worden 
weergegeven, alsook de atomaire stikstof percentages en N/C verhoudingen van de AEMA 
behandelde stalen. Condities die significante verschillen opleverden zijn aangeduid d.m.v. 
dezelfde letters a,b,c,… 
 
In geval van PDA modificatie werden verschillende depositie protocols geëvalueerd en op 
basis van XPS metingen bleek het klassieke protocol van Messersmith et al 7, de pioniers van 
deze strategie, het meest effectief te zijn voor PMMA en PMMAPEG modificatie. Voor de 
PLMA materialen bleek de combinatie van dit protocol met een voorafgaande O2 plasma 
behandeling te resulteren in verhoogde PDA depositie. De succesvolle modificatie werd 
aangetoond via verschillende technieken zoals statische contacthoekmetingen (SCA; daling 
van CA na PDA coating), XPS (verhoogd N%), ‘raster elektronen microscopie’ (SEM; 
aanwezigheid van clusters) en ‘atomaire kracht microscopie’ (AFM; invloed op oppervlak 
ruwheid). De belangrijkste resultaten zijn samengevat in figuur 8.5. 
 
Door de aanwezigheid van de oppervlakfunctionaliteiten kon er in een volgende stap 
overgegaan worden naar biofunctionalisatie van de materialen. Hierbij werden biologisch 
actieve componenten geïntroduceerd op het materiaaloppervlak, met het oog op het sturen 
van de celrespons en de uiteindelijke lichaamsrespons. 
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Figuur 8.5: Overzicht van de contacthoeken van de blanco materialen en de PDA gecoate 
materialen (links). In de SEM-figuren (rechts) zijn de PDA clusters zichtbaar (vbn. aangeduid door 
cirkels). Bovendien bewijzen de verhoogde stikstof percentages het succes van deze 
modificatiestap.  
 
 
8.4. Biofunctionalisatie van de verpakkingsmaterialen en hun in vitro 
evaluatie 
In een eerste stap werd een universele modificatiemethode ontwikkeld om de 
celinteractiviteit van implantaten te verhogen. Hiervoor werd gelatine geïmmobiliseerd op 
de PDA gefunctionaliseerde PMMA en PMMAPEG oppervlakken. Succesvolle immobilisatie  
werd aangetoond m.b.v. XPS (N% tot 10 %) en SCA (daling in CA van 20-30° t.o.v. PDA 
modificatie). In vitro celtesten hebben verder aangetoond dat de applicatie van enkel PDA 
niet in staat is om de proteïne-afstotende eigenschappen van PEG te maskeren. De 
combinatie van PDA en GelB daarentegen resulteerde in hoge celdensiteiten voor zowel 
PMMA als PMMAPEG, alsook in een hoog aantal focale adhesiepunten, wat 
verankeringspunten zijn van de cel met het substraat (zie figuur 8.6).  
 
 
Figuur 8.6: PMMAPEG wordt gekarakteriseerd door een proteïne-afstotend karakter. PDA 
immobilisatie resulteerde in een onvoldoende maskering van deze materiaaleigenschap, terwijl de 
combinatie van PDA/GelB resulteerde in hoge celdensiteiten en een groot aantal focale 
adhesiepunten (groen). 
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Bij vergelijken van een reeks PEG-gebaseerde materialen met verschillende mechanische 
eigenschappen, werden opnieuw gelijkaardige celresponsen verkregen. Dit wijst er op dat de 
combinatie van PDA en GelB in staat is om materialen met verschillende fysicochemische 
eigenschappen te laten resulteren in een gelijkaardige celrespons.  
 
In het kader van de glucose sensor zou de in vivo stimulatie van angiogenese, of dus het 
proces van bloedvatvorming, een gunstig effect hebben op de werking van de sensor 8. 
Voldoende bloedvaten zouden immers de diffusie van glucose toelaten naar de sensor, wat 
nodig is om representatieve glucosemetingen te garanderen.  
In deze context werd de immobilisatie van een vasculaire endotheliale groeifactor (VEGF) 9 
en/of vasculair endotheliaal cadherine antilichaam (VE-cad AB) 10 op de AEMA en PDA 
gefunctionaliseerde oppervlakken bestudeerd. 
Succesvolle immobilisatie werd bevestigd m.b.v. radiolabeling experimenten en XPS. ‘Live 
dead assays’ met ‘humane vasculaire endotheliale navel cellen’ (HUVECs), een van de 
celtypes waaruit een bloedvat is opgebouwd, toonden aan dat de aanwezigheid van VEGF, 
AB of beide aanleiding gaf tot verhoogde celdensiteiten, celviabiliteiten, alsook tot een 
verhoogde celadhesie (bepaald via telling van de focale adhesiepunten) en dit voor beide 
activatiestrategieën (i.e. PDA versus AEMA functionalisatie). Uit de resultaten bleek dat de 
AB geïmmobiliseerde stalen aanleiding gaven tot een betere celinteractiviteit, hoewel 
significante verschillen niet aangetoond konden worden. Het meest markante resultaat werd 
geleverd indien beide factoren (AB en VEGF) samen geïmmobiliseerd werden op het 
oppervlak. Deze conditie resulteerde in significant hogere adhesieresultaten t.o.v. de 
individuele immobilisatie van de factoren (zie figuur 8.7). VEGF en VE-cad AB vertoonden dus 
een gezamenlijk effect op de celrespons. 
  
 
Figuur 8.7: Immuno-assay studies toonden aan dat er een gecombineerd effect bestaat tussen 
VEGF en VE-cad AB, hetgeen weerspiegeld werd door een significant hogere adhesie (= hoger 
aantal focale adhesiepunten, voorgesteld door de groene kleuring) t.o.v. de individuele factor 
immobilisatie.    
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8.5. In vivo evaluatie van de methacrylaat gebaseerde glucose sensor 
verpakkingen  
In een laatste deel van dit werk, werden een aantal in vivo experimenten uitgevoerd in 
geiten en ratten. Om de productie van donut-vormige ‘dummy’ sensoren mogelijk te maken, 
werd een mal ontwikkeld die tevens de incorporatie van optische vezels toeliet. 
Implantatie van deze dummy sensoren (zonder optische vezels) bevestigde dat subcutane 
implantatie bevoordeligd werd t.o.v. intramusculaire of intraperitoneale implantatie. Verder 
werd aangetoond dat de blanco stalen aanleiding gaven tot de vorming van een zeer dens 
fibreus kapsel, terwijl de gemodificeerde stalen (zowel PDA als PDA/VE-cad AB 
gemodificeerde stalen) aanleiding gaven tot de vorming van een dikker, maar minder dens 
fibreus weefselkapsel. Verder werd in het geval van VE-cad AB modificatie een hoger aantal 
capillairen geteld in de nabijheid van de sensor, hoewel significante verschillen met de 
blanco en PDA gemodificeerde stalen niet konden worden aangetoond. Wanneer 
gelijkaardige oppervlakmodificaties uitgevoerd werden op een poreuze poly(ε-caprolacton) 
(PCL) matrix, resulteerde VE-cad AB immobilisatie daarentegen in de afwezigheid van een 
fibreus kapsel, maar in een sterke vascularisatie, zelfs tot aan de rand van het implantaat (zie 
figuur 8.8, C). Dit laatste resultaat illustreerde duidelijk de toegevoegde waarde van 
porositeit van het verpakkingsmateriaal op de stimulatie van angiogenese 11. 
                                    
 
Figuur 8.8: Fibreus kapsel gevormd rondom blanco sensoren (43 µm dik) (A), PDA en PDA/AB 
gemodificeerde sensoren (191 µm dik) (B) en poreuze PDA/AB gemodificeerde PCL scaffolds (C). In 
figuur C worden de capillairen, gevormd aan de rand van de scaffold, aangeduid met pijlen. 
 
Naast evaluatie van de oppervlakmodificaties, werd het huidige glucose sensor concept 
getest door implantatie van ‘dummy’ sensoren in geiten. Hierbij werden optische vezels, die 
verbonden waren met een externe laser en spectrometer, geïncorporeerd in het donut-
vormige verpakkingsmateriaal. Uit deze implantatiestudie bleek dat de mechanische 
stabiliteit van de meeste sensoren onvoldoende was. Voor een aantal sensoren kon een 
transmissiespectrum opgemeten worden, maar door optische verliezen bleek transmissie 
doorheen weefsel niet de beste optie te zijn. Bedekking van de centrale opening met een 
polyethersulfon (PES) membraan liet meer stabiele optische metingen toe, hoewel de 
signalen nog steeds te variabel waren om een multivariabele analyse van de spectra uit te 
voeren.  
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Uit in vitro analyse van de geïmplanteerde membraan donuts bleek dat verdere optimalisatie 
van het membraan-donut concept nodig was. Hierbij dient verder aandacht besteed te 
worden aan de montage van de verschillende sensor onderdelen, alsook aan de bestrijding 
van ‘biofouling’ van het membraanoppervlak.  
 
 
8.6. Conclusie  
In dit doctoraatswerk werd een methacrylaat-gebaseerde flexibele verpakking ontwikkeld 
voor een optische glucose sensor. Naast het optimaliseren van de bulkeigenschappen, werd 
de sensor-weefsel ‘interface’ gefinetuned d.m.v. oppervlakactivatie en biofunctionalisatie. 
Uitvoeren van deze strategie resulteerde in een verbeterde in vitro celrespons, maar in vivo 
overheerste naast bloedvatvorming vooral de vorming van een fibreus kapsel. Toekomstig 
onderzoek zou in dit geval vooral kunnen focussen op de combinatie van de ontwikkelde 
oppervlakchemieën met een poreus verpakkingsmateriaal. Verder werden de eerste stappen 
genomen naar een functionele implanteerbare glucose sensor, niettegenstaande verdere 
optimalisatie van de sensor assemblage noodzakelijk is. 
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